0001140361-14-041016.txt : 20141110 0001140361-14-041016.hdr.sgml : 20141110 20141110170105 ACCESSION NUMBER: 0001140361-14-041016 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20140930 FILED AS OF DATE: 20141110 DATE AS OF CHANGE: 20141110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VirnetX Holding Corp CENTRAL INDEX KEY: 0001082324 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 770390628 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33852 FILM NUMBER: 141209516 BUSINESS ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 BUSINESS PHONE: (831) 438-8200 MAIL ADDRESS: STREET 1: 308 DORLA COURT STREET 2: SUITE 206 CITY: ZEPHYR COVE STATE: NV ZIP: 89448 FORMER COMPANY: FORMER CONFORMED NAME: PASW INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: PACIFIC SOFTWORKS INC DATE OF NAME CHANGE: 19990322 10-Q 1 form10q.htm VIRNETX HOLDING CORPORATION 10-Q 9-30-2014

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2014
Or

  o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-33852


VirnetX Holding Corporation
(Exact name of registrant as specified in its charter)

Delaware
 
77-0390628
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification Number)

308 Dorla Court, Suite 206
   
Zephyr Cove, Nevada
 
89448
(Address of principal executive offices)
 
(Zip Code))

Registrant’s telephone number, including area code: (775) 548-1785

Former name, former address and former fiscal year, if changed since last report:

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):

Large accelerated filer x
Accelerated filer o
Non-accelerated filer o
Smaller reporting company o
   
(Do not check if a smaller reporting company)
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x

The number of shares outstanding of the Registrant’s Common Stock as of November 3, 2014, was 51,996,701.

 

VIRNETX HOLDING CORPORATION
INDEX
   
Page
1
 
1
 
1
 
2
 
2
 
3
 
4
 
13
 
17
 
18
19
 
19
 
Item 1A —Risk Factors
21
 
Item 6 —Exhibit
28
29
30
 
PART I — FINANCIAL INFORMATION

ITEM 1. - FINANCIAL STATEMENTS.

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)

   
September 30,
2014
   
December 31,
2013
 
   
(Unaudited)
     
ASSETS
       
Current assets:
       
Cash and cash equivalents
 
$
8,498
   
$
19,173
 
Investments available for sale
   
15,939
     
19,815
 
Prepaid expenses - current
   
759
     
357
 
Total current assets
   
25,196
     
39,345
 
Prepaid expenses - non-current
   
3,240
     
 
Property and equipment, net
   
52
     
53
 
Total assets
 
$
28,488
   
$
39,398
 
LIABILITIES AND STOCKHOLDERS' EQUITY
               
Current liabilities:
               
Accounts payable and accrued liabilities
 
$
2,429
   
$
1,748
 
Income tax liability
   
395
     
395
 
Deferred revenue, current portion
   
1,375
     
667
 
Derivative liability
   
431
     
2,564
 
Total current liabilities
   
4,630
     
5,374
 
                 
Deferred revenue, non-current portion
   
1,000
     
 
                 
Commitments and contingencies
   
     
 
                 
Stockholders' equity:
               
Preferred stock, par value $0.0001 per share
               
Authorized: 10,000,000 shares at September 30, 2014, and December 31, 2013, Issued and outstanding: 0 shares at September 30, 2014 and December 31, 2013
   
     
 
Common stock, par value $0.0001 per share
               
Authorized: 100,000,000 shares at September 30, 2014 and December 31, 2013, Issued and outstanding: 51,573,476 shares at September 30, 2014, and 51,236,141 shares at December 31, 2013
   
5
     
5
 
Additional paid in capital
   
130,625
     
124,589
 
Accumulated deficit
   
(107,760
)
   
(90,533
)
Accumulated other comprehensive loss
   
(12
)
   
(37
)
Total stockholders' equity
   
22,858
     
34,024
 
Total liabilities and stockholders' equity
 
$
28,488
   
$
39,398
 

See accompanying notes to condensed consolidated financial statements.
 
1

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in thousands, except per share amounts)
 
   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
2014
   
September 30,
2013
   
September 30,
2014
   
September 30,
2013
 
Revenue
 
$
292
   
$
1,612
   
$
809
   
$
1,911
 
Operating expense:
                               
Research and development
   
374
     
316
     
1,066
     
1,002
 
Selling, general and administrative expenses
   
6,168
     
6,429
     
19,119
     
22,150
 
Total operating expense
   
6,542
     
6,745
     
20,185
     
23,152
 
Loss from operations
   
(6,250
)
   
(5,133
)
   
(19,376
)
   
(21,241
)
Gain (loss) on change in value of derivative liability
   
1,817
     
(48
)
   
2,126
     
1,438
 
Interest and other income (expense), net
   
(35
)
   
47
     
25
     
105
 
Loss before taxes
   
(4,468
)
   
(5,134
)
   
(17,225
)
   
(19,698
)
Income tax expense
   
     
     
(2
)
   
(356
)
Net loss
 
$
(4,468
)
 
$
(5,134
)
 
$
(17,227
)
 
$
(20,054
)
Basic and diluted loss per share
 
$
(0.09
)
 
$
(0.10
)
 
$
(0.33
)
 
$
(0.39
)
Weighted average shares outstanding basic and diluted
   
51,572
     
51,203
     
51,454
     
51,178
 
 
VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)
(in thousands)

   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
2014
   
September 30,
2013
   
September 30,
2014
   
September 30,
2013
 
Net loss
 
$
(4,468
)
 
$
(5,134
)
 
$
(17,227
)
 
$
(20,054
)
Other comprehensive loss, net of tax:
                               
Change in equity adjustment from foreign currency translation, net of tax
   
     
     
     
(12
)
Change in unrealized gain (loss) on investments, net of tax
   
45
     
(31
)
   
25
     
(35
)
     
45
     
(31
)
   
25
     
(47
)
Comprehensive loss
 
$
(4,423
)
 
$
(5,165
)
 
$
(17,202
)
 
$
(20,101
)

See accompanying notes to condensed consolidated financial statements.
 
2

VIRNETX HOLDING CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in thousands)

   
Nine Months
Ended
September 30,
2014
   
Nine Months
Ended
September 30,
2013
 
Cash flows from operating activities:
       
Net loss
 
$
(17,227
)
 
$
(20,054
)
Adjustments to reconcile net loss to net cash used in operating activities:
               
Depreciation and amortization
   
18
     
30
 
Stock-based compensation
   
5,952
     
5,454
 
Change in value of derivative liability
   
(2,126
)
   
(1,438
)
Changes in assets and liabilities:
               
Deferred revenues
   
1,708
     
916
 
Prepaid taxes
   
     
14,963
 
Prepaid expenses and other current assets
   
(402
)
   
(369
)
Prepaid expenses non-current
   
(3,240
)
   
 
Accounts payable and accrued liabilities
   
681
     
(1,361
)
Net cash used in operating activities
   
(14,636
)
   
(1,859
)
Cash flows from investing activities:
               
Purchase of property and equipment
   
(17
)
   
(7
)
Purchase of investments
   
(11,928
)
   
(69,120
)
Proceeds from sale or maturity of investments
   
15,829
     
72,244
 
Net cash provided by investing activities
   
3,884
     
3,117
 
Cash flows from financing activities:
               
Proceeds from exercise of options
   
68
     
29
 
Proceeds from exercise of warrants
   
9
     
 
Net cash provided by financing activities
   
77
     
29
 
Net increase (decrease) in cash and cash equivalents
   
(10,675
)
   
1,287
 
Cash and cash equivalents, beginning of period
   
19,173
     
19,661
 
Cash and cash equivalents, end of period
 
$
8,498
   
$
20,948
 

See accompanying notes to condensed consolidated financial statements.
 

3

VIRNETX HOLDING CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(Unaudited)

Note 1 — Business Description and Basis of Presentation

We develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.

Our portfolio of intellectual property is the foundation of our business model.  We currently own approximately 36 U.S. and 66 foreign patents with approximately 75 pending patent applications worldwide.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Mobile-to-Mobile (M2M) communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S. and foreign patents relates generally to securing communication over the internet. Given the subject matter and the relatedness of our various patents and pending applications, we generally disclose them as a collection rather than listing them separately. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation (now Leidos, Inc.) in 2006 and we are required to make payments to Leidos, Inc. based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.

We intend to continue to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will continue to use these rates and guidelines in all future license negotiations.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and M2M communications in areas including Smart City, Connected Car and Connected Home.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos.  Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos and expanded the set of patents we acquired in 2006 from Leidos into a larger portfolio which now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.
 

4

We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.

Note 2 – Summary of Significant Accounting Policies

Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC’s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and nine month periods ended September 30, 2014 and 2013; (ii) the condensed consolidated statements of comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013; (iii) the condensed consolidated balance sheets at September 30, 2014 and December 31, 2013; and (iv) the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2014 and 2013. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated balance sheet, included in this report, as of December 31, 2013 was derived from our 2013 audited financial statements, but does not include all disclosures required by U.S. GAAP.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered into upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

· Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
 

5

· Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
 
· Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term.  For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but not in advance of collection.
 
· Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.

Deferred revenue

In August 2013 we began receiving annual payments on a contract with a total value over 5 years of $10,000.  From the inception of that license to September 30, 2014, we received a total of $5,000 ("August 2013 Contract Settlement"), all of which is non-refundable.  We recognized $292 and $792 of revenue related to these payments in the three and nine-month periods ended September 30, 2014, respectively.
 
During the three month period ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses. Revenues for historical royalties were estimated based on estimated past and future usage of our IP on our customer's products. No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
   
For the nine months ended September 30, 2013, we recognized royalty revenue of $1,911. In addition to revenue recognized under the August 2013 Contract Settlement described above, we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 7 - Litigation). These revenues relate to both payment for use of our patented technology prior to the signing of a license agreements and royalty payments after the execution of the license agreement; no amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
    
During 2014, activity under the August 2013 Contract Settlement was as follows:
   
Deferred Revenue, December 31, 2013
 
$
667
 
Payment received
   
2,500
 
Less: Amount amortized as revenue
   
(792
)
Deferred Revenue, September 30, 2014
 
$
2,375
 

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the nine months ended September 30, 2014 we had funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Derivative Instruments

Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.

Impairment of Long-Lived Assets

On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
 
6

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual Funds: Valued at the quoted net asset value (NAV) of shares held.

Corporate, Municipal and U.S. Agency Securities:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for September 30, 2014, included a warrant exercise price of $3.59 per share, a common share price of $6.00, discount rate of 1.78%, and a volatility of 90.28%. The assumptions used for December 31, 2013, were a warrant exercise price of $3.59 per share, a common share price of $19.41, a discount rate of 1.75%, and a volatility of 91.55%. The expiration date of the warrants is March 2015.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.

   
September 30, 2014
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
4,119
   
$
-
   
$
-
   
$
4,119
   
$
4,119
   
$
-
 
                                                 
Level 1:
                                               
Mutual funds
   
112
     
-
     
-
     
112
     
112
     
-
 
Corporate securities
   
8,607
     
2
     
(3
)
   
8,606
     
-
     
8,606
 
Municipal securities
   
691
     
-
     
-
     
691
     
-
     
691
 
U.S agency securities
   
10,908
     
2
     
(1
)
   
10,909
     
4,267
     
6,642
 
     
20,318
     
4
     
(4
)
   
20,318
     
4,379
     
15,939
 
Total
 
$
24,437
   
$
4
   
$
(4
)
 
$
24,437
   
$
8,498
   
$
15,939
 

   
December 31, 2013
 
   
Adjusted
Cost
   
Unrealized
Gains
   
Unrealized
Losses
   
Fair
Value
   
Cash
and Cash
Equivalents
   
Investments
Available
for Sale
 
Cash
 
$
11,699
   
$
-
   
$
-
   
$
11,699
   
$
11,699
   
$
-
 
                                                 
Level 1:
                                               
Mutual funds
   
73
     
-
     
-
     
73
     
73
     
-
 
Corporate securities
   
10,782
     
-
     
-
     
10,782
     
2,325
     
8,457
 
Municipal securities
   
2,173
     
-
     
-
     
2,173
     
665
     
1,508
 
U.S agency securities
   
14,287
     
-
     
(25
)
   
14,262
     
4,411
     
9,851
 
     
27,315
     
-
     
(25
)
   
27,289
     
7,474
     
19,815
 
Total
 
$
39,014
   
$
-
   
$
(25
)
 
$
38,988
   
$
19,173
   
$
19,815
 
 
7

The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.

 
September 30, 2014
 
 
Quoted
Prices in
Active
Markets for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
   
  (Level 1) (Level 2) (Level 3)
Total
Series l Warrants
 
$
   
$
   
$
431
     
431
 
Total
 
$
   
$
   
$
431
     
431
 

 
December 31, 2013
 
 
Quoted
Prices in
Active
Markets for
Identical
Assets
 
Significant
Other
Observable
Inputs
 
Significant
Unobservable
Inputs
   
  (Level 1) (Level 2) (Level 3)
Total
Series l Warrants
 
$
   
$
   
$
2,564
   
$
2,564
 
Total
 
$
   
$
   
$
2,564
   
$
2,564
 

The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.

   
Nine Months Ended
September 30, 2014
     
Nine Months Ended
September 30, 2013
 
   
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
     
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2013
 
$
2,564
 
Balance December 31, 2012
 
$
4,172
 
Gain on derivative liability included in net loss
   
(2,126
)
Gain on derivative liability included in net loss
   
(1,438
)
Settlements
   
(7
)
Settlements
   
 
Balance September 30, 2014
 
$
431
 
Balance September 30, 2013
 
$
2,734
 
 
8

New Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, “Presentation of Financial Statements – Going Concern, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.”  The amendments in this Update apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of  consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).  The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.
 
In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

In May 2014, the FASB issued (ASU) No. 2014-09 "Revenue from Contracts with Customers" (Topic 606).  Topic 606 supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.  In addition, the amendments create a new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers.  In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.  We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed.  The standard became effective for us on January 1, 2014 and had no material effect on our financial position or results of operations when implemented.

Note 3 - Income Taxes

We had no income tax expense for the three months ended September 30, 2014.  The income tax expense for the nine months ended September 30, 2014 was $2 related to minimum tax payments.  During the three and nine month periods ended September 30, 2014, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $2,100 and $6,200 for the three and nine months ended September 30, 2014, respectively.

There was no income tax expense for the three months ended September 30, 2013. The income tax expense for the nine months ended September 30, 2013 was $356, which was a negative effective income tax rate of 2 percent.  As a result of NOLs during the periods, the income tax expense for the nine months ended September 30, 2013 reflected only a prior year change in estimate of our taxable income. During the three and nine month periods ended September 30, 2013, we had NOLs which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $1,700 and $6,100 for the three and nine months ended September 30, 2013, respectively.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, including our history of operating losses and the uncertainty of generating future taxable income, management believes it is more likely than not that the net deferred tax assets at September 30, 2014 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at September 30, 2014. The valuation allowance provided against our net deferred tax assets was approximately $22,000 and $16,000 at September 30, 2014 and December 31, 2013, respectively.

At September 30, 2014, we have federal and state net operating loss carry-forwards of approximately $38,000 each, expiring beginning in 2027 and 2016, respectively.
 
9

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of September 30, 2014, we had accrued immaterial amounts of interest and penalties related to uncertain tax positions.

Note 4 — Commitments

We lease our corporate headquarters for $5 per month. Our lease expires in October 2015.

Note 5 — Stock-Based Compensation

We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan"), which has been approved by our stockholders.  The Plan provides for the granting of up to 14,124,469 shares of our common stock, including stock options and stock purchase rights (“RSUs”), and will expire in 2023.  As of September 30, 2014, 1,816,217 shares remained available for grant under the Plan.

During the three months ended September 30, 2014 we granted options for a total of 206,500 shares and none for the same period in 2013. The weighted average fair values per option issued at the grant dates during the three months ended September 30, 2014 was $11.47.

During the nine months ended September 30, 2014 and 2013, we granted options for a total of 261,500 and 274,625 shares, respectively. The weighted average fair values of options issued during the nine months ended September 30, 2014 and 2013 were $11.23 and $19.24 per option, respectively. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the nine months ended September 30, 2014 and 2013, respectively: (i) dividend yield on our common stock of 0 percent for both periods (ii) expected stock price volatility of 87 percent and 93 percent; (iii) a risk-free interest rate of 2.56 percent and 2.06 percent; and (iv) an expected option term of 6 years respectively.

During the three months ended September 30, 2014 we granted 137,666 RSUs, and none for the same period in 2013. The weighted average fair values at the grant dates for RSUs issued during the three months ended September 30, 2014 were $15.40 per RSU. During the nine months ended September 30, 2014 and 2013, we granted 154,332 and 156,415 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the nine months ended September 30, 2014 and 2013 were $15.30 and $23.72 per RSU, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.

Stock-based compensation expense included in general and administrative expense was $2,221 and $5,952 for the three and nine months ended September 30, 2014, respectively and $2,110 and $5,454 for the three and nine months ended September 30, 2013, respectively.

As of September 30, 2014, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $10,358 and $5,515, respectively, which will be amortized over an estimated weighted average period of approximately 2.52 and 2.83 years, respectively.

During the nine month period ended September 30, 2014 we issued 337,335 new shares of common stock as a result of share-based awards.  Options to purchase 256,096 shares were exercised and 78,739 RSUs vested and were paid out as well as 2,500 shares from warrant exercise.

Note 6 — Warrants

Information about warrants outstanding during the nine months ended September 30, 2014 follows:

Original Number
of
Warrants Issued
     
Exercise
Price per
Common
Share
   
Exercisable
at
December 31,
2013
   
Became
Exercisable
   
Exercised
   
Terminated /
Cancelled /
Expired
   
Exercisable
at Sept 30, 2014
 
Expiration
Date
 
2,619,036
(1) 
 
$
3.59
     
159,967
     
     
2,500
     
     
157,467
 
March 2015
Total
               
159,967
     
     
2,500
     
     
157,467
   
 
(1) Referred to as our Series I Warrants.
 
10

Note 7 — Litigation

We have four intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints.

VirnetX Inc. et al., v. Microsoft Corporation (Case 6:13-CV-00351-LED)
On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. We seek an unspecified amount of damages and injunctive relief. A hearing on claims construction and multiple motions by both parties was held on September 4, 2014. On September 10, 2014, the court issued an order granting in part and denying-in-part our sealed motion to compel interrogatory responses, denying Microsoft’s sealed motion to enter order focusing patent claims and prior art, denying Microsoft’s sealed motion to compel, denying Microsoft’s sealed motion to stay the case and granting our request for leave to file a Motion for Partial Summary Judgment. The jury trial in this case is scheduled for July 13, 2015.

VirnetX Inc. v. Cisco Systems, Inc. et al (13-1489-LP VirnetX, Case 6:10-CV-00417-LED)
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Subsequently, on February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we further amended our complaint to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents and to assert our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and just try the case against Apple on the scheduled trial date. The jury trial against Cisco was held on March 4, 2013. The jury against Cisco the jury came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents was denied and the case against Cisco was closed.

The jury trial against Apple was held on October 31, 2012 and on November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple Corporation for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit (USCAFC). On October 16, 2013 Apple filed its opening appeal brief to the USCAFC. Our response to the opening brief was filed on December 2, 2013, and on December 19, 2013, Apple filed its final response to complete the briefing of the court. A hearing was held on March 3, 2014 at the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. In our petition, we have asked the court to rehear its decision with respect to damages and affirm the district court’s damages award against Apple in full because the Federal Circuit’s decision is contrary to the patent statute and Supreme Court precedent. We are also asking the Federal Circuit to reinstate the jury’s award that Apple infringed the ’504 and ’211 patents on the basis that the district court correctly construed the claim term “secure communication link”. We are waiting for the Court’s ruling in this matter.

VirnetX, Inc. v. Apple, Inc. (Case 6:13-CV-00211-LED)
The Court ordered the parties to mediate over an ongoing license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not more than colorably different” with regards to the accused functionality. On August 1, 2013, a hearing was held in the United States District Court for the Eastern District of Texas, Tyler Division on our motion for an ongoing royalty. On March 6, 2014, the court issued a public version of the order previously issued under seal on March 3, 2014, awarding us an on-going royalty of 0.98% on adjudicated products and products “not colorably” different from those adjudicated at trial that incorporate any of the FaceTime or VPN on Demand features found to infringe at trial. On March 27, 2014, Apple filed its notice of appeal to the United States Court of Appeals for the Federal Circuit. On March 28, 2014 Apple also filed a motion for Entry of Final Judgment by Apple Inc. with the United States District Court for the Eastern District of Texas, Tyler Division. The Court stayed the proceedings in this matter while the Court’s ruling in the Case 6:10-CV-00417-LED is pending.
 
11

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)
On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case is scheduled for October 13, 2015.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.

Note 8 — Subsequent Events

Subsequent to the quarter ended September 30, 2014, options to purchase 423,225 were exercised and the shares were issued.
 
12

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Note About Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management’s Discussion and Analysis,” and “Risk Factors.” These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” (Part II, Item 1A of this Form 10-Q). We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

Company Overview

We develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.

Our portfolio of intellectual property is the foundation of our business model.  We currently own approximately 36 U.S. and 66 foreign patents with approximately 75 pending patent applications worldwide.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Mobile-to-Mobile (M2M) communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S. and foreign patents relates generally to securing communication over the internet. Given the subject matter and the relatedness of our various patents and pending applications, we generally disclose them as a collection rather than listing them separately. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation (now Leidos, Inc.) in 2006, and we are required to make payments to Leidos based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

We have an ongoing GABRIEL Licensing Program under which we offer licenses to our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. Our GABRIEL Connection TechnologyTM License is offered to OEM customers who want to adopt the GABRIEL Connection Technology™ as their solution for establishing secure connections using secure domain names within their products.  We have developed GABRIEL Connection Technology™ Software Development Kit (SDK) to assist with rapid integration of these techniques into existing software implementations with minimal code changes and include object libraries, sample code, testing and quality assurance tools and the supporting documentation necessary for a customer to implement our technology. Customers who want to develop their own implementation of the VirnetX patented techniques for supporting secure domain names, or other techniques that are covered by our patent portfolio for establishing secure communication links, can purchase a patent license. The number of patents licensed, and therefore the cost of the patent license to the customer, will depend upon which of the patents are used in a particular product or service. These licenses will typically include an initial license fee, as well as an ongoing royalty.

We intend to continue to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators.  We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE wireless networks. We also believe that all 4G mobile devices will require unique secure domain names and become part of a secure domain name registry.

We further intend to seek licenses of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All licenses with current royalty payment obligations have adhered to these guidelines and have met or exceeded these rates and we will continue to use these rates and guidelines in all future license negotiations.
 
13

Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Science Application International Corporation, or SAIC and renamed “Leidos, Inc.”   Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos and expanded the set of patents we acquired in 2006 from Leidos into a larger portfolio which now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.

We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.

New Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, “Presentation of Financial Statements – Going Concern, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.”  The amendments in this Update apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of  consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).  The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

In May 2014, the FASB issued (ASU) No. 2014-09 “Revenue from Contracts with Customers” (Topic 606).  Topic 606, supersede the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.  In addition, the amendments create a new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers.  In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.  We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed. The standard became effective for us on January 1, 2014, and had no material effect on our financial position or results of operations when implemented.
 
14

Results of Operation

Three and Nine Months Ended September 30, 2014
Compared with Three and Nine Months Ended September 30, 2013
(in thousands, except per share amounts)

Revenue
  
We had revenues of $292 and $809 for the three and nine months ended September 30, 2014, respectively, and $1,612 and $1,911 of revenues for the three and nine months ended September 30, 2013, respectively. The 2013 periods included $1,500 of historical revenue resulting from a settlement discussed below.
  
For the three and nine months ended September 30, 2014 we recognized revenue of $292 and $792, respectively from non-refundable up-front fees earned during the period. In August 2013 we began receiving annual payments on a contract (the “August 2013 Contract Settlement”) with a total value over 5 years of $10,000. From its inception through September 30, 2014 we received a total payment of $5,000 under this license. Revenues from these fees are deferred and recognized as revenue as earned in accordance with our revenue recognition policy, but not in advance of collection.
  
For the three and nine month periods ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses.
  
In addition to the revenues from the August 2013 Contract Settlement discussed above, for the three and nine months ended September 30, 2014, we recognized royalty revenue of zero and $17, respectively, as part of settlement agreements entered into with customers during patent infringement actions. This compares to revenues totaling $28 and $327 for the three and nine months ending September 30, 2013, respectively, excluding revenues from the August 2013 Contract Settlement.
  
In accordance with our revenue recognition policy related to a licensee’s product sales from prior periods, the amounts recognized resulted from negotiated agreements with licensees that utilized our patented technology prior to signing a patent license agreement with us. We record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured. Revenue to be earned from forward licensing agreements entered into as a result of the litigation will be recognized as the earnings process is completed, license fees are fixed and determinable, and in accordance with our revenue recognition policy.

Research and Development Expenses

Research and development expenses were $374 and $316 for the three months ended September 30, 2014 and 2013, respectively, representing an increase of $58 due primarily to an increase in stock-based compensation expense for the three months ended September 30, 2014. Research and development expenses were $1,066 and $1,002 for the nine months ended September 30, 2014 and 2013, respectively.
 
Selling, General and Administrative Expenses

Selling, general and administrative expenses include management and administrative personnel, as well as outside legal, accounting, and consulting expenses.

Our selling, general and administrative expenses for the three months ended September 30, 2014 compared to September 30, 2013 decreased by $261 to $6,168.  The change is primarily due to a decrease of $679 in legal fees associated with our patent infringement actions (see “Legal Proceedings”) and partially offset by an increase in stock-based compensation expense and related payroll taxes.  For the nine months ended September 30, 2014 our selling, general and administrative expenses decreased by $3,031 to $19,119 compared to the nine months ended September 30, 2013.  The change was primarily due to a $4,080 decrease in legal fees associated with our patent infringement actions and an increase in stock-based compensation expense and payroll taxes.  The increase in stock-based compensation and payroll taxes is associated with continued amortization on stock-based awards to employees and incurrence of payroll tax expense on RSUs vesting in the current quarter.  We expect to incur the same levels or increased levels of legal fees over the foreseeable future as we continue to pursue these infringement actions and we expect to report losses from operations as a result. See “Legal Proceedings” for additional information regarding these infringement actions. Management believes our legal expenses will decrease materially after our current court schedule is complete.

Other Income and Expenses

For the three months ended September 30, 2014, the non-cash gain related to the periodic revaluation of our Series I Warrants liability was $1,817, which compares to a non-cash loss of $48 for the three months ended September 30, 2013. For the nine months ended September 30, 2014, the non-cash gain was $2,126 as compared to the non-cash gain of $1,438 for the nine months ended September 30, 2013. The liability for the Series I Warrants decreased to $431 at September 30, 2014, from $2,564 at December 31, 2013. The gain from the revaluations of the warrant liability in the nine months ended September 30, 2014 was primarily the result of a decrease in our common share price during the period.

Interest and other income (expense) decreased by $82 to $(35) for the three months ended September 30, 2014, from $47 for the comparable 2013 period, and decreased by $80 to $25 for the nine months ended September 30, 2014, from $105 for the nine months ended September 30, 2013. This decrease is primarily due to realized losses exceeding interest earned in the quarter.
 
15

Liquidity and Capital Resources

As of September 30, 2014, our cash and cash equivalents totaled $8,498 and our short-term investments totaled $15,939, compared to cash and cash equivalents of $19,173 and short-term investments of $19,815 at December 31, 2013. Working capital was $20,566 at September 30, 2014 and $33,971 at December 31, 2013. The decrease in cash and investments during the periods reported are primarily attributed to costs incurred for legal expenses in defense of our patent infringement actions, payment of a non-cancellable lease obligation and losses incurred during the periods reported.

We expect that our cash and cash equivalents and short-term investments as of September 30, 2014 will be sufficient to fund our operations and provide working capital for general corporate purposes and legal expenses for the foreseeable future. Over the long term, we expect to derive the majority of our revenue from license fees and royalties associated with our patent portfolio, technology, software and secure domain name registry in the United States and other markets around the world.

Income Taxes

We had no income tax expense for the three months ended September 30, 2014.  The income tax expense for the nine months ended September 30, 2014 was $2 related to minimum tax payments.  During the three and nine month periods ended September 30, 2014, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $2,100 and $6,200 for the three and nine months ended September 30, 2014, respectively.

There was no income tax expense for the three months ended September 30, 2013. The income tax expense for the nine months ended September 30, 2013 was $356, which was a negative effective income tax rate of 2 percent.  As a result of NOLs during the periods, the income tax expense for the nine months ended September 30, 2013 reflected only a prior year change in estimate of our taxable income. During the three and nine month periods ended September 30, 2013, we had NOLs which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $1,700 and $6,100 for the three and nine months ended September 30, 2013, respectively.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, including our history of operating losses and the uncertainty of generating future taxable income, management believes it is more likely than not that the net deferred tax assets at September 30, 2014 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at September 30, 2014. The valuation allowance provided against our net deferred tax assets was approximately $22,000 and $16,000 at September 30, 2014 and December 31, 2013, respectively.

At September 30, 2014, we have federal and state net operating loss carry-forwards of approximately $38,000 each, expiring beginning in 2027 and 2016, respectively.

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of September 30, 2014, we had accrued immaterial amounts of interest and penalties related to uncertain tax positions.

Contractual Obligations

There have been no material changes to the contractual obligations disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, except for a payment of $3,750 related to a non-cancellable lease obligation, which is included in prepaid expenses on our Condensed Consolidated Balance Sheet.

Off-Balance Sheet Arrangements

None.
 

16

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

We invest our excess cash primarily in highly liquid instruments including time deposits, money market, and corporate debt securities. We seek to limit the amount of our credit exposure to any one issuer.

Investments in fixed rate instruments carry a degree of interest rate risk. Fixed rate securities may have their fair market value adversely impacted due to a rise in interest rates. Due in part to these factors, our income from investments may decrease in the future.

We considered the historical volatility of short-term interest rates and determined that it was reasonably possible that an adverse change of 100 basis points could be experienced in the near term but would have an immaterial impact in the fair value of our marketable securities, which generally mature within nine months of September 30, 2014.

Other Market Risks

We have no obligation to settle our Series I Warrant obligations in cash. However, these derivative instruments are accounted for as liabilities on our consolidated balance sheets and are marked-to-market each period based on their estimated fair value. The non-cash gains or losses from the decreases and increases in the estimated fair value of the warrant liability are recognized in earnings each period. The estimated fair value is determined in large part by reference to our assumptions and estimates of various factors. Our liability will increase by, and we will recognize a non-cash loss of approximately $200, all other factors being constant if the market price of our common shares increases by $1.  Conversely, our liability will decrease by, and we will recognize a non-cash gain of approximately $200, all other factors being constant, if the market price of our common shares decreases by $1.

We considered the historical volatility of our stock prices and determined that it was reasonably possible that the fair market value of our stock price could increase or decrease substantially in the near term and could have a material impact to our consolidated balance sheets and statement of operations.
 
17

ITEM 4 — CONTROLS AND PROCEDURES
   
Evaluation of Disclosures Controls and Procedures
   
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, as of September 30, 2014.

The purpose of this evaluation was to determine whether as of September 30, 2014 our disclosure controls and procedures were effective to provide reasonable assurance that the information we are required to disclose in our filings with the SEC, (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of September 30, 2014, our disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
18

PART II — OTHER INFORMATION

ITEM 1 — LEGAL PROCEEDINGS

We have four intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints.

VirnetX Inc. et al., v. Microsoft Corporation (Case 6:13-CV-00351-LED)
On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. We seek an unspecified amount of damages and injunctive relief. A hearing on claims construction and multiple motions by both parties was held on September 4, 2014. On September 10, 2014, the court issued an order granting in part and denying-in-part our sealed motion to compel interrogatory responses, denying Microsoft’s sealed motion to enter order focusing patent claims and prior art, denying Microsoft’s sealed motion to compel, denying Microsoft’s sealed motion to stay the case and granting our request for leave to file a Motion for Partial Summary Judgment. The jury trial in this case is scheduled for July 13, 2015.

VirnetX Inc. v. Cisco Systems, Inc. et al (13-1489-LP VirnetX, Case 6:10-CV-00417-LED)
On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Subsequently, on February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we further amended our complaint to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents and to assert our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and just try the case against Apple on the scheduled trial date. The jury trial against Cisco was held on March 4, 2013. The jury against Cisco the jury came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents was denied and the case against Cisco was closed.

The jury trial against Apple was held on October 31, 2012 and on November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple Corporation for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit (USCAFC). On October 16, 2013 Apple filed its opening appeal brief to the USCAFC. Our response to the opening brief was filed on December 2, 2013, and on December 19, 2013, Apple filed its final response to complete the briefing of the court. A hearing was held on March 3, 2014 at the United States Court of Appeals for the Federal Circuit. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. In our petition, we have asked the court to rehear its decision with respect to damages and affirm the district court’s damages award against Apple in full because the Federal Circuit’s decision is contrary to the patent statute and Supreme Court precedent. We are also asking the Federal Circuit to reinstate the jury’s award that Apple infringed the ’504 and ’211 patents on the basis that the district court correctly construed the claim term “secure communication link. We are waiting for the Court’s ruling in this matter.
 
19

VirnetX, Inc. v. Apple, Inc. (Case 6:13-CV-00211-LED)
The Court ordered the parties to mediate over an ongoing license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not more than colorably different” with regards to the accused functionality. On August 1, 2013, a hearing was held in the United States District Court for the Eastern District of Texas, Tyler Division on our motion for an ongoing royalty. On March 6, 2014, the court issued a public version of the order previously issued under seal on March 3, 2014, awarding us an on-going royalty of 0.98% on adjudicated products and products “not colorably” different from those adjudicated at trial that incorporate any of the FaceTime or VPN on Demand features found to infringe at trial. On March 27, 2014, Apple filed its notice of appeal to the United States Court of Appeals for the Federal Circuit. On March 28, 2014 Apple also filed a motion for Entry of Final Judgment by Apple Inc. with the United States District Court for the Eastern District of Texas, Tyler Division. The Court stayed the proceedings in this matter while the Court’s ruling in the Case 6:10-CV-00417-LED is pending.

VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)
On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED).. The jury trial in this case is scheduled for October 13, 2015.

One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.
 
20

ITEM 1A — RISK FACTORS

You should carefully consider the following material risks in addition to the other information set forth in this Quarterly Report on Form 10-Q, as well as our Annual Form 10-K filed March 3, 2014 before making any investment in our common stock.  The risks and uncertainties described below are not the only ones we face.  Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.  If any of these risk factors occurs, you could lose substantial value or your entire investment in our shares.

Risks Related to Our Business and Our Financial Reporting

We may not be able to capitalize on market opportunities related to our licensing strategy or our patent portfolio.

Our business strategy includes licensing our patents and technology to other companies in order to reach a larger end-user base than we could reach through direct sales and marketing efforts; as such, our business strategy and revenues will depend on intellectual property licensing fees and royalties for the majority of our revenues.  We currently derive minimal revenue from licensing activities and we cannot assure you that we will successfully capitalize on our market opportunities or that our current business strategy will succeed.  Factors that may affect our ability to execute our current business strategy including, but are not limited to:

Although we have to date entered into a limited number of settlement and license agreements, we may not be successful in entering into further licensing relationships and existing settlement and license agreements may not generate the financial results we expect;

Third parties may challenge the validity of our patents;

The pendency of our various litigations may cause potential licensees not to do business with us;

We face, and we expect to continue to face, intense competition from new and established competitors who may have superior products and services or better marketing, financial or other capacities than we do; and

It is possible that one or more of our potential customers or licensees develops or otherwise sources products or technologies similar to, competitive with or superior to ours.

If we are not able to adequately protect our patent rights, our business would be negatively impacted.

We believe our patents are valid, enforceable and valuable.  Notwithstanding this belief, third parties may make claims of infringement or invalidity claims with respect to our patents and such claims could give rise to material cost for defense or settlement or both, jeopardize or substantially delay a successful outcome of litigation we are or may become involved in, divert resources away from our other activities, limit or cease our revenues related to such patents, or otherwise materially and adversely affect our business.  Similar challenges could also prevent us from obtaining additional patents in the future.  Even if we are successful in enforcing our rights, our patents may not ultimately provide us with any competitive advantages and may be less valuable than we currently expect.  These risks may be heightened in countries other than the United States where laws regarding patent protection are less developed, and may be negatively affected by the fact that legal standards in the United States and elsewhere for protection of intellectual property rights in Internet-related businesses are uncertain and still evolving.  In addition, there are a significant number of United States and foreign patents and patent applications in our areas of interest, and we expect that significant litigation in these areas will continue, and will add uncertainty to the value of certain patents and other intellectual property rights in our areas of interest.  If we are unable to protect our intellectual property rights or otherwise realize value from them, our business would be negatively affected.

We are involved and will continue to be involved in numerous litigation matters defending our patent portfolio, which can be time-consuming and costly and we cannot anticipate the results.

We spend a significant amount of our financial and management resources to pursue our current litigation matters and related patent office proceedings.  We believe that these litigation matters and others that we may in the future determine to pursue could continue for years and continue to consume significant financial and management resources.  The counterparties to our litigation are all large, well-financed companies with substantially greater resources than us.  We cannot assure you that any of our current or future litigation matters will result in a favorable outcome for us.  In addition, even if we obtain favorable interim rulings or verdicts in particular litigation matters, they may not be predictive of the ultimate resolution of the dispute. Also, we cannot assure you that we will not be exposed to claims or sanctions against us which may be costly or impossible for us to defend.  Unfavorable or adverse outcomes may result in losses, exhaustion of financial resources or other adverse effects, which could encumber our ability to develop and commercialize products.
 
21

We may require additional capital to support our business growth, and this capital may not be available on acceptable terms, if at all.

We may require additional capital to support our business growth or to respond to business opportunities, challenges or unforeseen circumstances. Our ability to obtain additional capital, if and when required, will depend on our business plans, investor demand, our operating performance, the condition of the capital markets, and other factors. If we raise additional funds through the issuance of equity, equity-linked or debt securities, those securities may have rights, preferences, or privileges senior to the rights of our common stock, and our existing stockholders may experience dilution. If we are unable to obtain additional capital, or are unable to obtain additional capital on satisfactory terms, our ability to continue to support our business growth or to respond to business opportunities, challenges, or unforeseen circumstances could be adversely affected, and our business may be harmed.

We can provide no assurances that the licensing of our essential security patents under FRAND will be successful.

At the request of the European Telecommunications Standards Institute (ETSI), and the Alliance for Telecommunications Industry Solutions (ATIS), we agreed to update our licensing declaration to ETSI and ATIS under their respective Intellectual Property Rights (IRP) policies.  This was in response to our Statement of Patent Holder identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3rd Generation Partnership Project (3GPP) Long Term Evolution (LTE), Systems Architecture Evolution (SAE) project.  We will make available a non-exclusive patent license under FRAND (fair, reasonable and non-discriminatory terms and conditions, with compensation) for the patents identified by VirnetX that are or become essential, to applicants desiring to implement the Technical Specifications identified by VirnetX, as set forth in the updated licensing declaration under the ATIS and ETSI IPR policies. Our licensing declarations under the ATIS and ETSI IPR policies may limit our flexibility in determining royalties and license terms for certain of our patents.  Consequently, we cannot assure you that the licensing of the essential security patents will be successful or that third parties will be willing to enter into licenses with VirnetX on reasonable terms or at all, which could have an adverse effect on our business and harm our competitive position.

Because our business is conducted or expected to be conducted in an environment that is subject to rapid change, we may be subject to various developments in regulation, law and consumer preferences to which we may not be able to adapt successfully.

The current regulatory environment for our products and services remains unclear.  We can give no assurance that our planned product offerings will be in compliance with laws and regulations of local, state, United States federal or foreign authorities.  Further, we can give no assurance that we will not unintentionally violate such laws or regulations or that such laws or regulations will not be modified, or that new laws or regulations will be enacted in the future which would cause us to be in violation of such laws or regulations.  For example, Voice-over-Internet Protocol (or VoIP) services are not currently subject to all of the same regulations that apply to traditional telephony, but it is possible that similar regulations may be applied to VoIP in the future and that these could result in substantial costs which adversely affect the marketability of our products and planned products related to VoIP.  For further example, the use of the Internet and private Internet Protocol (IP) networks for communication is largely unregulated within the United States, but may become regulated in the future; also several foreign governments have enacted measures that could restrict or prohibit voice communications services over the Internet or private IP networks.

Our business depends on the growth of instant messaging, VoIP, mobile services, streaming video, file transfer and remote desktop and other next-generation Internet-based applications which are relatively new.  A decline in the use of these applications due to complexity or cost of these applications relative to alternate traditional or newly developed communications channels, or development of alternative technologies, could cause a material decline in the number of users in these areas.

More aggressive domestic or international regulation of the Internet in general, and Internet telephony providers and services specifically or a lack of growth in acceptance of the Internet as a long term viable marketplace for communications services may materially and adversely affect our business, financial condition, operating results and future prospects.

Our exposure to outside influences beyond our control, including new legislation, court rulings or actions by the United States Patent and Trademark Office, could adversely affect our licensing and enforcement activities and results of operations.

Our licensing and enforcement activities are subject to numerous risks from outside influences, including the following:
 
New legislation, regulations or rules related to obtaining patents or enforcing patents could significantly increase our operating costs and decrease our revenue. For instance, the United States Supreme Court has recently modified some tests used by the United States Patent and Trademark Office (USPTO) in granting patents during the past 20 years which may decrease the likelihood that we will be able to obtain patents and increase the likelihood of challenge of any patents we obtain or license.  In addition, the United States recently enacted sweeping changes to the United States patent system under the Leahy-Smith America Invents Act (“AIA”), including changes that transition the United States from a “first-to-invent” system to a “first to file” system and alter the processes for challenging issued patents
 
More patent applications are filed each year resulting in longer delays in getting patents issued by the USPTO.

Federal courts are becoming more crowded, and as a result, patent enforcement litigation is taking longer.

As patent enforcement becomes more prevalent, it may become more difficult for us to voluntarily license our patents.
 
22

If we experience security breaches, we could be exposed to liability and our reputation and business could suffer.

We expect to retain certain confidential customer information in our secure data centers and secure domain name registry.  It will be critical to our business strategy that our facilities and infrastructure remain secure and are perceived by the marketplace to be secure.  Our secure domain name registry operations will also depend on our ability to maintain our computer and telecommunications equipment in effective working order and to reasonably protect our systems against interruption, and potentially depend on protection by other registrars in the shared registration system.  The secure domain name servers that we will operate will be critical hardware to our registry services operations.  Therefore, we expect to have to expend significant time and money to maintain or increase the security of our facilities and infrastructure. Security technologies are constantly being tested by computer professionals, academics and “hackers.” Advances in the techniques for attacking security solutions could make some or all of our products obsolete or unmarketable.  Likewise, if any of our products are found to have significant security vulnerabilities, then we may need to dedicate engineering and other resources to eliminate the vulnerabilities and to repair or replace products already sold or licensed to our customers.  Despite our security measures, our infrastructure may be vulnerable to physical break-ins, computer viruses, attacks by hackers or similar disruptive problems.  It is possible that we may have to expend additional financial and other resources to address such problems.  Any physical or electronic break-in or other security breach or compromise of the information stored at our secure data centers and domain name registration systems may jeopardize the security of information stored on our premises or in the computer systems and networks of our customers.  In such an event, we could face significant liability and customers could be reluctant to use our services.  Such an occurrence could also result in adverse publicity and therefore adversely affect the market’s perception of the security of electronic commerce and communications over IP networks as well as the security or reliability of our services.

A security breach could require a substantial amount of expense to rectify and could result in a product liability claim that causes us to incur substantial liability and related legal and other costs.  A security breach may also harm our reputation and make it more difficult or impossible for us to successfully market to others.  These matters could harm our operating results and financial condition.

We expect that we will experience long and unpredictable sales cycles, which may impact our operating results.

We expect that our sales cycles will be long and unpredictable due to a number of uncertainties such as:

The need to educate potential customers about our patent rights and our product and service capabilities;

Customers’ willingness to invest potentially substantial resources and modify their network infrastructures to take advantage of our products;

Customers’ budgetary constraints;

The timing of customers’ budget cycles; and

Delays caused by customers’ internal review processes.

Long sales cycles may increase the risk that our financial resources are exhausted before we are able to generate significant revenue.

We expect that we will be substantially dependent on a concentrated number of customers.  If we are unable to establish, maintain or replace our relationships with customers and develop a diversified customer base, our revenues may fluctuate and our growth may be limited.

We expect that in the future, a significant portion of our revenues will be generated from a limited number of customers. There can be no guarantee that we will be able to obtain additional customers, or if we do so, to sustain our revenue levels from these prospective customers.  If we are not able to establish, maintain or replace the limited group of prospective customers that we anticipate may generate a substantial majority of our revenues in the future, or if they do not generate revenues at the levels or at the times that we anticipate, our ability to maintain or grow our revenues will be adversely affected.
 
23

Our products are highly technical and may contain undetected errors, which could cause harm to our reputation and adversely affect our business.

Our products are highly technical and complex and, when deployed, may contain errors or defects.  Despite testing, some errors in our products may only be discovered after a product has been installed and used by customers.  Any errors or defects discovered in our products after commercial release could result in failure to achieve market acceptance, loss of revenue or delay in revenue recognition, loss of customers and increased service and warranty cost, any of which could adversely affect our business, operating results and financial condition.  In addition, we could face claims for product liability, tort or breach of warranty, including claims relating to changes to our products made by our channel partners.  The performance of our products could have unforeseen or unknown adverse effects on the networks over which they are delivered as well as on third-party applications and services that utilize our services, which could result in legal claims against us, harming our business.  Furthermore, we expect to provide implementation, consulting and other technical services in connection with the implementation and ongoing maintenance of our products, which typically involves working with sophisticated software, computing and communications systems.  We expect that our contracts with customers will contain provisions relating to warranty disclaimers and liability limitations, which may not be upheld.  Defending a lawsuit, regardless of its merit, is costly and may divert management’s attention and adversely affect the market’s perception of us and our products.  In addition, if our business liability insurance coverage proves inadequate or future coverage is unavailable on acceptable terms or at all, our business, operating results and financial condition could be adversely impacted.

Malfunctions of third-party communications infrastructure, hardware and software expose us to a variety of risks we cannot control.

Our business will depend upon, among other things, the capacity, reliability and security of the infrastructure owned by third parties that we will use to deploy our offerings.  We have no control over the operation, quality or maintenance of a significant portion of that infrastructure or whether or not those third parties will upgrade or improve their equipment.  We depend on these companies to maintain the operational integrity of our connections.  If one or more of these companies is unable or unwilling to supply or expand its levels of service to us in the future, our operations could be severely interrupted.  Also, to the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and secure hosting services which will be required to accommodate a higher volume of traffic may result in slower response times or service interruptions.  System interruptions or increases in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  In addition, users depend on real-time communications; outages caused by increased traffic could result in delays and system failures.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

System failure or interruption or our failure to meet increasing demands on our systems could harm our business.

The success of our license and service offerings will depend on the uninterrupted operation of various systems, secure data centers and other computer and communication networks that we establish.  To the extent the number of users of networks utilizing our future products suddenly increases, the technology platform and hosting services which will be required to accommodate a higher volume of traffic may result in slower response times, service interruptions or delays or system failures.  Our systems and operations will also be vulnerable to damage or interruption from:

power loss, transmission cable cuts and other telecommunications failures;

damage or interruption caused by fire, earthquake, and other natural disasters;

computer viruses or software defects; and

physical or electronic break-ins, sabotage, intentional acts of vandalism, terrorist attacks and other events beyond our control

System interruptions or failures and increases or delays in response time could result in a loss of potential or existing users and, if sustained or repeated, could reduce the appeal of the networks to users.  These types of occurrences could cause users to perceive that our solution does not function properly and could therefore adversely affect our ability to attract and retain licensees, strategic partners and customers.

Any significant problem with our systems or operations could result in lost revenue, customer dissatisfaction or lawsuits against us.  A failure in the operation of our secure domain name registration system could result in the inability of one or more registrars to register and maintain secure domain names for a period of time.  A failure in the operation or update of the master directory that we plan to maintain could result in deletion or discontinuation of assigned secure domain names for a period of time.  The inability of the registrar systems we establish, including our back office billing and collections infrastructure, and telecommunications systems to meet the demands of an increasing number of secure domain name requests could result in substantial degradation in our customer support service and our ability to process registration requests in a timely manner.
 
24

Our ability to sell our solutions will be dependent on the quality of our technical support, and our failure to deliver high-quality technical support services could have a material adverse effect on our sales and results of operations.

If we do not effectively assist our customers in deploying our products, succeed in helping our customers quickly resolve post-deployment issues and provide effective ongoing support, or if potential customers perceive that we may not be able achieve to the foregoing, our ability to sell our products would be adversely affected, and our reputation with potential customers could be harmed.  In addition, as we expand our operations internationally, our technical support team will face additional challenges, including those associated with delivering support, training and documentation in languages other than English.  Our failure to deliver and maintain high-quality technical support services to our customers could result in customers choosing to use our competitors’ products instead of ours in the future.

Telephone carriers have petitioned governmental agencies to enforce regulatory tariffs, which, if granted, would increase the cost of online communication, and such increase in cost may impede the growth of online communication and adversely affect our business.

Use of the Internet has over-burdened existing telecommunications infrastructures, and many high traffic areas have begun to experience interruptions in service.  As a result, certain local telephone carriers have petitioned governmental agencies to enforce regulatory tariffs on IP telephony traffic that crosses over their traditional telephone networks.  If the relief sought in these petitions is granted, the costs of communicating via online could increase substantially, potentially adversely affecting the growth in the use of online secure communications.  Any of these developments could have an adverse effect on our business.

The departure of Kendall Larsen, our Chief Executive Officer and President, and/or other key personnel could compromise our ability to execute our strategic plan and may result in additional severance costs to us.

Our success largely depends on the skills, experience and efforts of our key personnel, including Kendall Larsen, our Chief Executive Officer and President.  We have no employment agreements with any of our key executives that prevent them from leaving us at any time.  In addition, we do not maintain key person life insurance for any of our officers or key employees.  The loss of Mr. Larsen, or our failure to retain other key personnel, would jeopardize our ability to execute our strategic plan and materially harm our business.

We will need to recruit and retain additional qualified personnel to successfully grow our business.

Our future success will depend in part on our ability to attract and retain qualified operations, marketing and sales personnel as well as engineers.  Inability to attract and retain such personnel could adversely affect our business.  Competition for engineering, sales, marketing and executive personnel is intense, particularly in the technology and Internet sectors and in the regions where our facilities are located.  We can provide no assurance that we will attract or retain such personnel.

The fair value of accounting for our Series I Warrants as derivative liabilities may materially impact our results of our operations in future periods.

We record the Series I Warrants as a derivative liability in accordance with ASC 815-40, “Derivatives and Hedging – Contracts in Entity’s Own Equity.”  These derivative liabilities are reported at fair value each reporting period with changes in the fair value recognized as gain or loss during each reporting period.  An increase in our share price or measure of our share price volatility, for example, will generally result in an increase in the fair value of our warrant liability and a non-cash charge during the period of such increase, which could materially and negatively impact our results of operations in future periods.

We may identify future material weaknesses which may result in late filings, increased costs or declines in our share price.

Although we believe that we currently maintain effective control over our disclosures and procedures and internal control over financial reporting, we may in the future identify deficiencies regarding the design and effectiveness of our system of internal control over financial reporting.   If we experience any material weaknesses in our internal control over financial reporting the future or are unable to provide unqualified management or attestation reports about our internal controls, we may be unable to meet financial and other reporting deadlines and may incur costs associated with remediation, and any of which could cause our share price to decline.

Risks Related to Our Stock

We do not currently pay dividends on our common stock and thus stockholders must look to appreciation of our common stock to realize a gain on their investments.

Our dividend policy is within the discretion of our Board of Directors and will depend upon various factors, including our business, financial condition, results of operations, capital requirements, and investment opportunities.  We therefore can’t make assurances that our Board of Directors will determine to pay regular or special dividends in the future. Accordingly, unless our Board of Directors determines to pay dividends, stockholders will be required to look to appreciation of our common stock to realize a gain on their investment.  This appreciation may not occur.
 
25

The exercise of our outstanding stock options would result in a dilution of our current stockholders' voting power and an increase in the number of shares eligible for future resale in the public market which may negatively impact the market price of our stock.

The exercise of our outstanding vested stock options would dilute the ownership interests of our existing stockholders. As of September 30, 2014, we had outstanding options to purchase an aggregate of 4,982,253 shares of common stock representing approximately 9.7 percent of our total shares outstanding as of September 30, 2014, of which 4,381,438 are vested and therefore exercisable. To the extent outstanding stock options are exercised, additional shares of common stock will be issued, and such issuance would dilute non-exercising stockholders' percentage voting interests and increase the number of shares eligible for resale in the public market.

The trading in our common shares is limited and the price of our common shares may be subject to substantial volatility, particularly in light of instability in the financial and capital markets.

Our common stock is listed on NYSE MKT.  Over the past years the market price of our common stock has experienced significant fluctuations.  Between July 1, 2013, and September 30, 2014, the reported last sale price on NYSE MKT for our common stock ranged between $4.95 and $22.65 per share.  The price of our common stock may continue to be volatile as a result of a number of factors, some of which are beyond our control. These factors include, but not limited to, the following:

developments in any then-outstanding litigation or patent office proceedings;

quarterly variations in our operating results;

large purchases or sales of common stock or derivative transactions related to our stock;

actual or anticipated announcements of new products or services by us or competitors;

general conditions in the markets in which we compete; and

general economic and financial conditions

In addition, we believe there has been and may continue to be substantial trading in derivatives of our stock, including short selling activity or related similar activities, which are beyond our control and which may be beyond the full control of the SEC and Financial Institutions Regulatory Authority ("FINRA"). While SEC and FINRA rules prohibit some forms of short selling and other activities that may result in stock price manipulation, such activity may nonetheless occur without detection or enforcement. We have held conversations with regulators concerning trading activity in our stock; however, there can be no assurance that should there be any illegal manipulation in the trading of our stock it will be detected, prosecuted or successfully eradicated. Significant short selling or other types of market manipulation could cause our stock trading price to decline, to become more volatile, or both.

The market price of our common stock may decline because our operating results may not be consistent and may be difficult to predict.

Our reported net income has fluctuated in the past due to several factors. We expect that our future operating results may also fluctuate due to the same or similar factors.  We had a net loss of $26.9 million for the year ended December 31, 2012 a net loss of $27.6 million for the year ended December 31, 2013 and a net loss of $4.5 million for the quarter ended September 30, 2014 with an accumulated deficit of $107.8 million. The following include some of the factors that may cause our operating results to fluctuate:

· the outcome of actions to enforce our intellectual property rights currently in progress or that we may undertake in the future, and the timing thereof;

· the amount and timing of receipt of license fees from potential infringers, licensees or customers;

· the rate of adoption of our patented technologies;

· the number of new license arrangements we may execute, or that may expire, within a particular period and the scope of those licenses, including the number of our patents which are licensed, the extent of prior infringement of our patent rights, royalty rates, timing of payment obligations, expiration date etc.;

· the success of a licensee in selling products that use our patented technologies; and

· the amount and timing of expenses related to our patent filings and enforcement proceedings, including litigation, related to our intellectual property rights

These fluctuations may make our business particularly difficult to manage, adversely affect our business and operating results, make our operating results difficult for investors to predict and, further, cause our results to fall below investor’s expectations and adversely affect the market price of our common stock.
 
26

Because ownership of our common stock is concentrated, investors may have limited influence on stockholder decisions.

As of September 30, 2014, our executive officers and directors beneficially owned approximately 18% of our outstanding common stock.  In addition, a group of stockholders that, as of December 31, 2007, held 4,766,666 shares, or approximately 11%, of our then outstanding common stock, have entered into a voting agreement with us that requires them to vote all of their shares of our voting stock in favor of the director nominees approved by our Board of Directors at each director election going forward, and in a manner that is proportional to the votes cast by all other voting shares as to any other matters submitted to the stockholders for a vote.  However, we cannot be certain how many shares of our common stock this group of stockholders currently owns.  Because of their beneficial ownership interest, our officers and directors could significantly influence stockholder actions of which you disapprove or that are contrary to your interests.  This ability to exercise significant influence could prevent or significantly delay another company from acquiring or merging with us.

Our protective provisions could make it difficult for a third party to successfully acquire us even if you would like to sell your stock to them.

We have a number of protective provisions that could delay, discourage or prevent a third party from acquiring control of us without the approval of our Board of Directors.  Our protective provisions include:

A staggered Board of Directors: This means that only one or two directors (since we have a five-person Board of Directors) will be up for election at any given annual meeting.  This has the effect of delaying the ability of stockholders to effect a change in control of us because it would take two annual meetings to effectively replace a majority of the Board of Directors.

Blank check preferred stock: Our Board of Directors has the authority to establish the rights, preferences and privileges of our 10,000,000 authorized, but unissued, shares of preferred stock.  Therefore, this stock may be issued at the discretion of our Board of Directors with preferences over your shares of our common stock in a manner that is materially dilutive to you.  In addition, blank check preferred stock can be used to create a “poison pill” which is designed to deter a hostile bidder from buying a controlling interest in our stock without the approval of our Board of Directors.  We have not adopted such a “poison pill;” but our Board of Directors has the ability to do so in the future, very rapidly and without stockholder approval.

Advance notice requirements for director nominations and for new business to be brought up at stockholder meetings: Stockholders wishing to submit director nominations or raise matters to a vote of the stockholders must provide notice to us within very specific date windows and in very specific form in order to have the matter voted on at a stockholder meeting.  This has the effect of giving our Board of Directors and management more time to react to stockholder proposals generally and could also have the effect of disregarding a stockholder proposal or deferring it to a subsequent meeting to the extent such proposal is not raised properly.

No stockholder actions by written consent: No stockholder or group of stockholders may take actions rapidly and without prior notice to our Board of Directors and management or to the minority stockholders.  Along with the advance notice requirements described above, this provision also gives our Board of Directors and management more time to react to proposed stockholder actions.

Super majority requirement for stockholder amendments to the By-laws: Stockholder proposals to alter or amend our By-laws or to adopt new By-laws can only be approved by the affirmative vote of at least 66 2/3% of the outstanding shares of our common stock.

No ability of stockholders to call a special meeting of the stockholders: Only the Board of Directors or management can call special meetings of the stockholders.  This could mean that stockholders, even those who represent a significant percentage of our shares of common stock, may need to wait for the annual meeting before nominating directors or raising other business proposals to be voted on by the stockholders.

In addition, the provisions of Section 203 of the Delaware General Corporate Law govern us.  These provisions may prohibit large stockholders, in particular those owning 15% or more of our outstanding voting stock, from merging or combining with us for a certain period of time.
 
These and other provisions in our amended and restated certificate of incorporation, our By-laws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay for shares of our common stock in the future and result in the market price being lower than it would be without these provisions.
 
27

ITEM 6 —EXHIBITS.

Exhibit
Number
Description
   
31.1
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
31.2
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
   
32.1*
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
32.2*
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
101
Interactive Data Files

* This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
 
28

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
VIRNETX HOLDING CORPORATION
       
 
By:
/s/ Kendall Larsen
   
Name
Kendall Larsen
       
   
Title
Chief Executive Officer (Principal Executive Officer)
       
 
By:
/s/ Richard H. Nance
   
Name
Richard H. Nance
       
   
Title
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
       
Date: November 10, 2014
     
29

EXHIBIT INDEX

Exhibit
Number
Description
Certification of the President and Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101
Interactive Data Files
 

 
* This exhibit is furnished herewith, but not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. Such certifications will not be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except to the extent that we explicitly incorporate them by reference.
 
 
30

EX-31.1 2 ex31_1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATIONS

I, Kendall Larsen, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended September 30, 2014;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)

Date: November 10, 2014
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Richard H. Nance, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of VirnetX Holding Corporation for the quarter ended September 30, 2014;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15 (f) and 15d-15 (f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)

Date: November 10, 2014
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on November 10, 2014 (the “Report”), I, Kendall Larsen, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 
/s/ Kendall Larsen
 
Kendall Larsen
 
President and Chief Executive Officer
 
(Principal Executive Officer)

Date: November 10, 2014
 
 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of VirnetX Holding Corporation (the “Company”) on Form 10-Q for the quarter ended September 30, 2014 as filed with the Securities and Exchange Commission on November 10, 2014 (the “Report”), I, Richard H. Nance, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
 
 
/s/ Richard H. Nance
 
Richard H. Nance
 
Chief Financial Officer
 
(Principal Financial Officer and Principal Accounting Officer)

Date: November 10, 2014
 
 

EX-101.INS 6 vhc-20140930.xml XBRL INSTANCE DOCUMENT 0001082324 2014-01-01 2014-09-30 0001082324 2014-11-03 0001082324 2014-09-30 0001082324 2013-12-31 0001082324 2013-07-01 2013-09-30 0001082324 2014-07-01 2014-09-30 0001082324 2013-01-01 2013-09-30 0001082324 2012-12-31 0001082324 2013-09-30 0001082324 us-gaap:RoyaltyAgreementsMember 2013-07-01 2013-09-30 0001082324 vhc:ArayaContractMember 2013-07-01 2013-09-30 0001082324 vhc:SeriesIWarrantsMember 2014-09-30 0001082324 vhc:SeriesIWarrantsMember 2013-12-31 0001082324 vhc:SeriesIWarrantsMember 2013-01-01 2013-12-31 0001082324 vhc:SeriesIWarrantsMember 2014-01-01 2014-09-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:MutualFundsMember 2014-09-30 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2013-12-31 0001082324 vhc:MutualFundsMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0001082324 us-gaap:CashMember 2013-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0001082324 us-gaap:CashMember 2014-09-30 0001082324 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2014-09-30 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:MunicipalBondsMember 2014-09-30 0001082324 us-gaap:FairValueInputsLevel1Member 2013-12-31 0001082324 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2014-09-30 0001082324 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0001082324 us-gaap:FairValueInputsLevel1Member 2014-09-30 0001082324 us-gaap:FairValueInputsLevel2Member 2013-12-31 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel1Member 2013-12-31 0001082324 us-gaap:FairValueInputsLevel2Member 2014-09-30 0001082324 us-gaap:FairValueInputsLevel1Member vhc:SeriesIWarrantsMember 2014-09-30 0001082324 us-gaap:FairValueInputsLevel3Member 2014-09-30 0001082324 us-gaap:FairValueInputsLevel3Member vhc:SeriesIWarrantsMember 2014-09-30 0001082324 vhc:SeriesIWarrantsMember us-gaap:FairValueInputsLevel2Member 2014-09-30 0001082324 us-gaap:FairValueInputsLevel3Member 2013-12-31 0001082324 us-gaap:FairValueInputsLevel3Member vhc:SeriesIWarrantsMember 2013-12-31 0001082324 us-gaap:FairValueInputsLevel2Member vhc:SeriesIWarrantsMember 2013-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2012-12-31 0001082324 us-gaap:FairValueInputsLevel3Member 2013-01-01 2013-09-30 0001082324 us-gaap:FairValueInputsLevel3Member 2014-01-01 2014-09-30 0001082324 us-gaap:FairValueInputsLevel3Member 2013-09-30 0001082324 us-gaap:InternalRevenueServiceIRSMember 2014-09-30 0001082324 us-gaap:StateAndLocalJurisdictionMember 2014-09-30 0001082324 us-gaap:InternalRevenueServiceIRSMember 2014-01-01 2014-09-30 0001082324 us-gaap:StateAndLocalJurisdictionMember 2014-01-01 2014-09-30 0001082324 vhc:Plan2013Member 2014-09-30 0001082324 us-gaap:EmployeeStockOptionMember 2013-07-01 2013-09-30 0001082324 us-gaap:EmployeeStockOptionMember 2014-07-01 2014-09-30 0001082324 us-gaap:EmployeeStockOptionMember 2014-01-01 2014-09-30 0001082324 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-09-30 0001082324 us-gaap:RestrictedStockMember 2013-01-01 2013-09-30 0001082324 us-gaap:RestrictedStockMember 2014-01-01 2014-09-30 0001082324 us-gaap:RestrictedStockMember 2013-07-01 2013-09-30 0001082324 us-gaap:RestrictedStockMember 2014-07-01 2014-09-30 0001082324 us-gaap:EmployeeStockOptionMember 2014-09-30 0001082324 us-gaap:RestrictedStockMember 2014-09-30 0001082324 us-gaap:WarrantMember 2014-01-01 2014-09-30 0001082324 vhc:SeriesIWarrantsMember us-gaap:WarrantMember 2014-09-30 0001082324 us-gaap:WarrantMember 2013-12-31 0001082324 vhc:SeriesIWarrantsMember us-gaap:WarrantMember 2013-12-31 0001082324 us-gaap:WarrantMember vhc:SeriesIWarrantsMember 2014-01-01 2014-09-30 0001082324 us-gaap:WarrantMember 2014-09-30 0001082324 2012-11-05 2012-11-06 0001082324 2012-11-06 2012-11-06 0001082324 us-gaap:SubsequentEventMember us-gaap:EmployeeStockOptionMember 2014-10-01 2014-11-08 xbrli:shares iso4217:USD iso4217:USD xbrli:shares vhc:Patent vhc:Institution xbrli:pure vhc:Lawsuit false --12-31 2014-09-30 Yes No Yes Large Accelerated Filer VirnetX Holding Corp 0001082324 51996701 2014 Q3 10-Q 2429000 1748000 395000 395000 -37000 -12000 130625000 124589000 5952000 5454000 2110000 2221000 39398000 28488000 11699000 73000 10909000 27289000 2173000 8606000 10782000 14262000 112000 20318000 24437000 691000 4119000 38988000 39345000 25196000 3000 0 0 0 0 25000 1000 0 0 25000 0 25000 4000 4000 9851000 6642000 0 0 1508000 0 8457000 8606000 19815000 15939000 19815000 691000 15939000 0 2000 0 4000 0 0 0 0 4000 0 0 0 2000 0 0 112000 2173000 73000 11699000 10782000 4119000 10908000 691000 27315000 8607000 14287000 39014000 20318000 24437000 15939000 19815000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr style="vertical-align: top;"><td style="vertical-align: top; width: 45pt; align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">Note 2 &#8211;</div></td><td style="vertical-align: top; width: auto; align: left;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">&#160;Summary of Significant Accounting Policies</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Unaudited Interim Financial Information</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC&#8217;s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and nine month periods ended September 30, 2014 and 2013; (ii) the condensed consolidated statements of comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013; (iii) the condensed consolidated balance sheets at September 30, 2014 and December 31, 2013; and (iv) the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2014 and 2013. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The condensed consolidated balance sheet, included in this report, as of December 31, 2013 was derived from our 2013 audited financial statements, but does not include all disclosures required by U.S. GAAP.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Basis of Consolidation</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Use of Estimates</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Revenue Recognition</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (&#8220;FASB&#8221;) revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Patent License Agreements</font>: Upon signing a patent license agreement, including licenses entered into upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Consideration for Past Sales</font><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><em>Current Royalty Payments</em><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Ongoing royalty payments cover a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Non-Refundable Up-Front Fees and Minimum Fee Contracts</font><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term.&#160; For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but not in advance of collection.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><em>Non-Royalty Elements</em><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="font-weight: bold; font-style: italic; text-align: justify;">Deferred revenue</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In August 2013 we began receiving annual payments on a contract with a total value over 5 years of $10,000.&#160; From the inception of that license to September 30, 2014, we received a total of $5,000 ("August 2013 Contract Settlement"), all of which is non-refundable.&#160; We recognized $292 and $792 of revenue related to these payments in the three and nine-month periods ended September 30, 2014, respectively.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">During the three month period ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses. &#160;Revenues for historical royalties were estimated based on estimated past and future usage of our IP on our customer's products. &#160;No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">For the nine months ended September 30, 2013, we recognized royalty revenue of $1,911.&#160; In addition to revenue recognized under the August 2013 Contract Settlement described above, we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 7 - Litigation). These revenues relate to both payment for use of our patented technology prior to the signing of a license agreements and royalty payments after the execution of the license agreement; no amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">During 2014, activity under the August 2013 Contract Settlement was as follows:</div></div><div style="text-align: justify;">&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">667</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Payment received</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Less: Amount amortized as revenue</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(792</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,375</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Earnings Per Share</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.&#160; Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.&#160; During the nine months ended September 30, 2014 we had funds which were uninsured.&#160;&#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Derivative Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.&#160; The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Impairment of Long-Lived Assets</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.&#160; Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value.&#160; If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Fair Value of Financial Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.&#160; The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).&#160; Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our financial instruments are stated at amounts that equal, or approximate, fair value.&#160; When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.&#160; We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Mutual Funds:</font> Valued at the quoted net asset value (NAV) of shares held.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Corporate, Municipal and U.S. Agency Securities</font>:&#160; Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for September 30, 2014, included a warrant exercise price of $3.59 per share, a common share price of $6.00, discount rate of 1.78%, and a volatility of 90.28%. The assumptions used for December 31, 2013, were a warrant exercise price of $3.59 per share, a common share price of $19.41, a discount rate of 1.75%, and a volatility of 91.55%. The expiration date of the warrants is March 2015.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.</div><div style="text-align: justify;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">September 30, 2014</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,607</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,908</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,909</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,267</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">6,642</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,379</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,498</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="text-align: justify;"><br /></div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div>and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,325</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,457</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">665</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">1,508</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,287</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,262</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,411</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">9,851</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,289</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">7,474</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">39,014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">38,988</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.</div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">&#160;</div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance December 31, 2012</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,172</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(2,126</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1,438</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(7</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance September 30, 2013</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,734</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">New Accounting Pronouncements</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, &#8220;Presentation of Financial Statements &#8211; Going Concern, Subtopic 205-40, &#8220;<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern.&#8221;</font>&#160; The amendments in this Update apply to all entities and require management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term <font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">substantial doubt, </font>(2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of&#160; consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).&#160; The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and results of operations.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In May 2014, the FASB issued (ASU) No. 2014-09 "Revenue from Contracts with Customers" (Topic 606).&#160; Topic 606 supersedes the revenue recognition requirements in Topic 605,<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;"> Revenue Recognition,</font> including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.&#160; In addition, the amendments create a new Subtopic 340-40,<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;"> Other Assets and Deferred Costs&#8212;Contracts with Customers.</font>&#160; In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed.&#160; The standard became effective for us on January 1, 2014 and had no material effect on our financial position or results of operations when implemented.</div></div> -10675000 1287000 8498000 19173000 19661000 20948000 4267000 0 8498000 7474000 11699000 2325000 112000 19173000 4411000 73000 0 4119000 4379000 665000 3.59 3.59 3.59 2619036 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 4 &#8212;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: left; width: auto;">Commitments</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We lease our corporate headquarters for $5 per month. Our lease expires in October 2015.</div></div> 0.0001 0.0001 5000 5000 51236141 51573476 100000000 100000000 51573476 51236141 -5165000 -4423000 -20101000 -17202000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Concentration of Credit Risk and Other Risks and Uncertainties</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.&#160; During the nine months ended September 30, 2014 we had funds which were uninsured.&#160;&#160; We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Basis of Consolidation</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">During 2014, activity under the August 2013 Contract Settlement was as follows:</div><div style="text-align: justify;">&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">667</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Payment received</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Less: Amount amortized as revenue</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(792</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,375</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div> 2500000 667000 2375000 1375000 667000 0 1000000 -292000 792000 16000000 22000000 18000 30000 431000 2564000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Derivative Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.&#160; The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.</div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 5 &#8212;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: justify; width: auto;">Stock-Based Compensation</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan"), which has been approved by our stockholders.&#160; The Plan provides for the granting of up to 14,124,469 shares of our common stock, including stock options and stock purchase rights (&#8220;RSUs&#8221;), and will expire in 2023.&#160; As of September 30, 2014, 1,816,217 shares remained available for grant under the Plan.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">During the three months ended September 30, 2014 we granted options for a total of 206,500 shares and none for the same period in 2013. The weighted average fair values per option issued at the grant dates during the three months ended September 30, 2014 was $11.47.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">During the nine months ended September 30, 2014 and 2013, we granted options for a total of 261,500 and 274,625 shares, respectively. The weighted average fair values of options issued during the nine months ended September 30, 2014 and 2013 were $11.23 and $19.24 per option, respectively. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the nine months ended September 30, 2014 and 2013, respectively: (i) dividend yield on our common stock of 0 percent for both periods (ii) expected stock price volatility of 87 percent and 93 percent; (iii) a risk-free interest rate of 2.56 percent and 2.06 percent; and (iv) an expected option term of 6 years respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">During the three months ended September 30, 2014 we granted 137,666 RSUs, and none for the same period in 2013. The weighted average fair values at the grant dates for RSUs issued during the three months ended September 30, 2014 were $15.40 per RSU. During the nine months ended September 30, 2014 and 2013, we granted 154,332 and 156,415 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the nine months ended September 30, 2014 and 2013 were $15.30 and $23.72 per RSU, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Stock-based compensation expense included in general and administrative expense was $2,221 and $5,952 for the three and nine months ended September 30, 2014, respectively and $2,110 and $5,454 for the three and nine months ended September 30, 2013, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">As of September 30, 2014, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $10,358 and $5,515, respectively, which will be amortized over an estimated weighted average period of approximately 2.52 and 2.83 years, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">During the nine month period ended September 30, 2014 we issued 337,335 new shares of common stock as a result of share-based awards.&#160; Options to purchase 256,096 shares were exercised and 78,739 RSUs vested and were paid out as well as 2,500 shares from warrant exercise.</div></div> -0.09 -0.39 -0.33 -0.10 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Earnings Per Share</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.&#160; Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.</div></div> 0.02 10358000 5515000 P2Y9M29D P2Y6M7D 0.9155 0.9028 0 7000 0.0175 0.0178 4172000 2564000 2734000 431000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.</div><div style="text-align: justify;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">September 30, 2014</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,607</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,908</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,909</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,267</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">6,642</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,379</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,498</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="text-align: justify;"><br /></div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div>and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,325</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,457</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">665</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">1,508</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,287</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,262</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,411</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">9,851</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,289</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">7,474</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">39,014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">38,988</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Fair Value of Financial Instruments</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.&#160; The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).&#160; Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our financial instruments are stated at amounts that equal, or approximate, fair value.&#160; When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.&#160; We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Mutual Funds:</font> Valued at the quoted net asset value (NAV) of shares held.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Corporate, Municipal and U.S. Agency Securities</font>:&#160; Fair value measured at the closing price reported on the active market on which the individual securities are traded.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Series I Warrants</font>: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for September 30, 2014, included a warrant exercise price of $3.59 per share, a common share price of $6.00, discount rate of 1.78%, and a volatility of 90.28%. The assumptions used for December 31, 2013, were a warrant exercise price of $3.59 per share, a common share price of $19.41, a discount rate of 1.75%, and a volatility of 91.55%. The expiration date of the warrants is March 2015.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.</div><div style="text-align: justify;"><br /></div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">September 30, 2014</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,119</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">112</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,607</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(3</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,606</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">691</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,908</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,909</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,267</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">6,642</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">20,318</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,379</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(4</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">24,437</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,498</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">15,939</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div style="text-align: justify;"><br /></div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="22" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">December 31, 2013</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;"></td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Adjusted</div>Cost</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Gains</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Unrealized</div>Losses</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Fair</div>Value</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Cash</div>and Cash</div>Equivalents</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td><td colspan="2" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: center;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold;">Investments</div>Available</div>for Sale</div></td><td nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px; text-align: center;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Cash</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">11,699</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Level 1:</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Mutual funds</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">73</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Corporate securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">10,782</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,325</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">8,457</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 28%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Municipal securities</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">665</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">1,508</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">U.S agency securities</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,287</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">14,262</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,411</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">9,851</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 28%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,315</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">27,289</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">7,474</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 28%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">39,014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">-</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(25</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">38,988</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,173</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">19,815</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.</div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">&#160;</div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance December 31, 2012</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,172</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(2,126</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1,438</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(7</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance September 30, 2013</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,734</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">&#160;</div><table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Nine Months Ended</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: top; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td colspan="2" style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Fair Value</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Measurements</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Using</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs (Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance December 31, 2012</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">4,172</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(2,126</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Gain on derivative liability included in net loss</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(1,438</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(7</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 38%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Settlements</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Balance September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 38%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 9.9pt; text-indent: -9.9pt;">Balance September 30, 2013</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,734</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.</div><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">September 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">431</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div>&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="14" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">December 31, 2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Quoted</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Prices in</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Active</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Markets for</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Identical</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Assets</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Other</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Observable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Significant</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Unobservable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Inputs</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right;"></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 1)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 2)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">(Level 3)</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; text-align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: center;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 52%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Series l Warrants</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 52%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,564</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table></div> -1438000 -2126000 4 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Impairment of Long-Lived Assets</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.&#160; Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets&#8217; carrying value.&#160; If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.</div></div> -5134000 -17225000 -4468000 -19698000 2000 0 356000 0 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 3 -</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: left; width: auto;">Income Taxes</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We had no income tax expense for the three months ended September 30, 2014.&#160; The income tax expense for the nine months ended September 30, 2014 was $2 related to minimum tax payments.&#160; During the three and nine month periods ended September 30, 2014, we had net operating losses (&#8220;NOLs&#8221;) which generated deferred tax assets for NOL carry-forwards.&#160; We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.&#160; Valuation allowances provided for our net deferred tax assets increased by approximately $2,100 and $6,200 for the three and nine months ended September 30, 2014, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">There was no income tax expense for the three months ended September 30, 2013. The income tax expense for the nine months ended September 30, 2013 was $356, which was a negative effective income tax rate of 2 percent.&#160; As a result of NOLs during the periods, the income tax expense for the nine months ended September 30, 2013 reflected only a prior year change in estimate of our taxable income. During the three and nine month periods ended September 30, 2013, we had NOLs which generated deferred tax assets for NOL carry-forwards.&#160; We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.&#160; Valuation allowances provided for our net deferred tax assets increased by approximately $1,700 and $6,100 for the three and nine months ended September 30, 2013, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, including our history of operating losses and the uncertainty of generating future taxable income, management believes it is more likely than not that the net deferred tax assets at September 30, 2014 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at September 30, 2014. The valuation allowance provided against our net deferred tax assets was approximately $22,000 and $16,000 at September 30, 2014 and December 31, 2013, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">At September 30, 2014, we have federal and state net operating loss carry-forwards of approximately $38,000 each, expiring beginning in 2027 and 2016, respectively.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of September 30, 2014, we had accrued immaterial amounts of interest and penalties related to uncertain tax positions.</div></div> -14963000 0 -1361000 681000 916000 1708000 25000 -35000 105000 47000 2015-10-31 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr style="vertical-align: top;"><td style="vertical-align: top; width: 45pt; align: right;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">Note 7 &#8212;</div></td><td style="vertical-align: top; width: auto; align: left;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">Litigation</div></td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">We have four intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. et al., v. Microsoft Corporation (Case 6:13-CV-00351-LED)</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. We seek an unspecified amount of damages and injunctive relief. A hearing on claims construction and multiple motions by both parties was held on September 4, 2014. On September 10, 2014, the court issued an order granting in part and denying-in-part our sealed motion to compel interrogatory responses, denying Microsoft&#8217;s sealed motion to enter order focusing patent claims and prior art, denying Microsoft&#8217;s sealed motion to compel, denying Microsoft&#8217;s sealed motion to stay the case and granting our request for leave to file a Motion for Partial Summary Judgment. The jury trial in this case is scheduled for July 13, 2015.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. v. Cisco Systems, Inc. et al (13-1489-LP VirnetX, Case 6:10-CV-00417-LED)</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Subsequently, on February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we further amended our complaint to include Apple&#8217;s iPad 2 in the list of Apple products that are accused of infringing our patents and to assert our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and just try the case against Apple on the scheduled trial date. The jury trial against Cisco was held on March 4, 2013. The jury against Cisco the jury came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco&#8217;s infringement of certain VirnetX patents was denied and the case against Cisco was closed.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The jury trial against Apple was held on October 31, 2012 and on November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple Corporation for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple&#8217;s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple&#8217;s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under <font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: normal;">Case 6:13-CV-00211-LED</font>.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple&#8217;s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit (USCAFC). On October 16, 2013 Apple filed its opening appeal brief to the USCAFC. Our response to the opening brief was filed on December 2, 2013, and on December 19, 2013, Apple filed its final response to complete the briefing of the court. A hearing was held on March 3, 2014 at the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury&#8217;s finding that all 4 of our patents are valid, confirming the jury&#8217;s finding of infringement of VPN on Demand under many of the asserted claims of our &#8216;135 and &#8216;151 patents, and confirming the district&#8217;s court&#8217;s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury&#8217;s damages award and the district court&#8217;s claim construction with respect to parts of our &#8216;504 and &#8216;211 patents and remanded the damages award and determination of infringement with respect to FaceTime &#8211;for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit&#8217;s September 14, 2014, decision concerning VirnetX&#8217;s litigation against Apple Inc. In our petition, we have asked the court to rehear its decision with respect to damages and affirm the district court&#8217;s damages award against Apple in full because the Federal Circuit&#8217;s decision is contrary to the patent statute and Supreme Court precedent. We are also asking the Federal Circuit to reinstate the jury&#8217;s award that Apple infringed the &#8217;504 and &#8217;211 patents on the basis that the district court correctly construed the claim term &#8220;secure communication link&#8221;. We are waiting for the Court&#8217;s ruling in this matter.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">VirnetX, Inc. v. Apple, Inc. (Case 6:13-CV-00211-LED)</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">The Court ordered the parties to mediate over an ongoing license in the following 45 days for Apple&#8217;s future infringing use not covered by the Court&#8217;s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court&#8217;s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are &#8220;not more than colorably different&#8221; with regards to the accused functionality. On August 1, 2013, a hearing was held in the United States District Court for the Eastern District of Texas, Tyler Division on our motion for an ongoing royalty. On March 6, 2014, the court issued a public version of the order previously issued under seal on March 3, 2014, awarding us an on-going royalty of 0.98% on adjudicated products and products &#8220;not colorably&#8221; different from those adjudicated at trial that incorporate any of the FaceTime or VPN on Demand features found to infringe at trial. On March 27, 2014, Apple filed its notice of appeal to the United States Court of Appeals for the Federal Circuit. On March 28, 2014 Apple also filed a motion for Entry of Final Judgment by Apple Inc. with the United States District Court for the Eastern District of Texas, Tyler Division. The Court stayed the proceedings in this matter while the Court&#8217;s ruling in the Case 6:10-CV-00417-LED is pending.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; text-align: left;">VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple&#8217;s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple&#8217;s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case is scheduled for October 13, 2015.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.</div></div> 4630000 5374000 28488000 39398000 368000000 4 -5134000 -17227000 -20054000 -4468000 -1859000 -14636000 77000 29000 3884000 3117000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">New Accounting Pronouncements</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, &#8220;Presentation of Financial Statements &#8211; Going Concern, Subtopic 205-40, &#8220;<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Disclosure of Uncertainties about an Entity&#8217;s Ability to Continue as a Going Concern.&#8221;</font>&#160; The amendments in this Update apply to all entities and require management to assess an entity&#8217;s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term <font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">substantial doubt, </font>(2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management&#8217;s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of&#160; consideration of management&#8217;s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).&#160; The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and results of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and results of operations.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In May 2014, the FASB issued (ASU) No. 2014-09 "Revenue from Contracts with Customers" (Topic 606).&#160; Topic 606 supersedes the revenue recognition requirements in Topic 605,<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;"> Revenue Recognition,</font> including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.&#160; In addition, the amendments create a new Subtopic 340-40,<font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;"> Other Assets and Deferred Costs&#8212;Contracts with Customers.</font>&#160; In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.&#160; We are currently evaluating the impact this guidance will have on our financial position and statement of operations.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed.&#160; The standard became effective for us on January 1, 2014 and had no material effect on our financial position or results of operations when implemented.</div></div> 6745000 20185000 23152000 6542000 -19376000 -21241000 -6250000 -5133000 2027-12-31 2016-12-31 38000000 38000000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 1 &#8212;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: left; width: auto;">Business Description and Basis of Presentation</td></tr></table></div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We develop software and technology solutions for securing real-time communications over the Internet.&#160; Our patented GABRIEL Connection Technology&#8482; combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology&#8482; as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our portfolio of intellectual property is the foundation of our business model.&#160; We currently own approximately 36 U.S. and 66 foreign patents with approximately 75 pending patent applications worldwide.&#160; Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Mobile-to-Mobile (M2M) communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S. and foreign patents relates generally to securing communication over the internet. Given the subject matter and the relatedness of our various patents and pending applications, we generally disclose them as a collection rather than listing them separately. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.&#160; Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation (now Leidos, Inc.) in 2006 and we are required to make payments to Leidos, Inc. based on cash or certain other values generated from those patents.&#160; The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We intend to continue to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology&#8482; to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will continue to use these rates and guidelines in all future license negotiations.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and M2M communications in areas including Smart City, Connected Car and Connected Home.&#160; Our technology generates secure connections on a &#8220;zero-click&#8221; or &#8220;single-click&#8221; basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Our employees include the core development team behind our patent portfolio, technology and software.&#160; This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos.&#160; Leidos is a FORTUNE 500&#174; scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos and expanded the set of patents we acquired in 2006 from Leidos into a larger portfolio which now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents.&#160; We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.</div></div> -47000 -31000 45000 25000 0 431000 0 2564000 0 0 0 431000 431000 431000 0 2564000 0 2564000 0 2564000 0 0 0 -12000 45000 -31000 25000 -35000 69120000 11928000 17000 7000 0.0001 0.0001 0 0 0 0 10000000 10000000 0 0 357000 759000 0 3240000 9000 0 68000 29000 72244000 15829000 53000 52000 1002000 374000 316000 1066000 -107760000 -90533000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: left;">Revenue Recognition</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (&#8220;FASB&#8221;) revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Patent License Agreements</font>: Upon signing a patent license agreement, including licenses entered into upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:</div><div><br /></div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Consideration for Past Sales</font><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Consideration related to a licensee&#8217;s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><em>Current Royalty Payments</em><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Ongoing royalty payments cover a licensee&#8217;s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees&#8217; underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees&#8217; sales is limited.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-style: italic;">Non-Refundable Up-Front Fees and Minimum Fee Contracts</font><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term.&#160; For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but not in advance of collection.</font></td></tr></table></div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 18pt;">&#160;</td><td style="font-family: Times New Roman; vertical-align: top; width: 27pt; align: right;">&#9679;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: justify; width: auto;"><em>Non-Royalty Elements</em><font style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.</font></td></tr></table></div></div> <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-weight: bold; font-style: italic; text-align: justify;">Deferred revenue</div><div style="text-align: justify;"><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">In August 2013 we began receiving annual payments on a contract with a total value over 5 years of $10,000.&#160; From the inception of that license to September 30, 2014, we received a total of $5,000 ("August 2013 Contract Settlement"), all of which is non-refundable.&#160; We recognized $292 and $792 of revenue related to these payments in the three and nine-month periods ended September 30, 2014, respectively.</div><div style="text-align: justify;">&#160;</div><div style="text-align: justify;"><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">During the three month period ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses. &#160;Revenues for historical royalties were estimated based on estimated past and future usage of our IP on our customer's products. &#160;No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">For the nine months ended September 30, 2013, we recognized royalty revenue of $1,911.&#160; In addition to revenue recognized under the August 2013 Contract Settlement described above, we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 7 - Litigation). These revenues relate to both payment for use of our patented technology prior to the signing of a license agreements and royalty payments after the execution of the license agreement; no amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">&#160;</div><div style="font-size: 10pt; font-family: 'Times New Roman', Times, Serif; text-align: left;">During 2014, activity under the August 2013 Contract Settlement was as follows:</div></div><div style="text-align: justify;">&#160;</div><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; border-collapse: collapse; width: 100%;"><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, December 31, 2013</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">667</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Payment received</div></td><td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 88%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Less: Amount amortized as revenue</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">(792</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">)</div></td></tr><tr><td valign="bottom" style="vertical-align: top; padding-bottom: 4px; width: 88%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Deferred Revenue, September 30, 2014</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; width: 1%; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; width: 1%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">$</div></td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; width: 9%; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif;">2,375</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; width: 1%; background-color: #ffffff;">&#160;</td></tr></table><div><br /></div></div> 809000 1612000 292000 1911000 1500000 112000 P6Y P6Y <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Information about warrants outstanding during the nine months ended September 30, 2014 follows:</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td colspan="4" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Original Number</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">of</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Warrants Issued</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Price per</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Common</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Share</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable at</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Became</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Terminated /</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Cancelled /</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">at Sept 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Expiration</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Date</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 8%; background-color: #cceeff;"></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,619,036</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup>&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">3.59</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">159,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">157,467</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 8%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: center;">March 2015</div></td></tr><tr style="height: 17px;"><td colspan="4" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">159,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">157,467</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left;">&#160;</div></td></tr></table></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt;"></td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; width: 36pt; align: right;">(1)</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: left; width: auto;">Referred to as our Series I Warrants.</td></tr></table></div></div> 19119000 6168000 6429000 22150000 156415 154332 0 137666 23.72 15.30 15.40 0 0 159967 159967 157467 157467 5454000 5952000 2500 2500 78739 0 0 0 206500 261500 274625 19.41 6.00 0.93 0.87 0 0 1816217 14124469 0.0206 0.0256 11.47 11.23 19.24 256096 423225 337335 22858000 34024000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: justify;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 8 &#8212;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: justify; width: auto;">Subsequent Events</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: left;">Subsequent to the quarter ended September 30, 2014, options to purchase 423,225 were exercised and the shares were issued.</div></div> 1817000 -48000 2126000 1438000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Use of Estimates</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div></div> 2100000 6100000 1700000 6200000 51203000 51454000 51178000 51572000 3240000 0 369000 402000 36 P10Y 66 75 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; font-style: italic; text-align: justify;">Unaudited Interim Financial Information</div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC&#8217;s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and nine month periods ended September 30, 2014 and 2013; (ii) the condensed consolidated statements of comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013; (iii) the condensed consolidated balance sheets at September 30, 2014 and December 31, 2013; and (iv) the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2014 and 2013. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). The condensed consolidated balance sheet, included in this report, as of December 31, 2013 was derived from our 2013 audited financial statements, but does not include all disclosures required by U.S. GAAP.</div></div> 5000 0.0098 330000 34000 2 P5Y 5000000 10000000 <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; width: 45pt; align: right;">Note 6 &#8212;</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; font-weight: bold; text-align: left; width: auto;">Warrants</td></tr></table></div><div><br /></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">Information about warrants outstanding during the nine months ended September 30, 2014 follows:</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">&#160;</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;"><table cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td colspan="4" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Original Number</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">of</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Warrants Issued</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercise</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Price per</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Common</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Share</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable at</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">December 31,</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">2013</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Became</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercised</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Terminated /</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Cancelled /</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Expired</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;">&#160;</td><td colspan="2" valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Exercisable</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">at Sept 30, 2014</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Expiration</div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; font-weight: bold; color: #000000; text-align: center;">Date</div></td></tr><tr><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 8%; background-color: #cceeff;"></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,619,036</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left;"><sup style="font-size: smaller; vertical-align: text-top; line-height: 1;">(1)</sup>&#160;</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">$</div></td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">3.59</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">159,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 2px solid; text-align: right; width: 9%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">157,467</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; text-align: left; width: 1%; background-color: #cceeff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 8%; background-color: #cceeff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: center;">March 2015</div></td></tr><tr style="height: 17px;"><td colspan="4" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left; margin-left: 7.2pt; text-indent: -7.2pt;">Total</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: right; background-color: #ffffff;">&#160;</td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">159,967</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">2,500</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">&#8212;</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; border-bottom: #000000 4px double; text-align: right; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000;">157,467</div></td><td nowrap="nowrap" valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; text-align: left; background-color: #ffffff;">&#160;</td><td valign="bottom" style="vertical-align: bottom; padding-bottom: 4px; background-color: #ffffff;"><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; color: #000000; text-align: left;">&#160;</div></td></tr></table></div><div style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; text-align: justify;">&#160;</div><div style="text-align: left;"><table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; width: 100%;"><tr><td style="width: 36pt;"></td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; width: 36pt; align: right;">(1)</td><td style="font-size: 10pt; font-family: ''Times New Roman'', Times, serif; vertical-align: top; text-align: left; width: auto;">Referred to as our Series I Warrants.</td></tr></table></div></div> March 2015 Referred to as our Series I Warrants. EX-101.SCH 7 vhc-20140930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Business Description and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Stock Based Compensation link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Warrants link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Business Description and Basis of Presentation (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Stock Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 vhc-20140930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 vhc-20140930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 vhc-20140930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Amendment Flag Current Fiscal Year End Date Document Period End Date Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Award Type [Axis] Summary of Significant Accounting Policies [Abstract] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Income tax liability Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Additional paid in capital Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense Allocated Share-based Compensation Expense Total assets Assets Fair value Assets, Fair Value Disclosure Current assets: ASSETS Assets [Abstract] Total current assets Assets, Current Unrealized Losses Available-for-sale Equity Securities, Accumulated Gross Unrealized Loss, before Tax Investments Available for Sale Available-for-sale Securities Unrealized Gains Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax Adjustment Cost Available-for-sale Securities, Amortized Cost Basis Investments available for sale Available-for-sale Securities, Debt Securities, Current Summary of Significant Accounting Policies Net increase (decrease) in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash [Member] Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Warrants by expiration date [Axis] Schedule of warrants by expiration date [Domain] Warrant exercise price (in dollars per share) Exercise Price per Common Share (in dollars per share) Original Number of Warrants Issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants [Line Items] Warrants [Table] Commitments Commitments Disclosure [Text Block] Commitments [Abstract] Commitments and contingencies Common stock, par value (in dollars per share) Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at September 30, 2014 and December 31, 2013, Issued and outstanding: 51,573,476 shares at September 30, 2014, and 51,236,141 shares at December 31, 2013 Common Stock, Value, Issued Common stock, issued (in shares) Common stock, authorized (in shares) Common stock, outstanding (in shares) CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) [Abstract] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Concentration of Credit Risk and Other Risks and Uncertainties Basis of Consolidation Corporate securities [Member] Schedule of deferred revenue Deferred Revenue, by Arrangement, Disclosure [Table Text Block] Deferred Revenue [Domain] Deferred Revenue Arrangement, by Type [Table] Payment received Deferred Revenue, Additions Deferred Revenue [Abstract] Deferred Revenue, Beginning Balance Deferred Revenue, Ending Balance Deferred Revenue Deferred revenue, current portion Deferred Revenue, Current Deferred Revenue Arrangement [Line Items] Deferred revenue, non-current portion Deferred Revenue, Noncurrent Deferred Revenue Arrangement Type [Axis] Less: Amount amortized as revenue Deferred Revenue, Revenue Recognized Valuation allowance carried against net deferred tax assets Deferred Tax Assets, Valuation Allowance Depreciation and amortization Derivative liability Derivative Instruments Stock Based Compensation Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock Based Compensation [Abstract] Basic and diluted loss per share (in dollars per share) Earnings Per Share, Basic and Diluted Earnings Per Share Effective tax rate (in hundredths) Stock Options [Member] Unrecognized stock based compensation expense Weighted average vesting amortization period Expected volatility rate (in hundredths) Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Discount rate (in hundredths) Fair value of securities on the basis of investment category [Abstract] Fair Value, Assets Measured on Recurring and Nonrecurring Basis, Alternative [Abstract] Fair Value, Hierarchy [Axis] Fair value of liabilities [Abstract] Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis, Alternative [Abstract] Ending Balance Beginning Balance Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value Fair Value Assumptions [Abstract] Fair Value, Measurements, Fair Value Hierarchy [Domain] Adjusted cost, gross unrealized gains, gross unrealized losses and fair value of securities by significant investment category Fair Value, Assets Measured on Recurring Basis [Table Text Block] Fair Value of Financial Instruments Fair Value of Financial Instruments [Line Items] Fair Value, by Balance Sheet Grouping [Table] Summary of changes in fair value of Level 3 Liabilities Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant Unobservable Inputs (Level 3) [Member] Liabilities stated at fair value Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Gain on derivative liability included in net loss Changes in fair value of Level 3 liabilities [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Number of patents allegedly infringed upon by Apple, Inc. Gain Contingency, Patents Found Infringed upon, Number Impairment of Long-Lived Assets Income Tax Authority [Domain] CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract] Loss before taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income Taxes [Abstract] Income Tax Authority [Axis] Income tax expense Income tax expense Income Tax Expense (Benefit) Income Taxes Income Tax Disclosure [Text Block] Prepaid taxes Increase (Decrease) in Prepaid Taxes Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Deferred revenues Changes in assets and liabilities: Interest and other income (expense), net Interest and Other Income Federal [Member] Investment Type Categorization [Domain] Investment Type [Axis] Corporate headquarters, lease expiration date Lease Expiration Date Litigation Legal Matters and Contingencies [Text Block] Total current liabilities Liabilities, Current Total liabilities and stockholders' equity Liabilities and Equity Current liabilities: LIABILITIES AND STOCKHOLDERS' EQUITY Amount of damages awarded in patent infringement case Loss Contingency, Damages Awarded, Value Number of intellectual property infringement lawsuits pending Loss Contingency, Pending Claims, Number Municipal securities [Member] Net loss Net loss Net Income (Loss) Attributable to Parent Cash flows from financing activities: Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Cash flows from investing activities: Cash flows from operating activities: Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations New Accounting Pronouncements Operating expense: Total operating expense Operating Expenses Loss from operations Operating Loss Carryforwards [Table] Operating loss carryforwards, expiration dates Operating Loss Carryforwards [Line Items] Operating loss carryforwards Business Description and Basis of Presentation [Abstract] Business Description and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total other comprehensive loss, net of tax Other Comprehensive Income (Loss), Net of Tax Other comprehensive loss, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Series 1 Warrants Change in equity adjustment from foreign currency translation, net of tax Change in unrealized gain (loss) on investments, net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Purchase of investments Payments to Acquire Available-for-sale Securities Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Plan Name [Domain] Plan Name [Axis] Preferred stock, par value (in dollars per share) Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at September 30, 2014, and December 31, 2013, Issued and outstanding: 0 shares at September 30, 2014 and December 31, 2013 Preferred Stock, Value, Issued Preferred stock, issued (in shares) Preferred stock, authorized (in shares) Preferred stock, outstanding (in shares) Prepaid expenses - current Prepaid Expense, Current Prepaid expenses - non-current Prepaid Expense, Noncurrent Proceeds from exercise of warrants Proceeds from exercise of options Proceeds from Stock Options Exercised Proceeds from sale or maturity of investments Property and equipment, net Research and development Research and Development Expense Restricted Stock [Member] Accumulated deficit Revenue Recognition Deferred revenue Revenue Recognition, Deferred Revenue [Policy Text Block] Concentration of Credit Risk and Others Risks and Uncertainties [Abstract] August 2013 Contract [Member] Royalty Agreements [Member] Revenue from historical royalties Revenue Royalty Revenue Expected option term Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Information about warrants outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Selling, general and administrative expenses Selling, General and Administrative Expense RSUs granted (in shares) Weighted average grant date fair value of RSU's granted (in dollars per share) Terminated / Cancelled / Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations Exercisable at End of Period (in shares) Exercisable at Beginning of Year (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number Stock-based compensation Exercised (in shares) Warrants exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised Became Exercisable (in shares) Shares vested (in shares) Options granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Common share price (in dollars per share) Expected stock price volatility (in hundredths) Dividend yield (in hundredths) Shares available for grant (in shares) Shares authorized for issuance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Risk-free interest rate (in hundredths) Options granted, weighted average fair values (in dollars per share) Award Type [Domain] State [Member] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)] [Abstract] CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) [Abstract] Shares exercised (in shares) Options exercised (in shares) New issue of shares of common stock (in shares) Stockholders' equity: Total stockholders' equity Stockholders' Equity Attributable to Parent Subsequent Events Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Line Items] Subsequent Event [Member] Subsequent Event Type [Domain] Subsequent Event Type [Axis] Change in value of derivative liability Gain (loss) on change in value of derivative liability Use of Estimates U.S agency securities [Member] Net change in valuation allowance Warrants [Member] Warrants [Abstract] Weighted average shares outstanding basic and diluted (in shares) The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for non-current goods or services that bring economic benefits for period more than 12 months. Increase Decrease In Prepaid Expense Noncurrent Prepaid expenses non-current The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for period less than 12 months. Increase Decrease In Prepaid Expense Current Prepaid expenses and other current assets Represents number of patents owned. Number Of Patents Owned Number of patents owned Represents period over which core development team, behind patent portfolio, technology and software, has worked together. Period for which core development team has worked together Period for which core development team has worked together Represents number of international patents owned. International patents Foreign patents Represents number of patents which are pending. Pending patent Refers to plan 2013 of equity based compensation arrangement plan. Plan 2013 [Member] 2013 Plan [Member] Disclosure of accounting policy for unaudited interim financial information. Unaudited Interim Financial Information [Text Block] Unaudited Interim Financial Information Litigation [Abstract] Amount of periodic rental payment required to pay monthly till the lease expiry term. Operating Leases periodic rental expenses Corporate headquarters, periodic monthly rental expenses Represents the percentage of on-going royalty awarded. On-going royalty awarded On-going royalty awarded (in hundredths) For an amount of damages awarded to the plaintiff in the legal matter, the daily payments awarded for damage infringement to the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Payment Amount of damage infringement payment awarded up to final judgment, per day For an amount of damages awarded to the plaintiff in the legal matter, the daily interest payment awarded the plaintiff up to final payment of awarded damages. Loss Contingency, Damages Awarded, Value Daily Interest Amount of interest payment awarded up to final judgment, per day Number of financial institutions holding the company's cash and cash equivalents. Concentration Risk, Number of Financial Institutions Number of financial institutions holding company's cash Represents an investment program funded by shareholders that trades in diversified holdings and is professionally managed. Mutual Funds [Member] Represents warrants designated as Series I Warrants. Series I Warrants [Member] Series I Warrants [Member] Term of contract for which deferred revenue is recognized. Term of Contract Term of contract Amount of annual payment on contract received. Annual Payment on Contract, Received Annual payment on contract, received Represents amount of contract. Contract Amount Contract amount Contractual arrangement, generally for a defined period of time, entitling the entity to use the rights and property of another party. Examples include, but not limited to, licensing the use of copyrighted materials and leasing the extraction of natural resources. Araya Contract [Member] The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants [Text Block] Warrants Date the warrant is to expire, in CCYY-MM-DD format. Expiration date for Warrants Expiration Date Document and Entity Information [Abstract] EX-101.PRE 11 vhc-20140930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 image0.jpg begin 644 image0.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH MHH`*2D)QUJ)IAG`!)]:ER2"Q-FD)_P`FH/W[GJ%%-:U9^6D8_2LG4D_A0]"1 MIHE/S,H/UJ-K^W7_`):"A;*'&2I)]Z46L(_Y9K6;]N]K(?ND7]I6F?\`6?I1 M_:=KG'F#\14_V:'_`)YK^51/90OPR+^59R6)6UBER=21+J%\;77GWJ8$$<8K M,DTB(\H2A[8-0D7MB=P/G1]_6LGBJU)_O8Z=T/DB_A9M"E'>J=I=I=1@H>1U M![5;3H<^M=]*K&I'FB9--,.WT]:.?3%(P#*<]QCBO)KN?4?#/Q?T^VO=6N7T M;44)A1VX63TK4#UL'CTH[4PY]OI7G_AJWO;_`,>ZQ>IJMRVD6S"**`M\I?\` MB_*@#T$H&Y-``'2L;3=1U:YUW4;2\TWR+*#'V>XW9\VML=.E*R`6BDHI@+28 M%%&:`%IO>HFFC218W=59S\@)Y8^U<]XPT34-9TF4:7J4]C?QJ3"T9^5B/44` M=-@#L*:ZY'3K7G7PJ\3/J&@75EJUS)_:^G2,MYY[:] M_:5Y'HJR;+2VW<2$=6^E3**DK,#KS$;74$:/A).&'O6LG0_6J[Q[YT8CI5E0 M`.*YL/2]G)H;=R-V5%W$X7'6N$^*FA2:SX.>]LUS?::XNK9AU^7DBMKQ7J8T MZWLX\[1*I)$8F`:-EVD>QKJN-QLD^YQUKXTCO?AE#KT3#[1+"(@ MO<3'Y;>%?"&I6GCW4-$N`__``CUKMWWQ`\3Z5J=ZLT=G@0*JX50:QK>[\;:QX MY\1>'8==CMUMHU:*8)]S/0`5;\'S/;_%?Q+/-:W$=O>%5MY6C(5L=>:3PS=/ M!\8/$=Y-:7,=K=JL<,S1G:Q7K0`GBW4?&&@ZMX6M(M7B?[7((9SL^\W=JM>, M9O$?@E+?Q!#K+WEKYZQW5I,/EVL<97WJ+XF2R'Q5X8,%G\:^,7T:UTJ&T)6?5'"HQ&3&F, MDXK"O_%%_HNLZ9+IES>:I:W$HAN[>2$YC_VP?2F>-=,U#6-$\.^)M"MI)KS2 M&5WM67#.N!N&/6N@TSQ_#J\<,=IH=\MZY`>*2':(_7)H`YCQ=;ZG<_&+0H+? M5IH$GMV>-0.(Z]-TFRN=/LA%=7KWDV,DN--^)/AOQ!+;2OI\43Q M3/$N[8Q]1Z5L^(/&HL=`EN].L+RZNF&VWC6(\G^]0!Y]\4K6.S\5G5]&2X;R MXU&MK;?=\G/?W]:]?T"ZT^\T*QGTO9]A:)?)V=`,=*Q?!VCVC>%#YRO-)J*E M[QIEPS,W4?A7&>!K^[\&>)]1\,26MY-H1F)L[GRSB,D_=^E`'L8Z4M(/NTM, M#C_'^BS:SX9<6I(NK9A-$>^1VJIX(\=6FOVBVET5@U*`;)HI.#GIQ7:@`IUS M7">*OAK9:UE*G*/)/Y,[X`=L4A->31W/Q'\ M,J(Y;:/5;=.C`_-BKT?Q5E@4C4]`OH&'4A":%/N@>'EO&S/3-J\?*..G%&P' ML/RK@8OBSH+K\T=XA]X34Z?$_0Y>(TO&;MB$U7,B/931VQ`.!^502 MW%O`&+LB>O/-8R:=KET/]-U)8@W5(%_K5ZUT.SMOFVM-)W:1LT]1-);ZDJ7J MW`VP0F53_$PP*NQK\HW*N1Z#I3E4*N``!Z`4ZF2-"@#@`#V%+M7'W1^5+10` M4444`)BC%%%`!BHWMX9/OPQM]5S110%R+^SK3_GU@_[]BG+96R?=MX1]$%%% @!5V3!0HP`!]!2T44$A1BBB@`HHHH`****`"EHHH`_]D_ ` end EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0`2PA3]O@$``&`1```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/@S`4AN]-_`^DMP9* M4>AX:\X3V#T;*N M@@486RJ9$A;%)`"9*5'*:4H^)B]AGP36<2EXI22D9`66C(:7%X/)2H,-_&YI M4U(XIQ\HM5D!-;>1TB#]3*Y,S9V_-5.J>3;C4Z!)'/=HIJ0#Z4+7U"##P1/D M?%ZYX'GI'Z])#%26!(_KA8U62KC659EQYTGI0HH]E7"C$/F=[1I;E-I>>0Q" M.Q6:F=\%-OO>_-&84D`PYL:]\MICT&5%OY29?2HUBPX7Z:!4>5YF(%0VK_T) M1%8;X,(6`*ZNHG:,:E[*+?W`S@S2O%];^$2.!`G'-1*.&R0D@X[I!P])%PW"/A8#$6$"R.RK!8*L/BJ0R+J3(LKLJPV"K#XJL,B[$R+,Z: M8''6!(NS)EB<-<'BK`D69TW^RUF=SZ]`V^O?/].VS)$`9=VJ`GOFGYYUT6/* M!3<@WIWQ2?_L`#]K'^+P.7ALE+:^(V#@]%/81OYF=ZA](3"NA%WH[PK/.T7? M33A=<"^]0].O$"`ZM&G;'QE^`P``__\#`%!+`P04``8`"````"$`M54P(_4` M``!,`@``"P`(`E]R96QS+RYR96QS(*($`BB@``(````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`(R2ST[#,`S&[TB\0^3[ZFY("*&ENTQ(NR%4'L`D[A^UC:,D0/?VA`."2F/; MT?;GSS];WN[F:50?'&(O3L.Z*$&Q,V)[UVIXK9]6#Z!B(F=I%,<:CAQA5]W> M;%]XI)2;8M?[J+*+BQJZE/PC8C0=3Q0+\>QRI9$P4P>J/OH\^;*W-$UO>"_F?6*73HQ`GA,[RW;E0V8+J<_;J)I" MRTF#%?.&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;',@H@0!**```0`````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````"\ETUKPS`,AN^#_8?@^^K(_1Y- M>QF#7K?N!YA$34(3.]C>1__]3+>E*W3:)>@2L$/DET?2&WFU^6B;Y`V=KZW) M!(Q2D:#);5&;,A,ON\>[A4A\T*;0C368B2-ZL5G?WJR>L-$A?N2KNO-)C&)\ M)JH0NGLI?5YAJ_W(=FCBF[UUK0YQZ4K9Z?R@2Y0J36?2_8XAUA_K'!]L_MJB"5>.D._6'7R%&&)0[4H,F>BWO#R]68RB8B&O MBX$QLQH8DW*XX0!)1\V&I!-B#>$Y3Z>E/#V!8L*=(3)!"H8DTI?JF4J_]5V] MBF0S9U8SIQ(%BED-*%(.-QP@Z:@I,QTUI>APYXI.U:`^T[?0WUT%,Y)-_&>R M_J)42LGAMAS2<;@S128*V-&0;-2$NVXF5-UP&P[I-\"M!D@YBGNJ4/18,>C< MYROML'@.+L[\_FR"%]M4X0"W_P'M?TOFMH(E18>[RYT9#D@%N-$"R4>PS M#CGDJ$'G41^.3;RY][?>K_5/W%>W6)AERM>,0F,LI3)LQ!1+&$&K"O-SS39/BPX@E[/22R:);-:0J^ M=PFQ$JK--.:&Q0-R#4.Y98T'*L_&.4_@;=]W?&(/JY"_E!6S%QW!:?0FGWU<@'`]ORU9+'9@/O'<>IGOU@ M?+TQQX<@;R/]LH*P3GFU1!GO6)$0.A5.A>%F'\[$H?I<0@N+JL\@F4LL=<_A M1LUBMS".59Y>YI/I/)A.0K@+7IYGD]$"!N/1\VC^-$4JD+F6\3XG`PXJ-SZ2 M*0M^@9M@`:9^8C<]I-*[T,P_%6P&JE^5YOIS,A[*A$M3HH$SC7/-!=,ZG#`= M*9X5W)8]&U/--5+Q;I&;V[:;($]3JO:A7(4!7PL.FX(*$XZB2.;"8!G8OE6H MN[;,#'9ZRL(%W<&NKKOB]=&D?GO2DTQ3;HKMA^?X0'>UD.NT)P5&1N\AA&1Q M"`)P..ARSZ)5_0::'3:75"G(V%@3REZOV<'PF1N^[JSBXSD=YH+\3;,_.80+ MIQ_MB)@SMP/:^9Y@T(J]7_ONH'9>"*/F8];<#FS'DD&#WY)&AWU,E]O!ZSRE MC2B8+[<#V/DHT(KZ),#,N1WH,*FP=PSE"2:A.%NKBL*@?:[5R)Z:C,'S.N#] M#]V#$HK@81QAT#)1=>.$?0REUX&R!OF$^UXC^@DJ6T"?DF@4H.31+AL#/YF( M)A'\_8I+\?LH2VL?__W#OP```/__`P!02P,$%``&``@````A`/J*CNBP!``` M0A$``!@```!X;"]W;W)K)F*?58>-_H_?S_-%KI6-TFY3W)1\HW^SFO]V_;7 M7]8743W7)\X;#13*>J.?FN:\,HPZ/?$BJ>?BS$M`#J(JD@8>JZ-1GRN>[-M! M16Y8IND919*5NE)858]HB,,A2WDDTI>"EXT2J7B>-##_^I2=ZUZM2!^1*Y+J M^>4\2T5Q!HE=EF?->RNJ:T6Z^G$L197L'Y"5O_A*7WWEV/#60;A<< M26.K_7O$ZQ0B"C)SRY5*JV=J'E>OGUD%CU+DNU1IMVGB%D*8=)5`4 M7]<&R@)3PIXB`RAEH_Z+80S#0^*>(;,'CJZV(%C4E@UI_SAAO0LYB+CP\?N" M*<7"C'#*\):8$DTI1"2>,D8BR*@]->I\6IF]43D(:G"4"]_$`@&Z?KL5IL1Q&+]'3K.-U263"" MAQVNEN',(<4:H>%@@!I$.'/L83Q*').'^J@<'_2GK@)HUQ]>T*8H:)4W>C=_ MFQ16B&"'F(\0:I&Q,4*9.<#8FCS81]9NKS2FK@'($EGA0?ZX/77ZC^TMR*(*6']#D'=*`H:WP`B! MLV&/:"LAQJCM#J6*#:N@4@FR2^@>R.8$-=MH?NS)S36U)("21.$<7I=AI/ M",/*P![E^?YUC^I6@#R2#3V`CE-Z5,L"VC"?!"$D!,LD"A$A.*,\=66*7\%\ MNO!4RZHZNH)71Q[R/*^U5+S(=M2"\%^_5:URP%;09T&[1+Z/9`O=-L%7`#K8 M<'D#3G/J2V4CVP>FC$N>V:=J*!WK7]>(+?*CAT<.8&ULK%==CZ,V%'VOU/^`>%_`?"0A M2K(:,IIVI5:JJGX\$W`2-(`1=B8S_[[W8IL%PV82J2^3!!\?CL^]/F-OOKY7 MI?5&6UZP>FL3Q[,M6F7-ZT-,V[257I^IZW M<*NTJ&W)L&[OX6#'8Y'19Y9=*EH+2=+2,A6@GY^+AFNV*KN'KDK;UTOS)6-5 M`Q2'HBS$1T=J6U6V_G:J69L>2ECW.PG33'-W/R;T59&UC+.C<(#.E4*G:X[= MV`6FW28O8`5HN]72X]9^(NN][]GN;M,9]$]!KWSPW>)G=OVE+?+?BIJ"VU`G MK,"!L5>$?LOQ$4QV)[-?N@K\T5HY/::74OS)KK_2XG064.X(5H0+6^KQ'L^1\T(@MJQ%JBZ$0_^"[:-P1IA"D(C!H* MFN\9[0V"H3M&WD3C%R42$PXP!F*O$:84F#.4@O4+8#/6X:1')&!J2_R($@2/E03$M$-BH"7[CC8WD$:8IA#8+?>[ MTJ$_V\T*=$M-#YG(F0GDSSSQN4,O<#H;@62[1TXD5'N?3\^L0]S\G%-,EV']@6Q MX4U")$AW^TPB*L2TW0EFY4#5[9W7H<<.!;$9B@HT'P#]X,2>A\(9ST/FSHO- M8%2@'R:C&I\QQ9DXII1M!#H4UDWD+.@2\,\4P=!?!?0#U//7YE]HZ@`U3>.O%W(\W1%VQ/= MT[+D5L8N>'/`JO=/^UO-DX_SC><)W'8Z7O.Y#[>@&?P3B6%"/#.2^)Z^.+D] M&5Q%5HY=5'_A"LZ6X$!R;@RM)]/<,5E<)IV7,` M?&1,Z!]H0G_IW?T'``#__P,`4$L#!!0`!@`(````(0"-NVK"B08``/0?```9 M````>&PO=V]R:W-H965TGA59CH6U+$-2-KM_WZ&&EL610BK-0WSAX2'/S)`\%A\^ M?J_.UK>B:9L[:MXI+7A_+RO+?__NOSAXUMM5UV.63G^E+L[1]%:W]\ M_/FGA]>Z^=J>BJ*S@.'2[NU3UUUWJU6;GXHJ:YWZ6ER@Y5@W5=;!Q^9YU5Z; M(COTG:KSBJ_7P:K*RHN-#+MF"4=]/)9YD=3Y2U5<.B1IBG/6P?S;4WEM;VQ5 MOH2NRIJO+]5U=@>*I/)?=CY[4MJI\]^7Y4C?9TQET?V=>EM^X^P\3^JK, MF[JMCYT#="N'_H`_5,6K^WH MO=6>ZM=?FO+P6WDI(-J0)Y&!I[K^*J!?#N(KZ+R:]/[<9^"/QCH4Q^SEW/U9 MO_Y:E,^G#M+M@R(A;'?XD11M#A$%&H?[@BFOSS`!^&]5I2@-B$CVO7]]+0_= M:6^[@>.':Y)0MW'8_[X>8](M2#X)EIX+(MI"K7Q[=(/P8?4-\IM+3(28T+8&3+!1(?$- M(K(I>)/;%_<^3.V2WA"BE$#2H`LR1W6Y4(/SU7.3(3I1&62.T13#U2G%4T2P M52')%$)(TBEB1*(HA=JD2CW(I%ZIZ`0K8I0,=\3?!S]"#!3MD#!?E1$;$8D1 MD>H0BDZ8R%BG7I\`[VT(XC!W-URKLX\0L^G+E7-.*BM6FADCO9-QL[_U:?Z4 M9L_WAK$539"GL2:Q^LQ5*CI1;63R$6)@$H-^FCLC(D&$C\O9#5V74*0Z"D5F MH,K4ITZ`J3P2W0@Q.GE&1&)$I#J$H@\V-9I&\Q(4G4Q+$#$ZG49$8D2D.H2B M4WBKT6&ASZ,`TSRZPS+`+08Q6&)\'?AKLLIB!'A]#9*V1.DS05>@\D"I4@C9+8#$DD)%S/I3M]JU75)OS`J$27Y9*ABU"/ MBV`H%JD105J-1D@BA[II=#:D)E(*V-Y3KBH5#F&D5+\8&?H)52$9.I(@K4+D MT4`2R2(5ZR#,495+>S"N3D,02H,VR@2/5Q[!NMV0/3"5B/IZJ2&$JEHM$"Z**I*J$LAN7ZL)LBEXTF_1,X0C2Z(C-D&0& MXDZ\X`SH'E55KW`HBY,01I-5HA"1FEE0+457.N"'SD2*>1H-:_9$B05JU.A?3GSJ)F275 M0E2UPG(LKULT*(:Z-1J=F!LAR0`1#[.)@4Z'QOL!_M:Z?)<-XC,V:$L&CR1( MFT6S#9(L-Z]''[RDVE'4%!(/I'<%'#V+DL+M9(LU&IM8\FBBD)@AJ1:BJA0^ M8E2HRYP>1_=A6)8WAS-73>CT)(]6K9$EU;(H:L5#:*K6_&"Z[T6VW.W=B/12 M(@F2ELUCW//HS4,L,3JY"VA2+8VJE]@B?0W#M>?D:!D]II$Z$21U;EC`&7G> M$DL>K4PCB[B$%;.99T&5>,F*]WY5T3P7<7$^MU9>OX@+5`Z/VX9O\7(W8CNX MC(,[-?)]`I>^_?>KH0'N7*_9<_%[UCR7E]8Z%T>@7#LA'"0-WMKBAZZ^]E=K M3W4'MZW]VQ/&PO=V]R:W-H965T/ITD`W:<6V$:@N<1#%&O&6J%.VZP+]_+1\F&!E+VY(VJN4% M/G*#GV:?/TWW2F],S;E%P-":`M?6=CDAAM5<4A.ICK>P4RDMJ86E7A/3:4Y+ M7R0;DL;QB$@J6AP823`-)N6`A*XMB/-JP(_)_E\B,ELZOOS1_"]N7A'IE;[+UJ4WT3+H=DP)C>` ME5(;!WTIW5]03&ZJEWX`/S0J>46WC?VI]E^Y6-<6ICV$0"Y77AX7W#!H*-!$ MJ;?!5`,&X!=)X4X&-(0>_',O2EL7.!M%PW&<)0!'*V[L4CA*C-C66"7_!E#B M3/4DZ8D$GB>29!@-TN%X<@<+"8Y\P`6U=#;5:H_@T("FZ:@[@DD.S/]/!"X< M]MF!?0F8-3"%W2P;#:9D!ZUC)\S\%I/T"`*BO3*H72J[GF8PF?<=N*(W#N*> MWIN8-RP`PN,,,><:4,D(]'=T4%AG2] M@VSTRA\&ULE)A=CZLV$(;O*_4_(.Y/^%I(-DIR=/AJ MC]1*5=6/:T*"<-*VB] M-9V%;1JDSNFAJ$];\^^_TB\KTV!M5A^RDM9D:WX29G[=_?S3YD:;-W8FI#5` MH69;\]RVE[5EL?Q,JHPMZ(74,'*D396U<-B<+'9I2';H)E6EY=IV8%5949NH ML&Z>T:#'8Y&3F.;7BM0MBC2DS%J(GYV+"QO4JOP9N2IKWJZ7+SFM+B"Q+\JB M_>Q$3:/*U]]/-6VR?0EY?S@O63YH=PKXIK7;=`;]4Y`;F_QOL#.]_=(4A]^*FH#;L$Y\!?:4 MOG'T^X&?@LG6;';:K<`?C7$@Q^Q:MG_2VZ^D.)U;6&X?,N*)K0^?,6$Y.`HR M"[<+(ZMZ04+?VE[#N#&GK`V+;BD:>17UM+J M7X0<'M0HXO8B`43?C[L+=^4[?J!7L3"B+L$X:[/=IJ$W`ZH&KLDN&:]!9PW* M0V88QYCKCU*%\+C(-Z[2:4$6#-;G?>?Y_L9Z!T_SG@F169K&R`0K$8D&A*?- M=>/AQ'V.(TY)!F*8DN*)SCH+J'V@,-0L)-U&N"O6/EKN0J0&35E;XT%BG&XNF8O.33,<\/1,M3 M'(7?,:B[Y4*JT&&>3Y7#8JJS*X?(/+YR=]M&6B+6$@D22QLM7=B2.ZE*0<@? MNMKS^7-8SG\I.A\BXW>!N8XM+_=TV%G*P_%T.(#GN"B>",,S\12''WLO9`U] M=IHU[^OZ=LXI<2B'#\<838U#4*B58AG2HXP30&P0.^_9H\ MV]0W.8?EW*4V'2*CR"W2$K&62+1$JB($!UY%!YZK`CY);/A>(*URB(S*"2T1 M:XE$2Z0J0G#"@6?]\\70T5(U!/>':5?'80_AK>"MIF6(;;`'%"[%.HU$KY$J M$=$$OCF:W!'/U8.#6ZKI\\\+I'8<]I`BUTB/Q#T2=+WU)5CZTF42O4:J1$0[ M^(YI8H>Z03BXOQ)MD#="/:2T`7442*Q72?1(JD1$(_B^:6+$DW6!NRWX';<@ M\T;AJ+9D_6VB16*]2J)'4B4B&@*K,S5$4QF^K<-X:!^`KP24[D=^SYE34S"C)$23MQ1*B:O`[`QZT]-*]A^YI"]\'NG_/ M\#V(P$NRO0#X2&D['/`+C%^8=O\!``#__P,`4$L#!!0`!@`(````(0#>CF;; MD!,``)*A```9````>&PO=V]R:W-H965TWK]\>5\-JU_NCL_ MV^T?7K\]/&]?-U_._]WLSO_S]?__[_/O[=N?NY^;S?Y,(KSNOIS_W.]_W5]> M[AY_;EX>=A?;7YM7Z?F^?7MYV,L_WWY<[GZ];1Z^'39Z>;[TKZYN+E\>GE[/ MHPCW;RXQMM^_/SUNJMO'OUXVK_LHR-OF^6$OX]_]?/JU2Z*]/+J$>WEX^_.O M7Y\>MR^_),0?3\]/^W\/0<_/7A[O6S]>MV\/?SS+D]B'?V3"OSP] MOFUWV^_["PEW&0TT>\RER]*E1/KZ^=N3'$%XVL_>-M^_G`?>?=`H%,\OOWX^ MG*'YT^;W[NCO9[N?V]^-MZ=OW:?7C9QN>:'"E^"/[?;/D+:^A4VR\65FZ_KA M)1B^G7W;?'_XZWD_WOYN;IY^_-S+ZWTMAQ0>V?VW?ZN;W:.<4@ESX5^'D1ZW MSS(`^>_9RU-X;<@I>?CG\/_?3]_V/[^<%VXNKF^O"I[PLS\VNWW]*0QY?O;X MUVZ_?5E$R(M#14'\.,B-C#[N]R_\NVOO^N8#46[C*')M)E&*%W?7U\6;NUOW ML922`PI/9308_^;"*UY]9"A>B5 M3J^F4Q>37$5AE"`,22D+" M:S2,6TT:WK?QS$UJB4@VJ4<-T<49QFCHAJ9N:"4-)_?2SHJ"=V..I).89"1= MW=#3#7W=,-`-0]TPT@UCW3#1#5/=,-,-<]VPT`U+W;#2#6O=$,07Q?$+KEZ\ M(+TFDG,6Q)?`^\L7Q-?`44O\FA^UQ"_Z\:[TM17$U\'MH93*U9^F@.1E)@4* M4CGRRV=RQ8=;F5?\S:UY090CB@?MI M9H4.TLH2-=AV5N@@G2Q10;I9H8/TLD0%Z6>%#C+($A5DF!4ZR"A+5)!Q5N@@ MDRQ10:99H8/,LD0%F6>%#K+($A5DF14ZR"I+5)!U5N@@09`U*DH0IZ"4IO?W M')5@09R$QR:S*\["($Y#:Y@X#X^-SO<@)Q&/S.5QX9*WZ_^A<(5;A84K*;GE MJ.%0%P]ONA7=4$TV>3^+!4\5NYK>J*X;&GE1U`2@Z6!:>4:]J&T'T\DQ_I59 M?;L.IN=@^@YFX&"&#F;D8,8.9N)@I@YFYF#F#F:19]0<<^E@5@YF[6""(`^I M26$09]=QRA=\C>*,LZ.\+,Q$BM/0'BE.31.I?)8[ULP$I^"_IZM1B(JJ$-EG M3J$V"E#4<%2`=$-5;U+3HJX;&GJ3IFYHZ8:V;NCHAJYNZ"4-1Y715S.KOH,9 MY!GU9C9T,*,\4S!KVMC!3/),T8PS=3"S'..I6CUW,(O$)&]:2]VP2AJ.7@F] MI[6#"8($);L*RIF62J8EO4(MNP_BJ];(.SW&(+Z2W]^?@^-+V4@[>2!BO/_; MTR[4\F3G:"I4\-5+48Z,'%TZ75(%MH*BBJ*&HHZB@:*)HH6BC:*#HHNBAZ*/ M8H!BB&*$8HQB@F**8H9BCF*!8HEBA6*-(@B8<-8%G'8!YUW`B1=PY@76U#/J MDSP*_D!]"O67<[FG2VM/H:"FX^7(V.H3BFI6%/3]7BUK5!VLHVB@:*)HH6BC MZ*#HHNBAZ*,8H!BB&*$8HYB@F**8H9BC6*!8HEBA6*,(`B:<=T&%H^1DGLJJ M@!,OX,P+K*EG5"AY-ON!"A5J7:'4)+T<&5N%0E&-Q-WAQRC>E?PQ)]XUC%!' MT4#11-%"T4;10=%%T4/11S%`,40Q0C%&,4$Q13%#,4>Q0+%$L4*Q1A$$3#CG M@@I'B;/.DKD!)U[`F1=84\^H3N$"C>.?S=KO[T*MJY.Z]2]'QG*,%1352%P? MJM-UMCAA@#J*!HHFBA:*-HH.BBZ*'HH^B@&*(8H1BC&*"8HIBAF*.8H%BB6* M%8HUBB!@PBD7<,X%<=)9$C>H\5@X\P)KZAG%2=;8?*`XA5H7)_4\L1R9XJ&P M^"4UL:I$O5'9\6X\U5T]WOCN2CW7JAD;ESSUA+:>;/Q^ZZDFI@T4310M%&T4 M'11=%#T4?10#%$,4(Q1C%!,44Q0S%',4"Q1+%"L4:Q1!P"3-LY-7>Q`GFZW< MI`EW.DJ<=;8H<>;%62VS"?-.)TCS+EQ1YATEO5&*/%FL\X%:=."Z&*F$+\?( M,O@*DVI*PO'?Z`5"M;3[Y$FL,VDP:3)I,6DSZ3#I,NDQZ3,9,!DR&3$9,YDP MF3*9,9DS63!9,EDQ63.1-8)A[GXYM^29+!)DXY",LI"0XSBD9."0D[+8T+8O MLWK)SP,_4KU";E8O[UI-:,KAVF7[6:TPJ<8DJLY^ICK7.$2=28-)DTF+29M) MATF728])G\F`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`9, MADQ&3,9,)DRF3&9,YDP63)9,5DS63*2"8:[)+(R-0T)*!>,X#BDI%8SCV)/2 MK&#A"MGC"N8X"XL6UAK/Q(IJ%4?9P]6W%295)C4F=28-)DTFK9B4HB]#NKA6 MY;T-_1W>19=)CTF?R8#)D,F(R9C)A,F4R8S)G,F"R9+)BLF:B=0PS#*I86P< M4E%J&,=Q2$:I81S'GHYF#0N7P/X/-2Q:.6O6L,R*"EQ>6_&05)G4F-29-)@T MF;1B$GT22?VDHQUW1@7.*UT4U2GK\`ZZ3'I,^DP&3(9,1DS&3"9,IDQF3.9, M%DR63%9,UDRD@F$"205CXY"(4L$XCD,J2@7C./9D-"M8N'SWN(+!?62TVM>L M7.H!5=G#)<$5)E4F-29U)@TF32:MF-Q>11^BO+B]JWU2)Z:=,>&GF=[_^)DM M.KSC+I,>DSZ3`9,ADQ&3,9,)DRF3&9,YDP63)9,5DS43J6B8>U+1V#@DJ%0T MCN.0HE+1.(X]28V*YH?K8-TKVH&;JUL+1?TIQAC9GNHSJ3*I,:DS:3!I,FG% M)*YH5Q>E*__NO5A=7:F%)NV,]ZZ+I:,_ZD01B6SWW?Z(=>S-#4!*< MNA/]:=G#NW'?Z+Y5D^J!$?WNYDHM"AP:_=[5[9VZG1X9X6]*ZFG@V-C>]_3^ M)T:__'*,*W7X4Q,4_3LUPEDZ@/>?JJMK\K*XKJR779CU#T M\2)5#2IIYWL$=1554Q+FF=J^EG:>W+Z>DG![]MLI9TG]]QFTDE) MSL%UC4XU\IZMLV_K'!B=JJX,C4ZUSY&M4A29]@X)(_4&8[CD$129SC.>S+E'9=99Z06?:3.A%S/ M@-0;4MF/4%1G/JE"44E[\\9V>,>NIB3,11V@EO:>#%!/R2&`KPI9P^A6EWG3 MUME*.T_NN\VDDY*\X^N:O7KP/:-;#;YOZQP8G9_41&AH]*JX(UOGV-8Y,3H_ MJ=G1U.S5QSI+NT^>[CF3!9,EDQ63-1,I.4ERG#PD*3EL'-)(2@['<<@F*3D< MYSVG\H[++#GA$M0/3&VB%:OFU$9-DLOAK]J3NF2YZ<)UKU6*48N!G(QTDJ4J M2]V(4;@KW:F!-@R0=]-U?""Y-UUX(&T>9\<81NY-U_$X_%O_3MW\]=*=A#7L M^"N*XINN9)AAM[[I&1B[EYLN-5,=&OVY-UW'X7-NNHS1Y]QT'?>'-UWJZ*;F M`(K^C9HIS=+#/WDMS)DLF"R9K)BLF4AE2L[IR4.2RL2FXF"27+.DDCP.XGTE M^6:+DZ1#9D#U'C M$'5C%%XIDQ`-`^25I>,QY):E"%B.H\WC[)C#*-RJM.P:_;?%6S6W[*6[.%&4 MDD'F%Z7C7C4!&AI[]@MZIC(R]JPV'AN=-S?J36-BQ)9:H^;34[-?7AWSL_6S M-/S)Q)TS63!9,EDQ63.16I2\%BHF^,HW>E?F=M( M8X2)JK*I:>MLI9TG+YPVDTY,3IZHK@FR1]!+=Y)S!'U;Y\`(G3DSZ3`9,ADQ&3,9,)DRF M3&9,YDP63)9,5DS63*2"8:Y)!6/CD)!2P3B.0TI*!>,X]J0T*UBXNO,#%2Q: M#&I,I_1;7=E/5HR&[_%%_Q54,_]J2G(CU-+NDQ'J,8D??%W?J#NB M!H=H,FFE)'><;1A$Q]A@S&3`9,ADQ&3.9,)DRF:4D9WHY MMW4N;)U+6^?*UKFV=4K]L6:*U)ZD_^3+++^N/#*GKG0I/$F0W(M4GB=!@"27 M+%-765N4["1OI$;%";_*Q:@X;JLD#YNI;ZK*?%%HC"PCK3"I,JDQJ3-I,&DR M:3%I,^DPZ3+I,>DS&3`9,ADQ&3.9,)DRF3&9,UDP63)9,5DSD=]V;EL7?7@F M$I0=C$-"!@X9&3BD9."0D_)[SFW'95:R<#VE^]RI$"V_-.=.^KEXC*P5S+:, M,WH8Q5%J3.I,&DR:3%I,VDPZ3+I,>DSZ3`9,ADQ&3,9,)DRF3&9,YDP63)9, M5DS63*2"18ETDSZ3`9,ADQ&3 M,9,)DRF3&9,YDP63)9,5DS43J6%1(D4U[)/O^6K)B,S!#.$5]9=B2A7#9)09 M&!N'=)0JQG'L"6E6L7#-YP=F8-$241E"^OS=]S,S,%Q'6BD@J3*I,:DS:3!I M,FDQ:3/I,.DRZ3'I,QDP&3(9,1DSF3"9,IDQF3-9,%DR63%9,Y'JE212^&CJ MD_J)K92NXVXURY"RE?2^9[-ZCBQEBXU#'DK9XCCV3#3+EDR-/E*V0FY.N@K7 MZH%VN1`AZZ0+296CU)C4F328-)FTF+29=)ATF?28])D,F`R9C)B,F4R83)G, MF,R9+)@LF:R8K)E(V8H2*?H>M,P/N*1N'??[MP65JU*Z,!.E=+%QR$4I71S' MGHU1Z;K<_=QL]M6'_7?VN/WK5293X:E(6\_>-M^_G)>] M^XIW?IEIKWKWM;QV^7:<>_GVFYPMY#MH[N4W*.;TE/W[+?5_+::_Y] M+:^][M_7#^V7Z4'LOG[^]?!CTWMX^_'TNCM[WGR7P[RZN)7%MV]//\*[Y>@? M^^VO+^=RV_W'=K_?OAS^^G/S\&WS%@+!W[?;??(/.1F7O[=O?QY.Y=?_"@`` M`/__`P!02P,$%``&``@````A`-Y`:J-U`P``5PL``!D```!X;"]W;W)K&ULG%;;CILP$'VOU']`?E\N@=Q0R&H3NFVE5JJJ7IX= MS^?<=V<`*T)-T\D."<.3YG9@RSN'\I"^>9<$%9E:#`]9%#JHSE MM-HEZ.>/Q[L9QL@:*#2VH?-6DR"FS^/.N8AQO"O#] M$D0X:[CU38^^I!EG@FVE"W2>$=KW//?F'C`M%SD%!RKM#B?;!#T$<1KXR%LN M=()^47(4%[\=L6?'CYSF7VA%(-M0)U6!#6-/"OHY5TL0[/6B'W4%OG$G)UM\ M*.1W=OQ$Z&XOH=QC<*2,Q?EK2D0&&04:=S163!DK0`!)NWSC"Q+2RYTPNUR%;@E MURQ$"DH0U,\JC`*_K7%E,$,NKB+2!J'/B.5OZ9^\ M1;\*ZNH_'Q53!8,9TF\0,WV"P\G,UQ^K4K.D0RPM'_`X^/\ZJ*"NCVXW&4QD MGC-M=>OFOW,=.YV6#B%:^M4(T'DT7N\C%=35'[8UK@QFJ`Y7$:E!C$VE(JB3 MW:/E8=[W$$$+#I\%%=3U$%E^TTL&,^3A*B(UB%.WA:K7["8M$S`?O*$2.JIK MH],,JQ-HR,=UB!I@5,:FOB['W)W.6Y_IA[MS"QAG9EXQ;^*2\!U9DZ(03L8. M:A8)@<>NVCGI(50OK,[Z*HCAK=E?7X_BM<9[-@#&FAKOR%?,=[023D&VL)7O M3J$?N!F,S(UDM9X+-DS"0*-_[F&`)?`^]ET`;QF3S0UL[-F1>/D'``#__P,` M4$L#!!0`!@`(````(0`2U45]HP(``)@&```9````>&PO=V]R:W-H965T[F,1MDFI+7XRY/AS./5RN%S=/JD6/PEBINP(G48R1Z+@N95<7^-?/ M^ZMKC*QC7C@ M2Z6-8@ZFIB:V-X*5PR+5$AK'4Z*8['!@R,TE'+JJ)!=WFF^5Z%P@,:)E#O3; M1O;VP*;X)72*F8=M?\6UZH%B(UOIG@=2C!3/O]2=-FS30MY/2-N1$56!;Y-\G6&R7`S^_)9B9U^](]OH MW2_E\) M"5D-)MTQQY8+HW<("@]TVY[Y,DYRX'W;%K\V"OSAOOY:X.@1,4=2P)S+I7CPD933P#H$CG>>O[US^IZ=/1A*])7]*8U'WN!+P,!S M/*+L&+'^%^+(%;@"E[OBP04&S\=]4WI2'*N`R8;BHMDTGI_4%[0*3Q(`*9U0 M^J(]*`N=(!2Y$J86:]&V%G&]];><`O,8'1O0[<17S4E\1?/5$"?C!V@,/:O% M-V9JV5G4B@HHXV@&HDQH+6'B=#] M:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`"NW2?)EN'K0/Z%?9(2K(8RTO2 M!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM=KGJ(Q#X?TSAH>W>&_4L;'I(* MQV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CMA4HEFY6*]&$8R\L\(3',3;B( ML()7$53&`A\!W8A5UJK59B7"-/90C",@>WLRH3Y!0TW2V\J(]QB\QDKJ`9^) M@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM M+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E;G4ZGT4IEL40-R#[6E_`;U69] M>\W!&Y#%-Y;P]?O/R\1?E>%G$__K#)[_\_'DY$#)H M(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B6^0('?`(=#.&<24G(W&^%<,0 M4V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`->G]UW9!V$8J9H"><;8>0`]SAG M'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/'M;U9`E4S"TK']MV0.&+N,QPK M')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U,2TTRI",GD!:+=FD$?IF7Z0RN M=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L>FT1.[P:3?$ M45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`''*]U]EQ+'W:<7@CLT<$1:!(B> MF8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684ZK;E\*YLM[UMV,3*DF?W1+%> MA?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7RQ=?E12F&*JT;$MMKF\X[6MEX M3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8;^AQB*X?$:H^/[?"Z'LZ.&SD9 M(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O-B&:*HL,M5UF;V)S+P>2Y:C"8 M6Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.%BW21#/&8I#[2>B_[J&:+ MT5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8 ME+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M<:%"#E4H":G?%]`XF-H!T0)7 MO#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P'ZE0$+(/994FR ME)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE:!@SN9/RY[VD&C0+=Y!3SS:ED M^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IVO5F>[;U%1?3$HLVJ9UD!S`I; M02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E<)&$]!_8_ZCPF?W@H3?4(3^` MVHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*DK&G3UDE;+=NL+[C3S?F>,+:6 M["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3*0I#D^P@8QQCOI05/V;QT7UP M]`Y\-I@Q)4TPP:&PO=V]R:W-H965T&ULE%A= M;Z,X%'U?:?\#XKT!FZ\0)1D-5-T=:4=:K?;CF1(G004<`6W:?[_77`=CTZ3D M9:;A'E_./=<^QEY_>Z]*ZXTU;<'KC4T6KFVQ.N>[HCYL['_^?GI8VE;;9?4N M*WG--O8':^UOVU]_69]Y\](>&>LLR%"W&_O8=:>5X[3YD559N^`G5D-DSYLJ MZ^!G3T]Y+PZ08KGHBRZCSZI;57YZL>AYDWV7$+=[\3/\DON M_L)3FN.G=B!3-OUKH`*A.Q6P_8;^SM9I32TG>VZ%^C? M@IW;T=]6>^3GWYIB]T=1,U`;^B0Z\,SYBX#^V(E',-B9C'[J._!G8^W8/GLM MN[_X^7=6'(X=M#N`BD1AJ]W'(VMS4!32+&@@,N6\!`+PKU458FJ`(ME[__^Y MV'7'C>V%BR!R/0)PZYFUW5,A4MI6_MIVO/H/042FPB14)O&`O8S3!5T&)`B_ MSN(@H[[`QZS+MNN&GRV8-?#.]I2).4A6D%E4YH$^GU<&)8DQW\6@?BB@6VC' MVY;&:^<-%,PE)$%(9%L*HB/2*<(C`\0!>@-'J/Q^CF*0SM%SA_1]&0E"HEYE M45J`1`&'&!&Z+(\`@XJARCQHO1H@_@@0Z(KV%T*A!DOG4!'AC0Y5#4SQ/ M?W&"D&7?U*4?+_5P.@Z3F$1JN,8*9O5\5@)LL/+UUR8("7I6)(@]8[:E6CQ> M$B6G1BN\AY8`&[146IQ`"/%[6E%@DAI'O2`:2M(HP0J9KY0`&Y3"(2U20@@J M10,2&_%T'/=BSUE-B$Y/^.QH=LW<=-"=Q^[EJPT# MIQE!C%30-W>E5(N3R%<"ZP2%_8X(?J$?FK5&S)A0";D8NM@LO7BBW;6P3DNX M[WQ:Z-4:+365I5Z(0;V(%TUX81Q721BJ5:WSNLONQ8>3L3A]T^\E!M_KC[X+ MY%0;^ST-0C5J%&-3+#\TOBE3FP'C@1=>(W>7Z9&K[OF'K MB<3(1KJN,E&I&.:XZ;#D+M/OT;JA^6I^2+DNOJY<8[3D)+.;&+V?=^T!!$T< M5M9@6?[$<2]&KS"3)7`+HM&CQH8@;"W^\ENZ'Z7K&!C=2R3&[!X*>"6H4S,V MA/X`X\(JNNUL%+_1QQ82F)8K,B!M%H='N5(?$;C#Z2M?9&1O" MO(V43C>&0!D5KER)P:X^$$/A5`][:MWK].[:%\0AUNRLT;=$8E`\"H=?M8'+ MQ3#>&3S?I:HPG9JQ-PW\T?%3?WA^YAW<1_1_'N'^B<$IV5T`>,]Y=_DA7C#<:&W_ M!P``__\#`%!+`P04``8`"````"$`)4\+<^P"``!""0``&````'AL+W=OW%SJTMKK%K,7]:]S<%:WNP6-*&RM?!%#EM,7U<=8SC90-Y MOP0Q+G;>P\F1?4L+S@2KI`MVG@8]SGGB33QPFL]*"AFHLCN<5!FZ"Z:+P$?> M?#84Z#^Z!JXI>JQZ,)B"L\HL/IL9I*1B[E30$`IJ`=OQ/$]& M,^\9*EAL)?FQ)#05BV-%%.PE'N#M&2'S0\;35=^Q*3'4%SE[MGBRMQWPQN;PXNVS` M08:'<)>AE-B"LNNF)8F&\O7'`KLH,>"@R:Z'4V(3+O7-*^=:$@]PUMKB])J! MDYHXUVVD"K*PWEI8]YJ6G,8ZO69@C?X'2P596-;-EVO)V?XZNVS`J?%V\.RX MW%]*;$%%UA9JB=E?]E9>UAAXD_?@*;&%9]UTN99H/'CJCJ)XE)H9+$Q)&*5! M_-80!AR,JW<4;U!;>-8S*]]J+O)9FI.`>@KJ(='C%?F&^8IVPFE(!<\KWQW! MW<3U#-0GDO7#,%@R";-K.*SA787`I/!=$%>,R=V)FK+[MY_Y7P```/__`P!0 M2P,$%``&``@````A``;]GW-43```T.,``!0```!X;"]S:&%R9613=')I;F=S M+GAM;.R=W6[<6+;?[P/D'0C#!RT#)5E2ZE8DVQRK;F:BYRGXL$"`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`ZQ(GF4$2@QP)5A/'#*$*]-@^]^ M_>777]H7S0#=X#&PG-\9\V9W'9E%'`)I2K=7$VP^8CO/DJ>;&W(5"0*0E+)B MR<%\=E-,\S]EPU?)UF:/7_5__B.2/,/43V;9[24/1,?:,\E!J\+EH%D]=P8P MF*45M6U\E=P_W/+1VBL7[;#`W[RBQRUI^1Q6KVAWJ[>[W^_M[.\]@E+"#(=80!(3VFZG(Q\D@G>18@\Z=`R#4?&1.;)A=Y8.\H\@H M8G6+64QD[W8RS6ZP/J801=D10-<%(WA+XMH3\#L;VF+D?,R3?X5O.$-J08#9 M+`?/K/05]^C`&I0<%J-1.L4N13WH.)O.`&FE*(E&,.TI'WXL%T`:?M,C#=VY M[[E5&O&X]2T^_;C%+3[S\,H6[W_LLI;#A?,+4,.[X_=`A=,WR>G9\8>#BQ/P MQ+<#A^SK`).6@%H&#C"&3+*J#`PT![I'.3/.+T$7\68(]/O='B;CRW$,9\:H4S[ M63<.@AP+6`MK>+84#-D,+S,@G2&3KL=NH)8P4'N1[[-9 MHNFWK[].RWQ@1!WFH[F"$=U56R=5 M]UBS%>9Y41A(H%D(=_F#NF=\D4Z_-K!,^@^N`N47A?XGAQT\V1V^RM!YZ/29:, MA+:2ZT5ASNOXX;ZA@C8]8GF=23SH\!_'DH/SWR5OWI[^_#@N*VJZ&A5?%G4; MDT0J)?^\(FJHR%XFLR*99N#D`O<-BT&638,$JOH/2&*)]\YG\HH M\+I['J[6SY0^YT,DY_(NW+^XGO9;VS2XRLD![$KV+OF-':,/._GDG<34`4)=H?]R15 MC"C+;NPEEZ17QV/11_RW_%A[!O<\3;9K]7.OYV4^5F[I*"L'T]PH:OB>Q_+Z89O/YP>&<@SY=JS\L^;BV\^/SMQ?'S^2-OA333^5& M`F_$#H<(L]$=@CI+DQEXTV25Y3Y(R%3YLNG,U)C[SWV^1TX#U1)@$IX3SGTF MZ\5\ULZ/WI\`6F')YY1,\9P!0"4JHH@;@Q&)519V=@AMREL-/;DA>T]Z!S68 MB4[42%R:&JC$=(W)P:I MC#XZJ3&N-)J)K+(+/'"&0_HN$FNH@_I_S`3PHYXKSG%058RWE+RF0?L%V7(ZY MCTI+&EI0\7ACT3#<9F00<9?4"(KDAM`#W%REKA:H$61#,H".,!=8BB%C>@WT MYOKMLAG4*A`#YPM'DL-1,1]RR=?5(Q@G_YRMSXIU_RM9>[?][EG;P/'NZIWG MI@.'>/->-&<0_9`LJ4@1#!Q7?D<2>H.:`Q(_O_P#8B<4@'G4O%/(+.-5R4M; M6)P!90R9X2X:57%UP?S6UE=,,.N;_(BBN2JUWFTZRY0"@\U1,1_-I5)^.&]U M"%83I;/)B!Y2TIC7D-(@\291+45>B4@*\4S-9.0)VQ5+S;"N6$DW8W9C"=94 MY6QTYP(1\D$K"0+NQ&XJI1SG*4=4)D-W38P9_+@'6]3%7HIDVYO;.]*>BB1QG4NUD'@?*$E0)P,.(#.O@T,6$M8%4(N0%A$YO59<1.:1C:=_&-I] M;'P]($)%5HH8MJ`HL+8>;.L<+R06N0<8Y=1`C#YEQ^!CGLV`,`(W:0DI!F)` MJM8):I!!T^H#*GZT7)01^@R?1F*JO,DG8+-"JFJ.L?_CV5DOP?Q29[FZDP], MDVN\SB0*TH($F=8LVF^D?B9ENQ5>^(@[3@< ME1&IB0Y1U:LTG_80*Y7HJZJ;GI.BXVN(+&:4Q`$EP@?B#`&V6VSDU&C,TA`$ M#W>-DF\^'+P_ZFE&-O5;*_V@NUF9&[#DA_QV,LK,H9C@"!LJ11_KLA4%G!O4 M::6)D;Z1WM*+25%:`<0)$9,_)GQX80=S#;?J.B-+ M@8&5_;]6@G42`&#E,#2GUCCT@A'[?UXPY7.L`:' MW^83451S]PMDDTML3^G6G'/P\D)0W!,,7N@)6DX2Z!84+%+B?DC2AHY,4+1D M&%B.>(.^*7_R=U..@O:(PP;&D.\JHC'214YC0RH4;1+0X2*+"@`X`!/3E<#F M?'PU38F(Y@!7";:G!J8HVR(,"(_6-S0!'7-W:!2%!!UVY:D76F;9I^1J/D58 MIO5*'1S42VNOYL&`A%=CX[(I0!4C`T2=8?DT_6#G%&&9@9_F!.5(;]55@!J- MYU=D<5BW'L!VGAZ_TQ]7I._S"7]IT?9;,S*!>AZ6]))L_0/]97;'*)W,"CV# M?">7Q'U-O^)`DA]EP(*9/3E;!Y]DBG;PZ":+!OJN\J_9<#W()M+!!%2%=WU% MV=5%LLB;,AB$9CSELEY;[E8Q,B[MTA-401/)Y7L_Q1`2:_!/OJGN^ M9."-&1CS`+4`0!+)`\5)'.&I@J"6$5+#4K>$,!#(3`&;^D"\T;FO,;9@L^8V-\F-RC/&W5L`2H*A8TU/'V4B@Q(8R*BM M>(A:HXDP%R&KMQZ0AU#5B>&M;!8RLTU@6P4Y^5BY!_`ZKB)%)BE=09B3=[WD M4Z")NJJX#+7.NDP('\#Z`>(4LIIQZ@DSP0^'!4&#HU[.AF$,(L2RHU M@3?@((\+>)Q,MJ)35WE!E\+[<2,#T)I$,&.JA@";C M?R70QQ-\X9FH^)HL)MA;TO1H-OZ<3XNQ^(:3).]N2++E1\WN M(7NS&P_2*_9$^T9=B)4H5[NLR&VT58YR:LR(!#9:.69S$\HL,:LDF2T^4(:E MCB59C(5S%FE%M@AEI@X`26Y&<)'`4#(P`GKF\F#>JKR5FUGQKR:_@VZ*?BB&CW)1X5*+18SL#H>EYNT.&X$ M=)(UA:"IXAN2W$%SPB#5&]52`Q?:T98@!E_-\Y"8VN*1&M%/A MY`Z3S^>WQ%PFHN>U#U*'ME(56L09:>!EG9*/?_*A:LLVCO$_MT.)7W]Y_`O: MSU9-S0XV\ENZS*VNA_&[9Y?#!2:0-EDWS%KZ/#9'(ZO$^,3Z%K1CBW-2WOPC M5.1D4Y5R]_R1@<++#(V;J#`L_(B8:.#IT`QUE4\Y/S[\RY__FVREY:+\<8GE M&SPO?:'KOQ=GS7C+/!<3.G^$8:\D'JA0,-3$6=(R(<:Z=Z(TM*_,!9M&^$'& M1<#!'!.N@-``T&[&46$_X$6@#4G0^U/+9M2+TBO7\F=FU5:0HD$`F3MO/(J5 M,,U^=D-VQ>9!_9!(7QM*0NJQQ/,,(5.WZ=7N)R?9_PWO_Y8)B(N+C9:VL+_3 M1.Z?R66*RR"LL=TY6+AEW;RVL*-V,^]O[/):_OD;2&U9R5#&AW5:X5]#X`WR M[E]DPPD"_SYZ,*1=Q$RD*F&RJ*"5&E.Z)`#>*_&WL$-J$@P/<:]2Q2HGNEL= M8=[Y79W1IE*:YV+%"\EC3\44V)*L`;8M*?[CP<$9^/N9HY45TKO`,BFW:U3YH,656K?((WB;?G4:02_@>R.?2RJ4^N)K$9M1&,(DW4KE1_=>Q]3 M'E$IL=-%H<5B!;#![IP1C\>L73=A!()`-/\E`6/)1'(7:]%N8&I[3G$,[7NLI[UF%A0-H9; M$$$E^JVGRL&.Z1>,)`YJM&OQ&ZZ$?A3>'C)S+*(U;65^"/3(W5E$(\1.W22F MGO@QUL:\6-+E(1XR)%T-YE^J?A03_6XP(_59M'M529"1Q&AJWH@F*MIL&-`)9J<1*/J9LWA9F,M)8;T?O0QMR\H'*"$D$J4];Z<&S;IR, MF3'^,'D(44"%FD-,IZR!QZ]US2H^!XS0B]1-:4-D*0&6#X"#7ZAEI4;8S$,@ M)21)GBZ*$%XRE&J(E%48@7XV8*IBC*AD!)!H.6C1#?J7AER)`S@C`1)4S<`?#_=[IE-L MJTMJ!-+A6<1BA-*8D&B60/E9*,\P[PGIZ!#0RA4*BOD2&_RE)7ZR#EW#PE5` M8F,1)2:K*04R)Q8P"JGI)2&("0%,+[ZAXFD=54H/!DJ9,$-R"4-2XV2PV-BD MHE!D(1R*UD;TB@4IY>)"*MW(C7WWTA\+DU'O=HB$.`LY+M3\R3M#E4O[:MUF M-;(CS:21=<4Y;6#F6ZNSF4#6'!5H#:Y)@@@IH!$&3P2IT?Y!#2?.;<\UMB5Y M72CA*X#PYN#\M;`!;+/=;/RW4B++]0K']9(G4<<.U*T7YN6+>1>EYZ@ACQM/ M*/>"&I31-218N0VY'Q*9P1]A,Q%*C'.A6JX)C4@P?Y=$"!F&&`_:0?35V4&%'5 MNGJA4GN?23R)](LS%[U-FB4*50(D)#B"38FI>%)643&1K"O4O#58T&B5G/(! M.ZI42Y5@:NS61+5`4L\TGN+4<$[BU]1B;0:)3*3WZXN%7QAYMEB3I`UD\Y6`#+X3VVP_BP;-0O&&6D#H>[5+XE"PS\PV97)SS)TW$!09 M($3.WM-_YJ9#D[1RC+(CPXR9*TV,+0T1R(XZ>4RC?9NIS##*YK,7A'X5X9!>A3EK6E[=+UI!-W85*ZJZ?S<(87>$I1FI341+`*B M6X<)(*TV#YA8$(+))98GIC)I9-66"2>>VHF'`:%Y?F_5S,W$QR5=9E*-A@)5 M#:^5S?`F8NG3)=GHJQPXY$@R,FR#&`_Q->BRDM#&[B'=BJK#*1UKH]Q-!/=< MA3.91-HO+1V(<*MKMHH*9!5J569I#D1"@XZBOB7F3W(TLQ19G;A4'G>95'GU MP2*;55)EYBXZYM M9)9["F^T_?*A^1[;RF#.F&@]%5HXW".E%.J02%/E*EQ`Z['=5P49\L!PF8KY MJZ#8PP;!WT#R2R9U825HA^Z8!!ZL>4:X4NF%FP1K.VL8 M."=E7(0*V9+I1OSDRZEX)^UA4P.^3$8U>,8ELSJ!DHH5_`X,;W"XU$0'%:"_ M,X`3/9KIM>P'@$VO651#B!$M#40B^1ZL6'&IA*C$T^2J*:>X%1*YJM79STM] MH,@KV"?\$7TC=QOZ:GG%QWC#J0[<.0Q[?3Z$_H2ST&WH2LTM^M\9_Z_\DQ`= M!P=M/7G^P_>\#AEBY;><%&17IF\4&M@MA^QINYSFNN^*(CEVSBYOZX(='93Y M!5Q[,=7%Y_:&V0^OB/H]WH],KEH1+3I0':UI(QH(SJT;9*_"'!7[7"#@:R>X M0.:-;V'Y\*_"_IY3DX-P4Q.!OME0(5WRD7I8@A(>[TQ7HAUF)PY),VP#D/(S MIF!_G*O0J,(0="RSVWR=:I[ZV.-0/@M!7]Y(ZD8]X>[U\)&KUR798&[<$TD1 M!^P0RVQ$[96BD?"5Q:?B-)0P(\D24/PGP# M'"0SA/++1F*\$?R9:M<4C!5\61Y$]@E"\:+*1?.71T*!<>VW:T86:'5>:/HB MU$9J'S<4=!L6ANZSD#1XS`L6B:)9!Z)YQLR3-'&B8>IF>U2S;H)PNIS-=FG6 MBBFL-7-@M5" MP%0GZBN)POF3<#!1CCY![U:=]?ZEV8P]A2H'1BEAJ;5>&BC88TTZTD&U"C9]K;>$B%LQ=1NC%L3Z"AE-C2B&"19_S.JLL^8J+8SAVM\IR@1RV MMKW0A1Y:X!N`.Q5M$TEC/??69)M(6V^9I]:+K%VNB-/<.T4=0/0X@B2S&%"6 MJ4%\?"2%<9RA%QLT+"J:>O.J7''P:*RR%<4AOK,?3&J#SSH.2:Y_(9\57^]* M;*"&Q43S*R,6>_]J$Q8+G3'!T*Z@4K#`&[ M/)%=E@J:E7\.+K,"":`\;59Q$^5^ELUV=F06"`23:QJ_&WJRD+&G?L:1Z;P. MFY#P"_3YYD1N,'V-&@0KNY7@B`0%L`7L_'4:>]>.3EI[TEQ$M)\,%!.P3Y[! M0<_<5#Q:M)ZA]:.A/$^W7VX;#'RZSQ^\+"I<0^I8"PBEHDU@UV*UFZ;7QU2[ M94H5@*C&P?Z>-J..YE:\%_%\^.:HJTKH_4BXF+-_RB%*'#756(S\2`/=NQJI M7<4,2-27[)P3<,')\BY=]?(LS=PG9PI?2+W M'[NQO],^0L^C:P;O:4$+-3Y[E2=C2*O)E#?6>:_M&;K=L40%#8*A)!6&]7^9 M;VFLL#%AQR*7V2!5:LOM7G-*<@!RWRP9/8+SKN85:*GM@KRS9*WN)EC9I]$1 MLK8IAH#(WD8!B?N511=:IVJZDJ/%CSG@>F&#-, M:'%5^>M*JEKI10L?(I_QK[7RA1!]H8(C2(V%3M;8#)"\5T_R/J<+OJW2$=Y^ M`$?":@5I%4*)`)Y,FXDY,G'!_%;75:1D\C^!`<(R5D7(P MHL=;VE;#F(HLOU'"X?\=J0Y&5.=_8K5D:E7F?[S`*0/#_SQ;V#U[L7*VP1CU M.,Z@=6)?VZP_;5\X"V@T:F;[][=T:KVBT<4V$\(9':7BB"0(5_N!-;Q7^UKG M#+7NS+M.N#W(,<@2@%#6QWJU[WAM!Q_)]MM]!!%^/)*!*947[=PEJH]#&&&% MG.K>>O\=.L*M>#L*7QP.$\[%4\U2(ORE??[2>&X')YH&56?%5B/X*;)-=29B MI#B&83H*QT!54WC$=+4I!BBC7H6'YU/ZR]4ZJPJ>L%5G(AI-S05PE'7S#^N> M,D-P&U&G."J2(=9EER.P5+:?+0 M("X(<)/B)E5,\\V_'4P"T%(/;AT*'5*?(=/P(2\_F>TYY2U3^Z?;HH_<;]MG M=71I6UI.Y5I7G?UJ(D-J3AD:\CFQNUB23ZCT1?W&]%NW6D[RF64E+?FJ]2[T MBY$@68SP5/VL>Y+`"G2MS%5P"JQ]PP:?*43G0"-MD\23\;-%Q(?U!F23I-I; M/,)][GCF4J!#VX!C0,[[V17E,V!0;TP>>E?=)>5FX$[@,U$I-S=V`&MGP7P\ M+Y7IJGMPV$CV"6[>TI0=]M]' M\KJJ-`9S**[QGAOXQ>QTU!KR%?`472,BJ"7<5PI`1_B.&#&<+0LG8GO1,J$Z MU[O+Y"3YV:IJO,B#N7H/^"4T])(>[!8BQLC#[#A^HT/#Q%K].I9")BM1M3S% MU:`4))FEP?Q51VVO0U_HN4YM-R\2DW/R]D1<[/[)V2X<"AJ6OK`ZI0O$!'\@ M6Z`L$-&C!9Y>8!OP%G45\$*VV>#2S70(IYJ]E$!>R%#ZVD$^U=G!1@;;=#O4 M40[V%[Q2EE[LXO1KX07L_NMU=2!!(1M?91KJ&]IDY(;.">95 MGV:WA5A$]E703S;::`MC?)^\^_0@#1HWN=5F!-E/XG3W9<-1J. M[K%#]HCG1UB@9FIU)OZJ7+6GZD.=%;:1:5+I`O?*J0`684!(;VX)JCJQIAEV MGYC8N3@%(3!5T#X%N;F&PM[DZ!"GN+%]7V5$0I0_N4U!,H%C=GB3&9`P3N/9 M:$GJ(:Y1`5_,#8)*4!D'9=9T5XQ]0P*$_^,..?X_97?L& MN)P@1[(C#6.U]A;]&G$Z5V.%STQ514T:<;KO+RBG3#];[UQ871BDOS"(%N:# MD[!U'1+YH$7H@LBH&8!CAAP9,M`6368F/8[_ZKP%.^DYE&0S\Q/#-1(KA/1U0N<&$3!-^/66KVW&JQ/X=Z:>.6!I\M MC(Y+#Y*&)*4V:+O!V1*&CD:6":6#4"4CH(G8+V,O?BU;6#.9CPQ4G=3>*.M` M!2'LD*1VHJ`<#+Z(O(PSLVA*,=;P037[GY M,?YK#4&V9-!->U3[)16[]O[@IV>:;P@4;K(E1WY%]$K^Y!V0TP_HT7*L\_V` M\@1;]\XU7:P%W24(4,.:A2E7,]&Q1EJ5Z3JKG!"A(J?X(]UL3;HTBBB M0"VQ$8+(F6`!ATM25!U81[FL1F/5O/`:8=MB0M=/<2M06XN%'U/F!_0T1`XV MK[""QGTTLQE.=69B3M(0XDH<*CNL@*5/`._.<'4CK] M8?W3_L;N2P$Z%P+R'E6P:%\CJ&_V7_S#QG+R2?*56*RD-6!E/52;O;!\S&:/=CD)><&O=.&:G9U"YN6$SJXFZ':D+ M<[35E6.\ISI>NG48,;:H5'/.:'=9TUG<05M!&SX^BZ'WG[DI*)9YZ>#S^%[,NUG)-7G#->^OMZ^ M$.!*IYDOF'&+]MO/5*:X80+;]ZSUVU=JJUT;SO8]V'(2PV;*5]^TUOD,U=I. M>R`[#;M]<6U[MWUIN7+@GR`@&6^D5YO&1\TZ:$/<*XSI31A-'&CE3W,WC?O_ M1DG_O>'3]A+.(EQM_W!@1;KV52R%G;')`ML_G5C;&=BV_]4:0+8/;$(=@+5T%^U488E:R3F='> MSHZU?*_2_CN5>E=\*>]-%36VZ?"N$72T?_LH--6^Z&Q-8C33H7R$#QT;WQYH MU8V=BH&LN/#:BHQ.O6-6$%0NK/VFM>W>UO9>Y^I6;Z?_HGWUO*K;=X?9;]\< ME]!U+#`FEG.5>I-%"05U)HO2F.G+@ODU(3]ZP!>D) M)U2"/`$*2V_].#%D0H?#^4=N?5]L2/QVUK=V>SI2Z(RL`9/R"`BQKU_`?8QU!(J"=:20!!L6Y'6/7X0^N*(Q!B79G@B#@QQNOBN#?98$3)(L3F4QS]Y%S+RP*NP/#4@ M6])`31JLQR(-@REQ[TY]Z(%R"PIR@%/,QVZ^L_G$W2K\3OZI,1]O=^6:UB[7 MHY`OG!E*J"*5!@GR'P4NUA#-C7:L`N`X;D.W6-!R6]Z/RGQ1"8N1;)NWGK7" MCK:PL@DQ[&Q4<<5EHK%Z[0ZR#.]04)CN+0+'9O_TC!XY:Y:@4&0'70X+^-6S MK4*1(%I[':VP'BG-H+%/&$$I9 M2EG/29K9ZF`[:_@GI[EH@P7R43/$B*^3(%&J/M>% ME0EH0RC.)?:DAH0HI,.**X0G3J@2\Q4OWZU?+O)\G3"(;9CSXSF,TYZ1>=R< MQM0NZGEY#+2VM_`2ET1+MXET[&ERRLL%X1!T,E5H_Q,E39=-DO2O.@EBH,:3 M3A*Q8!#6-.#G^&%#Q/HR_O0L)N,:0H4TVH%64:48Q[FEJE[T<;&;RR>).HK' MWA%0.0N9%FS,GJ_75N695ZZ9H)/[R ML!\P&](SBZH413E(G!+$UK'+@]5^*>LEMH)F")YK^L6#2VUJ+CD6^]1'D73\ M]:V:6VWV0AZV-P0N\Y!ZY2CL7R-7;)K%V93][=> M/.L]";D-G2\,R6K3!Q_%?'T56+&;T<=M,<_QFH8;$.W/%:6O4TK'0X3F@-(& M1Y$TCFR%K16)3[5_OM)JMU@B/.-X[ZX?B\2[=4H`TD222Y5$X+1UJ&H\TUX= MD0CNLO.^@T1[E#_&,U8,N21KK^.D%\4L]MBW;%')^S@=#9"U2N`0.[0%NYH. M_5L:_Y>*S3NV_#Q*:C9?UKN'K:1PB%M2`WXHH![.*='I6,\G29"TG%=+H/B_FU]=!+7$[BER?LK2:(NGS8D&XI/-H6^Q8ZWK#Z3(2$ MJP(F_9U-`R;>0^"!DJEWU:NB/$1)#+&*JN&](6+PU^+WK?3B7EU^+%)K3]+F M*A-1!;H0RE+U7B.TEWIU;L;)4I/CDMYK#80S96\ING1=:.,QJAL4B&%!))'7 M0@U25:_VV0O9XZ]N82^E+/HZGJQ3I(YUK)IN=YM#L(L<%:AQ*7MYI=;-O3H: M.I/9L,Y[_)2.3AT$_-3A"8/=[TS^:BW'K:Q$)74V@*I8&\RL\"ORT?]\OJ5R MU.+X0]X%4X:=Z#_@7?KK6UO)D[,6D$=$E%.KRJ(7?)CW==@D:_6;-'E/J!5J MXNBR4FKZH`(P$.[+$2@S>DY!0IOJ];CN\-*0_3,TZRP\DAQ_9;=C:6<8^(&W MUN`B>,8NPB_XB^J$IHAU8VJ_=L8UC2:M12G]6:V(TUUP";;MMW3G4@T9<&G4 MQT8`'^O1Z`446C5>:'["P849R,,YJ-2Q%T(DL,^0M^^;T%R$Y"P]96L%XR)5 M>&=("WAE$W";M!S4:J35LW:'P3_]"X.F-JB%)[21P!IR>4D\%02R!MM-@21N M7G9-E@W%,6LG&'\I]O2`1,-78(?GP;$`5(J?UL-VP;T5$2]I`]9I^8;8(P:< M8Y@`/AP1K>/>_#/".V96U>Q%LV<\,ZA"^EZGJ+E;O9T9+T5:CO%!<+YC9$GE MYL1;YBZ6?3*M^=M#9P?VDT[6]6?M`K6%8&3"&4)F,'56OUM%]5[H-#IKH%_9 MU6P?P!`][QGG40DC]8P^W894(XMM$-RX*\MX&;:"RE>%[E0Q?'$'@4\UX+#5 M,[;"K:T>.5Z47M"#CCQY?_H6A\F1)^Y3?.>1$F*$H"U%\*(\#[@8KP>;4@;T M'C1TV"BEF1S:F2)DFI7T=]E50FC9\-`U?"1)"UYVA]BU?`(J"CAP;KRTFI*> M4['DGC>''LM+L.:$YZJO$3TE2\7^"`4X3_=ZG#/;DAG]\!BN/["9`[D"AH3] MW/<(V&,$M>^V\YY1'C'AODWF:7\7[^RR8:W.VCD.G8D?:RO2>!'FT5)%VQ)- M=8)*.`[X=_I@I#>V5K_OVI9J-I5K:W>?JU:TK)% M<_Q(U8+:>)W5^Z1.@-:6')3CEHRAZAQEXM8">5QB:#AZOCI1M4HU6:J*YVGU MF2DRL&V=H_R3OED&:.=$;7"GH?=2;L;R;H(59&Q\GUGU(L,5BOBXKH=`)3XG M/*.E176*E-QN>ZJ:?36*G$4826[?/AHD>&#I2MT9C'G`-J&_;5'4E^BAHH88 M8"A<(%'&4H0-_`Q!*H;X#J"$%DD7AM`36YHV$D](L&*]NTY2%?;1+K,8.K2? MIYMP7U;9=R[11%7AYX"P>(]D0.-5>,M$J M%T'XT:TG++#P:NYGRYAP&464M['CJ)3P;4B4#FEJ]JLO5/.P[IGQ(30^6 MC10,J=*5H==>0ULX89Q:Q#0M8&*(?G$%_1'Y1Q`QG2LD M!47Q1AL:+)^QQ8Z-.I6Y7CIZF)`-UA["0BT#NVKSEX&:D1,U6RFO'\^>G,]$-()W=9[[2`;@US^`&_;*XWEQ>,X4R'B-D1&SJ-F*P.CVH2\16=3/2I8Y*P M8UJL!WCN&B?XAZ5TM?S&#H^,T_#C"58X6HUNA2AS$G,.N."]P"%8&<\V=25J M_H[4F>W`Z(?/9_`.-(P:+W4\R"O;N*AQT4)7(:[B5YDV^5IVG'B[+'U+VN9M MP:Z-O'3!$YTL;VWK+4XBQP`VFSR3X5,34@]48ZH2*23VW2T5[W$83"?F$3S* MQUE-*+[@'2%]K3)5NFNS MBYSO?KCGD&U;^ M()R+XR'>TUVA=P\Q_:N2_ABJ28>S56I/![/BDGNPD=TN."^#.!Q@SD+Q!K;: MZUEUWT.+VUVV.!LL%$7N>ZFE`_`G](U8M09A0"P$3U2O-)-6?\I&^F+5025[ MJ$8Z%KGOV&ME]Q(UF*%M)]709QIZ34KY1'_J[`$W]T("MI_.@DZ575!>L<"G0(*S+A4PNOK,?(KX5VK35 M>P%RV-[:CU-S<\'":\0H>V>KPH(,$3*M4FOO6(U.>N2!!(ZB,AM8=B,&*N) MX*:*>58#7@B)'Q/ELTM0>23VT._LWT>91X3-.\9S3TP_@D1[?F2$:+.]O]/; MV]X-S&P%8@_317(9^!`*W(W]K]\T<6\B%C6V^[::I[0";^^8(?-7+)M
- MN728XZ/'K,$P;`.)\>3K43KXM'X^0%VQCC7P]I,QJX/]ZL;@CJP0QE5[&R20 M$HUO6O[BXCALED]26/,\]?SD+J?)7XZR;0/D##=CIL9,GY\]8.)-?E"?V*CP M6#`)ZH!L]7R_V*_&D$R\[,=_VEP"LXI]5I@+_%6&SU]WM[?(M,;YJP@O9K&\4JH8QV-K=Z?7[V\:A+9*" M.UN[@1P+5']8Y[]MV=\TX6@$=C?Z(6.+.]JW7*3FNJ@D&V'Z[HA;Q+'3DF5W MA]LDY3IK8"DP"L?K#AH`*HXH!*NMO^:"/!4"&D7UTJ$J"93N0XHV9%#-46SW MMK>WW#3N]E[N;E?1V[+*PGTEA2:_?3Q2Y%N!X+N]G=V=OV[H!Q,$%COOOHCTVU5'5),0$=`9(+H$7E;G M(68(O M8)%=`C*A:'#Z&+I^?Y=(CP_D+3]*`M#1:,7SNQ8^UB$`>!J\.MI1@)L_;OQVJ M/&F17>>G8PMW.Z/AOZ1"29\6:2#S3GM$>VQIO'O$%!;OMC,5:?WUJ_Q+__OG M.O;WUU^JUSZOC_GB3-)0]U5/M4'&<[P4_JX^+:.C5?7!5HOKF_U0__*09NTO MTZR?PQ'.5X*N@H[V$0+M""4.1C*)LA?.W1JE7TIB;T5YYT?\BW''*2N/O'J9RSU!1DWL.#%W0B??L0^51W- MP49B#HVA;^V1>A\]C0P>!:[01I88>:Y3KM MD^+Q(#B9Q'S\!Q)*EK;`E>69DEI69M)T!1E&Y.!XN,V.F+H@-;&1D,U+1QM\ MC7DC>9&:VQ>RY+]EYM]=UN[%$+V>R^W MM\A_:).J/%[OY8O]'E%TS6:@PGP<&B^Q6*$K$*&XE_\ZU(%$GFT?ERS!?WJ` MU3EHG^E1BEWOJ]2`[V1SC>03'T(BPU4)I+".]H1+(&NDP!IDZNSS8/553O&T MR[&/4BH3PG@68:=5U-DIN"BAMUE0!=3Y)NOY>-VN2=SY/+#R:SXO:X\4\!U! M=U1O6M!T4$RUG:$DC\M.#WWVW@:I1=UI^()W2*^O$'W4=5UA^%7V12K[PDEC##Y4526"[8C(,^[\I_VU=\#[G=0:MZ^*V^' MA0_JEVM`!`/C`Q,-D0NOQO_5`/[X6A#6"M]=8XTH#9%;'?MO>TP"YK"C6NK9 MP0>8X%L`W_$.WK0A57'SX:,OG^W/RJ@[*KDUT_@ZF,;FW0>33"/ZS(H8V`C8 M)$54=2^_B6MLPYVOYG=@0>27L;QV&]3U_,E.`&+0Z*MCY/\//B\G\2B52 MDQU5>GX*34:L7L^94=[IKO`*+$.I3T]>7CE]+P@5>$KJJ,"`"Q=U$?XATQZ\ MJ+*!#B"G0@=&EVZNW35D>'@99(VZ`!:BCZ(K:-J1ILH1O^I87^7LOAL/C3G- M24)FP#6Y_-AR/E/=;KWN6`L6PS?NV@1_ND^:S49>\QD"7!ZA6`\=(=XT\X7( M)">*XT8.?%(8NMA!(VZ]Q^YD^@NV$`]8%L86G./.DB,7OEZ/7)(^))"5LL&+ M;6H@8[H$.XI`%-LVK^ZSZN3D+3?."'/`*^S"D/8MWU5W@E])-9A=75O,ZGI# M-)=QK&AZR7MDO[CEP-EX=(7$6N(AXE#UC2:G8.MA`&&C\*H..$8'JUJ'06N] MUW9ZRDM[31*AV.];-H!V!%0N*6()9E6.&W)$[W`)9$?.5&!;"#'=(A("80%G MX,'$RN;$S-R>K((X*/^7:_"`"@8O%!RW*(*!&8!%6^BX8FQ$Q5@C5IJ;#S;8 M7DET@@B:N]>,ZX_00MZRDV]?XBL.B-(ZXX3L$$X&-LH+T0?9V4)U!0@O;!?= MCWB*<0J4#"Q<2(!*WL(J<[3BLKM-G"CIJ M'R!D0ZF-IC`H2SKH@,AS*Q,FT.%Z\.V@I`J_):F^APF.LHO>O;30S1ACR1\) MC.?BGN-1<4=/,A/A'*B<\X#O4D7QDSF\*Z<`/(AO%\X7]^X_)%'W[$RZ%$MU MUY?7':C5*M`"><-G;,4`VX;?F!%6]KT11T(P&ZY\5S4J&37?G^!5XMIX%6+O M$D')1G2)>^H+A@;QF@Q_:S=4P13*RKM';U).&;RN-C(+C<>(F7B8JHP/8JSH MU#$2V*^/9,-`FRF=\')(P+P,,O-4.O$E#":/[0+I((UR$YQ).70%A[JE6@VH M1=-"JMGP(9(8<@MDIH4>"U2UM3R)P%(C?0,:$-_)Q_[8)A2&XH7E)J@M^;VF M\M]R[EP;UM3QBSB3A?A:C4IS1?+T0L>36*[K:K4O[N&^ MKM_G<@TN&:C+Q^NK)-W8``]IEAYKG<^X`55[-^5.A)[]V\#21J:@2K.M,#P+ MZBU49>P#$R*E&Q7\I\?%ROWHT`AO9;Z\I]@W&3GR^0C9`UIF<_G4'8O!B9TD MW7%DQNZI4A-80BAP`/X;1PV-!N$WO[S$G!!?U4DK<'5=QYVRM/$@AIN(PD*( M+UP%6MBZ$-7-&+W$@"C(10&5Q5>E:_47X\!:O.]@*&AB!84==E'\IR6];4>] M(>'HMW\XV-E^ND.?<,Z:G%`%N#IO[[B&*NX.$758YNZGM-9S:PM5B]8Y4DI63,+)'!OS\X_[S@!Z$A%!Q M8@/_=-:K-C(G1=E]T8KI7A;_S]__@6/!&*I_;MU-61]ZSF`CU/X@58_>&4T- M5O]+RE2^<(D*0=(S"2*"S%NTO=+WL$R^ERYHK'X^>JTL5Q9J? M0%;XE9]1#=PL@.\N#CT&Y>9FKK94237E&I+;1=VR0*5A>2ZV"ZK$Z>3AT/8[ M!X[PW6? MSH].#D_)CJ;+AOAQ6C4MN]/&N2RQ5`]O(+6,Y$%J-._"WW!NJAT&M%AS"P+C M%1RR&\&\@!^2H`3'[B<2^E[B]D[R&[`>0[=Q\@0?Y+\5BQJ<*=JAQ]!TMKRV M6FV@8,MV&.Q&^D%NW>=QY?Y\\6M!`E^N+BZV:GE1%QT"N2(*1PN2GL*4^J74 ME<'6D+)*VU8ZNQ_(T/4O@T?=AEPJ+MF6;1$'*AP9(!`]5+02!]-A5T8285P$U,#$+A(CHL_V>+ MY6"+#D=>*D?P^#%A<33>C#I20]-"6'DS)C;9(N#TO]PNS&[FM]=*:S4J8FW^ M2B%9/>+[.>@`DQ4!:"6#PGA2+%-`[WIBTBF9>"3B"V85=Q->*!^W_#AT3!<] M8>28/LR%D=''55$17W"&-85W:!^"<09I:>/LKCAI!7N3ROX2U]1Q-K=@8,H0*B3\CXGH!HP@%:W,H=/K(%G)SWD?K2@R2A6T%ZB##M+7 M8P0L6@P"[>(R4VVU0B!GTU`9!09%#(H5A! MV>5*_%*OSO**J!-2LJ('D?KO$"9A11H1M=WTE]&;D&C3!6H=B:U&IW0:)CK- MQ]I;(9Z^!EQC:`&Q9`\?'6(38DA3*22A\6,\:1`^+@+QI>,4NHGF6K7A`2:, MM2,T!7UD%!#3OCF]N%[(8HOO0V?3_6L//;T4.I9P"<*/_7S9?U&5N;_^ZM'# MWQFOZ:(9/=\5=R@N2HF-^D.YLGI1NIYZ5VG"JSA+_;1S*NG&]OW[YO&4EDB> MN$E5,ZMN`MSZ*NFKD[GL-[$V3BIJ2=%BK5LS-V`MMA-P#6P+BI,6`ZXI19`# MS\,*,]U]JB'4+AFL:[.L:!TR-:(&&Y[04,7'?6HKY+L2(1'/BJU:':F$^WFQ ML[6F%?$I\I.+K89N7^XI2*SWP,`[$\1(0O+[I?$4L!(]T#;+E.R,2,V4Z-R( M\,S#K:VI\,S8T=;HH,H0ZESS?1>8(*S\$UGQ2=/6R8:25S:+2^YG.Z_T9YYGCI M3_?)+3^\N*;;^!:1V6]IB*%\/MFN#G9L+OLE!NUI:!-"I3.4!GQPW\_IKO[N M8O'&-X5R>@4$'D"5.I^W/BE61'V>AQWFDRQPQC<-%P M']D%D99HZIKCHX$2TVT&SQPB5`R3VT']WS*BA6/+$>@B@C\O_O3#9>EO-9>) MH&C*LP;5I0O7MS:%$1F>ZO#?W#(N7_RL<7BK6JU$72D$N3KMA)W955":2==1*90367K MCLPTB9#CC2MYX?XC2C5:"JCF%(!(;R#AZDA#"?Z';'0,*LW/9'D.%+0N_NB; M99"':0X@RG$+LP?G0_I*M.2\17>>],Q)*2@]GCKG'P()%T\T5H2DU/B&?46. M3@@&5"O2=&1(@=)F9<7C,4D'#GB+)F_: M*7&8HK&VB]L]TCP#:Z6C55+2>\T>I2\CP]63PW&7_-5`#;):C7(R/KDT76+C MEBUE2ZI/0AN2]SL.I3<0_*"0,"?@X5!!'$N_;$9"L=$J)R*%Y!H-//X)N028 M(&J(H*%(23WABM!+:MQ&1XF`Q*07X7:Q"&)_0IGJ9KUGC!PG1NS!H/G.FG1]*0VXK$U+*V!X2RS`:LM+SMYV M<01?4H*F\SZ:4HJLYURZ>@]2'P=]0T(*8Z?!A/A#[K!%+V7&D9BV+5 MG.E]\]=OY$%Z6=\)HTDL80VAKM)%R@;EFWCO;MS.8^/6Y>ODY2^:H\DVJ?S^ M"#G((2+#7<5S0D]Z%IQ\*09W+?=JE4;,":CU:B243/@*Y=`4QG:<+2UA(M,5 MVO>^A[L*4CFF?Y)E(-[CR)'[/ZXZ`H=?3!NCS/A\OR M/)M9BKE0*E)G0(CC=/[(3+M%D"_),=_9PU;PFDP"!QK"3NBF33T/N;+D MP!3XHK;`^INFZVTGYGW5*8LD;^>_1GZG@ZXE^=I)#I4;O1A/41*VM!%1N!]S M+VT8AW>0SS*``I_G88GN00!ASYI')8:[>=8\T60/)O`GL:T^Q#+\O@'6D7L5 M6K1VWPL"V;>]F7LXS4\ELY_&FD/I_U& M&8/J&?S8C1*,<\8GZIMA:^QM'VXLJO+$MQ^?T`O@;'R?^U83AK-'!K]F236" M`.DX@_TITI(7`/*CX2S[A8W$'.._NEI5$B[8%XX!)=A4ED51T_PMP@4A<\&# M!6*CKT_$GX8SW:+*Q_7[PS\T5[@6WQ-`"G$^GGTQ0GP>#5_5,W\75:.\XCG< M!5K`F]G/)$E0F?Z7X1\/ADGLDU_&TP]<:PF;6T-'Q$G[+.\.S'91Q7!SP$FW MU2,07A`82A?OJ0VTCS5-?I3)(["J[EV7Z1GS;::/^!CM'A4!00X]KY^ZO<4] MBZJ]^J($;@6TX7KDC>DCM[.T+TP,9J#M^-01T_91T'NGM,J=_OAJ_F&^_K/' MR4U?0`+J4/_S]DMED!Z]&R'-H2(>$*=$JSX8(M6MK>7T4+<:V=O#8=NE>79Y MV!E^E`LH@G=T@D(U*CO)S5HI;]YZ#PT'U+QHN0O@'19O5+,4!F&G`=WRQZ^`B(Z.^WZO6 M"%("0T'^0(L;C,O1"T!/ZP,;HM-:8CV];A$BM7Y,1@GZZFT,AV-B0/,K.=TP M+E7J-.)<.^7%9?WQ-PW$)VY;+&JBM=B;Z_-C\FIX.62T"O5%T2#GIGMXRVF1 M:\89%BI.MR;9\`#03[I11`:Y1.P\G$?V#BA`_UIY]],0"]W#7Z]^!6KVK794NC&#>#>SZ^>;`X296?5M:B84& M:%?JW#?N):<_MUN@H)=*O,4!25L]#%A M3F&4".?H=FVU/K7D26)_>+9RW?EO839MK!C)7(< MJ#W0BAKRX6Z>$Q"Q32G^LM#6;!U`EEQ(*2T7BXX_C=BZEZMUTU.8DG75Z1U< M,>'@4SDC]':T?`,X`E`%&Y,,EL'.UDLXU3FB^69+D342ITJJJ*L/4=I(K37# MI34LZQFR9EA=-?P#[M@PO*M;I6/(\/>21K6-7NP:L0C(N,4.O0I%#0?_-(1O M=GE`"23AI#0<#3(=CKVU45J8W`_R7

.,]D^)U1F9+QOT9Y^['O;0*C7B#% ME0PH]XE;74TAE9LR3#)57U;P7^C,C&ED[Y7K+0* M!J5!@+!A`@`IM2<-AOK!1\'3F;?[]*&:G*_<3G&N_0W`2QL14[#7<\563IQ.2>&2_TRYZ2K\^R:ZS;=3 MK#A+^0R8K?A(]EA6\B/G43L(V5#5SR,%:DVWWAG]J2O(;O%F.)%^O],40S_UJ1L,T+3-Z'_!9E'P/5^\LNX^(FYP-ROF' MDVW'DRE<28U*OD>N@PAPA?"&\:\HL2\&S6($JFY'Z8,K@4#[]F,P&=N77!#* MA$-CD88XO1L=#?E/ZFQ+:6U7Q8=1.GFYXO3M<_RO\T]=[Y(#\I-RA4 M7F%\-G[Z"`>T"M]R%6:DZ=S]")PJT=\A1(;+3W/BFD\088N5FEYJ2B>KI>KO M%XMW?_JO`````/__`P!02P,$%``&``@````A`,5@-5'D"P``/VP```T```!X M;"]S='EL97,N>&ULY%UM;^/&$?Y>H/^!X+5%`M261%&6Y%@.3CJS/>!Z#7(N M6J`I"EJB;,9\42GJSD[0_]Z9Y=NL2(I+<:4]H!%REBCMS#//S,[N#I?DS?V'@S/179ZM_?_O; MW]QLXU?/^?3D.+$&(H+M3'^*X\UUK[==/CF^O;T,-TX`WZS#R+=C^!@]]K:; MR+%76VSD>SVCW[_J^;8;Z(F$:W\I(L2WH^?=YF(9^AL[=A]NTNG3+*:6_:`TFW-\'. MM_QXJRW#71#/=",_I"7?O%_-]"M=2TQ>A"L`\8?_[,+XN]\E?][\\Z?/SJK?_WT3?F[G[[5>YD:(A-\<%CF9?^@6/@ZD=Q++;B]68-@F^^<*FSA=HV9=7?CC=#$K#MLE35O&YC\ M!;`D0*9ZR>\:?OT8V:\#@W$IUF`;>NX*43PNV)0S'?(75W?6XH[I)CR6@P-4SXGV7/TR.0S>E(5^U5@D"15PD"15YEJY2>A,R?]A0H MV"CNJP2!(J\2!(J\.I:<@Y4@4.15@N#<7LV658N[.XM56LHS,VGSXU073N+;ZV*K1EBG M/H31"A;JV6F8@0EKQ.38[8WGK&-8D4;NXQ/^C<,-_/L0QC&L)-HN)4&O*L9^)JPAR;_;$Y,JZ2 M!9LDU;ZSM4=:Z,R56X@Y.O^PZVK$F_G]06 M1?4<%DB`5T1,-0C2ILQG8Y,*1AO;M+45\DNI;\P-?+'9<86E#2W*=C8TJ+"R MH86HC7S<9-[EA.>E"TS/%4CV^.9^?AP,4)0T)'A(AD_3$Y[R2$YZ"&<[WMJ2 MFCU+9.D1M8)P"]#:#8I'Z!!M`[K"ZH)V)^B,+86<9L\PT[(U2'!W9H5!HQ2`6)X.FBWZS1 M#SP)\]%%/]2=*NT'7I3JA^`2UB\S'G";41K4X`(:U(?PR$0`U84,`3A!!0+< M%I5R`.&I`@&LVC($$*`%`H!S("JZ](,!R680`X5*T'\JE9!C,BLYE2>TLB[] M@OX#5EI<^NU$,\FW$.@%S?#A`(!.*NM2K*H40]P./:V@`#XH MR_G*""%)%S`4C$`:.,2(O*@D.1=T%@`.,S*7.`\A08&I2#4$@*,$`G'$0-'X M.Z`8%(W`-!H4#<$4`C<&G[%/4$]P(Z0B#(!'2:\HY@D#;L0X(PT$@JH,2:+! M4)4B*095.;)PA:$J11((JC(D]82J%$DQJ,J1Q!6J4B2!`(PHR9#4$ZI2),6@ M*D<6KABJ2I$$@JH,23PQ/'&*[-&R:5)$)?73\7'U4^UEW5A('=0MFL#O6?-D M]92L',$7;"U%EM)X(9J-V[2Q=JH]A9'["RPR\8*T)1QP(ATO8(S=)3WR);(W M]\X++$63TTXOZ_I:+R#)ZAO[P<@CK,54Z(?2NJZU42Z=GPY8NA/1:#G651KK M\GN!P=>V&P.D$0,K+*@&@5RG&*2'@*0N@CU7-4TP2"K'0%QUAAXB55N'9(!+ M.+&T:$&08)YM2-Q=L,`\12J6QAQ1[87A_BJ"'Q^2^O,IB2#Q)P>+4B)HGL+- M#>U&3NE<4#ALY\17A(?1`^>K>X(3F>'^6E-EI$K!C5:(!JYPQ$=E[0*1QEVV:#TRHI.(J`1(*+NU[6&@Y8'5./!\JR2W=,,` MDQH)0Y^H(Y1T:QD+=$GC<3=?E6)4N-/(H*"DO;:'\&>(CAUT.W0/Y0`D\PT4 MUEU0!EYI/:<]0IRX\VF)C(6[E"GZK]I^5127LV'%`9P=W`6)J"WF.>40`CVFRH&V/XWV/%& MKA_FKQ[.]\=I>%M/N+E[__?:A?9VB>O0_.3)`/=+[EP/;D*$$S'XU06[C8N<)FPHZ@M+FB2RN*Y'PER;U;YD>W++W"AR2*XJ*S"CUB-)K+` MY+:R"C_BGF`B"TQN*ZOP(R`DLDQ0TE96X4?P`I4%X=965NY'$_MX8>-(D/NK M2C_RL8J;:$5P45F%'_E8'0K&*I55^)&/532Y+:["CR"5\&7"%VUE%7[D\X0I MF">HC84?>>Y'@MSO9U0^X@W!B$^D%+Z#=X0C'-M%.$JD%%[CHWPH&.6)E,)? M?'R;@O&=2"D\!?*(129\(6Y1[J,ASZXIR.[<7F59EP\8'&=$8,!MP)<[#Q[/ M$N+#7=@F<:P*$H-PT!>2].0LG[4%W/,C%\3W!QQ&103=O6P\.[#C,'K5<&-X M+HYW^DA0W)_",.>(EV#`1Q%`?X9'X'IP]MM& M#+1.T/#QAYM!VXB!UHD8/JGB_$E$S/M@L\L]Q.=2'+I%1'QP@V=GQ4<.S[`! M($4D?71V<63G\<=W*4.0F(]XIYA,'^'&,!F)6/TB?03"W/HC"ZFH_F[BY&YF+][9TW[1G_Q7Z`,GZQU#8]FZO#D*O:$+:@##PT M[;^? MPB][41=,P6U]\&55>'8X*/,T@#!B-5?KV MR&4":0!?DW"&5A.1@PGX](H,ZPG"R%ZUNBQ5QXA,YY/9(IA2P+T=E^HI0Y/$ M2TY2B>(_#='6E#82MD;@^ZQ_#^%RY.)INQB^V\4T'*O`U[MI`O7(%-NL:W'V MH$Q!KZP8%CU=@>'WHP%A0/8!X8@L(%\1D9"2ETVP]E\@Z$E+;#4!GQU!;2*^ M$)@WT-`)@3B,%X(P"L$TH;*M?F#Z#1V_0V+:$980B((I!.MD"B7Z<61P$7#& MON\ZZUJA)NX,8F83\4>$I1",F`H_5H9P1&#W74;FMM^M)DQE"YN(AT2OW5(& MG3!>&<*VLGO;[U83IK*E3<1#XHJR^2W*$+:54;?0-6)*HVZE#Y$KVJ"AQD<- M84>;4^I;C5C:^EIOJC$>(E>TX3MS]/F`L*/-;0.-6-IZSUK;$.D)J]J6MVA# MV-'F-H)&+&UNW(;(%6T4CHSQ@6MH1YW3A-N6L>0Y#1._PUS3A^>PD=AQQQS5 MI[=YFE"G);@,M\BL>87,Z'(Y7P1]]U@YIGAN&SH_/NP:VHYCZ'9N MRYCZPMYY*U"_+4RFWX.M#T_M\?KT&6_&+W2[EP[?`Z%;AN\PU_3!'F[0A[03 M/[>#J6;,V(2]\S9^0Z9'[/C=],K`@ MSLK=#S#<5NS`_V;U(2NEE_,]+`TF"PAQK<=C?:-$U8R).Z%@K&TNC_#?A\/8 M%4P`W@NA+CKSY^6.VT> M;"V$(\#0VIS6SG6+.+:\%HK92'>BA3>E-HHY6)HJMIT1K.@/J28>)2&VUUZ2*@BS'0MSE?QI*G3UX)K;6NZ]&%M]E*\!L*),OP$;K!P^]*_P6 M'([?G+[M"_##D$*4;-NXGWKW3! M^YXDG43CT60V'\`28T1]@C?,L=72Z!V!I@%-VS'?@ND"F,]G!*EX[-J#`C&=PXE,F2R_-"XV,AWR,9=-K_'?6'`'?H5CH-_)@J8N`:')T$Q)&C MT$O#'?7@G(*-@35+D\"+RH@98Z5?PSH2G7Y$U(-/15_;`T41@Z+3=T2A!8=G MZL&GHJ_-@J*(0='9._;Z87[PJ0PKL#]T*IZ=V(R8PP)GZ3A@T&V<3?CI*F$J M\44TC25<;_W<2:%$83>,Q'763[7P`D92QRIQSTPE6TL:4<+1))I!F0T.-5PX MW?6#8:,=#*/^L89_CX#O+HD`7&KM7A9^;(:_V>H?````__\#`%!+`P04``8` M"````"$`QP*/KFHC``!FO```&0```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`J=8ZW(VU01_>Y/WS.R^;SY]9?[N[]?V=1OE7WX M?N-N)+5FW=H=\U,I<9BQ?C1AV4SE5-X[F7>OK>5M+GJP6?9?OYZ>U'YY^R^; M&3]XFVNUB2Q:L'#3H)-MQZ`3@RP&W1CD,>C%H!^#00R&,1C%8!R#20RF,9C% M8!Z#10R6,5C%8!V#30RV,=C%8%\!;\U-#KYB@_%G^(J3<;Z"7KX&H//40]=I MP0)9VC'HQ""+03<&>0QZ,>C'8!"#80Q&,1C'8!*#:0QF,9C'8!ZQ6,5C' M8!.#;0QV,=A70.`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`X?!RV];JE/C?QKC*[:\5!+>X=M%6-\U4O:EV$/(D./3G0)1?`%%^2525CZ)0*UI!?@U$^0T0Y;=$ M%?G+J&MWM(+\'BBQEG=[;?76%X=UW2/@V%U+5/'-EK>JH#91Y9HN9/83K0P9 MBVLJ)M8N$`=(3E25Y[ZNR-BC%9JL#T3Y`1#EAT15^6A_,J(5Y,=`E)\`47Y* M5)6/0@LS6D%^#D3Y!1#EET15^2@>LJ(5Y-=`E-\`47Y+5)&_C+IV1RO([X$* M^7!R=6$4=5=N/9\5:W`G#F)G+5'%,UO>JH+:0/7#CJ*C*`-BZW2!V#HY$+5Z MBOI`U!H`46L(1*V1HC$0M29`U)H"46NF:`Y$K040M99`MNMB#.,RVFZM:`4/ M6`-1?@-$^2U0*!_=BW:T@OP>J)`/'F1W6;;%171O M:-4.5JAL&\BF0&:4\*.WLJ>X[C!'HU:+AG$&&2Y$NT",GN5`1POKP5D6)X1AQL=+J&'EB/^U#JUS(7-=* M5(E:MA2U@9BQX]$I408K3A5=($X5.1`S]E2K#RMJ#8"H-02BUDBUQK"BU@2( M6E,@:LU4:PXK:BV`J+4$HM9*M=:PHM8&B%I;(&KM5&L/JT(K\!%W'.\%/E*8 MA[L=H&"^O(R65BU:'>9+H'/>I(%XABD#XH#J`G%`Y4#4Z@%1JP]$K0$0M89` MU!H!46L,1*T)$+6F0-2:`5%K#D2M!1"UED#46@%1:PU$K0T0M;9`U-H!46L/ M5&B%;A,_6C@^M=2=>>0V)7)%5&Y-T0ZOY3.:%=W&9Z3'=[R5S3;NGEJ+8S(9 M5#B4ND`4SH$HW*-PM9+Q_1,9*3\`HOP0B/*C9\F/D9'R$R#*3X$H/Z-\LEGF MR$+A!1"%ET`47CTAO$86"F^`*+P%HO".PD?:>X^,A7SHENZQP?/O>'7_E($U MN`8*9[-H)]>B%=W2:W%$=;R57YET#^H6`8%NDC ME;(#(,H.@2@[`@H7'-'2=PPK6P%SY)Y%@V("*Y8X!6*),X_81-$$,$<>7LL" MB,I+("JO@,)KB6JYAA7E-T"4WP)1?N?1#RN^1YY".712]_CA!4[JGU94G;1$ MT=P9;21:]8,5G=0C:G6\E9\[SZ^B*%4&%8[E+A#'<@Y$X1Z%*VXB>P]DI/P` MB/)#(,J/GB4_1D;*3X`H/P6B_(SR;NZ49IDC"X470!1>`E%X1>$CS;)&1LIO M@"B_!:+\CO+)>N^1I1`.W?*G/%EQO[2([_0>!5/J511<:"$CAUW;H^H1$8]. MR\,O]L.GDVAVRJ##$=T%HG3ND?V#L=$#<@/71*!M#ZXDY]="2J/44\BQQYE&EC:*98<[2H+,`XL4L57H52C?J\>FI-638 M3!L@*F]5>1*R79J:N2N?0H54/J/38Z-;6AP8S#(`XA0RA0:L1D%6+ M]_>KJ#_&T+(["JUT%2#--H4\2YP!_;"-YBR-'BO22^A0>@542C=.+Z*QL%;E M#1";:0L9*N^`2N7:V=5I)+V'3I$IG&LM\/.37=8I1CLLC\)^C**N+??;-)>1 MP[/MT:FE5+HVFK`[L/)KT(:U;;@.S2#-R:`+Q-)RZ!PMK0>KRS)L&I;4ARQ+ M&@"QI"$TCI8T@E4P%:O[^V8+K-3]O14K,87\T4K,8/7#QIU["XO^<41(:4OH M'"UM!:NRM,O&531%K;6P#1`O;0N9HX7M8%46EAPW_CH24[VMYG7JH+9'AY-#Y_'MHD,+ MC.A,45=1KJBGJ*]HH&BH:*1HK&BB:*IHIFBN:*%HJ6BE:*UHHVBK:*=H[U'B MY)"AXY[TO&>/A4PT"Y7/6RJ/LEO>JH+:0!8(Y?U93@[1BN[DY;E9Z*I53E25 MC]8-/5I!O@]$^0$0=ZA#HB/R(UI!?@Q$^0D0Y:=$5?DHK#2C%>3G0)1?`%%^ M2525C^Z7*UI!?@U$^0T0Y;=$%7DY.40KR.^!=*UI(:J4M[[XY%"A$[JK1Q7? M;"EJ$U6N24X.T0K7E`%QT=T%XCTY)ZK*1[NA'JT@WP>B_`"(\D.BJGST>&M$ M*\B/@2@_`:+\E*@J'ZVD9[2"_!R(\@L@RB^)JO+11F5%*\BO@2B_`:+\EJ@B M+R>':`7Y/5`A']RF+1"9@IAI^CT^0/^_N;>&U>"$(%&RX MY>00K5#9-M#1C5/'6]G0*1_GG5]%XSB##O>$72!NTW*@HZ7U8'7T^4D?5BQQ M`,02AT!'2QS!ZFB)8UBQQ`D02YP"'2UQYJU^W*)SZ+"T!1!+6P(=+6WU9&EK MZ+"T#1!+VP(=+6T'JZ.MN8=546(X3-RCHNHP.?Z$WT*>,AS\PR8.YY:WJH9, M@;@(ZGAD0Q@C)(,59XLN$.5S(&;LJ58?5M0:`%%K"$2MD6J-846M"1"UID#4 MFJG6'%;46@!1:PE$K95JK6%%K0T0M;9`U-JIUAY6A5;H(_$CHR=\1)\-G1Z> M:%07$-'JJD4K.$0;B(]D.T`\P)(!<4!U@3B@BU@"(6D,@:HV` MJ#4&HM8$B%I3(&K-@*@U!Z+6`HA:2R!JK8"HM0:BU@:(6EL@:NV`J+4'*K1" MMW&1^Q=,+66@OWI&][1$T0/P:)/7HA7=QF>DQW>\E( M(RD'HFZ/NE77CO8E?62D_`"(\D,@RH^>)3]&1LI/@"@_!:+\C/*I5IDC!W47 M0-1=`E%W=5QWC1S4W0!1=PM$W1UUC[3V'AD+^=`G[6[Z$I]TYM'^PB/S,$9E M+J.=7,L]5(D>MP!Q.'4\PL+DY"+>4V7(Q)':!>)(S8$HW0,ZNB[HPXKR`R#* M#X$H/P(Z*C^&%>4G0)2?`E%^YM&/&V:.3)1>`%%Z"43I52A=/ZU'=Z$U\E!Y M`T3E+1"5=Z'R9>,LI;\&!DI M/P&B_!2(\C.@'[7+'`947@!1>0E$Y95'_N9T?BX^*2VR@0J%MT`4W@'Y@S1G M\3F:/0R**H<^^5,>I)SJ@Q2@8`:5@T*THJOZ)S",K7:\E>UOBLURHQ[/Q!ET M.)R[0!S.N4=V^@2E]8"":LK!-FA1?@!$^2&T*#\""N2OHJ$PAI9=.0>,/'^& M%4N<0IXESCQB6YU'ASWFT.'%+(`HO53I52C=L)\[A4_NUY"A\@:(REM5WH7* M5_;R[%!Y#YE".73@Y/.;?W)@R)[JR;Q;HLI6M^6M*JCMD6VQX%X=('\8YN*T M%@WZ##K,U`7BH,^A0ZL>4.!:ZKF^YLPX4/DAM&@U`@KDU7,/\D<]5YIO"GF6 M.`-"6]4OHQO;W%O8L4,B&H%KR##/!HC*6\C0:@?D M#PY=7<8=O(=.D2EP78M>A^N!?WS6K5`,EPQ`83]&0=<6K="R;8_< M*UD9KB'-TC9`+&T+G:.E[6"%TG0`0;HH+1Q`3SU>>E[TOU$^.7+OQCIX^NE) MY,?7L*K^QBF:S%NTX3#RXIQ&.FJ5*>HJRA7U%/45#10-%8T4C15-%$T5S13- M%2T4+16M%*T5;11M%>T4[0,4^E?ZZ=*+G[;;`\AX10%4]:;:E?B3STCG:3,C M7*RC*%/4590KZBGJ*QHH&BH:*1HKFBB:*IHIFBM:*%HJ6BE:*]HHVBK:*=H' M*/2GESV&:>AC&"`Z1$M16U%'4::HJRA7U%/45S10-%0T4C16-%$T5313-%>T M4+14M%*T5K11M%6T4[0/4.@C\6.8^(GVLTXV-O3IC$?<*K9`>,]N`_F3V8E7 MHM$"\T^FJ*LH5]13U%50=[B1K%&]"*URBU&R4Z"^\DT>.3#JW8;3XC=S-=M$%#HB/R(UI!?@Q$^0D0Y:=$E*]=1;N?&:T@/P(%]!JE"CH\`.J7E,4ANYHQLRC,QX5ZJI53D3Y>OR&X!ZM MT&1]E1^HU9"H*A^YZXA6D!^K_$2MIHIFBN:!5MB[+@9;?9Q9CN:7]VX9RZT^ MYVQX5.W=$@6]>T!LGUK\&XZ.UZIDS#P*>O>@A5;,F9'R]7BOTZ,5,O95?J!6 M0Z*J?+2L'=$*\F.5GZC55-%,T3S0"GO7-N@_I7>=3C1V/:KV;HDJG=1N'!#; MIQ8?_>K0"NV3>13T[D$+5CDS4KY^$C5_CU;(V%?Y@5H-%8T4C55KHE9313-% M\T`K[$H74_P9`[6,308#U:-J5Y8HZ,H#JK:UQ,<.5FCKS$2<\P1=*5:YMZJ4 MV%/45ZV!6@T5C12-56NB5E-%,T7S0"OH-[=.2?3;"X\$%RKA``2J])I'5ADT M?MNCLVJLIQY_A*]#*V3,@"HW3Y7/8<6'IHB7W(L\0!$$L<0NMHB2-8^9<%G$97-X8P MRYH`L:PI5#C@9D`_$)Y#16/Q9W%LZQ\_S"H4HSG^<`JYX@'Q=J[E,U:.'+<] M6HJ&NXYN894VTK"G+P@PU>T)XCBR%<'AS,6?7F\N+?PCN;@GQ'<6CZII` M4!L9:=51E"GJ*LH5]13U%0T4#16-%(T5311-%HJ MRA7U%/45#10-%8T4C15-%$T5S13-@1)+#!>].M9ASPN7GCF9J,<\XC!N>:M@ M`U!:N:7N88ZO747QIX[/:%;L-I^1$V-7K7(BRFNXE%:0[P-1?@#$2@R)CLB/ M:`7Y,1#E)T"4GRJ:*9H#);8)+N"DG?OBZ-E9&;BJ;LJ!6-N61T'O'B)>;)_: M51P;U8R91[:^09-UU2HGHKS&1FD%K;[*#]1J2%25CWQS1"O(CU5^HE9313-% M\T`KG&M=P.EG]&X9N`IZUZ-J[TIXJWUV0&P?C8W2"NV3>13T[D$+5CDS4EYC MH[1"QK[*#]1J2%25CX)S(UI!?JSR$[6:*IHIF@=:8>^Z&-3/Z-TREA7TKD?5 MWI6(5_OL@-@^&ANE%=HG\RCHW8,6K')FI+S&1FF%C'V5'ZC54-%(T5BU)FHU M5313-`^T@JX\3\?87CP-%SKA31:HTI4>5:=AHFI;1UO\#JW0UIE'U:Y4JUQ1 M3U%?M09J-50T4C16K8E:317-%,T#K;#?DE&VERYFSS6R!E3M-1\.J\1&O94+ M#QV61AH;I15[K=0*>DWD<\W84]0'XHUXX%'%P8:P8CQSI&@,1*V):DUA1:V9 MHCF0+GK.DT&S2J\];T5;R$2#K0R>5?8@WJBZ!_$H6-!J0)16[#6OSI!B5^5S M9JPZ11P0I17D^]"B_`"(.Z@A,U;EXX`HK2`_AA;E)T"4GS(CY?7Y/ZT@/X>6 M;F#.DX&N2G<_:\=9J$2]749>GHB+(B/C>&V/GHB+PNIHE#*#/".'72"6F$/+ M8BF'F4(BL3U8'2VQ#WF6.`!BB4-H'2UQY*W\CU_J9^?1(=XQE%G8!(B%39]5 MV.RIPN90UF#IN0M"R5KKGSQ.*10C?RHC7>&/!258ZC-6@Z4>/1$L]5;'0Y<9 MM+CO[&J).:QLBWW,G\H+.EYB'UHL<:`E#F%UM,01K,K#Z2E_\FW,PB9:V!0R M1PN;P>I'AHJRA7U%/45 M#10-%8T4C15-%$T5S13-%2T4+16M%*T5;11M%>T4[0,4^E,<)SS^KIES#0<" M57-,# MJC2>HK9'+LYW6!77X]_7=FB%2\J`N"KM>F2Q)UCEBGI`%AGX<8E]6D%KX%'I M\H$#7KA`4-4!CT_UA7G46&4HJ<:JMV!%U/;(Q;H9$(-$797/ M%?4\:"P?7F&8[_K"HVIC"6I[J["Q MXE_`=&B%JF=`U<82^5PKT?,H;*RXQ#ZM4.(@*#%LK#CB\$1CE?O:P+,\JC:6 MH/9%B:+&BOJY0RM4/0.J-I;(Y]ZJ,A?T/(H:*RJQ3RN4.`A*#!LKWDX_T5B' M;3.TKR\.>V2@EJ*V1V%CU:)[5H=6T,J`JHTE)>9:8L^CL+'B$ONT0HF#H,2P ML=P^[`43O-^V58>A1W8%E8DT"C&W+@Y6J%0;R%(.&24,V?%6_C5C&L3)(,.@ M8!^M?)4:M?@%Z@/(:.CP(MXZN7.6)O3J"1_5+52A M].YU$!^LUZ.'="U:X1K;0.S"CD?!*[_J]>A8:H:,-@E6^BN*T79A%40$XGKE MM$*]>D"L5]^CJ%[1&Y$&R/BC>H7^[I;R57^/?^_YK/C_A=\0L*[70('/U:/] M1HM6N.ZV1Y776G6`0JVHI3-H5==,M?BU)5U8A5I1O7):H5X]5(+/K_I`@59\ MPG8`K83WNRV&-/X_"9Q?^$U+M2-*%`V,:"G9\AFK+X`".CKX.][*PMC)$[@9 M5*JK]V2-HGM`CM:H#RL?>;XXC1QE`(-*Y/GMPZ?;V\?VS>/-K[]\ MO;W_X[9U^^7+PZL/=W]]L[%=NW0O-C_P5_>WO[][_?[\K/G>I,Q!HA2+*3== M^#&5UVK-]_;6F(2:I>S+14V4Y[I6MY3B?BHIIY92 M7'F<4K<:V#>*M)SW#:N!A>LUQ5XCTW1O'$FE6`WLW1&I%*N!O3$@D7+6:+K# ML9IB=_JFNX]KBNW5FNYVKBGOK=+)\EVC)>ROK<))>ZMNJK;O&\WWY2+6.;=\M)=4ZME>U ME%3KV,;,4E*M58L>8F^Z0LM;-CL!:2FI* MM>.3EI+J'SMZ9RFIMK;#778]*7^S`T26DJJ;'>JVGDNEV-GN9B]9:SL7;"FI M6MN94DM)U=K.(UI*JM9VO,WZ)U5K.T)E*:FZV2\1FNX"=)T/X=5-7LS2-/]*E93[`4AUFZI%'L#2-/](%;SM,^L;G9(3E/LUZ/6 MIZD4^^&G^6@JQ7ZS:35(I=@;5)KNI\):CKU(I>E^,:PI]CZ5IGM;2BK%QESY MX]?H[FLO;;"4E/?:#_XM)=6G]I-R2TGUJ?ULV:XT53=[NTRSFTRQE\PTW2MD MM-;V-A)+27FBODM)U=I^N&T]EZJUO1*IZ5X(I'6[ MMEI?)_.T+*653+&W]33=NWA4K6U7ZE[:DDJQ,9>\4GN=A*6DKK1M5]I)7JG] M`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`5U[N?4*FK+UXUV>?OMY?W-Z.;)W:-U-+)".F\J1UI([1_T.YY9O".M MGY$5PKF?^%)+H?W#LV;E4DNA_<,S/_&EUL*ES>C9GUBG]M*F]KQ]W-;VL2C: M/SSW$^O,7MK,/O&)7W9+W''%'+_^_/K'[S]^^/>>-HT M7GG:K8Y%HY/]JA-9W[PJNH\6FJ&8ASXF^%AR M(15\K-,+81L=?APGQ]O M[/3JT4:'M>'$6ST@8\@$DD!2R!2206:0.22'+"!+R`I20$I(!5E#:L@&LH4T MD!UD#SGX$A2"M%""0FA7CVLY#3WS&JE-$U:(DW#U&$6K1Q_4KQZ0"22!I)`I M)(/,('-(#EE`EI`5I("4D`JRAM20#60+:2`[R!YR\"4HFO9F*:B:T\O',3RL M#B5O`2&-21-20DI)4U)&FI'FI)RT("U)*U)!*DD5:4VJ21O2EM20=J0]Z1!0 M6"-MB\<_Q7SA=4E[WQ4M+4KAVA(W="RJ7UQ($U)"2DE34D::D>:DG+0@+4DK M4D$J215I3:I)&]*6U)!VI#WI$%!83VUGR*^G)]::DG+0@+4DK4D$J215I3:I)&]*6U)!VI#WI$%!8(VTK MR*^1+UUS7$O)+YZ^R^3=OU]=1==`@HK*>V*>37TQ-KCNLA^67CMY6Z.^81:$R: MD!)22IJ2,M*,-"?EI`5I25J1"E))JDAK4DW:D+:DAK0C[4F'@,(::7MV?HU\ MZ9K3]?Z"$Y:C\#KG.EYS^B@]TXW;)G>X#$U("2DE34D9:4::DW+2@K0DK4@% MJ215I#6I)FU(6U)#VI'V)'DYR9NAL)[:1I]?3T^L.:XOZ*\Y?JO0K3F@D"2DAI:0I*2/-2'-2 M3EJ0EJ05J2"5I(JT)M6D#6E+:D@[TIYT""BLI[8]Z-?3$VN.ZR;Z9>,W&-V: M`QJW;V[%:PXH851*FI(RTHPT)^6D!6E)6I$*4DFJ2&M23=J0MJ2&M"/M28>` MPAIINX%^C7SI=8[K*OK%TS<:_34G>K?KL7W;+RR>,6E"2D@I:4K*2#/2G)23 M%J0E:44J2"6I(JU)-6E#VI(:THZT)QT""NJI?0$SJ*?3:\XQ/#Q5*=E)Z)$T M)DU("2DE34D9:4::DW+2@K0DK4@%J215I#6I)FU(6U)#VI'VI$-`88T,]9!O MGW^=T[ZR&UWG*(7W5M&[88\6U=];D2:DA)22IJ2,-"/-23EI05J25J2"5)(J MTII4DS:D+:DA[4A[TB&@L)Z>UT-N7]N.RP8-XT>-LF5H3)J0$E)*FI(RTHPT M)^6D!6E)6I$*4DFJ2&M23=J0MJ2&M"/M28>`PAH9ZB%_P;U5^ZI_7#Q]=]B_ MSHG?`=,-_7KJ-]1E:,*HA)22IJ2,-"/-23EI05J25J2"5)(JTII4DS:D+:DA M[4A[TB&@L)Z>UT-N_Y9'7#8=W1[_.EMW;^6B/!J3)J2$E)*FI(PT(\U).6E! M6I)6I()4DBK2FE23-J0MJ2'M2'O2(:"P1MIN8'QO=?4@UR9/7!2[+J)W+]7^ M71^IG^O^L>>CD_:IF;UY>F5OE1XK:MQOYP5=V\M^X<=M^X3^QWWB4[JVHO\I M.[KU/R9HW/YE(?DN7M2$E)!2TI24D6:D.2DG+4A+THI4D$I215J3:M*&M"4U MI!UI3SH$%-;(8(NR_6NI3Q0+6Y*7'?FUXH*>*&D7)2=/*_QK>P4M_+QM'^H9 M->W:5GY-=^15Z^,E:$R:D!)22IJ2,M*,-"?EI`5I25J1"E))JDAK4DW:D+:D MAK0C[4F'@,(:&6J!R5^4?;*FV?*Z[,BO:1?T1$WK=GY)VYM/P<=M+UJ?4=+' M\+##XL@O:=*8-"$EI)0T)66D&6E.RDD+TI*T(A6DDE21UJ2:M"%M20UI1]J3 M#@&%-3+481E=/5G25^RH./)*6H-.E[1&A7NNKUSO*-;.3Z\2XKXC0R+TMOU,6E"2D@I:4K*2#/2G)23%J0E M:44J2"6I(JU)-6E#VI(:THZT)QT""NOI>7?P5[R#5[*6SB-I3)J0$E)*FI(R MTHPT)^6D!6E)6I$*4DFJ2&M23=J0MJ2&M"/M28>`PAJ1%>&KK#EMGNB$Y2AX M4G$=OY'1GK+;#:W$QJ0)*2&EI"DI(\U(1\%U#OHI8T9-2`DI)4U)&6E&FI-R MTH*T)*U(!:DD5:0UJ29M2%M20]J1]J1#0&&-M/T-OT:^\"VP*]B8U)$U)"2DE34D::D>:DG+0@+4DK4D$J215I3:I)&]*6U)!V MI#WI$%!83\]K@5VQ!>;(*XA'TI@T(26DE#0E9:09:4[*20O2DK0B%:225)'6 MI)JT(6U)#6E'VI,.`84UTO:?OL::X[I=_IK34;3FQ&]D7/51=F\%FC`J(:6D M*2DCS4AS4DY:D):D%:D@E:2*M";5I`UI2VI(.]*>=`@HJ*?KY_4HC^'AY;$C M?\TAC4D34D)*25-21IJ1YJ2D04%@C M@SU*N=]YYMONU^Q9.HK6G/B-#(OJUQS2A)204M*4E)%FI#DI)RU(2]**5)!* M4D5:DVK2AK0E-:0=:4\Z!!364]O;]<]AI^^MKKM6L']OY2A8<]`P'C-J0DI( M*6E*RD@STIR4DQ:D)6E%*D@EJ2*M235I0]J2&M*.M"<=`@IK).XA/U$C;!5? M.PIOH:+7+AXUJON-Z.,/DBK)S;KUF&_L58SC^QH3C;H[_A+J[6UTG93H_W[? MO@@2?K7GM3.OV+_L#<7A/W4=R8L^]OT#U^Q]*`5M M^INX9691ND*,21-20DI)4U)&FI'FI)RT("U)*U)!*DD5:4VJ21O2EM20=J0] MZ1!06$]MZ\$_!3VQYG2=BN!2TI&_YH#&UZ`)*2&EI"DI(\U(,H7'/BEIE%V9K3;Z@T851"2DE34D::D>:DG+0@+4DK M4D$J215I3:I)&]*6U)!VI#WI$%!83\]KA\B_O!7?4ROY:XZ+,AHS:D)*2"EI M2LI(,]*=`@HK*>V:DG+0@ M+4DK4D$J215I3:I)&]*6U)!VI#WI$%!8(VVST:^1+[W.<=U.:TR_NG$4K#FW M41_ST:)LS>DW5)HP*B&EI"DI(\U(\@W["&3QJ0)*2&EI"DI(\U(RO2F#0A):24-"5EI!EI3LI) M"]*2M"(5I))4D=:DFK0A;4D-:4?:DPX!A34RU$/^@G[.+7O(2N&:$[T4\VA1 MMN:PA\RHA)22IJ2,-"/-23EI05J25J2"5)(JTII4DS:D+:DA[4A[TB&@L)Z> MUT.6W[:*>\A*_IK#'C*C)J2$E)*FI(PT(\U).6E!6I)6I()4DBK2FE23-J0M MJ2'M2'O2(:"P1H9ZR.UOY3^SA]R^T!V]U*<4KCGVBEWW4I]%V9KCLCM[SK$ M9>/(9O]1HXS&I`DI(:6D*2DCS4AS4DY:D):D%:D@E:2*M";5I`UI2VI(.]*> M=`@HK)&A'O*77.>PAWS;MX*]=V%OHU=='RW*UIQ^0Z4)HQ)22IJ2,M*,-"?E MI`5I25J1"E))JDAK4DW:D+:DAK0C[4F'@,)Z>EX/^98]9"5;8!Y)8]*$E)!2 MTI24D6:D.2DG+4A+THI4D$I215J3:M*&M"4UI!UI3SH$%-;(5^HAW[*'K!1> MY\3O(5N4+C!CTH24D%+2E)219J0Y*2LBW["$K^6L.>\B,FI`24DJ:DC+2C#0GY:0%:4E:D0I22:I(:U)- MVI"VI(:T(^U)AX""&KF3%>%K])"/><(>LE*XYL3O(5M4O^:0)J2$E)*FI(PT M(\U).6E!6I)6I()4DBK2FE23-J0MJ2'M2'O2(:"PGI[70[YC#UG)6W-(8]*$ ME)!2TI24D6:D.2DG+4A+THI4D$I215J3:M*&M"4UI!UI3SH$%-;(4`_Y"_HY M=^PA*X5K3OP>LD79FL,>,J,24DJ:DC+2C#0GY:0%:4E:D0I22:I(:U)-VI"V MI(:T(^U)AX#">GI>#_F./60E?\UA#YE1$U)"2DE34D::D>:DG+0@+4DK4D$J M215I3:I)&]*6U)!VI#WI$%!8(T,]Y"_HY]RQAZP4KCGQ>\@696L.>\B,2D@I M:4K*2#/2G)23%J0E:44J2"6I(JU)-6E#VI(:THZT)QT""NOI>3WD]M<'HAZR MDK_FH*T\9M2$E)!2TI24D6:D.2DG+4A+THI4D$I215J3:M*&M"4UI!UI3SH$ M%-;(4`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`SCM[W[NV MN"W>KY2D5V'[XBXZ-SQ:E'[8L9+<@=J&^`E+%R6MN>X*<\-[OG/I+&2'4031_*OW.GAD6B4+16IDBT54R7;,&.NF499KKF2 MY"N98:9;E62I:K4+)<)7-5&F6YUDJ6JU:R7!OFVFJ4Y6J4+-=.R7+M MF>N@4<=<88W$SPU._SW,>SX>4`K6R_OHTNK1HK0@QDJW?8U,E.YZ2I3L@$J5 M[(":*EFN3,ERS90LUUS)M M9+DV2I9KJV2Y&B7+M5.R7'LERW50.N8*RZ;MY/NGWR?*QC7^K4I?M?^`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`*YS'JNCY:E.[9L:/VWV#UIC9:L"<:Y:Y!KV7?AM>AB::VQ2!5 MLL5@JGE.CI9IU/WQ,(IK7=/:2',E&RG7'"='6FA4L!0_Q.6OZ8,H7`1KE'V( M0M.?_!"E1OWISJTTM7WEM9*-5FN>DZ-M-*H;[?[Z(5JBMIK9!FN4;+"=ICDY MV%ZCNL&&CAM-?1PM/&Z>>JQT7M?_H7MBY/]JJI(=\X^D,6E"2D@I:4K*2#/2 MG)23%J0E:44J2"6I(JU)-6E#VI(:THZT)QT""FOGJ2=&9SV2?.`#(T?^FT.D ML:/^S:';^'0QL0A=B1-22IJ2,M*,-"?EI`5I25J1"E))JDAK4DW:D+:DAK0C M[4D'1P-O#CW$SU6^[-GC,4UTRNX>P?A/MUV41V,E6<7L_(PWARS*RLFEMYN% ME%%3(S]]=-V0692FGRE9^KF2W:'F1B?2+RQ*TR^5+/U*R=(71G[ZJ*U46I2F MKY0L_5K)TM=&?OKH?+FQ*$V_5;+TC9*EWQEYZ?'FD$5I^H/2P+5F_(2GJ]9G M_[K0`Q_]./)J\Y$T-O*^$]X;0Q:EZ0]*Q_3A:5IN5X+N:+RXGG>:;K-$:VM'0;&" MQ@^.[*V:"2E1LKV3*MG>F2I9KHPT4[)<'')1[I'#:'3[$!W'B>:Q MV[14R6[3IDHG1\LT2OKS]IG0OMHT[NS8-&'4<, M#Y/VPA9+E*YJHTRG*ME2Q7K62Y-LRUU2C+U2A9 MKIV2Y=HSUT&CCKG"&FF?1SRC1MSC"QONU8.C8,G$RT,694NFV]`>R4XTREY@ M293L@$J5[(":*EFN3,ERS90LUUS)M9+DV2I9KJV2Y&B7+M5.R7'LERW50.N8*RZ9]*/",LNF>(03=NOZQ M@G]RBF[R'A_Z*"L;1U:"$Q?E'H#?1=<6B2:Q(RE5LB-IJF1Y,\OK?\;HOF2F M&UKZN9*ESY4L_>*L]$O=T-*OE"Q]H63I2TO?/@V-]TJE6UC>M9+EK94L[^9T MWJUN87D;)\M[8F\?=,-C^J`F1Q?Q(YG3;[1U\>$)K[=P-8MNYAZ] ML+XN>[-C:J*FER<7=_&=5:(A(SM@T][LB)WV9NFSWDY>(QSNP@E(IUUKV><3F*UPTI6!=A![@4++)+P2*[%&QGLE+['S9>437L MTH:0@L404K`80@KVG"&D8-VF-H04+(:0@L404K#._FP?2;TBN]0KLDN](KO4 M:V?Z.E?\L[M2KD@NY8KD4JY(+N7JS+U]/RO6K/'\97?`!3&_! MNHLWC+PPKXJ[=-Z+0%+%G>D+-->7]]%A*67L/H6M6%+&SNR@ES)&>BEC9\&G MQ9VUAGGKBI0QAI`RQA!2QD-#/$1'BI2Q2R?7TG:/CX?8?9A],:ELC"J5W9GM MM]OHJ;F4=C^B3H&4MC-++Z6-]%+:0?KKZU'T$I74-K)+;2.[U#:R2VT'V1_N M;Z+L4MM^]JBV!Y\(_97W.487W;,:_ZI7S;M]EJ6YB_-LK.:_AM2;>\?F[FH4 MGBKHS+[T4M;.GBAI#2%%C""EJ#"%%/33$0%'W0YPN:HPJ M18U1I:B=Z7Z[O(_.CE+4_8A>42.]%#722U$'Z>^N[Z*#5(H:V:6HD5V*&MFE MJ(/LHX?[>-*EJOWT454//CGZ:U7-ATBC"V=!Z3Q$]V%2Z'V8[F4I],Z>>%.I M#^M>.;EZN!A%>UEJWV4/%G2,*+5_SHAR.+BP8&4=6.,QJAP.&%4.AW-&E2-D M:-2!(Z0?]?01@@\B1\@Y'T0.&A?F=OC]PWWTA%0.FOY#Z'3*F0`CRD%SSHAR M'`4CRN^RQ)>>,*,=6-.+0L>6/&!U;4NU!#R1^S'7>4XC1 M19LGO@UU9G?,<5+U,"EQF%S& MP.1J'";%"Y-*A4EIPJ0T85*:,*E#F!0>3`H/)H4'DRJ#R9+M6U16\E!@H*R> M_;!_=-$FBNO*67"S^!!=1DBI]6%Z9$NIP:348%)J,"DUF)0:3$H-)J4&DU*# M2:G!I-1@4FHP*368E!I,2@TFI0:34H-)J<&DU&!2:C`I-9B4&DQ*#2:EYEM4 M:NWCG?.[N*.+[G%0>$'K+%BI8%(^,"D?F)0/3,H')N4#D_*!2?G`I'Q@4CXP M*1^8E`],R@HPOW',BZ4*_4[$TK69.ZL&N[QY2B*1_X+3[7KZ\B'H;,KE]F`XADXLA9'(1)Y/;VXDA9+[[,!U"YAM#R'PC3N:[ M-QMB%-]F20GT83J$E("SXPM#80F,XLB8*+K@4/-KP%E0`V;^5XN: M=A,=PMLT4;NQ=Z%2-2]NZID-<7D1W:1F7ICNO9F:-\1F M0RS5O"%6:MX0Q8"5`U:I=?FB"6\[O#SFGW^%*4<[KC#5@@GOXKSO,1ZY.#'; M5=+="/_^D4PX-I4)[\S;53+AB),)[\V&N+R(^@8RX7V8SH9,.(:0"4><3'AO M_A#1];1,>!^F0\B$8PB9<,3)A,/*`9,)]_-%$]ZV/;_*A+O^J7^J'CD+)KRS M<,)[LUTUBM]_DPGOPW17R81W%DXXXF3">[,A+B^BV9`)[\-T")EP#"$3CCB9 M<)C,+DQF%_ED=A$GLPN3V87)[/KYHMEMVW]?97:[/J(4DNZ75Z.1LV!V.PMG MMS=_U\=_X5#3>9O*[':;AK/;I]./(K,+DZF$R50BGTPEXF0J83*5,)E*Y).I M1)Q,)4RF$B93Z>>+IK+M-G$J[0=MS[NB'KFF53"1SH*)[,R;#5F7.[N1U:1_ MH'1Y$3U)D<.T#],)DHET%IR(,81,)+:5B83)1"*?3"3RR41B6YE(F$PD\LE$ M(I],)+:5B83)1/KYHHEL^SN8R+_4=V]_E3]NYSCS;Y.4_-LD9S?R>;TYY<55 M-X*$>7/:V;6]\B#G6F>9=!R5FL&H4C/.;%2IF7-&E9KI1VU?E;N^BKZE%!#&DP+">%)`_7A:?%)`IY-+ M-?G)HVIJNR]?N9I<0R>HIL["=XCB&TNIIB[,>ZM;JLEM*M^A+\2A:NK"KN4_ M?=AE_/A?JLEE\^_G.:I4TSFC2C6=,ZI4$T:5:NK,^ZY23>>,*M74C_IGU83Q MI)HPGE13/YY73:>32S7YR:-J:OM`J*8;N[PXL]DC+[3P5.0LN+Z`2;W`Y&(" M)I4`DQ,/3"H!)M,.DSF&R1S#9(YA,J$P61%@,HL#J`=L, MV';`F@';#=A^P`ZA1675]I9.E=695ZU=BRJ\_>C,KDAD$7)D5Q]25,ZT#\R_ MF>^%Z+$D-=9OIB8U!I,:@TF-P:3&8%)C,*DQF-083&H,)C4&DQJ#28W!I,:< M#?2!VZ7_Y!R>N30<\T0]0#5_:7`6W'HX>ZH/;&$Z:\E(S3]OJ-FPTS[.;S4/ M](&YZ:S?U(:8]V9#Y)YY9[JXU;SPPO1;+'NS(5:]V1#%@)4#5O4VT/2];+M% M/&:?WP,\)HHGO&M%24]7O]OCR,6%$][%B=FN&CW@OH2;RH1WFP9-`\;)A`\, M,=#TM3#]Q#+A&$(FO$^G<3+AO=FWN+Q`T]?"=%.9<`PA$]ZGTSB9<)A,.$PF MW,\7+M*7;0/IJTQXUXD*ENECSLJ::O&T+"O(ETF_I-7Q?G#2$3V0^AV\I$PF0BD4\F MLC,OGTPDMI6)A,E$(I],)/+)1&);F4B83*2?+YK(MH]S:B+/O89V_2#;S:]& MEYWY-T)*_HV0L^`2^C+^T7(Y(KML$J:3(4>D&\'O]*K9$#*1_;;^01^=PV5N M^S`=0N860\C<.K,A9&[[;?TAT.FU,!U"IAM#R'1C")GN@2$&7J6P,!U"*L`? M(JJ`MO=RJ@+./)2[%DZX)CN3\O,::-%:*Y?9+LR:H'(2[JQ=@OI-!UIT&A:. M$+5"I4[<"'[#5\U&E3HY9U2I$Q=V/,1I72.6=462FZ,/?WG"YO M;J,+1"DD#"B%A`&ED,X94):2)P:4LO('C,JJ[0VAK/[2TR3YJ4.>+3IK;WZM M3M@%=IMZG5$I,;>I'!JV*9\IN+"GNL":S>Z#Y5J_&\$;54KLG%&EQ+JPTZ-* MB;EL-JJ4&$:5$CMG5"DQ%];]!8K!$L.`4F(84$KLG`&EQ)X84$K,'S`JL;8U MA!)[?FM8?FN1=>7,SC:R3L&DB&!RIH+)"@23\H!)><"D%F`R\3"9>)A,/$QF M&29+!TSF%2;S"I-)A,FTP=8#5@_89L"V`]8,V&[`]@-V""TL*_EK\4-E]?PV MTS%1='6KYJ]7E_&_'/0XLC`]AX\';#)@R8"E`S8=L&S`9@,V'[!\P!8#MARP MU8`5`U8.6#5@ZP&K!VPS8-L!:P9L-V#[`3N$%I5:V_OR5[`G?DM!SB18J=3\ ME8HFY>.VM3@I'YB4#TS*!R;E`Y/R@4GYP*1\8%(^,"D?F)0/3,H')N4#D_*! M2?G`I'Q@4CXP*1^8E`],R@]V674Y2AZ15E*K0_3%4U*[?]8.[?EMI$KBOZ*:SX@)D$0E%@35UFB M[O>[K#?%0WNFXAE-29Z*\_=9!VB`0.\MV4KRHK+71J-/G][=!)H-L&&#!14] M#JM)6:S6L1>JQ7W=86VUN*]?;9;16+W2C+YV78-GU#6?B0WR*8Q\-FR:?E[# M/1^R.J1M%+E,Q?JWPBU;W6R0RW3KY:$=H>UU9+0AC7C(3-F+.'T$_J]3XHX/D]<8JL6 M,**%D;B&3;GR[K4@^ZZ`Q'6'M2T@<8GU5]:T"A(GU9*XAE7,=\]72^*ZP]IJ M25R_VBQQL?+QFL0U*R6#=8QXT#^2.4B<,!+7L"QQV;=J)*X[K&T!B4MLD#BI M@L0)(W$-RQ*754OBNL/::DE,2 M&R1.&(EK6):XK.M)7'=8VP(2E]@@<5(%B1-&XAJ6)2ZKEL1UA[75DKB&V<3% M/>-K$I?N,0>.D_M.YCAA)*YAP\2-LX\]$M<=UK:`Q"4V2)Q40>*$D;B.7 M5TOBNL/::DE+GXJQ)7'Y]].+2,F;0W^V9+Y)OCU6%M9(N.,9=T1R?KG=G:B_3+NJ<'7R(O_U^MVNZ&I)?J]C+\:UWQZ6XBK'^6\$ M'+1'L-V-1@\_7LJX.N][-B[!X^[].Y_/=;F\"YHK_<%:9E'(>"RSHC+NSSSACW%@1_[*N,,MTSK)*Y,6[98'@4V5T.PR,57=F0 MX=$POLIH4T+?)#8\7;:@SX!(IV/.?+%ONEI7AQ5Y?IW"BT;K/$5V:8<.JP6BJZLA]6$X;5A&$U85A-&%83AM6$835A6$T85A.&U81A M-6%831A6$X;5A&$U85A-&%83AM6$835A6$T85A.&U81AM3[+K!9WK?T9[-NX MO/\X_^7?B^73Q^4??%2._L:>E_3#]._'/`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`ZM]>WFFJH_/%K!:UI^I ME"U8&Z2NP?X;M&W9@V*%A1X8=&W9BV*EA9X:=&W9AV*5A M5X9=&W9CV*UA'PR[&[+,/K%0]_^8J6(_?_[%95Q^^OM/&UAV7ON6SZZN3*=-0JN_8Q"MK-`XI2M7SD*KMWII MN;70ZB]O5%L/K7[?K6C3$1I7<*Z^Z3BT>J*5G.^B M&$7/\:ISJT7/\1YKH\U(R,SF8T8<,QO'#'/-Z@T+TEZL-;/.FI'`FB4,E-;IB+7 MS8Z_/&\5N68;ASE;1:XKF^N*7% M]K"9V";$QB8MIQ`;NY"<0FQLLS%*26SL1'$*L;%+P2@%]?#TDE%B2O,SVH1< MLSW9E<$';+AU"CY@YZA3\`%;(XU2$$'S?7CNG8+V\$H.5X;8>'>#4XB-Y_Z= M0FS-Q@>IAY[CJ5139DP97E/I%-K#:PR=PMEX)9U3\`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``/__`P!02P,$ M%``&``@````A`.T:/`5Q!```[Q```!@```!X;"]W;W)KVPGQG:\[&35EV&XOCX^/O?Z)&;U^:W(@U=:\8R5ZY`,AF%`RY3ML_*X#K_^ M\_1I'@:\3LI]DK.2KL-WRL//FU]_65U9]<)/E-8!$$J^#D]U?5Y&$4]/M$CX M@)UIB9$#JXJDQM?J&/%S19.]G%3D43P<3J,BR67#GR1I17C[%`/`!\_IM=?Z?9\52CW!/L2&QLN7]_I#R%HH`9Q!.!E+(9.?UVQ?G];A:#J8S(8C@O3@F?+Z*1.089!>>,V*?U62W)$&B1L0?#8@BT$\ MGY#)5(#**!I:H^]) M!&T$R(-`68>S,,#N.>KZNB%DLHI>48NTR=EZT04,8)`NUYW;59GM6$HQFMIQY!X-Y7B,89U=-6.CS1 M9FD*05PA=%:G(X2+&=1^($3C>28!TP:5,1`S9'>$\"MC-2$$7@SZ"Z%\#_5M MU=^*!X$X*W9'N(^[6U9'"&%G!K4?"-&8GTG`],-&"#-D"^'Q2/(S1Z-KDD0; MH-D1([KQS]Q$-=XCA'5-N@*<38%4)GN4+$ MO6DOT=('(>'URQOKPFJ6=N)AGVI6X9ZF2YH=:0[ MFN<\2-E%W"#B&*_!.JRN-ULR7>[(5!S+SL@,(_+=M#,RQ\C<.V>!D85O)![B M'B6INFBQOF&Y(P1SE&%W1C!'F4EG),9([&-`1A@9>4?&&!E[1R88D=/T,`:^%PAOM"NM5OOQG`8#44F,DK2T_W['&1/'`Z6P+RW@X\F9,^,SX,6W]VKO MO(FF+66]=-G$=QU1%W)=UMNE^_=?3P\SUVF[O%[G>UF+I?LA6O?;ZN>?%D?9 MO+0[(3H'(M3MTMUUW6'N>6VQ$U7>3N1!U+"RD4V5=_"VV7KMH1'YNM]4[3WN M^[%7Y67M8H1Y7&*W;\Y"U^512-;N>DF$,Y# MHN*U[63U+X*8#H5!N`X2`'N]SB=\%K$H_CJ*AXSZ!!_S+E\M&GET MH&O@F>TA5SW(YA#YE!GR&'+]+%7(407YKJ+TL2"+%NKSMDK8PGL#20L-21$R M=9T!0A#9":$J`>P&BI`XI1A`"2^+?V*D-MF,`I\P.H=P&Y&=(^)D@%@<0;HQ MQ^O<%!A:8"1%0IZ<(B0<0:+AP;WDV36$10V"W$Y-@9UW55FXAVP1"^5R9%"+`8^P6B?%'S0LQ^%SBP)D.H$F'26R.LDU+&?&HPVZS"H;V/:;'?$(AU2#D]Q#Z M]`38Z\%G_L^4'8\8?B$Q;$9K]-D$R!+X1#YQX38[1DJ?IF!F?Y].@P#DRW M]TV9$<0L,EUKD[O+_QD:.-1V&#S,-QVMS\/)Y0V(>'*FXX"`0QP#L?G=-0[8 M^3Q@/IU0&J3/`R,>F-G+9M6F===`8.<3@?DF82V;[?DLX6<&9R'BA'%S7FQV M9"[<>"30V^W.(WV5,@1I/XMFW/25;KPQ`+XZA49^BR,G\^$VCOTN>TXPW]0( ME=0@Y!C,9H8!4K37V:@#;(9W30J.4\`^&J2"J09=[GM-[C1-OCP:'"HU-K[K MOM*CJ7*D>*D&G1S/_M*26:NCPMNJW34F^(4QP4Q7ZWHB"%D1RIF.@(MFI\U) M.?7=(X*COUOG@1F/U]P0A(^?DD[,=`A<_50Q,A]N/`D7Y@0CHSU5OYI'<\*/ MI\1U,@O!^,QD8"M(QL2-''$2V`K2<<$1I!TE85,"R`@@_FS.PO7(_ZGRA9'! MB&.D?>BEB[\(9V%"SK6ZF5$ZXSKWD]``4$:\=\%KB4HT6Y&)_;YU"OFJ[E08 M_#@9/L7[GA3N>_K+$6]8@.N60[X5O^?-MJQ;9R\VL-6?3*'[8X)M.'OIK M@6?9P45+_W('%VL";C'\"8`W4G:G-^HB8KBJ6_T'``#__P,`4$L#!!0`!@`( M````(0#4SK6-=P,``"X+```8````>&PO=V]R:W-H965T&UL MC%;);MLP$+T7Z#\(NMO:O<%V$%E.&Z`%BJ++F99HFX@D"B0=)W_?H6@MI!K; ME\32O'GBFSV/7MG"9THR4AY7]^]?3:&9;7*`R0SDM M\D1%XB/:85+B.PI*Y"`1W9P M>,4PRNJD(G=\UYTX!2*EK1@6[!X.NM^3%"ID14"#+;C&\7]F/WF([MYWULJ[/'X+/O/?;XD=Z_L)( M]HV4&(H--DD#=I2^2.AS)E]!LC/(?JH-^,&L#._1*1<_Z?DK)H>C`+`"W=IB+ M)R(I;2L]<4&+OPKD7:@4B7\A@8P+B>>/_5GD19/;+(Y:42TP00*MEXR>+6@: M^":OD&Q!;P',C3*UCE;K1U)!HR1YE"PU%ZC@8,_K>A8NG5=U'"5[94,.VU69&W\0*,JM;=12&@U;4XI$7&-V<:'%O MZOM3O7Y;#0"G==0Q:,+`J_N%2;#AVT3_;JP@\/56N^G;341R$[&]AM#D371Y M\GBYO0]EDN&?4=Y80<+:/V./;J[$DBNQ;3\V\KHMJ0F"`ZSOUWV"9)(AR#C[ M8@51@D+3LGYP%!B]G/2COI&Z[0='01?51,DQQ;@$;KLDDPQ1QD$7*\@'HOK! MH:A^=""J'QR%76]HHN:ZJ.M'A@3K8N9&6\4*TAX9?J#OO(T6C[Q)5VMUF6EQ M.#+_BP&=JW:BR* MO0582[%<%V[8P#O*17-@[R4VTEW_0\``/__`P!02P,$%``&``@````A M`!/#!0Y,"@``+B\``!D```!X;"]W;W)K&ULK)K9 M0:7[6)LE2BS;?T'[ON]WBDS;JEBB2U+BY.VG0:(!$H?CB:=\ M8\H?&H<@NAO$PKM_?A]?4[^\\^7@G^[3N9ML.N6=]O[CX?1\GU[,F]_*Z=3E MNCL][E[]DW>?_N-=TO\\_/M?=^_^^[3+]?KFYO)7/8OWG%W MN?'?O!.5//GGX^Y*_YZ?,Y>WL[=[#"H=7S/Y;+:4.>X.IW2HX)[_1L-_>CKL MO;J__WGT3M=0Y.R][J[4_LO+X>W":L?]W\@==^KG\" MT73JN'<[SR?_O/O^2L_].W>[V[-V\`_('P_[LW_QGZXW))<)&XK/7,E4,J3T M0W9XZ>T_W:9%S12-WF\X\W`4]M#QX[Y?([]3EQ7]OG0^/_@][7Z^7J?^>]L[/+]B3Y9.[C MG[IWV5.7DLQ-OBB5]OXK-8#^IHX'&1O4);O?P?7]\'A]N4\72C=%)UO(D7GJ MNW>Y-@]2,IW:_[Q<_>,J-,HIJ5"DH$3HJD3R-TXN6RDX?Z]QJS3HR@TIW-SF MBT[Y,RTI*16ZZI9\6H22(^@3NB:(?-`/%561KJIBZ29?+N:*)=F9'U3,<0_* M'ZJJ\VDWY!QU?_E#J9#>7SHQSZ$@?ZC:Q4^W(<]^E#^42N7O.D'V4=#O\H=I M_@?=EN<.ES]4C<]W6X$?7/Y0*CE*Q(_[+1,F4I"7]=UU]W!W]M]3--J1R.5M M)\?.G"L5.2/#Y]`Y^M]2E')3J@@I(_>+2I,J%:&`E!'8?YKHE#* MR"CD1E49F+#,6R''%ERE;H. HV:-F@;8..#;HVZ-F@;X.!#88V&-E@;(.) M#:8VF-E@;H.%#98V6-E@;8.-#;8V$`*(=B:[2M3`!KPGHNZ+A1R]:KYBX),R M-`N)#'SY8CD>8]701@[2>G0LQDUJVH0?K@ZD`:0)I`6D#:0#I`ND!Z0/9`!D M"&0$9`QD`F0*9`9D#F0!9`ED!60-9`-D"T0(1,;-[$.!;A7H5Q%S;"Q&:5+R M%3$J9>C]3H.OCK]"UHE'8%49?12DVH0?L`ZD`:0)I`6D#:0#I`ND!Z0/9`!D M"&0$9`QD`F0*9`9D#F0!9`ED!60-9`-D"T0(1,;-[$-10ROTJX@Y-A:D-/W] MBB"5,D&0)'6\=!3)-C,"%8B-2!U(`T@32`M(&T@'2!=(#T@?2`#($,@(R!C(!,@ M4R`S(',@"R!+("L@:R`;(%L@0B"J(D*W"O2KB#DV%F>TX(W%V?^Y>I8R\0!4 M)#[VVD>V#3UR0J M;@O20H"1J&H4%;?B2-2T%:L+%4F1*!$JE&BVH&>1>%Y8?JAI(WZ<.I`&D&9((D_<`INV)I$^*%EKN8XVXMMW M0;H'-GU-HM*5>!@,M!%+#T%Z!#9C32+2CA4$$VW$TE.0GH'-',@"R!)T5F"S MUB3:1&O`V6@C;N(6I(4`(U'5*"IN[4X*C!JAPB82$D+%33P)S.@52P+:Y?V* M))`R\210))X$UHA1TT;<674@#2#-D$2>N`4V;4TBW5FRNK.CC?CV79#N@4U? M$[F#G,_FK(<:Z')6'8+J"&S&0"9`IJ`S`YLYD`60)>BLP&:M2:0#'6L4V6@C M?M0M2`L!1J**"$-!J%B(^%FH8`@._V)A+/>M$N+X1IZ675\.^Q]5GUX(M+F0 M,,DNT%&`.B"0*O$P#H3OTT6S7UM#5$?40-1D%)G5*$07[L$V6]'[SKS#2N8= M%C2U8ZRX8I>1D>\I1!>VZK.5>:`!HB$CHS52B"ZL-68KHS5!-&5DM&8*T86U MYFQEM!:(EHR,UDHANK#6FJV,U@;1EI'1HC,$%0%&C$X10A8)`9$0`W22H.PB M>AP%I9)L7#QBY3$#3#_HH%@%[-Q_"P+V$]$;'ES0%AIW1%5NI\F`#H^IY6E5 M#5&=4=#((+P:"A6RP3%9OI2K9`O6Z-E4-J58H#K6;*#%XJ8);4:TU-$1GBM: M<^`.6SGA2=U-T5+NLD%9/V^/D;E97R$Z.^5>&2A4R`?*N6*E8J?7D(6,]HB1 MT1ZC]H21=".?,N9SUCQFREI&?L;(R,]9RS1]H9!J>KZ8M7IMR3)&><7(**]1 M>4/&KYVI0*#V^H51P\U5R(2O0*TP[.5:PY0,U8<<4ZH@:BID+Y@KYCBY$9 MD]J,3+LZ"M'Q.-^QRU9&J\?(:/49F>P?,`I3+SE!PFZ(M'/$M8SVF)'1GBAT M&QLU,$%`?L9:1G[.R,@O&(5-3TH04%YQ':.\9F24-PI]W/`M5S1]3@FB;FGT M*4$4,S>@!%&,NSTQ0:#Y=&`=U8]GA#P!@HPHFFD1OV42ID7TR8B>%ZF#)!-; M5?E5C7RSF&>J(:HC:B!J(FHA:B/J(.HBZB'J(QH@&B(:(1HCFB":(IHAFB-: M(%HB6B%:(]H@VB*B>`7?4KPB2W`X#>!H%W=Y/#[EL4XT/O]''*I3H&@O/6=:D9O?-E\Q(-6Q=^&AA^@G3TSL]>S7M]O:3V_D_Y MV=^M?!%I''Z42/TCOTH,LMXJHFTJ-Y@5"N@D+:&@2`7!+,)^CA(5!".95;!U7#G-1BG: M!W2#V79"496*:+EHL1&S!U7KC'P1DO'E2L- M+%@YKEQO8,':<6G[,X&77=H12N`5EQ;/"9Q:*]=FFO+H%77-KI2.#4)KFDQ)*FX\KM!2QH.6XK+,CHG*&/ ME=]VS]Y@=WX^G"ZI5^^)1K5L,"DXAY\[A_]@+?9?NT3(R M*]>I3[Y_Y7_HSAG]I?O#?P```/__`P!02P,$%``&``@````A`"RAU=4T!``` MJP\``!@```!X;"]W;W)KP,FY*>2K))4O:UT*ZU.MWO/%)P$%3#"3M/^]SMC`VL;M]=4?4G"S/B;CV_& M$WOUY;DLO"?:\)Q5:Y^,0M^C5)*COE>GR_EBQ)GDHX+V?29RD';9\&,"7>=HPS@YB!'"! M(CI\YT6P"`!IL\IR>`.4W6OH8>UOR7)/%GZP64F!?N;TPK7?'C^QRU]-GOV= M5Q34ACIA!1X8>\30^PQ-L#@8K+Z3%?C>>!D]).="_,,N7VE^/`DH]P3>"%]L MF;W<4IZ"H@`SBB:(E+("","G5^;8&J!(\BR_+WDF3FL_BD:363@F$.X]4"[N M6/AN%T(W^W"<32*YA,RF6+ZX\BL&Y`K^<(\GP"1T1!CEA+)+WK#!IIBU`781," MH3Z!$**L??C41!N;#'8JAD![]T$3,V3?A]@LXT]AB2C0'%";GL&PMFW06S3[ M$)LF]*LNIGL#=HV&P9)-7T5E`72-7FQ)Y(KYW9Y&KTVO88/!)IO6(F>/[+*] M;C$RP6[1WUONO`4PO7+K(8S)H;7HQ8C&=M?T078Y\`].&PAOEP.#S>2M11-` MMQ@"+,Q,*$`4`^LK!4`8DT-K,0686CW1!]D"X&9[OP(RVDS?F30-#),A`FXL M/9M487:]"A+'XJ'F*>;6]L;,TJ%;J/XN];%+K+G[=BO(:(N`FI]`H-NM^R[* MD0WGF-9X*$1\_78@[3A4?[1RSGYK<.KBS3TT% MB0EJ.73`8:5EDW-A^@$A$,>J1VLRA5C80O11@YUQU7`DP^G8F?2&>'4^$L>` MG'U`A^&`E,A2?&UCQ*&MPZLCDEPU(V6T50A])K8-H9O,">&8DQ_183@GX7PM M6\3HAWAP*NNC^GY0IVIUCBQI>,7C&3D\,GMCI MF8!'7AFL/'"EV;JSP`(7$M!RQ@,I%Z=MO-RJ*Y.5>`=E.CG2;TESS"ON%?0`C1&.L&\;==E2#X+5L#7@PL0$7)+D MSQ-&(W+U];G(G2=6B8R7:S<8^:[#RH2G67E%"??KYM=?5E=>/8H38[4#A%*LW5-=GY>>)Y(3*V(QXF=68N3`JR*N\5H= M/7&N6)S*247NA;X_]8HX*UV%L*S>@\$/ARQA=SRY%*RL%4C%\K@&?W'*SJ)% M*Y+WP!5Q]7@Y?TEX<0;$0Y9G]8L$=9TB67X[EKR*'W*L^SF(XJ3%EB\]^")+ M*B[XH1X!SE-$^VM>>`L/2)M5FF$%)+M3LA_7?$ MB5]_J[+TCZQD4!MYH@P\1/$?*M>>-F'I[-O!!U MV0_D*=)2@[NXCC>KBE\=%!9HB7-,91HL`=(N7B%TD8]'/;.+U% MLW.Q::+`=3&'MUU;:.0LV7195!:@:_3FED1#/HO.QZBUZ2ULR-EDTUADQY%5 MMM"-6X]@3`Z-14]&./&[Y2I:G9.=#OJL:0WA[720LQF\ ML6@"Z!9#@(4920K@(U4W"D`P)H?&8@I@-YO.R1:`-MO[%9#>9OC6I&E@F`P1 M:&/IT4B%L7][&4@EM$5#]$P3: MW;IOO0:B41_3"H^$"&BWQ]:D5\2K M#3(8ZI#A!RJBWR(E-(K5%,+^LO[TZE7$35TRZ+?)UJ0+\6JCQ.GWJEYF<4(&Y*O,;M M2/X]X3;,<$3W1W`^<%ZW+[0/N_OUYC\```#__P,`4$L#!!0`!@`(````(0!O M$J'M\#D``'IE`0`9````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`#YO]]]>-_5ANR2-__^\<65#/S^YR^__/CB^N[[V_M7 MUR,)_^XO[SY_2=YW*5]\]_8?G[]\_-#V0<=O-"2Y=DGD3Y?D_FS\C8N7/[]^ M4/EXQT\N?[HD5_(='VY'MW?=1S_S<>_/?6A']UF\J?;[/&R#SV2FCH.V/V'VW3T^/W-U>W]PW&2S^RI MD99']Q]NVPOWU4@JJA_62NNB+SK2:NK^0S_O_26[:*1UU?W',S^M5E-W[+A- MKQXNW,%:3R,KJ,N^J=;3R`KJTAH>:1F-K"`N_]$'OM)RZ/Y# M]]*%!]V5UL.53>O%'U@G]LHF]K(/K-/:K0C/_<`ZK59)YXNC9R[9,D:"F1T'9]Y7-"Y*AI" MABJ"3"$))(5DD!PR@\PA!60!64)6D!)206K(&M)`-I`MI(7L('O(P9>@BJ1@ MOD45=6F.5:2S_]J)7S*HJ_$0I)M-(%-(`DDA&22'S"!S2`%90):0%:2$5)`: MLH8TD`UD"VDA.\@>L1W.T/0L'I`II`$DD(R2`Z90>:0`K*`+"$K2`FI(#5D#6D@ M&\@6TD)VD#WDX$M0-%V#^AO<,7=I<.$2W?>\=D%^'<67OT/(4$60*22!I)`, MDD-FD#FD@"P@2\@*4D(J2`U90QK(!K*%M)`=9`\Y^!)4D?3&OD45=6G"I<>) M7S*CZZBNQD/04#20*22!I)`,DD-FD#FD@"P@2\@*4D(J2`U90QK(!K*%M)`= M9`\Y^!(437M0MI0IJ2$E)*RD@Y:4::DPK2@K0DK4@E MJ2+5I#6I(6U(6U)+VI'VI$-`88UTW;MO<'[J;JFCI44I7%NNHWZ,10V+"VE* M2D@I*2/EI!EI3BI("]*2M"*5I(I4D]:DAK0A;4DM:4?:DPX!A?74-?V^13WU MS<-N(*]3=`@H++"N1?@M"LRU&OL7`+K'1Z^[Y[1Q-8VN MHYH;6Y06SX0T)26DE)21HM^V?CMQK[!TSVW[RO):@0T951"2DD9*2?-2'-205J0 MEJ05J215I)JT)C6D#6E+:DD[TIYT""BLD:XWZ-=(U_GIGE@]L_/3/;"(+Y*& MMJ-_GL,Y;(BR>@)--;U=K2>DE)21&REI!24D;*23/2G%20%J0E:44J216I)JU)#6E#VI):THZT)QT""@NL:T=^ MBP)S;4W_;#=T.JV:1M=1S8V[%\'"2IF0IJ2$E)(R4DZ:D>:D@K0@+4DK4DFJ M2#5I36I(&]*6U))VI#WI$%!83UUCTJ^G)RZ27!_3+QN_M>DNDD"3[F7`L&RF MI(24DC)23IJ1YJ2"M"`M22M22:I(-6E-:D@;TI;4DG:D/>D04%@C71_2KY'N M(NGN*RZ27#_3+YZAQ>FO.='+/^/N!=*P>":D*2DAI:2,E)-FI#FI("U(2]** M5)(J4DU:DQK2AK0EM:0=:4\Z!!344_=.;U!/Y]><8WC8O5:RZ^$Q:4*:DA)2 M2LI(.6E&FI,*TH*T)*U():DBU:0UJ2%M2%M22]J1]J1#0&&-G.I>?\6-6?<: M>+=T>&N.DM]:'%T_A-?68XL:KIM)4U)"2DD9*2?-2'-205J0EJ05J215I)JT M)C6D#6E+:DD[TIYT""BLI[A[_<2:,S2I=?9?=W\[0"KI[GIX7WE,FI"FI(24 MDC)23IJ1YJ2"M"`M22M22:I(-6E-:D@;TI;4DG:D/>D04%@CIQK0UX^R3CQ1 M+&PX=W^#1(KEQJL5%R15Y#WV>`Q7G*Q76X_&+IR:I@W/V-I>[<^D1)NRBI?RO\ M&WL'+OR\71_*_[Q/?$S7MO(_9D]>M8Z[O\X4%O"$-"4EI)24D7+2C#0G%:0% M:4E:D4I21:I):U)#VI"VI):T(^U)AX#"&CG5`I._5?MD3;/E==637],NZ(F: MUNW\DK9WJ\*/VW4^GE'2KE'BEW1/04F#)E>@*2DAI:2,E)-FI#FI("U(2]** M5)(J4DU:DQK2AK0EM:0=:4\Z!!36R*D.R^CZZ9)F1^6J)[^D7=`3)>VBPF7: MWND)/F]W(Q;4='=:^8K'',<\Q[LS_T"*GLN_UBC_ABU^S&$Q>L$^(4U)"2DE M9:2<-"/-205I05J25J225)%JTIK4D#:D+:DE[4A[TB&@L,!.W?Y_38'Q]O^Z MISLYN+SKD:CFQA9E]31LJ#1E5$)*21DI)\U(O\=>5U%QYVC92\EB-I0IJ2$E)*RD@Y:4::DPK2 M@K0DK4@EJ2+5I#6I(6U(6U)+VI'VI$-`88UT=^C^A=K7GM3NH:CWX]/7&=T_E]->=`@HJ*>;N`%]?LTYAH?]'$?^=0YI0IJ2 M$E)*RD@Y:4::DPK2@K0DK4@EJ2+5I#6I(6U(6U)+VI'VI$-`88W$/>0G:H2M MXAM'X2U4],[&6*/ZWRX^_EREDEQ>6X_YUM[C.+XF/=6H^^/O9-[=1==)B?[O M#]U;).%7>UX[\X;M3"59`[U/:$_E^Q>Y792\IC>LFDJV`D^5KH[?X^HV_L'/ M1`..KTZ%7^1TS^W[[@V%+[^\?_OWUQ^[)TLG'^U>RW#'C_GG&W;M)7JG0KSQUN;K7';Q]98_&CKD2'5$N7+PH>ZX0?N^NLX/SH?RL MM?O:S;MZP/Z+D M5Y/\GGOX'M_8HJR>7"Y;2Z>,2D@I*2/EI!EI3BI("]*2M"*5I(I4D]:DAK0A M;4DM:4?:DPX!A?44MTR>6)?8&;EQ9+,_)DU(4U)"2DD9*2?-2'-205J0EJ05 MJ215I)JT)C6D#6E+:DD[TIYT""BLD:YCP7/:LUOY-WWGP^^/*(5K3G2Y.+8H M6W-<+JNZ*:,24DK*2#EI1IJ3"M*"M"2M2"6I(M6D-:DA;4A;4DO:D?:D0T!A M/77MB6]13WV;0^K)OTB*^B.O;UR47V*X2!IBK,!`4\ND40DI)66DG#0CS4D% M:4%:DE:DDE21:M*:U)`VI"VI)>U(>](AH*#`;F6NOT6!'?.$=QY*?C6-;J.: M&UN45LJ$-"4EI)24D7+2C#0G%:0%:4E:D4I21:I):U)#VI"VI):T(^U)AX#" M>NJZ)?Z"=?XB2?[)J?B&5`PAJ)&U=?^;[#+3M:2N&:$S?K+,K6')?+JF[*J(24 MDC)23IJ1YJ2"M"`M22M22:I(-6E-:D@;TI;4DG:D/>D04%A/I_N'S[[HOATZ MB-Y%TEW4L'VM47Z)Q1=)%F,%YI+[!09*N&%*RD@Y:4::DPK2@K0DK4@EJ2+5 MI#6I(6U(6U)+VI'VI$-`88%U34[_I/:5G:3;OEGJW]4I^=4TBFMN;%%63RZ7 M7T^@A!NFI(R4DV:D.:D@+4A+THI4DBI235J3&M*&M"6UI!UI3SH$%-93W/E^ MXB)IZ'#K[+^^'=K92F/2A#0E):24E)%RTHPT)Q6D!6E)6I%*4D6J26M20]J0 MMJ26M"/M28>`PAKY1MWK6W:OE<(U)W[L9U%:8A/2E)204E)&RDDSTIQ4D!:D M)6E%*DD5J2:M20UI0]J26M*.M"<=`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`@IKY!MUK^_8O58*UYSXW6N+T@5F0IJ2$E)*RD@Y:4:: MDPK2@K0DK4@EJ2+5I#6I(6U(6U)+VI'VI$-`83UUC>'+FT%WKH_L-8.4;($9 MDR:D*2DAI:2,E)-FI#FI("U(2]**5)(J4DU:DQK2AK0EM:0=:4\Z!!36R#=J M0-^Q`:T4KCGQN]<696N.RV55-V540DI)&2DGS4AS4D%:D):D%:DD5:2:M"8U MI`UI2VI).]*>=`@HK*?G-:#OV(!6LMD?DR:D*2DAI:2,E)-FI#FI("U(2]** M5)(J4DU:DQK2AK0EM:0=:4\Z!!34R+VL",%YZ2L;AL<\80-:*5QSXM>G+6I8 M>/62E<,V)7Y^V**VZ"6E*2D@I*2/EI!EI3BI( M"]*2M"*5I(I4D]:DAK0A;4DM:4?:DPX!A?7TO![R/7O(2OZ:XZ*,)HR:DA)2 M2LI(.6E&FI,*TH*T)*U():DBU:0UJ2%M2%M22]J1]J1#0&&-G.HA?\5SJWOV MD)6"-><^>NM^;%&VYJ"M/&540DI)&2DGS4AS4D%:D):D%:DD5:2:M"8UI`UI M2VI).]*>=`@HK*?G]9"[7X*)>LA*ML",21/2E)204E)&RDDSTIQ4D!:D)6E% M*DD5J2:M20UI0]J26M*.M"<=`@IKY'0/V7X?YJ*?!;IG!]F1_$LG@2/[M$YF.L)+B[G%_EVZ5=-DO#=VSJ^Q(?G],2V!,FBC)W9K] M*M1]],+]U*(T5Z)DOT.5*EEK.S/RTT>OJN46I>EG2I9^KF3I"Z,SZ1<6I>F7 M2I9^I63I2R,_??0\I[(H35\K6?JUDJ5OC/ST41ME8U&:?JMDZ5LE2[\S\M(_ M1%.[MRA-?U#B[V+=?Z,^]C%/U%/JV]%!N8(F;L/N1_6\/[L`W%J7IMTJ6OE6R]#LC+_U#-+5[B]+T!Z5C^G!Q MC=OD\>)ZV6F:W?/[GH)B!4TTZFI8@:>D1,GV3JID>R=3LEPY::9DN>9*EJM0 MLEP+TE+)I9+DJ4JUDN=9*EJM1DN:/'=P/T>W6QJ*T`K9*EKY5LO0[ MI3!]="[:6Y2F/R@=TP<%]B#KT(D>^W//WL[HH:<]-WC@N@T8=A9+D6 M2I9KJ62Y5DJ6JU2R7)62Y:J5+-=:R7(U2I9KHV2YMDJ6JU6R7#LER[57LEP' MI6.NL&R>]WC@@8\'',G2XI^:HCN\L459V?2YKJSBIRY*5IONG#J*>S*)9K%# M*56R0RE3LL2Y)?8_),Z?[A-9^KGFLO2%DJ5?7)1^J1M:^I62I2^5+'UEZ4_N MEEHWL<1K)4O<*%GBS1.)M[J))6Z5+/%.R1+O+?&9_7W0#8_IP[*,GT@\L9KQ MP<.#HW`UB^[DQA9E9>DVM"-JZJ+Q8S90L1@?%2J-LQ%+)1JP6OK7;_?'GTF,-1M'9&-Q)CB[(B[7,%:V=/;NV\>XRZ5(EFL6,Y5;)C.5.R M8SEWU/W+JU8FO/=PG\C2SS67I2^4+/WBHO1+W=#2KY0L?:EDZ2M+WZV=V"VU M;F*)UTJ6N%&RQ!M+?&:W;'5#2]\J6?J=DJ7?6_J3G_N@FQP3AV4I-R-!67Y5 MR^:ARQ+=4#N2F;9">(R:"V/=T`Z[B2/_'UQP)/]4Z_&4]NKQ5;0Z)9K'CNA4 MR5)G3)TKW1Y31]VOF>:PM',E2UMH#FL/+Y3";Q\=94O-]<2:.NQ)/:)+36\C M5HZ\?12M#+6-IGG62O9E&J;>A*EOKN)_F&2K:6PWM4J6>PKNA$$3MZ'\RZ^Z8Z=*-WU9O;H>H6)='MLH M=1MYHV6:QZ)RI;YBHU/;3'/8!G,E6T(*S6%1"Z6P8J/Y6&HNN?:UHYI7`=A' MI::W$2NE/]Q'M8VF.W:M9%^FT3R6>J/4I[ZYOH^.A:VFL6U:)HZ[KV*)TSTX< M=?].I#>UT8(]U2AW#7HC^S:\#DTTM2T&J9(M!IGF.3M:KE$/Q\,(M>Z^JHTT MYTB%YC@[TD*C)*5]^T>4_S"B%\7R'Z9`=VZIZ<]^B$JC_G#GUBYB9%]YK60[ MM]$\9T?;:%0_VL/-8[1$;36S#=8JV6`[37-VL+U&]8.=/&Z&?2M[+3QNGGJL M=-DS^P<^5U*R8WY,FI"FI(24DC)23IJ1YJ2"M"`M22M22:I(-6E-:D@;TI;4 MDG:D/>D04%`[CT\],;KHD>0Q2WAIX,A_:>V^^BZ(;/IJ??8O?1SS1.7:/PWR:G/LHCR: M&'G?Z3ZZH)I:E'ZG1,DNNE,E.TUG1G[ZZ`HQMRA-/U.R]',E2U\8^>FCQUL+ MB]+T2R5+OU*R]*61GSZZDJXL2M/72I9^K63I&R,_?72CLK$H3;]5LO2MDJ7? M&7GI\>:016GZ@](Q?7B:[AZFX-;(^P<@+SM-]X]D_-NAQYZ\RAR3)DKV5LV4 ME"C9WDF5;.]D2I8K)\V4+-=D/2L?T88'%SXB^\NS-9T>/ MIYX=X^,T=5'ND<-H=/<8'<>)YK';M%3);M,RI;.CY1HE#1QO M8J-E=:91-N)[36/#;:6LE& M:Y3.CK9Y-.HX8'B;2-@K6X?./4A^[\.CJ MH">OB3EV41Y-E.PB:.K(?WE(HVRU2)5LMC9+DVS+75*,O5*EFNG9+EVC/70:..N<(: MD1)\3HUTX5&-.`IZE'AYZ'&(LB73D3V2G6J4O<"2*-D!E2K9`94I6:YR7+=5`ZY@K+IGLHX%_B/;&T=.%1V?0DZXA_W/+ZGQ$G4/>!+/U<5=*UG>1LGR;L[GW>H6EK=5LKP[)O'H=?O?X+H3FYL45:3;D,[G*8N2B],7MW' M]U2)YK$C-56R(S53LM2YDM3=N>LZ]YDL_5PWM/2%DJ5?*)U-O]0H2[]2LO2E MDJ6O'/WQCJEU(TN]5K+4C9*EWH2IKZZOHGO\K6YCF5LER[Q3LLS[,//#S6U4 M%`?=YI@Y+,OX@<<32R4?;#SV%"V5T9W#V**L+-V&5N)3C>K?OK@:Q*UGF1LDR;QRYD]/='6K239(E;C6+)=XI6>*]DGN1YC9^C^:@`%U/15F)NKA^C02S3$>XZ:#F:'=:;F MI<\'"SXM7G'3,&^(^6`V1*'F#;$8+!CB,;J*6&J8#.&MZG@1:N" M%'4_Y)4M"U+4SFQ=D*+NS4LO1>TLJ+@318TAI*@QA!0UAI"B/C7$B:(>ACA? MU!A5BAJC2E$[T_UV]1"=!:6HAQ%U79&B1GHI:J27H@[2W]_<1P>I%#6R2U$C MNQ0ULDM1!]E'CP_QI$M5^^FCJC[Y#.B_J^K^V4]8U>.=H".M?'KE^?#6*]K+4OLMNEVE2^QA1:O^2$>5P<&'!RGKB<,"H2@<6%NAS\\/D3/.N6@&3Z$3J<< M-!A1#II+1I3C*!A1?F$EOLJ4`PDCRH&$$>5`NF1$.;:B$4\=6_Z(T;'UU`.K MR]X&&+WB(ZO!;,V6H\?%F,#DV$"?'!DR.#9@<"+#9"9.J1YQ4/4Q* M'":7,;#5"9/B19Q4*DQ*$R:E"9/2A$D=PJ3P8%)X,"D\F%093)9LWZ*R.OV8 MZMF/[4>O^*!JL*!_]AA=1DBIN4V#4H-)J<&DU&!2:C`I-9B4&DQ*#2:E!I-2 M@TFIP:348%)J,"DUF)0:3$H-)J4&DU*#2:G!I-1@4FHP*368E!I,2LVWJ-3D M?/V,WM?H51OHMZ&3.X0ID/(Y&((F5S$R>0.=F8(F>\A3(>0^<80,M^(D_D> MS(88Q;=94@)#F`XA)>#L^.I/5`)=RY\E\!47'.[907`@.PMJH+>P!@;SOUK4 MM),:&,+TJTD-]'9K;S7)T8PXJ8'!;(BK5]%-JM3`$*9#2`U@"*D!Q$D-#.8/ M$56RU,`0ID-(#6`(J0'$20W`9,)A,N%^OFC"N][Q-YGPO@D='O3.@@GO+9SP MP6Q727P@E'G$SX8#;$U:NH;R`3/H3I$#+A&$(F''$R MX8/Y0T37TS+A0Y@.(1..(63"$2<3#I,)A\F$^_G""1^=[ML__P@_)HHN`-7\ M"7<63+B9[:I1_";;=&1ANJL2M6#"&9=IG`QK0UR]BF8C]\)TB)F:-\1;E*T]8=<)JM3Y?-+M=^^];',YR'./R7BV8W3[.^QZ3D8N+ M=GW\5P>],-WU,KM].F]7I6K>$#*[&%:F$B93B7PRE8B3J83)5,)D*I%/IA)Q M,I6PZH3)5/KYHJGLNDV<2OMQN\NNJ$>N:>6?B-6"B>SCO+TL$]G;K7S(X36! MJU?1DQ0Y3(1:QD%D]J;?YODPH+;)&>WT@GPYA07 M5Q;FS:D;P=YJD(/3F=V)R9SV%@T1G9A6_];1(]R M9.:',!U"9AY#R,QC")EY;"LS#Y.9]_-%,]^U6[[QS+L.3C#SSN3NW*9T%*VW MX]'(A=GK>7*$]R:/3FW3$7ZN<@@+1X@6`EF]W0C^4Q%I\4T/GD4DU^ M\JB:NN[+-ZZF+F5\#==;^*Y0?&,IU=2'>>]G2S6Y3:7%,!3BJ6KJPV[D-G0( MNXH?_TLUN6S^_3Q'E6JZ9%2IIDM&E6K"J%)-O7G?5:KIDE&EFH91_ZB:,)Y4 M$\:3:AK&\ZKI?'*I)C]Y5$U='PC5Y/T5JPN;/:.^GR07,OJY7LO?2NG+*KB^ M@$F]P.1B`B:5`),3#TPJ`2;3#I,YALDR]$:U9J;-A,36H,)C4&DQJ#28W!I,9@4F,PJ3&8U!A,:@PF-0:3 M&H-)C3D[T0?N7B`[.X>7+@U]VRF<1&?!TM";=QTOL]C;4WU@"]-9DYETFP;G MC2&=QLE,#N:=AM@'MC#=5"870\CD#NDT3B9WL#-#R'P/8;JIS#>&D/E&G,PW M3.8;)O/M[$33=]1UBWC,?D5+J&\[A1/N+)CPWL()'\QVU>B1]R5#F.XJF?#> MPJ8!XF3"![,A3C1]+4R'D`G'$#+A0SJ-DPD?S!\"35\+TTUEPC&$3/B03N-D MPF$RX3"9<#]?N$AWUW;?9,*/B:+K1S5_PIT%$VYFN^I$T]?"=!]YB,7%PP&R>:OA:FNTHFO$_G[:I4S1M" M)GP8]LQLY%Z8#B$3CB%DPH=T&B<3#I/9ASVYNUZF=W!_%T?-2&F7ICN4IG=?M-P=H=T&B>S"Y.I MA,E4(I],)>)D*F$RE3"92N23J42<3"5,IA(F4^GGBZ:R:R9Q*I_;])5WOGF8 M.@LFTO6N_"?P;MNGFKX6IA,D$]FG"R<20\A$NCB[9Y2)A,E$(I],)/+)1&); MF4B83"3RR40BGTPDMI6)A,E$^OFBB>SZ..G1Z+4R'D+G%$#*WSNQ;R-R> M'`*=7@O3(62Z,81,-X:0Z3XQQ(E7*2Q,AY`*\(>(*J#KO9RK@,ONA*_Z%DZX M)CN3/[P&6K36CD>ZJ35!99GN-^T^][#IB1:=AH4C1*U0.>#=!_$;OFHVJM3) M):/*&N#"SHXJI8-1I72\J*T4?YOZJT-7M7?16@!02!I1"PH!2 M2)<,*$O)$P-*6?D#1F75]8905O_5TZ0KUVZRY?CUR%EW:6QUPBZP"_,ZHU)B M?;KN#]N4SQ1JE-@E MHTJ)N;#^+U"<+#$,*"6&`:7$+AE02NR)`:7$_`&C$NM:0RBQY[>&K_H64[AT M.;.SC:Q3,"DBF)RI8+("P>3.`";E`9-:@,G$PV3B83+Q,)EEF"P=,)E7F,PK M3"81)M,&6Y^PYH1M3MCVA+4G;'?"]B?L$%I45ET'BF7U_#:3_,@JKXF<^>O5 M5?QO`$FI#6%Z#I=2@TFIP:348%)J,"DUF)0:3$H-)J4&DU*#2:G!I-1@4FHP M*368E!I,2@TFI0:34H-)J<&DU&!2:C`I-9B4&DQ*S;>HU+K>EU]JYW\Q822_ M[\J*!Q!BMKW7>:;QDV[.\;=ZI#<,9Z_GW.Q$:A,V9;GQT9(GR3J=8,Z+M-JQW'ZY5[#?E M6#[9;'O08>NKMSQ+JCWL%&LV/6I856V2T9B]ZAZ0/_=Z"-=>G%W^?I*]@8LRW6M(QD MUFQ]6;W7L,FZ_TAF5:[#2&;-^.OE:DEH6ZRIEH16S!HSIG"ZQOS.F8*O)*@# M:[9N`8D31N(J-N:\U6E!\JR`Q+7%FA:0N)IUEU-J%21.JB5Q%9O@JI>K)7%M ML:9:$M>M-CFB8^;C-8FK9DIZ-P/#FO42)XS$52Q)7/)4C<2UQ9H6D+B:]1(G M59`X822N8DGBDFI)7%NLJ9;$5BZ@>W<^K%DO<<)(7,7ZB4L? M<9.XMEC3`A)7LU[BI`H2)XS$5:R?N+1:$M<6:ZHE<16SB8L[UMS7N*D"A(GC,15K)^X MM%H2UQ9KJB5Q%;.)BSN,UR2NOB/I):YF^+HS^B93Y.2R+=9$1BYK1L^VFYJY MVKH8%WBQQ%`GE\ALO:/N-&W#^G$E\^HD6^(BV3\2%\FNBM5QC;+T:_^DOAM7 MUU0L=Y<9I[+=#F_RA*G=HIUNJ!FZ]WAW8K% M55K;+7DN<^/-[CB%ML6R]&M<7/ZTM:Z+27#T0UNL"8Y^D.!(N@TN>;F5S->; MOA1NZ6)X&M]_N;?W8ZJ!AG>`.6]8++EWW?-04(SC:E71$ MW!FD1T7V?TW^CZJ;C=Y9LF;)`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`:KU9NN[;+>B@PO9/0=,*V[*"AA6V707-*FRK-DGBILWAA&TF M=IL)B9C8/$Q(P\1F84(2)C8'$R*8V`@*#HJB'"63OI^-B^FL6IN7*'.4Y=A& M,"8"5H687A@3P=A&,"$"6\]LDG%P\2S.[`YIR3H0I]"I$]NI$SIU8CMU0J=. M7*?.1EO36;5H)$T"RM(?&#'.<%EC8AL3M1]DQD1MZYF-AT1@C8"R'-OVC&D/ M'^9S$6`X1D>G8#A?SY"6LI3`;#.BI3P^5V4V&D]G?DA!6?H!;$0$?O@:83@_ M>(TPG*UG-AP0@D4>H$E@DXA!ZR! M^N.X7V5$L=9&]$ MS:MF;AMBL\/R+"O/G&X;%,9RJY!KOL1HZLF(C:_J.85<\X4T56:<:V;VM#XO MST*V/1F]P$>5=&_SC)96JSG2[&0[9SJ,-V-#78"C(, M4-VM2U`8P-81R^RFY2(Z#9@E1?FT7$RGVHS!VG<:%;G&A\\-5U[6Q''1:+O;4ML6*Q]!<_2R\RZ?END;=+M:]3_G#;<=J MKWQ:KG/4[>B#//K`Y0=M&)K+$=HH-)?'+ MM3T^-C;E!3"GQ4?'IKSTY;3XT-B4E[^ MFFL#VC`TUX;X7B/]]\*)DS;,_79\@':3X^BE?6[B,]MVZML*S;4=?\;Q9]N. M%L>?;3M:C"^V[6@QOM@XXU.%'+=6BQ^"X=BT%SOQ@S`MC3-^4XO^XQ>C--?,\10< MFW8[?I^KX-BT6OS"$SZS;4>+X]:V'2V.6]MVO!O'K6T[6ARWMNUH<=S:../G MI#@VK7:[E4UOMYRK[U#NK'*/\G[+C9SW6SF*.P[NMX8HKIXE>UM:Y1SEPM9S M3CT7MIYSZKFP>[MD;Y=6N4*YLLHURHV-X)H(;FP$UT1P8_=VQ-Z.K'*,$UO/,?6U;91SFP4>\3]8&->I^H#^S> M#MG;H57NBV+ZOG"CY'VQB>+&E_MB"\6-+DOVMK3*8FN`1]W5PIS8YC:V;91M MJRQ0=FQV%F1GQV9G079V[-ZNB/K*1GV-V*"9XU)Z1J&=NM]E&V;;*`F7'QK8@MAT;VX+8 M=NS>=MG;KE7V4/:LLH]R8"/8)X*#*H(W[13-\[NW?SU\6IT\/'WZ_<_GC<^K MC^6":QXN;#Q5*V<'U;?ET]Q?)L"G]\?/S2 M_(>3^YO_/#[]NWQP]NY_````__\#`%!+`P04``8`"````"$`Z7]CG>T"``!' M"```&0```'AL+W=OQX!50G%C! M]'--BA&/PR]9*20Y%9#WD^N3N..N%S-ZSF(IE$BU!71V(W2>\\;>V,"TVR8, M,C"V(TG3"._=\!A@>[>M_?G-Z$4-GI'*Q>639,E75E(P&\ID"G`2XL%`OR0F M!)OMV>[[N@#?)4IH2LZ%_B$NGRG+<@W57D)")J\P>;ZC*@9#@<;REH8I%@4( M@"OBS'0&&$*>ZON%)3J/L!=8R\!9N`!')ZKT/3.4&,5GI07_TX#V+EH=\*]W;EP+-=W5N;M\WUVH[XVXXYHLMM*<4'08*!/ M5<2TJQL"5^="P]#[\C];P`]#LC( M8X380Z8J_7=1:5B@.:`VO8)Y;5O02S)[R%0F].O0S.OGKVLT`Z[5 M]%5L(L`^D+>>6'0-\Z\]1[VV>HL:`QZK:2/UZ*F[[#B,C-X$IV68MSEY/@A] MX\DS+&,);618"V^SF3C2@_IJ-(.RF0V:5$H%(NS&8)K.-1]M)_/>\^< MIDG\`'.[GG+3N!<>K^(7(?3PG&?OA_OZM$YY_/#H7\$?5B&8/>PC07&B9X_9C#!YO"]'`L`*=" MZ&YAC.S_`NS^`@``__\#`%!+`P04``8`"````"$`K&TO*><"``!&"```&0`` M`'AL+W=O[F%7(I" MJH2JNY6VTFJUEV<'#%@%C&RG:?]^QUR\7+)5*_4%\.3X<.;,>,CVYKDLT!,5 MDO$JQ*[E8$2KF">LRD+\Z^?=U08CJ4B5D()7-,0O5.*;W>=/VS,7CS*G5"%@ MJ&2( MPL'3E,7TEL>GDE:J)1&T(`KTRYS5LF*@OH[%;H/.=K^]H&IMTV89"!MAT) MFH9X[P;1&MN[;>//;T;//&GJ?Z!!LMF>[ M[YH"?!H'/W^E+,L55'L)">F\@N3EELH8#`4:RUMJII@7(`"NJ&2Z M,\`0\MS8B]A>7ZS@K0Z$BENF.:$:/X)!4O_[08MV-J.;R.`^X]AV,X M7MFWZ/;!O=]W;6V62W^U6T0CN M?(!&S:(UZDIJT8<^,!`]$=0CIH+`J`\0I%E"#->!:8NQ@D.+<:&Y#6@YAD0& M,E7I?XA*S0+-`;4Q"N:U[4"OR320J4SHUZ&9EX]?WV@:W*@Q56PCP#Z0YT\L MNH3YUYZC7EN]1XT&C]5TD6;R-%T6#2.C-\%I&>:M3]X"#'SGR=,L8PE=9%@+ MSY\VC0&9:K1SLIT-)149C6A12!3SDYZ!&SC4)FK&\][3IVD2/\#8;J;<-.X% MT47\(H`>GO/L_6#?G-8ICQ]$_@7\816`V7.>P[K[C-B&",9X33+Z0$3&*HD* MFD**CJ5'IV@_!.U"\1J\A6G.%4SPYC&'[S6%Z>%8`$XY5_U"&VG^`>S^`@`` M__\#`%!+`P04``8`"````"$`/AO7ILD$``"'$P``&0```'AL+W=O>%^6__Q97D1^5-QY+QT$"$K5NZQ M+$\+SRNB(T_#8B!./,/(7N1I6.(Q/WC%*>?A3DY*$X\-AU,O#>/,K2(L\H_$ M$/M]'/%[$9U3GI55D)PG80G\Q3$^%4VT-/I(N#3,G\ZGKY%(3PCQ&"=Q^2J# MNDX:+7X<,I&'CPGV_>*/PZB)+1\ZX=,XRD4A]N4`X;P*:'?/@1=XB+1>[F+L M@-+NY'R_!3BB5Q_ M[,B$R5YG]H-DX*_$[*O\7E.X\/QQ)T3[`CVMAB]WK/BP@919A!!2,2 M"0#@KY/&5!K(2/@B_U_B77G$K_E@Y@^#T0Q1'GE1/L04TG6B,/$:USZ;K8WAL&P]*/^"U&+'; M3\!(40@CY9%`;QJ#`EJ'O&T\3$!(U"<`HB@K%W^5I#$=P:;R\5&EK=-$=]FV M+B;*\:>@I"@H#G#3(NAR6SN]![-U,6&B7M5DVONH*31REFA:%BL+F%+@C8P4 MV7RNQ:?5VK0/&G+6T=06*2&RRK:J15L)W:+NFSHO0`)[=AY%T2'4%I4+-A\; M&6F=3#;HF%+TX'TVR%E?O+8H^UG(I@8S5Z\.--+'#W-#'6MDIC$I[&@FC1Z?Q$]9 M[49^9!@C#Y6LTD:5GIV9>6B].GD@Q3.1W=`Z?JV<_O5(:$PZM+D)[4W)]0W- M?;]]I+>1&U4F*P%IO*K7$O5A?JY4^HA:0ZNILE*$!34]$8":B MGFB!UDM'_:Z0-B:U5M^44M^BI>-A,,"$OFW;U5,9W$Q%,#13\::B^KTD57H; M-:%*:%T3JDEO6XNL$IE]\]#55;_53*5M@^LQ6B-KOW5JP.NE[:RKK8V)J5>-9-&$K-HZPTDR3!&'EK55$DRWX>:B=V^ M919MO9&DKKK*X)U.,E]-KEX=DGJI*ZNE5%&UQJ22I`JN3A*)FW',^$'_5J(+ MF7$0-R:]6LUWE*M7FXCJ5EI=X%*>'_B6)TGA1.),-TXVQ=6K-5?7X0UCN`\S M4O;.R`@C(^O(&"-CZ\BDN5V;T?SI8@O1MJSCSS`B[UV=.7.,S*US`HP$MA$V M!`))H!F-T+;%MX`JQ4J>+32"!:M)()#*X5@4!+H MM9G%9Y!3>."_POP09X63\#V*=CB@[QYY]2&E>BC%"2J!CR&BQ`<0^?.(#UX< ME_;A`,Y[(&PO=V]R:W-H965TJ6 M)=G<_?/K>$C]],Z7O7^Z3ULWV73*.^W\Q_WI^3X]GS6^W:93E^OV]+@]^"?O M/OW;NZ3_>?C[K[MW__SC\N)YUQ0IG"[WZ9?K]=7)9"Z[%^^XO=SXK]Z)+$_^ M^;B]TK_GY\SE]>QM'X-"QT,FE\V6,L?M_I0.%9SSGVCX3T_[G5?S=V]'[W0- M1<[>87NE]E]>]J\75CON_D3NN#W_>'O]MO./KR3Q?7_87W\'HNG4<>>TGT_^ M>?O]0-?]RRIL=ZP=_`/RQ_WN[%_\I^L-R67"AN(UVQD[0TH/=X][N@+1[:FS M]W2?=BW'K5NE=.;A+NBAQ=Y[O\2^IRXO_GOSO'_L[4\>=3<-E!B"[[[_0[BV M'P6BPADHW0B&8'1./7I/V[?#=>*_M[S]\\N5QKM(ER2NS'G\7?,N.^I2DKG) M%872SC]0`^AOZK@7L4%=LOT5?+[O'Z\O].WVIEC.YBUR3WWW+M?&7DBF4[NW MR]4_+J63E`I%XJF2A*YO&[%Q&LY0I'3 M.;R.*,'_+;\IL86**V3NTS20E+H7FI5^/E`NW&5^TD2RDSX5]+%TCRI[B%E# MR-9,4#=!PP1-$[1,T#9!QP1=$_1,T#?!P`1#$XQ,,#;!Q`13$\Q,,#?!P@1+ M$ZQ,L#;!Q@1N-+P\,&XTF!&!P7-A].C&),.$2F4H`*,HI'G\*Z)0R(@HY$95 M&,3"T@@Y]N`B-1/43=`P0=,$+1.T3=`Q0=<$/1/T33`PP=`$(Q.,33`QP=0$ M,Q/,3;`PP=($*Q.L3;`Q@>L"B0:3A\JM@@^,GAL?/BWDZ%;S%2$G9.[3]#*ZB-0P\QBZ.*PNCJNK#:P6H[0H^8H8%3)T M?Z?)-XH_O#M+IX^"-'+A"ZP!J0-I`&D":0%I`^D`Z0+I`>D#&0`9`AD!&0.9 M`)D"F0&9`UD`60)9`5D#V0!Q74051%5$.*ZN-K!:D-+R5PO2Y(T@+Q2%=Q"+ M'$.5D%`C8L%I&]-CDH]:7FK-H;W4)YHCO/7F2!)L@H-%:!5(#4@=2`-($T@+ M2!M(!T@72`]('\@`R!#(",@8R`3(%,@,R!S(`L@2R`K(&L@&B.LBJB#"875Q M7%UM8+4XH[V.%F?_<>,D9/0`E"0^$>=*62,A(B=.HQJ0.I`&D":0%I`VD`Z0 M+I`>D#Z0`9`AD!&0,9`)D"F0&9`YD`60)9`5D#60#1#7151!5$6$X^IJ`ZO% MI#ADC6_F/YZ*A;<>>I+$YCX@-2!U(`T@32`M(&T@'2!=(#T@?2`#($,@(R!C M(!,@4R`S(',@"R!+("L@:R`;(*Z+J(*HB@C'U=4&5HLS.K_2XNP_SGU"1@]` M2?2YSSPEBIRBN0]('4@C),5<=#C0!)]61&)KD5)!GWK;D1-7WP'I+OCT(A*7 M-C:*_1E*VOJT_"]K3['%_XK$ M"'3TS&"DIX8Q%%7EQ9=40U1'U)`HGA[HU5(HUJ\EXRRCK;RX$1V4[Z)73Z&X MO+$7Z"LOEA^@_!"]1@K%Y,M&5(R5%\M/4'Z*7C-$%.-F6BM MO+BI&Y2GPUL1E11-ZK9.Q[<1BU=0TM//38@G.M4-B\9"AL(:HC:D@4N_(F>K44BC?"Z-JV M\N)&=%"^BUX]A8*G+%G+N+R^4H&&35:,B!+"!**_-`O-OX4^2$KB"#4PUP<3L<7X^$B MZ:9,9QG7E_WN1\6G`P\JG;!(S],3-/E<+3SBIEKXJBI6B(KJ,4<540U1'5&# M46Q5)%%LMFBQ%^U.U!E-2=T#@Z:VE1ZH+ZB`:,E-80M4;L MI;3&B":,E-84M6;LI;3FB!:,E-82M5;LI;36B#:,E!8%K(P`+6`A!&BJ1A8% M04R/HZ`4O"*B1ZPXTX:(+=UPP,[\UR!@/Q&]\I0\'KT2A:^&B(>\5?$6@;@_ M*51C%#0R"*^Z1/EL^'2Y9-G9O#&I-J1/20O4LK&`:+*XJJ_%B(Z)H@BWBL8: MNLU>Y:`)^9NBH=QAA]LH6[N,5&4]B>B5`TZ4OD3Y7*!L%6W;3*\!"RGM(2.E M/4+M,2,QC-'#>HE)TAX@;%V#KF4TAXQ4MICB0K: MK($)`O)3UE+R,T9*?LXH;'I2@H#RDLLHY14CI;R6Z..&;[B@ZG-*$%FETJ<$ MD4Q50`DB&7=[8H)`\VE5%-?7,X*R&3.BJ)9%?)=)6!;1FU;1NDC(&&D@D;JF MJG@O4=_YU!#5$340-1&U$+41=1!U$?40]1$-$`T1C1"-$4T031'-$,T1+1`M M$:T0K1%M$%&\PD!2O")+&'":P-%/'W(]/L63HOB,_7_B4#Y84G-W\-_&J;<&F MQ(AP^")PY99>!`YN6J;!*HI7A(-[KV&B\R^'.BQ8+AHFFAX)8*`*G=HFCOR2+19:D=M'Q!5F2:FG8CCB/0+&F[31# M0R;*)/I%P>OVV>MOS\_[TR5U\)YH&LP&JXAS^)N$\)^KW+-^]Z_T6X)@^_I" M/Q[Q:-^9%1O;)]^_\C]4&UL(*($`2B@``$````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````G)51;]HP$,??)^T[1'EO`[2=)F12 M46!J)5J0DK:/D>M:P4#?P/6OPV_?V-SHTLP*,%Z%$+9 M@;]$+/M!8,42"FXOR:S(DFE3<*2I600ZRZ2`L195`0J#7J?S(X`U@DHAO2CW M`?TF8G^%YP9-M:CY[$N\*0DX9,.RS*7@2*<,'Z4PVNH,ORROP][-UH-& MQYYUA(:$#,>,L<0<["R;2B4*J5_*@&K6E;I/O MSS":/8TG3]%DG-`HFDT?QL.8)G?#Z?!I-#EC2_Z*8LCU^*>DZ3G1 M[BHK%5B;C,$*(\OZ/FX+>,>M/))[7[2H*@IN-HG.DD@NE*0.HKN3#(70E4)G ME@=JX`*2F*_!'7.DBT)BW8-N>X1:O"?$!&E"OM3(=MLZSFROW!@B:2I2+ MS_=&U9N%WQ6!))/5YS@G2^!6YW39W.KL3D*5>Z/.<)[VM(+GL%PY\[0UI-N" M7.9NH):6)_T^T[39Y&38U^-4_H/"I]-_5-KE??18?7B>IE*]V^&UL(*($`2B@``$````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````G)%!2\,P&(;O@O^AY-ZF:44DM!FH[.1`<*+L%I-O6[!)0Q)M M^^_-NJY.].0QO&^>/-^7:M'K)OD$YU5K:D2R'"5@1"N5V=7H>;U,;U#B`S>2 M-ZV!&@W@T8)=7E3"4M$Z>'2M!1<4^"22C*?"UF@?@J48>[$'S7T6&R:&V]9I M'N+1[;#EXIWO`!=Y?HTU!"YYX/@`3.U,1!-2BAEI/UPS`J3`T(`&$SPF&<'? MW0!.^S\OC,E94ZLPV#C3I'O.EN(8SNW>J[G8=5W6E:-&]"?X=?7P-(Z:*G/8 ME0#$#OMIN`^KN,JM`GD[L/[--8GW^PK_SBHI1CLJ'/``,HGOT:/=*7DI[^[7 M2\2*G%REA*0D7Q<%S4M:EIL*GUK3?38#]23P;^()P$;OGW_.O@```/__`P!0 M2P$"+0`4``8`"````"$`$L(4_;X!``!@$0``$P`````````````````````` M6T-O;G1E;G1?5'EP97-=+GAM;%!+`0(M`!0`!@`(````(0"U53`C]0```$P" M```+`````````````````/<#``!?&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"B*[7,O!```.0\``!D````````` M````````TA$``'AL+W=O&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`.5_&#IK!```IA(``!D`````````````````@A\``'AL M+W=O&PO=V]R:W-H965T0&JC=0,``%<+```9```````````````` M`.LW``!X;"]W;W)K&UL4$L!`BT`%``&``@````A M`!+517VC`@``F`8``!D`````````````````ESL``'AL+W=O&PO=&AE;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(```` M(0`-A70W]@0``!83```8`````````````````#9%``!X;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A``;]GW-43```T.,``!0`````````````````A$T``'AL+W-H87)E M9%-T&UL4$L!`BT`%``&``@````A`,5@-5'D"P``/VP```T````` M````````````"IH``'AL+W-T>6QE&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"BAV9.H`@``$@<``!D````````````` M````$:H``'AL+W=O&PO=V]R:W-H965T MA#D``/1D`0`8```` M`````````````)'0``!X;"]W;W)K&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`/S@18HC!0``[Q,` M`!@`````````````````\@X!`'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`.E_8YWM`@``1P@``!D`````````````````DV_.6L"``!"!P``$``````````````` M``"@>P$`9&]C4')O<',O87!P+GAM;%!+`0(M`!0`!@`(````(0"@G/JB,0$` M`$`"```1`````````````````$%_`0!D;V-0 XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
Subsequent Events (Details) (Stock Options [Member])
9 Months Ended 1 Months Ended
Sep. 30, 2014
Nov. 08, 2014
Subsequent Event [Member]
Subsequent Event [Line Items]    
Options exercised (in shares) 256,096 423,225

XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2014
Income Taxes [Abstract]  
Income Taxes
Note 3 -Income Taxes

We had no income tax expense for the three months ended September 30, 2014.  The income tax expense for the nine months ended September 30, 2014 was $2 related to minimum tax payments.  During the three and nine month periods ended September 30, 2014, we had net operating losses (“NOLs”) which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $2,100 and $6,200 for the three and nine months ended September 30, 2014, respectively.

There was no income tax expense for the three months ended September 30, 2013. The income tax expense for the nine months ended September 30, 2013 was $356, which was a negative effective income tax rate of 2 percent.  As a result of NOLs during the periods, the income tax expense for the nine months ended September 30, 2013 reflected only a prior year change in estimate of our taxable income. During the three and nine month periods ended September 30, 2013, we had NOLs which generated deferred tax assets for NOL carry-forwards.  We provided valuation allowances against the net deferred tax assets including the deferred tax assets for NOL carry-forwards.  Valuation allowances provided for our net deferred tax assets increased by approximately $1,700 and $6,100 for the three and nine months ended September 30, 2013, respectively.

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of deferred assets will not be realized. The ultimate realization of the deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Based on the available objective evidence, including our history of operating losses and the uncertainty of generating future taxable income, management believes it is more likely than not that the net deferred tax assets at September 30, 2014 will not be fully realizable. Accordingly, management has maintained a valuation allowance against our net deferred tax assets at September 30, 2014. The valuation allowance provided against our net deferred tax assets was approximately $22,000 and $16,000 at September 30, 2014 and December 31, 2013, respectively.

At September 30, 2014, we have federal and state net operating loss carry-forwards of approximately $38,000 each, expiring beginning in 2027 and 2016, respectively.

Effective January 1, 2009, we adopted accounting guidance for income taxes, which clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold and measurement attribute for the financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. We are now required to recognize in the financial statements the impact of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position.

Our tax years for 2005 and forward are subject to examination by the U.S. tax authority and various state tax authorities. These years are open due to net operating losses and tax credits remaining unutilized from such years.

Our policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. As of September 30, 2014, we had accrued immaterial amounts of interest and penalties related to uncertain tax positions.
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W8SA?.#!A-E\P-35D M.64X,S$P,C4B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O M5]O9E]3:6=N:69I8V%N=%]!8V-O=6YT/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQI=&EG871I;VX\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7T1E=&%I;',\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE M#I!8W1I=F53:&5E=#X-"B`@/'@Z4')O=&5C=%-T M#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H96%D/@T*("`\ M8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E;F5D('=I=&@@ M36EC'1087)T7S'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)RTM,3(M,S$\'0^)TYO/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)UEE2!&:6QE3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)TQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)U$S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)S$P M+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V M,E\T,C(T7S0W8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE M.#,Q,#(U+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'!E;G-E M2!A;F0@97%U:7!M96YT+"!N970\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4@86YD M(&%C8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M/B@T+#0V."D\"!E M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO#H\+W-T'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'!E;G-E2!A;F0@97%U:7!M M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@Q-RD\3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W8SA?.#!A-E\P M-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S0U M,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY.B`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`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2!A;F0@28C.#0X M,CL@=&\@96YT97)P2!R871E&-E961E9"!T:&5S92!R M871E6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M3LG/D]U2!S;VQU=&EO;G,@<')O=FED92!T:&4@6QE/3-$)W1E>'0M M86QI9VXZ(&IU6QE/3-$)V9O M;G0M3LG/D]U2!A;F0@2!A<'!L:6-A=&EO;G,@8V]M<&%N>2!T:&%T('5S97,@:71S(&1E97`@9&]M M86EN(&MN;W=L961G92!T;R!S;VQV92!P2!A;F0@=&AE(&5N=FER;VYM96YT+"!C'!E8W1E9"!T;R!G96YEF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU&%M M<&QE+"!O9F9E7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O M;&EC:65S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S M='EL93TS1"=F;VYT+69A;6EL>3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M3LG/E1H92!A8V-O;7!A;GEI;F<@=6YA=61I=&5D(&-O;F1E;G-E9"!C;VYS M;VQI9&%T960@9FEN86YC:6%L('-T871E;65N=',@:&%V92!B965N('!R97!A M3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2UO=VYE9"!S=6)S:61I87)I97,N($%L;"!I;G1E3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2!FF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`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`G)U1I;65S($YE=R!2;VUA;B&ES=&EN M9R!L:6-E;G-E(&%G7!I8V%L;'D@8F%S960@=7!O;B!A<'!L M:6-A=&EO;B!O9B!A(')O>6%L='D@&5C=71I;VX@;V8@=&AE(&QI8V5N2!H M87,@;V-C=7)R960L('=E(')E8V]R9"!T:&4@8V]N2!A6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H.B`Q.'!T.R<^)B,Q-C`[/"]T M9#X\=&0@F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2!087EM96YT2!P87EM96YT2!R97!O M2!O8FQI9V%T:6]N2!R97!O MF4@2!R97!O6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[)SX\=&%B;&4@ M8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!C;&%S6QE/3-$)W=I9'1H.B`Q.'!T.R<^)B,Q-C`[/"]T M9#X\=&0@F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU3H@)R=4:6UE6QE.B!I=&%L:6,[)SY.;VXM4F5F=6YD86)L92!5<"U& M2!R96-O9VYI M>F5D(&]V97(@=&AE(&QI8V5N'1E;F1E9"!P87EM96YT('1E2P@=&AE(&9E97,@87)E(&=E;F5R86QL>2!P6QE/3-$)W1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&IU M6QE/3-$)W=I9'1H.B`Q M.'!T.R<^)B,Q-C`[/"]T9#X\=&0@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B'0M M86QI9VXZ(&IUF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'!E;G-E(')E:6UB=7)S96UE;G0L(&%N9"!D86UA9V5S+"!I9B!A;GDL M(&%R92!R96-O3LG/CQB65AF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L(%-EF5D("0Q+#4P,"!O M9B!R979E;G5E(&9O6%L=&EE&5C=71I;VX@;V8@=&AI6%L=&EEF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L(%-EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M(%-E2!R979E;G5E(&]F("0Q+#DQ,2XF(S$V,#L@26X@861D:71I;VX@=&\@ MF5D('5N9&5R('1H92!!=6=U6UE;G0@ M9F]R('5S92!O9B!O=7(@<&%T96YT960@=&5C:&YO;&]G>2!P2!P87EM96YTF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L(%-EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L(%-E3LG/B8C M,38P.SPO9&EV/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<] M,T0P('-T>6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M#L@=VED=&@Z(#@X)3L@8F%C:V=R;W5N9"UC M;VQO#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE M9G0[(&UA6QE/3-$)V9O;G0MF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\ M+W1R/CPO=&%B;&4^/&1I=CX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)V9O M;G0M3LG/D5AF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B'0M86QI9VXZ(&IU2!T:&4@=V5I9VAT960@879E2!D:6QU=&EV92!S96-U2!L;W-S97,@;VX@;W5R(&1E<&]S:71S(&]F(&-A6QE/3-$)V9O;G0M2!I;B!T:&4@86-C;VUP86YY:6YG($-O;F1E;G-E9"!#;VYS M;VQI9&%T960@4W1A=&5M96YTF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`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`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IUF5D(&=A:6YS+"!GF5D(&QO2!S:6=N:69I8V%N="!I;G9E#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E6QE/3-$)V9O;G0M M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\+W1R/CQT#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L M'0M86QI9VXZ(&-E M;G1E3H@)R=4:6UE"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E M3H@)R=4:6UE6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$ M)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)W9E#L@=VED=&@Z(#(X)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T M9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&UA6QE/3-$)W9E M"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE M/3-$)W1E>'0M86QI9VXZ(&IU#L@=&5X="UA;&EG;CH@8V5N=&5R M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@8V5N M=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UE M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q M-C`[/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q M-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[ M/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[ M/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UE6QE/3-$)W9E6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E M6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B3H@ M)R=4:6UE'0M:6YD96YT.B`M-RXR M<'0[)SY#;W)P;W)A=&4@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B'0M86QI9VXZ(&QE9G0[(&UA6QE M/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE M/3-$)V9O;G0M3H@)R=4:6UE'0M:6YD96YT.B`M-RXR<'0[)SY5+E,@86=E;F-Y M('-E8W5R:71I97,\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E6QE/3-$)W9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M"!D;W5B;&4[ M('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M2!L979E;"!W:71H:6X@ M=&AE(&9A:7(@=F%L=64@:&EE6QE/3-$ M)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V M97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R!T M97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0Q M-"!V86QI9VX],T1B;W1T;VT@'0M M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X M.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X] M,T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@ M8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A M;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M M.R!P861D:6YG+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C M,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C M,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R M/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V9O;G0M#L@ M=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG M+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^ M/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T M:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P M>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O M;G0M"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R!T97AT+6%L:6=N M.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS M1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D M97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^ M/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@3H@)R=4:6UE'0M:6YD96YT.B`M-RXR<'0[)SY397)I97,@;"!787)R M86YT6QE/3-$)W9E6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[(&)A8VMG'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED=&@Z(#4R)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M3H@)R=4:6UE6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[(&)A8VMG6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!D;W5B;&4[('1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@,24[(&)A8VMGF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W9E#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M M"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@3H@)R=4:6UE6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CPO='(^/'1R/CQT M9"!V86QI9VX],T1B;W1T;VT@3H@)R=4:6UE'0M:6YD96YT.B`M-RXR<'0[)SY397)I97,@;"!787)R86YT6QE/3-$ M)W9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W9E6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@"!D;W5B;&4[('1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[(&)A8VMG6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\+W1R/CPO=&%B;&4^/&1I=CX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+V1I=CX\=&%B;&4@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@ M8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P M,#`P(#)P>"!S;VQI9#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T M=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/B8C,38P.SPO=&0^/'1D(&-O;'-P M86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S;VQI9#LG M/CQD:78@3H@ M)R=4:6UE6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P M.SPO=&0^/"]T6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O M;G0M3H@)R=4:6UE6QE/3-$)V9O;G0M MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\ M+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E6QE/3-$)V9O;G0M2!I;F-L=61E9"!I;B!N970@;&]S6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M2!I M;F-L=61E9"!I;B!N970@;&]S6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M3H@)R=4:6UE'0M:6YD96YT.B`M.2XY<'0[)SY3971T;&5M M96YT'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E3H@)R=4:6UE'0M:6YD96YT.B`M.2XY<'0[)SY"86QA;F-E(%-E<'1E;6)E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)V9O;G0M3LG/DYE=R!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]D:78^/&1I=CX\ M8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)V9O;G0M3LG/DEN($%U9W5S="`R,#$T+"!T:&4@1FEN M86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)V9O;G0M2!I;F-O'!A;F1I;F<@=7!O;B!C97)T M86EN('!R:6YC:7!L97,@=&AA="!A2!R97!O'!R97-S('-T871E;65N M="!A;F0@;W1H97(@9&ES8VQO2!A<'!L:6-A=&EO;B!I3H@ M)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B2!4;W!I8W,@;V8@ M=&AE($-O9&EF:6-A=&EO;BXF(S$V,#L@26X@861D:71I;VXL('1H92!A;65N M9&UE;G1S(&-R96%T92!A(&YE=R!3=6)T;W!I8R`S-#`M-#`L/&9O;G0@F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&IUF5D('1A>"!B96YE9FET('=O=6QD(&)E M('!R97-E;G1E9"!A"!A M"!L;W-S(&]R(&$@=&%X(&-R961I="!C87)R>2!F;W)W M87)D(&EF('-U8V@@'!E8W1E M9"!I;B!T:&4@979E;G0@=&AE('5N8V5R=&%I;B!T87@@<&]S:71I;VX@:7,@ M9&ES86QL;W=E9"XF(S$V,#L@5&AE('-T86YD87)D(&)E8V%M92!E9F9E8W1I M=F4@9F]R('5S(&]N($IA;G5A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#XG/&1I=B!S='EL93TS1"=F;VYT+69A;6EL>3H@ M)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU"!E M>'!E;G-E(&9O"!P87EM96YT2!A<'!R;WAI;6%T96QY("0R+#$P,"!A M;F0@)#8L,C`P(&9OF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU"!E>'!E;G-E(&9O"!E>'!E;G-E(&9O65A&%B;&4@:6YC;VUE+B!$=7)I;F<@=&AE('1H"!A2UF;W)W87)D2`D,2PW,#`@86YD("0V+#$P,"!F M;W(@=&AE('1H2X\+V1I=CX\9&EV/CQB2!D:69F97)E;F-E2!O9B!O<&5R871I;F<@ M;&]S"!AF%B;&4N($%C8V]R9&EN9VQY+"!M86YA9V5M96YT(&AAF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU&EM871E;'D@)#,X+#`P,"!E86-H+"!E M>'!IF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2`Q+"`R,#`Y+"!W92!A9&]P=&5D(&%C8V]U;G1I;F<@9W5I M9&%N8V4@9F]R(&EN8V]M92!T87AE2!I;B!I;F-O;64@=&%X97,@"!P M;W-I=&EO;B!T86ME;B!O'!E8W1E9"!T;R!B92!T86ME;B!I;B!A('1A M>"!R971UF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU"!A=71H;W)I='D@86YD('9A"!CF5D(&9R;VT@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M3LG/E=E(&QE87-E(&]U'!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3LG/CQT86)L92!C96QL<&%D9&EN M9STS1#`@8V5L;'-P86-I;F<],T0P(&-L87-S/3-$1%-01DQI3H@)R=4 M:6UE3L@=VED=&@Z(&%U=&\[ M)SY3=&]C:RU"87-E9"!#;VUP96YS871I;VX\+W1D/CPO='(^/"]T86)L93X\ M+V1I=CX\9&EV/CQBF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M M86QI9VXZ(&IU2!O9B`X-R!P97)C96YT(&%N9"`Y,R!P97)C96YT.R`H:6EI*2!A(')I M'!E8W1E9"!O<'1I;VX@=&5R;2!O M9B`V('EE87)S(')E2X\+V1I=CX\9&EV/CQBF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IU2!A;F0@)#(L,3$P(&%N9"`D M-2PT-30@9F]R('1H92!T:')E92!A;F0@;FEN92!M;VYT:',@96YD960@4V5P M=&5M8F5R(#,P+"`R,#$S+"!R97-P96-T:79E;'DN/"]D:78^/&1I=CX\8G(@ M+SX\+V1I=CX\9&EV('-T>6QE/3-$)V9O;G0MF5D(&]V97(@86X@97-T:6UA=&5D('=E:6=H M=&5D(&%V97)A9V4@<&5R:6]D(&]F(&%P<')O>&EM871E;'D@,BXU,B!A;F0@ M,BXX,R!Y96%RF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&IU&5R8VES960@86YD(#3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W M8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U+U=O M'0O:'1M M;#L@8VAA'0^)SQS<&%N M/CPO6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)W1E>'0M M86QI9VXZ(&QE9G0[)SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C M:6YG/3-$,"!C;&%S3H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[('=I9'1H.B!A=71O.R<^5V%R3H@)R=4:6UE6QE/3-$)V9O;G0M3LG/B8C,38P.SPO9&EV/CQD:78@"!S;VQI M9#LG/CQD:78@3H@)R=4:6UE'0M86QI9VXZ(&-E;G1E M3H@)R=4:6UE'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`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`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD M:78@3H@)R=4 M:6UE'0M86QI9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG M;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P M861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&-E;G1E#L@=VED=&@Z(#@E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E#L@=&5X="UA;&EG;CH@#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z M(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z('-M86QL97([ M('9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO#L@=&5X="UA;&EG;CH@3H@)R=4:6UE6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE M/3-$)V9O;G0M#L@=VED=&@Z(#@E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC M;VQO#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@ M8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI M9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W M8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U+U=O M'0O:'1M M;#L@8VAA6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@ M5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV/CQT86)L92!C M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P(&-L87-S/3-$1%-01DQI MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E6QE/3-$)V9O;G0M3H@)R=4:6UE2!I;F9R:6YG96UE;G0@;&%W&%S+"!4>6QE3H@)R=4:6UE6QE/3-$ M)V9O;G0M6EN9RUI;BUP87)T(&]U6EN M9R!-:6-R;W-O9G0F(S@R,3<[6EN9R!-:6-R;W-O9G0F(S@R,3<[6EN9R!-:6-R;W-O9G0F(S@R,3<[6QE/3-$)V9O;G0M2`T+"`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`F M(S@R,C`[;F]T(&UO2X@ M3VX@075G=7-T(#$L(#(P,3,L(&$@:&5A6%L='D@;V8@,"XY."4@ M;VX@861J=61I8V%T960@<')O9'5C=',@86YD('!R;V1U8W1S("8C.#(R,#MN M;W0@8V]L;W)A8FQY)B,X,C(Q.R!D:69F97)E;G0@9G)O;2!T:&]S92!A9&IU M9&EC871E9"!A="!T2!O9B!T:&4@ M1F%C951I;64@;W(@5E!.(&]N($1E;6%N9"!F96%T=7)E65D('1H92!P6QE/3-$)V9O;G0M2!I;F9R:6YG:6YG M(&9O=7(@;V8@;W5R('!A=&5N=',L(%4N4RX@4&%T96YT($YO2`R,"P@,C`Q-"!A;F0@;VX@075G=7-T(#@L(#(P,30L(&ES2!J=61G;65N="!O9B!I;F1E9FEN:71E;F5S2!U M2!I;B!O=7(@<')I M;W(@;&ET:6=A=&EO;B!A9V%I;G-T($%P<&QE("A6:7)N9718('9S+B!#:7-C M;R!E="X@86PN+"!#87-E(#8Z,3`M0U8M,#`T,32!I;F9R:6YG M96UE;G0@8VQA:6US(&UA>2!A;'-O(&)E(&%V86EL86)L92!T;R!UF4@;W5R(&EN:71I M86P@<')O9'5C=',L('=H:6-H(&%R92!C=7)R96YT;'D@:6X@9&5V96QO<&UE M;G0N($-U2P@=V4@87)E(&YO="!A('!A2!O=&AE M2!G;W9E7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3H@)U1I;65S M($YE=R!2;VUA;B6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)V9O;G0M&5R8VES960@86YD('1H92!S M:&%R97,@=V5R92!I3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W8SA? M.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO3H@)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&IU3H@)R=4:6UE6EN9R!U;F%U9&ET960@8V]N9&5N6EN9R!U;F%U9&ET960@8V]N9&5N'0^)SQD:78@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ M(&IU2UO=VYE9"!S=6)S:61I87)I97,N M($%L;"!I;G1E6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L M('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M M3LG/E5S92!O9B!%3H@)R=4:6UE6EN9R!N;W1E&5S+"!A M;F0@9&5R:79A=&EV92!L:6%B:6QI=&EE'!E6EN9R!V86QU97,@;V8@87-S971S(&%N9"!L:6%B:6QI=&EE6QE/3-$)V9O;G0M9F%M:6QY.B`G M5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P M<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M2!O9B!F86-T;W)S+"!I;F-L=61I;F<@=&AE('-P96-I9FEC M('1E2!D979E;&]P;65N="!A'!E8W1E9"!F=71U6%L M='D@;V)L:6=A=&EO;G,L(&%F=&5R(&-O;G-I9&5R871I;VX@;V8@=&AE('!A M&5C=71E9#L@*#(I(&1E;&EV97)Y(&]F('1E8VAN M;VQO9WD@;W(@:6YT96QL96-T=6%L('!R;W!E2!AF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF5D(&]V97(@ M=&AE(&5X<&5C=&5D('!E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@)R=4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6%L='D@9F]R('!A2!B87-E9"!U<&]N(&%P<&QI8V%T:6]N(&]F(&$@ M2!R871E('1O(&AI&5D(&]R(&1E=&5R;6EN86)L92!P2!I3LG/B8C,38P.SPO9&EV/CQD:78@3LG/CQT86)L92!C96QL<&%D9&EN9STS M1#`@8V5L;'-P86-I;F<],T0P(&-L87-S/3-$1%-01DQIF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E3H@5&EM97,@3F5W(%)O;6%N.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!W:61T:#H@,C=P=#L@86QI9VXZ(')I9VAT.R<^)B,Y-C6QE/3-$)V9O;G0M3L@=VED=&@Z(&%U=&\[ M)SX\96T^0W5R6UE;G1S/"]E;3X\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B2!P M87EM96YT6UE;G1S(&%R92!O8FQI9V%T960@=&\@<')O=FED92!U2!OF4@=&AE:7(@'!E M8W0@=&\@6EN9R!S86QE6%L='D@3LG/B8C,38P.SPO9&EV/CQD:78@3H@5&EM97,@3F5W(%)O;6%N.R!V97)T:6-A;"UA;&EG M;CH@=&]P.R!W:61T:#H@,C=P=#L@86QI9VXZ(')I9VAT.R<^)B,Y-C6QE/3-$)V9O;G0M3L@=VED=&@Z(&%U=&\[ M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B&5D(&UI;FEM M=6T@9F5E6UE;G0@=&5R;7,@86YD+V]R('!A>6UE;G0@;V8@82!S:6=N:69I8V%N M="!P;W)T:6]N(&]F('1H92!F964@869T97(@97AP:7)A=&EO;B!O9B!T:&4@ M;&EC96YS92!OF5D(&%S(&5A3LG/B8C,38P.SPO M9&EV/CQD:78@3LG/CQT86)L M92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P(&-L87-S/3-$1%-0 M1DQIF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)V9O;G0M3L@=VED=&@Z(&%U=&\[)SX\96T^3F]N+5)O>6%L='D@16QE;65N=',\+V5M M/CQF;VYT('-T>6QE/3-$)V9O;G0M2!R979E;G5E(&EN M(&YA='5R92P@'!E;G-E6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M)SX\9&EV('-T>6QE/3-$)V9O;G0M=V5I9VAT.B!B;VQD.R!F;VYT+7-T>6QE M.B!I=&%L:6,[('1E>'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`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`Q M-"P@86-T:79I='D@=6YD97(@=&AE($%U9W5S="`R,#$S($-O;G1R86-T(%-E M='1L96UE;G0@=V%S(&%S(&9O;&QO=W,Z/"]D:78^/"]D:78^/&1I=B!S='EL M93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R<^)B,Q-C`[/"]D:78^/'1A8FQE M(&-E;&QP861D:6YG/3-$,"!C96QLF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE M/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ M(&QE9G0[(&UA'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M M6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M3H@)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE.B!I=&%L:6,[('1E M>'0M86QI9VXZ(&IU2!D:79I9&EN9R!E87)N:6YG2!T:&4@=V5I9VAT960@ M879E'0^)SQD:78@3H@)R=4:6UE2!L;W-S97,@;VX@;W5R(&1E<&]S M:71S(&]F(&-A3H@)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE.B!I=&%L:6,[('1E>'0M86QI9VXZ(&QE9G0[ M)SY$97)I=F%T:79E($EN6QE/3-$)V9O;G0M3LG/D]U6EN9R!#;VYD96YS960@ M0V]N6QE/3-$)V9O;G0M M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O;G0M3H@)R=4:6UE6EN9R!A;6]U;G0@;V8@86X@87-S970@;6EG:'0@;F]T(&)E(')E8V]V97)A M8FQE+B8C,38P.R!296-O=F5R86)I;&ET>2!I2!C;VUP M87)I6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM M97,@3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[ M)SX\9&EV('-T>6QE/3-$)V9O;G0M3LG/D9A:7(@5F%L=64@;V8@1FEN86YC:6%L($EN6QE/3-$)V9O;G0M3LG/D9A:7(@=F%L=64@:7,@ M=&AE('!R:6-E('1H870@=V]U;&0@2!T M2!G:79E2!T;R!U;F%D:G5S=&5D('%U;W1E9"!PF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IUF4@=&AE('5S M92!O9B!O8G-EF4@=&AE('5S92!O M9B!U;F]B6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B2!396-U6QE/3-$)V9O;G0M3LG/CQF;VYT('-T>6QE M/3-$)V9O;G0M&5R8VES92!P3H@)R=4:6UE3LG/CQB6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E M"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X M="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@#L@=&5X M="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B"!S;VQI M9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B"!S;VQI9#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO'0M86QI9VXZ(&QE9G0[ M(&UA6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&QE9G0[(&UA6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W9E'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M2!S96-U6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=4:6UE6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F M9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=4:6UE#L@=VED=&@Z(#(X)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT M.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CPO=&%B;&4^/&1I=B!S M='EL93TS1"=T97AT+6%L:6=N.B!J=7-T:69Y.R<^/&)R("\^/"]D:78^/'1A M8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)W9E'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E M;G1E"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\+W1R M/CQT#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/"]T9#X\ M=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L'0M86QI M9VXZ(&-E;G1E3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ M(&-E;G1E6QE/3-$ M)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@ M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L'0M86QI9VXZ M(&-E;G1E3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&QE9G0[ M(&UA6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA M6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE M/3-$)V9O;G0M2!S96-U6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=VED=&@Z(#(X)3L@8F%C:V=R;W5N M9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E M>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M)SY4:&4@9F]L;&]W:6YG('1A8FQE2P@;W5R(&QI86)I;&ET:65S M('-T871E9"!A="!F86ER('9A;'5E(&%S(&]F(%-E<'1E;6)EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G5&EM97,@3F5W M(%)O;6%N)RP@5&EM97,L('-E6QE/3-$)W9E#L@=&5X="UA;&EG;CH@6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M"!S;VQI M9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M M"!S;VQI9#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX] M,T1B;W1T;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ M(')I9VAT.R<^/"]T9#X\=&0@;F]W6QE/3-$)W9E6QE/3-$ M)V9O;G0M#L@=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S;VQI9#L@=&5X="UA M;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E M969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)V9O;G0M"!D;W5B M;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O M;3H@,G!X.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D(&-O M;'-P86X],T0Q-"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@ M8V]L6QE/3-$)W9E3H@)R=4:6UEF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T M;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@ M=&5X="UA;&EG;CH@'0M M86QI9VXZ(')I9VAT.R<^/"]T9#X\=&0@;F]W6QE/3-$)W9E M6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V M86QI9VX],T1B;W1T;VT@6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M M#L@=&5X M="UA;&EG;CH@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S;VQI9#L@=&5X="UA;&EG;CH@ M;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S;VQI M9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[(&)A8VMG'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[ M(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B'0M86QI9VXZ(&QE9G0[)SY4 M:&4@9F]L;&]W:6YG('1A8FQE('-E=',@9F]R=&@@82!S=6UM87)Y(&]F(&-H M86YG97,@:6X@=&AE(&9A:7(@=F%L=64@;V8@;W5R($QE=F5L(#,@;&EA8FEL M:71Y('-T871E9"!A="!F86ER('9A;'5E(&9O6QE/3-$)W9E"!S;VQI M9#LG/CQD:78@3H@)R=4:6UE6QE/3-$)V9O;G0M'0M86QI M9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF M(S$V,#L\+W1D/CPO='(^/'1R/CQT9"!V86QI9VX],T1B;W1T;VT@6QE M/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE M/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$ M)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE M9G0[(&UA6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B#L@ M=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E"!D;W5B;&4[('1E>'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D M;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@ M3F5W(%)O;6%N)RP@5&EM97,L('-EF4Z(#$P<'0[)SX\ M9&EV('-T>6QE/3-$)V9O;G0M3LG/DYE=R!!8V-O=6YT:6YG(%!R;VYO=6YC96UE;G1S/"]D:78^/&1I=CX\ M8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)V9O;G0M3LG/DEN($%U9W5S="`R,#$T+"!T:&4@1FEN M86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)V9O;G0M2!I;F-O'!A;F1I;F<@=7!O;B!C97)T M86EN('!R:6YC:7!L97,@=&AA="!A2!R97!O'!R97-S('-T871E;65N M="!A;F0@;W1H97(@9&ES8VQO2!A<'!L:6-A=&EO;B!I3H@ M)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B'0M86QI9VXZ(&IUF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B2!4;W!I8W,@;V8@ M=&AE($-O9&EF:6-A=&EO;BXF(S$V,#L@26X@861D:71I;VXL('1H92!A;65N M9&UE;G1S(&-R96%T92!A(&YE=R!3=6)T;W!I8R`S-#`M-#`L/&9O;G0@F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&IUF5D('1A>"!B96YE9FET('=O=6QD(&)E M('!R97-E;G1E9"!A"!A M"!L;W-S(&]R(&$@=&%X(&-R961I="!C87)R>2!F;W)W M87)D(&EF('-U8V@@'!E8W1E M9"!I;B!T:&4@979E;G0@=&AE('5N8V5R=&%I;B!T87@@<&]S:71I;VX@:7,@ M9&ES86QL;W=E9"XF(S$V,#L@5&AE('-T86YD87)D(&)E8V%M92!E9F9E8W1I M=F4@9F]R('5S(&]N($IA;G5A7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3H@)U1I M;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM97,L(%-E3LG/B8C,38P M.SPO9&EV/CQT86)L92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P M('-T>6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=VED=&@Z(#@X)3L@8F%C:V=R;W5N9"UC;VQO M#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&UA6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\+W1R M/CPO=&%B;&4^/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$F5D(&=A:6YS+"!GF5D(&QO6QE/3-$)V9O;G0M9F%M:6QY.B`G5&EM97,@3F5W(%)O;6%N)RP@5&EM M97,L('-EF4Z(#$P<'0[)SX\9&EV('-T>6QE/3-$)V9O M;G0M3LG/E1H92!F M;VQL;W=I;F<@=&%B;&5S('-H;W<@=&AE(&%D:G5S=&5D(&-O6QE/3-$)W1E M>'0M86QI9VXZ(&IU6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG M;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@ M)R=4:6UE#L@=&5X="UA;&EG;CH@8V5N=&5R M.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UEF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^ M)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E3H@)R=4:6UE#L@=&5X M="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B3H@)R=4:6UE'0M:6YD96YT M.B`M-RXR<'0[)SY#;W)P;W)A=&4@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$ M)W9E6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M#L@=VED=&@Z(#(X)3L@8F%C:V=R;W5N9"UC;VQO'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@#L@=VED M=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E6QE/3-$)W9E"!D;W5B;&4[('1E M>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E6QE/3-$)W9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO3LG/CQB6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^)B,Q-C`[/"]T9#X\=&0@8V]L'0M86QI9VXZ(&-E;G1E M3H@)R=4:6UE"!S;VQI9#L@=&5X="UA;&EG;CH@8V5N=&5R.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A M8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI M9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)W9E'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!W:61T M:#H@.24[(&)A8VMG6QE M/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[ M('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[ M(&UA'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG M;CH@#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E M'0M86QI9VXZ(')I M9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O M=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E M.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@ M=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT6QE/3-$)W9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R M.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)W9E'0M M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9E6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R M;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X M="UA;&EG;CH@3H@)R=4:6UE'0M:6YD96YT.B`M-RXR<'0[)SY4;W1A;#PO9&EV/CPO M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA;&EG M;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@-'!X.R!W:61T:#H@,24[(&)A M8VMG6QE/3-$)V9O;G0MF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O M;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E6QE/3-$)V9O;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^ M)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[ M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E3H@)U1I;65S($YE M=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE M9G0[)SY4:&4@9F]L;&]W:6YG('1A8FQE2P@;W5R(&QI86)I;&ET M:65S('-T871E9"!A="!F86ER('9A;'5E(&%S(&]F(%-E<'1E;6)E6QE/3-$)W9E#L@=&5X="UA;&EG;CH@6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)W9E#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D M/CQT9"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R<^ M/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M#L@=&5X M="UA;&EG;CH@;&5F=#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O M='1O;3H@,G!X.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A M;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M.B`C,#`P,#`P(#)P>"!S M;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O M;G0M"!S;VQI9#L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@ M#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[ M)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@=&5X M="UA;&EG;CH@'0M86QI M9VXZ(')I9VAT.R<^/"]T9#X\=&0@;F]W6QE/3-$)W9E6QE M/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@ M=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S;VQI9#L@=&5X M="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B M86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\+W1R/CQT M6QE/3-$)W9E6QE/3-$)V9O;G0M M"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N M9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M.24[(&)A8VMG6QE/3-$ M)V9O;G0M6QE/3-$)W9E'0M M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE/3-$)W9E#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K M9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N M/3-$8F]T=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[(&)A8VMG6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M#LG/B8C,38P.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O M;2!S='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O M='1O;3H@,G!X.R!T97AT+6%L:6=N.B!R:6=H=#LG/B8C,38P.SPO=&0^/'1D M(&-O;'-P86X],T0Q-"!V86QI9VX],T1B;W1T;VT@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\ M=&0@8V]L6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E3H@)R=4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B M;W1T;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;BF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9E'0M86QI9VXZ M(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT.R<^/"]T9#X\=&0@;F]W6QE/3-$ M)W9E6QE/3-$)V9O;G0M M6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^)B,Q-C`[/"]T9#X\=&0@8V]L6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R<^/&1I=B!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT M9"!V86QI9VX],T1B;W1T;VT@6QE/3-$ M)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0M#L@ M=&5X="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2 M;VUA;B6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S;VQI9#L@=&5X="UA;&EG M;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F M.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9EF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@"!S M;VQI9#L@=&5X="UA;&EG;CH@;&5F=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E M'0M86QI9VXZ(')I9VAT.R!W:61T:#H@,24[(&)A8VMG'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q M)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@ M,24[(&)A8VMG6QE/3-$)V9O;G0MF4Z M(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!W M:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M6QE/3-$ M)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9EF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M3H@)R=4:6UE6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO2!O9B!C:&%N M9V5S(&EN(&9A:7(@=F%L=64@;V8@3&5V96P@,R!,:6%B:6QI=&EE'0^)SQD:78@3H@)R=4:6UE2!O9B!C:&%N9V5S(&EN('1H92!F86ER('9A M;'5E(&]F(&]U2!S=&%T960@870@9F%I6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O M;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE M=R!2;VUA;B6QE M/3-$)W9E6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)W9EF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E6QE/3-$)W9E6QE/3-$)V9O;G0M3H@)R=4:6UE6QE/3-$)V9O;G0MF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI M9VX],T1B;W1T;VT@3H@)R=4:6UEF4Z(#$P<'0[ M(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O;G0M3H@)R=4:6UEF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ M(&QE9G0[(&UA6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG M6QE/3-$)V9O;G0M6QE/3-$ M)W9E6QE M/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$ M)V9O;G0M3H@)R=4:6UE'0M:6YD96YT.B`M-RXR<'0[)SY3971T;&5M96YT'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQOF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E"!S;VQI9#L@=&5X="UA;&EG;CH@;&5F M=#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C8V-E969F.R<^)B,Q M-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)W9EF4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=VED M=&@Z(#,X)3L@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G M)U1I;65S($YE=R!2;VUA;B6QE M/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC M;VQOF4Z(#$P<'0[(&9O;G0M9F%M M:6QY.B`G)U1I;65S($YE=R!2;VUA;B'0M M86QI9VXZ(&QE9G0[(&UA6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ M(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!D;W5B;&4[ M('1E>'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0M'1087)T7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQD:78@3H@)R=4:6UE6QE/3-$)V9O;G0M M3LG/B8C,38P.SPO M9&EV/CQD:78@3H@)R=4:6UE"!S;VQI9#LG/CQD:78@3H@)R=4:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)W9E M6QE/3-$)V9O;G0M3H@)R=4:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)V9O;G0M3H@)R=4 M:6UE'0M86QI9VXZ(&-E;G1E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(&QE M9G0[)SXF(S$V,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@#LG M/B8C,38P.SPO=&0^/'1D(&-O;'-P86X],T0R('9A;&EG;CTS1&)O='1O;2!S M='EL93TS1"=V97)T:6-A;"UA;&EG;CH@8F]T=&]M.R!B;W)D97(M8F]T=&]M M.B`C,#`P,#`P(#)P>"!S;VQI9#LG/CQD:78@3H@)R=4:6UE'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[)SXF(S$V M,#L\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@"!S;VQI9#LG/CQD:78@3H@)R=4:6UE'0M86QI M9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#LG/B8C,38P M.SPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=V97)T:6-A;"UA M;&EG;CH@8F]T=&]M.R!P861D:6YG+6)O='1O;3H@,G!X.R<^)B,Q-C`[/"]T M9#X\=&0@8V]L6QE/3-$)W9E MF4Z(#$P<'0[(&9O M;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B6QE/3-$)V9O M;G0M6QE/3-$)W9E3H@)R=4:6UE'0M86QI9VXZ M(&-E;G1E#L@=VED=&@Z(#@E.R!B86-K9W)O=6YD+6-O;&]R M.B`C8V-E969F.R<^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)W9E#L@=&5X M="UA;&EG;CH@F4Z(#$P<'0[(&9O;G0M9F%M:6QY M.B`G)U1I;65S($YE=R!2;VUA;BF4Z('-M86QL97([('9E#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD M+6-O;&]R.B`C8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@ M8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I M9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@ M=&5X="UA;&EG;CH@6QE/3-$)W9E'0M86QI M9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[('=I9'1H.B`Q)3L@8F%C M:V=R;W5N9"UC;VQO'0M86QI9VXZ(&QE9G0[('=I9'1H M.B`Q)3L@8F%C:V=R;W5N9"UC;VQO"!S;VQI9#L@=&5X M="UA;&EG;CH@6QE/3-$)W9E'0M86QI9VXZ(')I9VAT.R!W:61T:#H@.24[ M(&)A8VMG6QE/3-$)V9O M;G0M#L@=VED=&@Z(#$E.R!B86-K9W)O=6YD+6-O;&]R.B`C M8V-E969F.R<^)B,Q-C`[/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE M/3-$)W9E'0M86QI M9VXZ(')I9VAT.R!W:61T:#H@.24[(&)A8VMG6QE/3-$)V9O;G0MF4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA M;B6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(&QE9G0[(&UA M6QE/3-$)W9E6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI M9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S M($YE=R!2;VUA;B#L@=&5X="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)W9E"!D;W5B;&4[('1E>'0M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD M+6-O;&]R.B`C9F9F9F9F.R<^/&1I=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0[(&9O;G0M9F%M:6QY.B`G)U1I;65S($YE=R!2;VUA;B#L@=&5X M="UA;&EG;CH@;&5F=#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W9E"!D;W5B;&4[('1E>'0M M86QI9VXZ(')I9VAT.R!B86-K9W)O=6YD+6-O;&]R.B`C9F9F9F9F.R<^/&1I M=B!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[(&9O;G0M9F%M:6QY.B`G)U1I M;65S($YE=R!2;VUA;B6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG#L@8F%C:V=R;W5N9"UC;VQO"!D M;W5B;&4[('1E>'0M86QI9VXZ(&QE9G0[(&)A8VMG6QE/3-$)W9E M'0M86QI9VXZ(&QE9G0[(&)A8VMG"!D;W5B;&4[('1E>'0M86QI9VXZ(&QE M9G0[(&)A8VMG6QE/3-$)W9E'0M86QI9VXZ(&QE9G0[(&)A8VMG M#L@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)V9O M;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-#4R83`V,E\T,C(T7S0W8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839? M,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@8VAA'0^ M)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\W-#4R83`V,E\T,C(T7S0W8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X M7S@P839?,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R2!O M9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`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`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!R M871E("AI;B!H=6YD'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I;F-L=61E M9"!I;B!N970@;&]S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T7S0W8SA? M.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@ M8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO69O'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO69O69O'!I'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M-#4R83`V,E\T,C(T7S0W8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839? M,#4U9#EE.#,Q,#(U+U=O'0O:'1M;#L@8VAA'0^3V-T(#,Q+`T*"0DR,#$U/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W-#4R83`V,E\T,C(T M7S0W8SA?.#!A-E\P-35D.64X,S$P,C4-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-S0U,F$P-C)?-#(R-%\T-V,X7S@P839?,#4U9#EE.#,Q,#(U M+U=O'0O M:'1M;#L@8VAA2!3 M:&%R92UB87-E9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!3:&%R92UB87-E9"!087EM96YT($%W87)D(%M, M:6YE($ET96US73PO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6EE;&0@*&EN(&AU;F1R961T:',I/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S8@ M>65A'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO&5R8VES960@*&EN M('-H87)E'0^)SQS<&%N/CPO6UE M;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)S(@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES960@*&EN('-H87)E'0^)SQS<&%N/CPO6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO&5R8VES86)L92`H:6X@'0^)SQS M<&%N/CPO'!I&5R8VES86)L92!A="!%;F0@;V8@4&5R M:6]D("AI;B!S:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M<#XQ-3'!I M'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!I;F9R:6YG960@=7!O;B!B>2!!<'!L92P@26YC M+CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO2!A=V%R9&5D("AI;B!H=6YD'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^)SQS M<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C M:&5M87,M;6EC XML 18 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2014
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2 –
 Summary of Significant Accounting Policies

Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC’s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and nine month periods ended September 30, 2014 and 2013; (ii) the condensed consolidated statements of comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013; (iii) the condensed consolidated balance sheets at September 30, 2014 and December 31, 2013; and (iv) the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2014 and 2013. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated balance sheet, included in this report, as of December 31, 2013 was derived from our 2013 audited financial statements, but does not include all disclosures required by U.S. GAAP.

Basis of Consolidation

The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Revenue Recognition

We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

Patent License Agreements: Upon signing a patent license agreement, including licenses entered into upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

 Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
 
 Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
 
 Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term.  For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but not in advance of collection.
 
 Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.
 
Deferred revenue

In August 2013 we began receiving annual payments on a contract with a total value over 5 years of $10,000.  From the inception of that license to September 30, 2014, we received a total of $5,000 ("August 2013 Contract Settlement"), all of which is non-refundable.  We recognized $292 and $792 of revenue related to these payments in the three and nine-month periods ended September 30, 2014, respectively.
 
During the three month period ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses.  Revenues for historical royalties were estimated based on estimated past and future usage of our IP on our customer's products.  No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
 
For the nine months ended September 30, 2013, we recognized royalty revenue of $1,911.  In addition to revenue recognized under the August 2013 Contract Settlement described above, we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 7 - Litigation). These revenues relate to both payment for use of our patented technology prior to the signing of a license agreements and royalty payments after the execution of the license agreement; no amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
 
During 2014, activity under the August 2013 Contract Settlement was as follows:
 
Deferred Revenue, December 31, 2013
 
$
667
 
Payment received
  
2,500
 
Less: Amount amortized as revenue
  
(792
)
Deferred Revenue, September 30, 2014
 
$
2,375
 

Earnings Per Share

Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.

Concentration of Credit Risk and Other Risks and Uncertainties

Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the nine months ended September 30, 2014 we had funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.

Derivative Instruments

Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.

Impairment of Long-Lived Assets

On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.

Fair Value of Financial Instruments

Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

Mutual Funds: Valued at the quoted net asset value (NAV) of shares held.

Corporate, Municipal and U.S. Agency Securities:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for September 30, 2014, included a warrant exercise price of $3.59 per share, a common share price of $6.00, discount rate of 1.78%, and a volatility of 90.28%. The assumptions used for December 31, 2013, were a warrant exercise price of $3.59 per share, a common share price of $19.41, a discount rate of 1.75%, and a volatility of 91.55%. The expiration date of the warrants is March 2015.

The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.

  
September 30, 2014
 
 
Adjusted
Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair
Value
  
Cash
and Cash
Equivalents
  
Investments
Available
for Sale
 
Cash
 
$
4,119
  
$
-
  
$
-
  
$
4,119
  
$
4,119
  
$
-
 
                         
Level 1:
                        
Mutual funds
  
112
   
-
   
-
   
112
   
112
   
-
 
Corporate securities
  
8,607
   
2
   
(3
)
  
8,606
   
-
   
8,606
 
Municipal securities
  
691
   
-
   
-
   
691
   
-
   
691
 
U.S agency securities
  
10,908
   
2
   
(1
)
  
10,909
   
4,267
   
6,642
 
   
20,318
   
4
   
(4
)
  
20,318
   
4,379
   
15,939
 
Total
 
$
24,437
  
$
4
  
$
(4
)
 
$
24,437
  
$
8,498
  
$
15,939
 

  
December 31, 2013
 
 
Adjusted
Cost
  
Unrealized
Gains
  
Unrealized
Losses
  
Fair
Value
  
Cash
and Cash
Equivalents
  
Investments
Available
for Sale
 
Cash
 
$
11,699
  
$
-
  
$
-
  
$
11,699
  
$
11,699
  
$
-
 
                         
Level 1:
                        
Mutual funds
  
73
   
-
   
-
   
73
   
73
   
-
 
Corporate securities
  
10,782
   
-
   
-
   
10,782
   
2,325
   
8,457
 
Municipal securities
  
2,173
   
-
   
-
   
2,173
   
665
   
1,508
 
U.S agency securities
  
14,287
   
-
   
(25
)
  
14,262
   
4,411
   
9,851
 
   
27,315
   
-
   
(25
)
  
27,289
   
7,474
   
19,815
 
Total
 
$
39,014
  
$
-
  
$
(25
)
 
$
38,988
  
$
19,173
  
$
19,815
 

The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.
 
  
September 30, 2014
 
  
Quoted
Prices in
Active
Markets for
Identical
Assets
  
Significant
Other
Observable
Inputs
  
Significant
Unobservable
Inputs
  
Total
 
  
(Level 1)
  
(Level 2)
  
(Level 3)
   
Series l Warrants
 
$
  
$
  
$
431
   
431
 
Total
 
$
  
$
  
$
431
   
431
 
 
  
December 31, 2013
 
  
Quoted
Prices in
Active
Markets for
Identical
Assets
  
Significant
Other
Observable
Inputs
  
Significant
Unobservable
Inputs
   
  
(Level 1)
  
(Level 2)
  
(Level 3)
  
Total
 
Series l Warrants
 
$
  
$
  
$
2,564
  
$
2,564
 
Total
 
$
  
$
  
$
2,564
  
$
2,564
 

The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.
 
  
Nine Months Ended
September 30, 2014
   
Nine Months Ended
September 30, 2013
 
  
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
   
Fair Value
Measurements
Using
Significant
Unobservable
Inputs (Level 3)
 
Balance December 31, 2013
 
$
2,564
 
Balance December 31, 2012
 
$
4,172
 
Gain on derivative liability included in net loss
  
(2,126
)
Gain on derivative liability included in net loss
  
(1,438
)
Settlements
  
(7
)
Settlements
  
 
Balance September 30, 2014
 
$
431
 
Balance September 30, 2013
 
$
2,734
 

New Accounting Pronouncements

In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, “Presentation of Financial Statements – Going Concern, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.”  The amendments in this Update apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of  consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).  The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

In May 2014, the FASB issued (ASU) No. 2014-09 "Revenue from Contracts with Customers" (Topic 606).  Topic 606 supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.  In addition, the amendments create a new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers.  In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.  We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed.  The standard became effective for us on January 1, 2014 and had no material effect on our financial position or results of operations when implemented.
XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 8,498 $ 19,173
Investments available for sale 15,939 19,815
Prepaid expenses - current 759 357
Total current assets 25,196 39,345
Prepaid expenses - non-current 3,240 0
Property and equipment, net 52 53
Total assets 28,488 39,398
Current liabilities:    
Accounts payable and accrued liabilities 2,429 1,748
Income tax liability 395 395
Deferred revenue, current portion 1,375 667
Derivative liability 431 2,564
Total current liabilities 4,630 5,374
Deferred revenue, non-current portion 1,000 0
Commitments and contingencies      
Stockholders' equity:    
Preferred stock, par value $0.0001 per share Authorized: 10,000,000 shares at September 30, 2014, and December 31, 2013, Issued and outstanding: 0 shares at September 30, 2014 and December 31, 2013 0 0
Common stock, par value $0.0001 per share Authorized: 100,000,000 shares at September 30, 2014 and December 31, 2013, Issued and outstanding: 51,573,476 shares at September 30, 2014, and 51,236,141 shares at December 31, 2013 5 5
Additional paid in capital 130,625 124,589
Accumulated deficit (107,760) (90,533)
Accumulated other comprehensive loss (12) (37)
Total stockholders' equity 22,858 34,024
Total liabilities and stockholders' equity $ 28,488 $ 39,398
XML 20 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities:    
Net loss $ (17,227) $ (20,054)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 18 30
Stock-based compensation 5,952 5,454
Change in value of derivative liability (2,126) (1,438)
Changes in assets and liabilities:    
Deferred revenues 1,708 916
Prepaid taxes 0 14,963
Prepaid expenses and other current assets (402) (369)
Prepaid expenses non-current (3,240) 0
Accounts payable and accrued liabilities 681 (1,361)
Net cash used in operating activities (14,636) (1,859)
Cash flows from investing activities:    
Purchase of property and equipment (17) (7)
Purchase of investments (11,928) (69,120)
Proceeds from sale or maturity of investments 15,829 72,244
Net cash provided by investing activities 3,884 3,117
Cash flows from financing activities:    
Proceeds from exercise of options 68 29
Proceeds from exercise of warrants 9 0
Net cash provided by financing activities 77 29
Net increase (decrease) in cash and cash equivalents (10,675) 1,287
Cash and cash equivalents, beginning of period 19,173 19,661
Cash and cash equivalents, end of period $ 8,498 $ 20,948
XML 21 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 2,221 $ 2,110 $ 5,952 $ 5,454
New issue of shares of common stock (in shares)     337,335  
Stock Options [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options granted (in shares) 206,500 0 261,500 274,625
Options granted, weighted average fair values (in dollars per share) $ 11.47   $ 11.23 $ 19.24
Dividend yield (in hundredths)     0.00% 0.00%
Expected stock price volatility (in hundredths)     87.00% 93.00%
Risk-free interest rate (in hundredths)     2.56% 2.06%
Expected option term     6 years 6 years
Unrecognized stock based compensation expense 10,358   10,358  
Weighted average vesting amortization period     2 years 6 months 7 days  
Shares exercised (in shares)     256,096  
Restricted Stock [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
RSUs granted (in shares) 137,666 0 154,332 156,415
Weighted average grant date fair value of RSU's granted (in dollars per share) $ 15.40   $ 15.30 $ 23.72
Unrecognized stock based compensation expense $ 5,515   $ 5,515  
Weighted average vesting amortization period     2 years 9 months 29 days  
Shares vested (in shares)     78,739  
Warrants [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares vested (in shares)     0  
Warrants exercised (in shares)     2,500  
2013 Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares authorized for issuance (in shares) 14,124,469   14,124,469  
Shares available for grant (in shares) 1,816,217   1,816,217  
XML 22 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Litigation (Details) (USD $)
0 Months Ended 9 Months Ended
Nov. 06, 2012
Patent
Nov. 06, 2012
Sep. 30, 2014
Lawsuit
Litigation [Abstract]      
Number of intellectual property infringement lawsuits pending     4
Amount of damages awarded in patent infringement case   $ 368,000,000  
Number of patents allegedly infringed upon by Apple, Inc. 4    
Amount of interest payment awarded up to final judgment, per day     34,000
Amount of damage infringement payment awarded up to final judgment, per day     $ 330,000
On-going royalty awarded (in hundredths)     0.98%
XML 23 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 24 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Basis of Presentation
9 Months Ended
Sep. 30, 2014
Business Description and Basis of Presentation [Abstract]  
Business Description and Basis of Presentation
Note 1 —Business Description and Basis of Presentation

We develop software and technology solutions for securing real-time communications over the Internet.  Our patented GABRIEL Connection Technology™ combines industry standard encryption protocols with our patented techniques for automated domain name system, or DNS, lookup mechanisms, and enables users to create a secure communication link using secure domain names over wired or wireless (4G/LTE) networks. We are currently beta testing our GABRIEL Connection Technology™ as part of our Secure Domain Name Initiative, or (SDNI), on various platforms including PCs, smart phones and tablets. We also intend to establish the exclusive secure domain name registry in the United States and other key markets around the world.

Our portfolio of intellectual property is the foundation of our business model.  We currently own approximately 36 U.S. and 66 foreign patents with approximately 75 pending patent applications worldwide.  Our patent portfolio is primarily focused on securing real-time communications over the Internet, as well as related services such as the establishment and maintenance of a secure domain name registry. Our patented methods also have additional applications in the key areas of device operating systems and network security for Cloud services, Mobile-to-Mobile (M2M) communications in areas of Smart City, Connected Car and Connected Home. The subject matter of all our U.S. and foreign patents relates generally to securing communication over the internet. Given the subject matter and the relatedness of our various patents and pending applications, we generally disclose them as a collection rather than listing them separately. Our issued U.S. and foreign patents expire at various times during the period from 2019 to 2024.  Some of our issued patents and pending patent applications were acquired by our principal operating subsidiary, VirnetX, Inc., from Science Applications International Corporation (now Leidos, Inc.) in 2006 and we are required to make payments to Leidos, Inc. based on cash or certain other values generated from those patents.  The amount of such payments depends upon the type of value generated, and certain categories are subject to maximums and other limitations.

We have submitted a declaration with the 3rd Generation Partnership Project, or 3GPP, identifying a group of our patents and patent applications that we believe are or may become essential to certain developing specifications in the 3GPP LTE, SAE project. We have agreed to make available a non-exclusive patent license under fair, reasonable and non-discriminatory terms and conditions, with compensation, or FRAND, to 3GPP members desiring to implement the technical specifications identified by us. We believe that we are positioned to license our essential security patents to 3GPP members as they move into 4G.

We believe that the market opportunity for our software and technology solutions is large and expanding as secure domain names are now an integral part of securing the next generation 4G/LTE Advanced wireless networks and M2M communications in areas including Smart City, Connected Car and Connected Home. We also believe that all 4G/LTE Advanced mobile devices will require unique secure domain names and become part of a secure domain name registry.

We intend to continue to license our patent portfolio, technology and software, including our secure domain name registry service, to domain infrastructure providers, communication service providers as well as to system integrators. We intend to seek further license of our technology, including our GABRIEL Connection Technology™ to enterprise customers, developers and original equipment manufacturers, or OEMs, of chips, servers, smart phones, tablets, e-Readers, laptops, net books and other devices, within the IP-telephony, mobility, fixed-mobile convergence and unified communications markets including 4G/LTE. We have published our royalty rates and guidelines on our website. All forward moving licenses have adhered to these guidelines and have met or exceeded these rates and we will continue to use these rates and guidelines in all future license negotiations.

Our software and technology solutions provide the security platform required by next-generation Internet-based applications such as instant messaging, or IM, voice over Internet protocol, or VoIP, mobile services, streaming video, file transfer, remote desktop and M2M communications in areas including Smart City, Connected Car and Connected Home.  Our technology generates secure connections on a “zero-click” or “single-click” basis, significantly simplifying the deployment of secure real-time communication solutions by eliminating the need for end-users to enter any encryption information.

Our employees include the core development team behind our patent portfolio, technology and software.  This team has worked together for over ten years and is the same team that invented and developed this technology while working at Leidos.  Leidos is a FORTUNE 500® scientific, engineering and technology applications company that uses its deep domain knowledge to solve problems of vital importance to the nation and the world, in national security, energy and the environment, critical infrastructure and health. The team has continued its research and development work started at Leidos and expanded the set of patents we acquired in 2006 from Leidos into a larger portfolio which now serves as the foundation of our licensing business and planned service offerings and is expected to generate the majority of our future revenue in license fees and royalties. We intend to continue our research and development efforts to further strengthen and expand our patent portfolio.

We intend to continue using an outsourced and leveraged model to maintain efficiency and manage costs as we grow our licensing business by, for example, offering incentives to early licensing targets or asserting our rights for use of our patents.  We also intend to expand our design pilot in participation with leading 4G/LTE companies (domain infrastructure providers, chipset manufacturers, service providers, and others) and build our secure domain name registry.
XML 25 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)
Sep. 30, 2014
Dec. 31, 2013
Stockholders' equity:    
Preferred stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Preferred stock, authorized (in shares) 10,000,000 10,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, authorized (in shares) 100,000,000 100,000,000
Common stock, issued (in shares) 51,573,476 51,236,141
Common stock, outstanding (in shares) 51,573,476 51,236,141
XML 26 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Warrants (Tables)
9 Months Ended
Sep. 30, 2014
Warrants [Abstract]  
Information about warrants outstanding
Information about warrants outstanding during the nine months ended September 30, 2014 follows:
 
Original Number
of
Warrants Issued
  
Exercise
Price per
Common
Share
  
Exercisable at
December 31,
2013
  
Became
Exercisable
  
Exercised
  
Terminated /
Cancelled /
Expired
  
Exercisable
at Sept 30, 2014
 
Expiration
Date
  
2,619,036
(1) 
 
$
3.59
   
159,967
   
   
2,500
   
   
157,467
 
March 2015
Total
       
159,967
   
   
2,500
   
   
157,467
 
 
 
(1)Referred to as our Series I Warrants.
XML 27 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document and Entity Information
9 Months Ended
Sep. 30, 2014
Nov. 03, 2014
Document and Entity Information [Abstract]    
Entity Registrant Name VirnetX Holding Corp  
Entity Central Index Key 0001082324  
Current Fiscal Year End Date --12-31  
Entity Well-known Seasoned Issuer Yes  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   51,996,701
Document Fiscal Year Focus 2014  
Document Fiscal Period Focus Q3  
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2014  
XML 28 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Description and Basis of Presentation (Details)
9 Months Ended
Sep. 30, 2014
Patent
Business Description and Basis of Presentation [Abstract]  
Number of patents owned 36
Foreign patents 66
Pending patent 75
Period for which core development team has worked together 10 years
ZIP 29 0001140361-14-041016-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-14-041016-xbrl.zip M4$L#!!0````(`":(:D7DAWO\[ZT``#@]"@`0`!P`=FAC+3(P,30P.3,P+GAM M;%54"0`#IS5A5*`L``00E#@``!#D!``#L7>MSV[:6_[XS^S_@>F=[ MDQG+%B6_9">]XSA)ZVV:Y-I)VSL[.QV(A"3<4H0*D++5OW[/`?@6];+U(!5^ M:1T2C_/XG1<`$:_^\3ATR9A)Q87W^L`Z:AX0YMG"X5[_]4&@&E39G!_\X_O_ M_(]7?VLT?F`>D]1G#NE.R%NN;%>H0#)R+]S`AQ$4^7SWZ?WMAW>D?=0\:ATU MR8T8323O#WQB=3JGI$%:3>N$?!F(H1(>N6.!#W.3:]MF;J".R+7K$MU<$7S\\/!PA$^.A.P?MYK-]C'WE$\] MFQV$[5WN_3&G.;[N4A4W?YQJ_]#6K8&#SK%^&S=5O*@A#&L=__;SAWM[P(:T MD:<'IW>2CFEJSH[-RZ@I5^*D99W/8]:TB#MX8Z;\[-B*V4=],3XV[Z";U6XT MK4;;BCJ!GON4CN)>/:JZ>H;P!78YR79Q&"^>!%X4-`]\.9.'SC&\C1IZP;"X MH>/+8W\R8L?0@DENQQV$MT0?X35R_6P1>+Z<%#,1OBP0E1U("08RJU_XMD`" M'N6V*NZE7V$7*]M%<;NX`[PH:NZ/Y(SV\*:@`WNT!\4=\$T!#^-!0M"82X_Y MCT>V&.J6S4Z[&;9;QC3!I`EYA;9TJ;25W+$>T;9UB1I[?:#X<.2BR>AG`\EZ MKP]@_D8TU]&C<@[(L1E'>P10J>>S1Y]PY_6!K=M933[W)^&S M^"EW\'F/,TDT72S#3"2?F]N?#KYO@I4W+UKMULFKXWSG:*KC@KG"F4:`1N'D MYP?Q2/\MN-CO(_$WK6B4Y%VN$_.<5)=.H]U,)G92':*GJ:FC1Z'LYHK3LIKM M2@C1H,PW\D#4M^/!PS=KD4=E0)611P8?ZY1'VVJ!JZB8/-H-JP4>;B/R:)Z' M[J==&:1DW`^$OO,5W4][@^XG%F=U#"_OS5<5YP:]>3L.CM5%YZK!<8/H;%71 M^;4VZ?RJ`JI,,-A<<,P&@]_?LAZ#6L&Y8V/F!>Q:2NKU@7G/_P+I[_4C5[_? MB0EU_1RF_N&1N)P:&?6%,(: M\G(QQP??1VUGL/[JN'"VA,KC(C+W*@H^`4?7DD[H#8PCJ>WO/X:@2+PL8+G& MCLF;?K_5JT`9A-S#<$S=_DI1GE7W,]/\&4P4,KDM5&RQ`JL5O&,%;[2DC)/V M6M6[4O7SJY`,/M;KX3,KGC4^=HZ/DBWA:E2\IUS^0MV`O9G$?_X(FJ'2'DP^ M0&KE:J3$[VZ]4>`K_<(R,BL"UL^!'U#W?>`Y%0?5TZ%W"W3ZJZ$;(D<#C8&]9U[]G=B"Y#VEWM4%2P3@Z5P_[!>>996WM MG3:FS@TF]YNL1[_>?Y&,JD!.]L4US4/(;&[KK*GB0*ZKU+I*K<022PW*OV53ZM05;KSPWL5@6Z[1F2[!L9LJ=0^;7T(JGW:5O.TO8=N MI4N,OZH-C31+9L4LR]=^A9'\YT"O'ZATXG7:=\.1*R:,W?O" M_N/3J/IVGV$O,?>9?.YJ;:-4'_W,?#:]1D@)$%*N+\'G4XD:(:5`2(F2A?RZ M>XV0W2.D7"OH\Q%RQY0O(0%GCI;=7J*CD,<:&0NB2XV,;SFJS*M=:F34-4OM M,W:/C++5*G7^N;/\9*-?)5DZE?E6 M0+@.$.P:]'7J]6WCKUJI3,NRFJ?:">%?9Y6X;CEC&:V&!99QNHIEF"YGF[`, M+<3JB_.L).(\L9I1B`1Q7BR[:O?[?=!5[,\`9/!NS-*_.LT^K[:SFL%DZ@AC M$;=;R-EVOLJ8"YU6<^70B8B^6`>B`X\;.'\%5.20-M3?OV7?AX0-J&0J&BIZ MEQX>QYHU=FO&V%R)DY9U?OGU_NU3AV[GAG;X&`"=%Q_V^!@,F:2^F$+3TO2D M!5P\8FJZM\P30^[-GW"1`@'O01Y[])^HV%> M.(Q?QF_P!0EM\H[U"JNN@^][U%7`T53/>*:;0$H]#U<0]`GI M><-VIAFV>F?\QF(2&E&1.6^8F)ZWP@XTXY^U!RJD)6ICFBQ-2#K7G#E,3,@[ M[9#)K\QU&W]XXL$C]Z`UX3&'W"H5,)FFR#3&MC]ATZBE:;B8LG^A]2X<)T_: M+\(-/'#X$U">RZ2:)BAN81HL)N2C2-.1ZYZ?/X+.'1L)Z7.O3_!G!4$!'6'+ MN*%IM[)@R[Z0DVEB]/OH]6(:/E#99^3:MIF+SAK4KP=(TY49 M,4_.'>MSY6.%1?#8_30]20-\OYB@7[CTF/\;^5%`L@%"QPL*TM1DQYM2&@A0 M@J'?>@Y[)#^Q`@&%370+:+"8HG1..'.8*4+$<"C`J#"-.B3W.H213X&/U1_R M54"7[J$[F.:IUM-$0DK=/B#H5?4SG:$0A]E\""[Q]0&0?6IU.F?G32M#])PY MIGU4VFF^AX>JR$LEODXW6$/+9?V:GQ'Y)9+1M`4Y)D<]T0KLN(Z`;M$X9@&5^X+3+77W;PF'D MGB)*XK0^'"#L?^TY8>]4Y\BS31.+)&9`U4J#J@'99.NDU0&#>'7\A`G+P:7> M-5C`I75^YYRVIW3/-7%HV^(QF5$NSJ- MT"(8!JX.3I_\`48_,1Q)-L"2=LQ(R,.+#T*IEX?D(_.)Z!$8JH"1:"`]3F88 M,PJ.`0-\ZD'W)['7:)_GV5MESO(QO0SN(`5>#]..P['Z`5\_HMPAW",V'7&? MNE-Q+U5KMYULJ!LGCX#1*ZE%=JG9Q>=%8CU'6%K4&DXWVC M2Q7\C?H`95#L2=X]XM]LBO"HI^[X!ONENX6]%@:\^1R==DYSR%EJUMVQE_NA MPR+V3DY/*L;>^0KLX3)YI=C+'2Q>Q%ZK93V+/:68KZ9(UT^?&#K;G5Q:H@=[ MVHQ+B>#BY&*)&0\)?KJ'Z&_WD+>00KL"%X`:>&\Q^5^S4/Q_Q63%W_Q)NA7+ M9L&MSPL\IW76Z13P43#[DJS]'/@!N/'W@>>HA,6D[2$Q'S$Z)/HS1L1:FQPV M=;9$Z+B*^6V)=<=74.]`++-3G.]D*T&.!=Y MI/-6/@7:AECB6X`+X;ESH2U];_2B@+YFLUY*MO$5I.N5[>YNKYTOY(NSYMG> M"'F3`'Z.D*WF^45K?R+4CJZN72#CD];9>F6\I"LNRKQ*Z2963:JL_#I*J2/^ MVJZA71"4FFVKJ`9YNEB>Q_'"!?*3_!)@A1.4S5K'R@G*6<=:JVC75*!&W^![ M>H%Z8EGKS6J?%VH6+41<=`J7!98A=]:.CG[]O(V%]LEI`5%3VPG/(60I#W!J M=8HRO"E"QI2[N)O4Z`G94-1EY-V?`6X>)X'XD*0W`GZ00BGRU8-X[?*_<*\, M_GU(N@P&8'KQ?WZ:]Z1X$%'Y7LA[H-&0F%"8HD^3EU"'Q+W1I,W<5RAAYI@K M@-;#_49U/M_U?RLZ?T(TJ?6\(3V7;%FC8GJ>GY1L5&7/26$J)N4UUIJ5M*+5 M*M.**7>;&EJ8#58NH=C$4E<%,XIG;-U43>,;6$*NH%-\3ME0,87O),=X_C)) MQ:1<)D^YK?W9ZH6[-1[EJ&"4V_-,<"DU+DAX*F:A:\UE*FC/^VBYB[8/*J>D M;-50LBE+%'/SDY:ZQ7R2A7%0G%MJ$A8 MF:O-K1+N"#%K3/K-<`-U?&[$RJNX/JYO?1=R34 M9YUK/.NVT.^L5 MS#/!4%)-;BJW*-FYEJE3DKM#PU*_OUX_?-=5C&ST5,1R7*VZTO(#Y5YY=W.1 MNHKMYLZODY_(^D8UOJ'-O65TM_/-O>U)>1\-9TLKI7MN"B4Y2[<]*53=)12[.HC\;4:X+:TQ5$Q#VS2CO@E893NCNLM#8:P^^3?=;*LEE1#;$ M;_[_I3]_J7SRABJ^G<-'\<1ZWC+#>NKC.,OQM`T-K&57<;XF2E8"3'\I;@O: MV,8)IUUJX7E?X-R"`IZXK;J,3-?\==>R^(8UG5W:'2K7_!&^JH)T$U]XVH(L MMGKR?7>IQ+,^LKOL,=Q]S"I*MC^R_,&E+2NC9(YZX3>2VTL?K]O'>%C6A9>+ ML^:RYZ?W,@24]\'[^4S?!\,AWLTJ>N2>]SW> MXS;>`1K>DX=75GX6>$WX].EQ#>M/O<^2*1A0WYQS[3FI09(QHB&^`)]O7&'_ ML?A^Q>]<_\KA8Z+\B'_2@?:-'A]R=7)*_?^%#B'T?V0.Y$T/J_?V0Z">' M$!DE[UT1W5H!JB^)U1SY5P??]?VK<,3H3Q^%16SFNB/JX+V9>-FF_K<:43O^ MMTL5R/SM_>?W'[CROV"G@PQ1J6G(:E0^<,$+R?N#K"B6Y&.*D6)Y/S"M<$=1N1)++ M>N'$'P5DC"WR'1V.KO[KHF59FI3CE%J.?62XQE--BD+,R:.?TGPXCIN9^7S[T#YO#[?W<062M_5%[E*#!H2&?2H'TA(`!\&W!X0()5X MS&9*(;IQ?DIZF";&S.%0+_A+3<4,D:0$`8W%"/([U+GA!_OY`\G,A;(>]Q@9 M`M4#,M(7^BK"8$P'@O'(UPD?:3[47_6>&]!Z.:I=1@.CH]?\/$JG.*R:L\5#PF'3^'KB/PH'B#G MEH=ZB#78@R,`?#Z`UW8#AVEX\L09&`5`^(CA#X*;Z'E#9SH"J-I\Y$(+*),! M3ZZKWR,/3F037SU-%U[)SK0XKH?`L4W)B\C"6LTK*+6/R`_7UY_C9];5RR/R M94D5'D8\A+-R)!GO@C\D5,\YI4?R`"\<(&2,PI%B2$0@S9M(DD4B.R3=P`>Y M`2=YR3GQA_NS\HI9.ZIX#-'9)PKS)M9#R4/&8@N(%!@95!":["]<>LS_#2S. MU9?(1VM7D5D@6!X&`O#>$`\>6GS05=SA5$)N<42NM25!H`U--$*KTIU]23U% M;>-\DYC$7#X$&H'6JB/EJV(HQ'?P:(A67V:,F$S`:%9'I<60P4;H)?'PCLX8 M8A./#%^10$'*#$G`'XRP2`Q:^5#SUF^P:!0P-`X[N``.P0 M^I7$H192I7&5CPK:>0,:;;WY#V0%KK[--'!Q6)A7$B1,$,52*Y"/R M"0%/A-<7.&(7?0!D)=!D3-T`5Z/1%.+VD2/&MOX`J(99S6DFD(8F'K,6[&IB M0<(+]Y0O@]#)YEHI'PK8\(Y;^D"E8^8)KU_'6;6@T)N#(C&;2*Z6/T2I`C4" M;],&?GYER$2.;."/0-#P!08FE[!'#,H,PXLV=@]H@2`-.M6C%.A0H@V[G(T- MIUWDFRKA8?E@PG4D?6#'Y'2((/U&RU1G!@`7%-R_`Z8TF"'I@09@:&`?(Z)5),J*LWA`0&!!`;4#B2P@EL(!EBB$[^(A6& M+LJ4#*E+NM'GV5H%6MR02D@UX".<&O,'UV7&=\/`X))`YWI)2:'M"W";*!4= M@;#"E-2T]9D]\(0K^A-0Z)BY8F14+B'MZ$?J^!`SDE()NK$P"T(@@BA`1LP( M)%DO2*VF0%(/0@1_3-X(^%\FI7]_??\FGL4G8:Y MGR,TO4WA\^@`(`5^,QHA";T8PKD35K>A-Z;Q?>GP;VT++($0Q+?$,K0_'T!Q MH)`W,'T!E9IVNH")R+XT(M'VDT!%A@P@[!R16R^,$C:7=C#$86SM4+3YJ#`L MIJ3.O;%PQSATEG*4OT8W0@-#DJVU$FBXA'@T*)RD#160UO-Q^LQ@H85#JN-S M.W"IU*[#6'F.4)U&C!!Q$A&F]26U:TDYK"[S'_1"2EB]HC6'&DC;3Q3*M%BP M2H):&.>(AL&"PG,G:?]GJ,>V(5^2%]9+\@!/01AI MD::2ZD=F!R"W*_*B]3)R<-IUILP$!#W7VA`.PL:E&:`/&D-L&'/,YI-Y));O M4L_3?FE<"1+9XX^FB\/0%7.=$(1K""1Y]2+BE*N-`W>;.#+,_97)+R8F..?#EE8ZXLC7@19)BW.) M0E1!%($_=$DR"U7:[40IRN7SW,F,G9@R[_)-;W)%#2]&4SM),S?&,J3D*+DB M\[;-6NI4:S3&V^1S@Y3#M]$*E.1)S[6B#)B0I_6!`VE MEI8,.['N3*#"%#45)PJH@NQ91UK30K$HCX:*Q&9)6IM.5'7`,KE[M%650C=5 M<0@%(7G85H=GT<6=2H2GQE4:IY`O.1AB>ER_+DQMD3.LYLQZG'F.L$5$YY+= M.4ENVLZ?L#%?%*.R&6O6S:_:NPYR^QGDV%!'H?"0V%UHQ)]-BF8BD&FRH?CS MZ?_;>_?GMG%D4?CW6W7_!UZ?V>\X5;0CZF4[LS-5CI/,\582^\3)S#VU=6N+ MDB"+$XK4\&%'^]=_W0V`!"GJ98L2)&/KG(DLD4"CT=UH]%,8V:7X$,IAS,U+ M\TXAY>K/%4/UY/+0%D4BAWP;)2N5<"CTE;`X:43B+@AR\M)A)BU&I'XB-X>/ M3(HB\?H,V"@\!70<&GE;2L5MXZ_4C4!&^%-^J1Y[)VX0T.Q2@!(48L:8@GO$ MA0%C'^:N2YC:O"A#186=A".+3J%((SZ M!3U=V29N2//)@B_@%F+ZU+J,\<@@-0%$;(*"T1M/<"/HQ"`S7"R`X[>TL7&5,H:[\%'G$BZ/OKS=!$3EY."(4BYK9F;8\<J MSV%P\B5W=GR;G'P@1\@')GP\G[S`&Z=C_`)O0'0";.6Z]2&,8X%W&0QE9<0$/FH=-HT!)=54K,%W5_8SM5#@-_6*.9)<2(( MBX]BI<[CFZIL35)CQ[E/FF;>#7QA%:"R=\HJ)"N/NR``/9Z)7]!W(1:*C.J1K%=SOG"8/8XO% M:_(J8LOAN!J0HV^")]V84629<,[,634/B,QV8,"&C`SP(E`R\Q?$<#6*`KSP M8&P6#\NRW,$#;2BI!W3O@)5H*NK-[>(E2'M^=2!Q+%2:]S[;TLU"SE24-LH] M(=>R,KU/1B!+OZ5B:QF2UH5:;]9)0I:(]GPW/"[=U)2BMU\JAC:J5?Q.K`NTWOX1H3KHJOGW@W$)8-' MTM!=,;MN4FR,O,-*,V42`K:$AYZ.ZXXUA>."-O\GIV$W&HW"@2VMHVA7F^2G MGYO;"H%;9H.TI;%-W'_$M#A'!Z>PCH_4Q4@U"P:2Q'_TRI8^[XP-BBJ0"N8? MA8BAGYH736*[G\[@0R&J2`VEP(D MG\/,:D]3#T5Z#TZ/9?"`MH(!5CQ.9"92HQ!:PJ/V!$7# MY287-U6QC#)9X!@=;I31>6:=6!\S1]*)#MRT4\7K!#EEKC_<6-BQEP+ M_8HD+X1O47@(9]9$=[$9NR_=!%=S;?V,]W+#M_KSK3@0N0*`]/B`IM;560G= MKVXL8F!FHT\VIT&L=GG>S#6YAQ>:Z`0M#.XDAD'DIU5NT`^TKE^.@$%!"F0@ M+;K_GI__#29U^]_O(R#/`4X<1F^L_^CW&1L.ZTG#GB$':^Q&]UYP@G^\L5AIAY\=\*_+%Y&A*9@S^;BS=!"X?J^(IKXSSG>5T#4`DO%FI/.XF@- M,#:[7S3F3QM%J;HZ;G21R[O8S?*ZW;/%"PS"Q\B=_'+$_SW:ZG;.HRK%AE"7 M&!C2_[04`\*+GIV<6^3Y`E9VQ_-;`&,EYJR12&C,)EYYM6+/E3"_"?84"L<) M?_:-U9S\V.>C^R.+XS=86@NCT-VLPE8>.K91)EZ$O.V>YD*KDX#\1X/^AP!9 M9$>NZ8"H&U`MCN[CLXMFK<*ADHQTT\]>+4!!'8*HO8(@TEAYF+U#S%JE:Y5% M[>6RJ*;C?0Z+`T#6($PIF>Q9QZ'VEX\U$:")"M0ZZVQ5RK6?(N76U8N*KD_] MZPH4#$;OW0@MF;%U"T+C;N1&56Y1+3R?6&>G3RX<@G<"\,8C2LV.>/9XFO#* M0@"-1U%!V;.N+$F)ME-X=$PIYF'_^P@0AG9F>`N-=1R/J,MACM\]LX*4A"F9 MA1/*?.;YR'P$G+UHH^8QP8K5_9WG$UCK@!VP1);Q6`Z7`$(%;P8@'"VB1$** M?59J^^3C2-\`YF*((8<%5(GP4RJ2DN?WJO-Z(IREUA?O/@[&=-OR,R.?W*_P#=X/L)L MDJ2BWJ(NS':#CD6LST:)\/@!(P!!&F<1[)/(P[!SV.0QKD5DQR16\HCU??ZD M>$2UB(V7I%D:YDS]LU/KLAARA[4`\N)0$08>4"*,Y(@/#%-V?.L=FX0Q8/L: M?Z;(-J4D58$1)NC>";3B[ MQVGO3Q%1C^Z8-$AC#-7($14AT?38-)1U2'@-1/IZMK;%>,PB>JWG!M]YOJ_/ MHW9&WD1F+B_8BCS[&`'.J_L,"#HL/*!+;,`1G1?NJR*,/>1EQ9.3UTFZ MSHLNZRL*#MZ)FI%YUH:L(0*"[H0?!&'`8W-CGH2(3#6)&!U'&(/'QCSV MC2>OR\0\<@T/V`^^(H2$SB.5N;&.T"/'07%-F$GA1M_9X"0)3^A3PA,&Q<&8 M%9\98<)_5DDL7SM/WRC&YV'P,I;EA#54X'(J1RF4')N#O+M"U-U-*>IN3QGI M&E;M13*N^F,(^OA'BO^ZI,I#.7]62(R'C2KEI:!LD;\V3%65$H:Y:7Q$+8<%QKC+LB MCAB"2-2C4!GBB_PZRRD=4RL+?H`27<*9DL;$4'TJY M5A$%(>/H^'K59*)B6;9"&,I01L[R*FT14QF=BRR.7\HK'C$5V[*$7!9I4EI8 M7BP0_\ISLBK028]R&-B//F.#F"NO4?@G#[%55JY@1$$"8I"*5LC82!IN#SFW MP`5YEPW$DEH-6_LC\4-!;//=]/I,O;@4J@Z@)*=D0+7R:%;!29P6O#(4L$;` M"R+CL(+D>"@4<`!JK\J9,9(M0GC,D(?N@5A$SV*#$(PT(E(7XRCOE@^U?*A[ MD"Q\D!'L+I(@^N16"$X#271J\7.7S,2OR6<0BR%\./2.0)+';N`*EF;208,SM`BO8YI>*4GJ[B$5W.2Y>T+ M=?-RKM")3HL)N%O)U52[]/((.9F/PD^J@13,@MWQH.:Z$D?E\>?+WU\IQK(1 M\W=N=MI]V;BL[YQMY9TAR4"%99LO>8.WO%U/`>]OU-R0&9K-]@,+-(N"^)1$ M*LHWA_*"I,AB*U23Z%'4/WB#M-BK$F4?'-6#W1L-=[][,W?_XOY4[@KHQ+Q6 MIVOUO"`<>R(%B$M%JB[':_*JDG>^LB*CI54;\*Q)(K,IS+4\K&%?('%9E7J3 M]3EP,T,`^X'6L5AJ@1@4WSKM7.06>)N7H\M,^",#.Q6G;P=^K8.[,@]DY M[70$S$I>\T"\F>16%2H,\0DU402]HRW[?2V4$TQXQ>9X%#YR@2-UY'X8@Z9Q M'Z$5)PTBYO*28FC=B2N^%Y=\BHR?H7Y%/@%_J3GD7M93TL+;_7T8347;C56[ MJCPMB6S!)O`@<.X[SN*_-8\'?VY@2Y\23%;.PJY]'E@[8#CXY:C9W'`D4P&" MVNT*XAA:+^"D[-_?"M+GA0YM='(-Z&G_R6E+TUR*@T"E5>PZJB'M&D+2F9"^ M94J"2CJ_H1YA:,G0T@9HZ2/IGH:8##&M-0U>_U6B(3N9H2)#16M-<^7&H^TZ M*VE:O`N7IWZ?1QD9,C9DK.,TUYF]IT"BES+X6/V2[)BNKZ-(?F:B32GYM+E_ M^7U54L_DWNN5_J)=`E_;=IR+];A9A^Q[0\R&F&>7=V((V1"R(61#R(:0-2%D MHUX88C;$;(C9$+-NQ+R'*L9V+#PU5?[8>36QO2UJM@`.'2N/&=(PI&%(PY"& M(0U#&H8T#&GHA9Z=[XDAC;TH@+O_[G"1"S[;FN!E649VR#ZKPJ&CK<&0AB$- M0QJ&-`QI&-(PI&%(0R_T['Q/#&D),SAI"M5MAWG'J[ MB&B"]YUOMJ$Y70,@#,49BC,49RC.G*N&Y@S-[0'>=[[9AN;V^F1]\?[9K(ZK M4HK0^&JU,)+5P*'G=K>QAUV^#=7M-=7II8D8BCM\BCMNZ4MR-2QW4>=C0\E[ M3F>Y MO,EK3??^10C;KJULO48(.S3JK0>H%F8_IV%?-,YKE0I+^QKL<,<,D;\$(J\W M_L'0MZ'O'4=;U*O6;9[`:\#!9D,P#-^\!+XAY:?>4M;F<#!$OELB;]O-;KTA MQX;WOEL:[=K=]*$K^#NU=-=E!G\"#-4&R>1[4`E`MC,O-AMUR]L"29(A< M%Y3M(9&W#7T;^CY@^C[>-P(_1$N2%N1H^,8H/X;(=0%4"R)OVZVS/;"6&AK7 M!65[2.-.Q[YH'0J1UV1*:N]WZ-37,'']6G6\MFY&9@#(&H1ISV?Z.6XWVV!T M301H8;UNMNUV:[LNFK;&+AK#/89[M#7)&<8QC',@C+-E6]_S.6?O;'V&(0U# M&CW0<(_AGBU@X-QN7VS7`F^8QS#/@3#/#LR>]7&/8O9\G;B`\`JLJ1/_F<:) M-YSFV.U%UNML!`4?-)C59[XO%O/+4>.(_HXG;E_^O=J^E+>E;.045`0+]]U) M#(/(3SF*&HV_Y3`7#+S/M4#W69"P:+EHV-8\L';`,-!:L[EAIT,!@@W;J>GY M1X;\C>#Y`S[-.]9GXQZ+K)9C6\V&LV:IU*W@?)[G8*.3:T!.^T]-6YKF".#J@VPM"0 ML9;37`U5P-(1M"-H1L"/DE$[+1+PPU&VHVU&RH63]J MWD,E8P>=YDP;AMVW85@`AX[=$@QI&-(PI&%(PY"&(0U#&H8T]$+/SO?$D,9V MT//B/>(?V0/S+>?-1J_Q^V<9V2'[K`J'CK8&0QJ&-`QI&-(PI&%(PY"&(0V] MT+/S/3&D<;`N+[UN<9_2)'5]:PC@;K:Y\LXM$'MK"*G!&7VV9@;^?J)]YWMM M2$[7^`=#<8;B#,49BC/'JB$Y0W+:HWWG>VU(;J_/U1?OG+T*HTD8N0F#\?II MY"7>LGHQQD*VO['F3L,^.Z^W.[0FJ-_Y?ANRT_5@,!1G*,Y0G*$X<[0:LMM[ MLFO:K6;'4)VANJU2W;G=[M3;G<4X\>MQX@=>WYNX_FYN^\8>MU5[7--VC!78 M4)VQ`AN*,Q1G*,Y0G#E9#=7M,=5UNWK=]`W-'3[-.7:G46\K29W]^I4UT??7 MV?_M],YR[UG0G]9U_U^$,"UZ;\YI7[!#X]YZ@&IA_G/:=O-\N]V99[H1:-1@ MUA#Y(1)YO;=*0]^&OG=+W\U`)0+>S+S3.[Y>S! M1<00N2XHVT,BWP-3DJ%O75"VA_2]%Z:DNI&P<[1ZL;8U]-(9[#/=H:Y,SC&,8YT`89]O& MON>SSMX9^PQ'&HY<1Q$\MR_.ZTW2,>>9X9X#Y1[GHO9D7L,]AGL.EWNV;?BL MCWL4P^?KQ`6$*UB3'WN1]3I[2/F^5DLE-T".&(SD^^$C8,,B^&)X(X$OHV1D M]:;P+';:??22D1=8"3[N>A&B.V76R&.1&_5'4]L*T\CR/;?G^90`"F"["1M8 M;J(^[\96.+3NV"1AXQZ+K%;#MIH-IVVYP^;9U6H*,"U7H\81_1U/W+[\>S6,EA%:QJ=@+*`%WYW$,(C\E%--H_&WG$DV'4&Y M%9_2K&A8.BV@`9`-\SKMM;GR*4Z:6LSZ]/PCPPD0.K\TF"3"?W.@[2V(\ M;S6!Z!K=E,@(FL!S&8,^LJ2BA`9"U@-JL2[<>].# M=Q[HGJ$'0-?!)#7L:]A77_;]%H2&:0S3Z,PT*\2):4`.YEYYZ'1X_)&L@BL=>YZ(W?/?/FTYSQB6K7[K2-LL[&9XR/&5X MRO"4X2DM>*K=.I32;(:7]@%00_1UA5+6E4,^[ZI88Z[_GN20KRTJMEO(X3D1 MW7476BK88KC)<9;C*<)7A*KVX:MOZLN$F3;AI9Y`: MLM_H?BW-N#/Y8_L04?5"\L=FTAXU,-:8,#]-HC5,^IA)'S/I8R9]S,BV`\X_ M,>EC)A/&L._>LJ])'S-,\\*CKS>]S=O=4?V$W';2K&KG5K.-VTB-,MMX$.E, M9AOW/H=:'SNJR7PR4;`FHMQD:9C(>N$\U;0[71T*TQIN,MQD MN$DG;C))52:IR@2J[V/$KDG_,%QEN,IPE>$JPU6Z<]7V-6;#3X:?##_M`S_M M784JU#NE`8_8H(]0D[P:,7MI]C>>?$^P%5G]]1]=&$:C\Q-TXC-F85\6>[2C.)@:XU@<4D MX:RXUS@^\3?7"ZPPL`8PVH.+!:D4GY(7]/T4O47P3,`2RP_CS6;1[<1/K8DO M7SM7\''3=II=K7BX[B4ON7HK>>R9>%FFCACQ8L3+_B5> M['5JI8:7EE4]%>N&S&T0:R;`W@38OYAV*`AO"/];QT8?+N[=' MKRPOCE,VJ'[TVV3@)@R>O;S[!H]^#D]IFA.G8UM2@V\V?KZ-6`Q("('9\X[SL_5;B/-W/=#C)O#)7Q#T!+7`XS`<&XO3!/+#:SW\'*6XR--L20XG%`2CR%86)I^Y@*P!1QCEE7G9)KB3B4^SN+YO8=<5 M#EDPL"+V5^H!V+!<]YZP38_%,8OQ`?YP$6@W![I?`/J>@.YSH*T>.1;":!)& M+I$&3L=^3.`?_"N=P'X+/%F3"![U)CX`E8Q6F M`X]&BB61G5IW$]:G>#S?GW(*5K!P[+R"H<,';P!?6P,V]`)/TAD^FK!H;&V- M2.*TAX`G2-MXN"2V5=C-X^:K;#L0\YCAQ]F"@:">PF^`2EK_!"8*!\)O@U]X M&'OGC<4/`,IQ*U^Y@EQ,%X3]B3WT`V&2(B!A#"BYYSL$%U763Q`[.3D4MGX" M^A&.WLXAE5LXR%@@MAY'++!FE@O2`NF//7@\D1%)!IY.?9Q1(64)8"82E@#3 M*:+MQR1"VHVE]""Z"[%SRHHP!F&BP&G3^\?=PB2C8!G M4>(`5](6`ECP(-`9H%-=PA^LQ.B2Y`5E>N.)VT_XNNY3;T"Z^:,'(FSDPJJ0 M.-)(P>K\.7Q5SH7SYSS5_81!K_W1\!*WU'PYW0#](6S]<,! M25%Z,9'OP33*T8ZT<#>"'3MYZ\8`U:T[I3%H1!.]H",)8W.)3$=:/R3.UV-Q!L7 MUM$7H`74+891.";U*`(T@N#VDI%U!0/#;D?QD23S;J-;E(_R6Q#R@#@@6%(N MD*3XL!'0R[W0!X1HST2I?+EC;TT[L.1RO^1PV07]0#GOQR$H[5XP`"Q$TY-8 MZ$"52\LH+AG!_>Q^A,HHHN%:O,W7&DN5Z$H1!"HZ8?/P4DA0E=6L/LA^/'.( M'S-]O-5NH#Z^/012=S2+=_$CWGG'A@QX<@"+BN$6EGL-YA'3Z3SM^CJ0Q1ML M(2XC1:]"W.7DYDD=5BK/N2.P1B=\#@#;X7`$P0`ZPX$,C+L8?B]3Y$ M,04B3$@^DM5]"2I2*8,92S52IXLGD$_F:O^TJ[2U(25 MXM!S%!14^K8OW7,E=8_4%)]D>&N)#&^=.(YU5+[=`\E^"S)^&%A?W1_66Q;` MS2RQ_D`EP@6X$NN&HP)0_#$$7?[*C4!0`;V@1@&*J77GP5I`Q\;7\0G;(F+$ M/Z^`X6&PPBO6^Q\>2(#3(](:LEW"^PC)+#=7_@N M7E7D+06#^\(,M1CF9_7+J(T%:O%=>H+>Q+_Z'+.%-RQO")(1!$N<>?01K>(\ M'>#+7,YPR4+BYX&,#/`IE782&CYC#'@?+FHN%M(ILF(!F:#N@:`IB9,TQGW[ MAPM"!6!TE+HW(Q>MHJ#_HJ2`W917W;GL":-5ZEY=2=O0%_VXINAR@R7P4!))$1+H0_O`<$@B$C_MF[YA>XZP),8I/4Q2$OZ].KDA+\O(<%W86K\1QF! MOR]?ER^3=0?`^,*&OQSU$9,-I^$D(7VZ:#6.8`,]_NNW1J-Y!'37]\:N'_]R M=-(Z^O7$:73/.HU&(\?#.K-KM.Y6MN[6"NMVFN=GM:[:%=(->9@RAU=;[&4B MWZ*7*G9W^=K.VQ?G*ZRM--4.%]5RFBUGV89=.&>MO5I59J M-B[:-5%@GHEOY>;\DV^G=Y9[SX+^%(XX4`*YY?R?GT@9_7\G^4NVQ;.>;5&Z MS+?G`X2/^Z M#AY8G.#Y]74Z8?3XM[NO$:7^3^^R=?*GEVQ)N]E=1=Y5K._IN[(2VJ^$[X%5 M[MQ>;$JVA'>LEZRY+]O=D@K%60H;C="\NM"2K+4FR31'=IB59L]552\S!L7Z=F[$NZV^?+SX! M/'UO@D;7G;-%O4)8K/-MN.IF'(2NQG'Z'%T-Q(*>JIIV=+<,D:TS/1&Y6`;L MB:!=F[V[W>=JNJ(9NL5^L*COQ>2F[C/K&$/TL,1]1%$L5HR!/*].1`_UZZR' M^GP4^VX[=]E"PME7JNT3'989"\9;@XLIY=$`UO8V>2(GS,++H&=OZ MG%)@!/R6*]<@BWV,YNA-^*H>](XLKS! M+T?7"1N?.$>_-KN@1+2Z2[9H];7EFQ6.QU["0V"4L^>?Z-2UR*L[B];\E?R- MS`F\U!7[:U4(R,K-4,H!(U6I2W/*K/JR@\NRMBU]Q.TO1^_N;C]\].+D*[ZT MJ68NRSNV;"HRIK)0?D7RD("HW<%)"LEC/%TH3)C5MOZ_4B)[(8=KVR#/S>]R MTR3D8"M$NFH>EXY13'\P6"`Z^C'THY_95D?,'?R5NE&"X7483?)3AXXO:JMT M:MW`P_PU]F/B1;QYTTT_"5'X8L#P"H$@B[F\4GZ@8LW3;-!0!-)G@>1`35%] M=$5+V(_8>Q-X/O!XE`)/OJX?CFHGST(XP@`(`Y!D6Q-7=K^:HVA4`!8&%"!_ MZT8W$>65#4A_OF411;2O@JC"Z7[]^0/*N[MDHATNJ0+GM2SICB]) MWN\H-'`!_+\_.1BE=%,J#5D+6*M8DM<#2Q"`C*"$W:<=CQ=M.:$]YDM8!<22 M#O1K!Q[I.NWJ;58'KQW8BFV>!;9SUFJ?=9\*+)Q>HS"B4,IU`+[,7WL"AIV& M^-\"J/,9M@;Y"NC>".1AFE"<)@8(K0/ZC?)>/:2BS+!%V#?#DW-@GT1LQ((8 M0V"O`TR!LHXQ)/J539'4F)K@_D`[FPR6O\5P>%CO99)$7B]-9)KAYS!`N",X M?/"Q:XRI9W%2L?!\1CXAS',SA%FR.<04Z@Q?P^+XOH9_\LM6H8K$+!J5T?`=/AH-MGM;T<[+L3P/V;K:+=`" MT9?.-OK`,3IYQ-27/T,UT\4+8.@DY4DM(C?G M&S`+]H[&6UY\:EU:$\'ME!V*B8`]7B)+5"P(T'Y!5F;*!6.8<.A;[QAET8`, M@)\ITTI&?Y622M^E616*E1I8/S+*XQE2T`5/:'P$+D,>YY`H@Q=3^`8A9?CU MF(\9YCP!ZY%G]L5I[T],!:+\\-ON/J*+<+D3SR)B+A=-%6G"*XE#J(`&/R5.0QP.&` MH,.,+!;+M*4!1S3Y!>82QDIFJ;G2))-?E,-$K`1`8F%0>KA"+N4_4B[35">B!QD14Z;=/I=> MQ"X]Q@(+^'L,,*Z6EK>(6#.ZSY+(17Z^C=+N$AT_O"2-7?3PD#JTP,\CAQ.C MO9TJ0^GI^'FJ;^9N3DE&7C"+2WY>"P*W\0'38$&NB[H?>5VR5E;ZP*5GK,$HW?/*D>1K$FG?+V:@ZMS;BN1`'"/II\)S$,(C^MXM5Z6*VL'^_F MS$<[UZ]8^+(RP+,<:%H7FFYFSUM>MUMOBP(=JX2O(@8TK@8NRDUA-14&5_/! M%GG>="C:RYJ('%'A[='UD9$B=XS&A'_SHB6B M$%*M=;5-]X]#[/YQ?'91;Q_2O6\O5(<@:J\@B#16'F;O$*:IB*GQKW.-_]99 M9ZM2;@B4H\P>?!.A\&/.!:P9SI3TO![H]!=A2U=Y_SP:5ED;-_LDJ/#XS+J=YT5RT MBIGYMKV8=:3HV;/7@B5`>0E@'NO+W4V7Z"9`Y]&\]R5IY63Z,XC MK@4S[60U*XGNYO-6,XD8.LFEXT\8`BH=R.K#\-EGHECFI?+.,XG,.2\M9?F, M6US+>K%BK?*VK+66V5[PLTN0SWP4CV#^VS.$;KOEE"">/T%]D*["PLU.M_TL M4*^#.(E2\I'/!S8V01(ESW`E`G6-D,"0K-EL6@PKRDH@\_KJ(C""B98JL368 MI6G9DPDK+'L\<&N(I1)X9I"(^;D*T;P14U5[)3(C:UTX8E3^OM!D^WN/)>'R/ M-:,!C;P^=5"%RZD9@A18M M7T3=;VI08%N\NTJOT%UE8=9P/O3-4!U8C$O#TJ#4L44.J9.P6=BNQ&06/RVS MN*-O9K'\TQCBDUSN;#$4#E@0)13V+R,C@(VGOCAE`G1 M3WW*L"H_56]`^;4HBH["H[`N#(B[ZVSH6QSZ&-\]PH]'KVPAY$=NS*/DW`G* M?QZXFTGR$4Q`/5"*`IU&RSH7R$YB]RCD$1QL?S#!$\%IVTZS;;>[%R)EBLKF M4X)U(7MM2@]5'3(X^C&HQG4I+57`T3^D^.< MML_V88=6"GM'?/..*RML5=>AK:)WSMIVM]D1VV:C/CCAS3+\Z0K[0VTO1'H` MWY_!$P'G4?JX*\T6??F3V4! MH8%`A0>F'O,'4KE7926NN8$H0KE.$_?@=,AZ'!U[,$K66T6(3BJ_]!!BP@'I MP##$^5DV!L)ST9)__HQ#P!@N93*<#)&Y/)E6104QD)Q..]W"^\W31C@^O1.--#HO@:6JN"D-TJ1UF7-S@/6#-M86GTSJSN]VNA8>4O2DA62$2<4"< MHX(K5X69N+%SVB;ZPL%.U\[%J11*3J=MMUI-^M'I=.VVTQ'H6%/VK+?L)PFC MSFF+B\F?0%TX:TI,E$'EX',%JI0N!!`-F9?@Q0#2291&"Q`1XJ&2G^HRXR%LNTW7F!SV'O>E. M.TUQ5)VW^-FS)WM5*8*5;LUS3R`A$5MP`+5:'6IIE]_!"CI%R2X8*P8G:M=; MN/[=B#V%_M"TX$@D3HDH9/3EP/\[X2 MA..1P:;#OTWU:D&&Q\=26S3E'YDJR(1"]BIQ&F42WJPH'6^+"[*6"+$W MY5=:/,"R9W,K&K8N5LXA86N4A0-FSO8@*VD;%LHJ\1'X4:'H_U)#5BH+"/Y8 M!VSLCNKQ$BC+X9+GJP+>#$`X&G5U))5)39/.QY%-M3&ENOK(YK4*J/-KGN>L MSNOQSMV3,$$#L.O[N";T\ST4^@5AY01ZEVL+*QRJ2]@X%PA9#U;LXTJF`ZR< M-4J#0<0&H$3/5,_*WN`%5KZZ/[[`6[QF9`I3YBZX]V'QO^.MM'.U1%5U[ZN^H MT7P.D_]AR<+@J]G:RMGL""L'=;4&0`W0Y`OQ$+6MXXG8_P+S1%Z?.W3Q63TW M(`>3H%P)^1VX.FT9]W^499\T1Z@13T+0:8!ZWD[W0QB)K_"YJ@+P!45CI9WY M];;Y/Q>?FA?OMH#]RE4\;4MV+(LVL1_S117N2??3V>ZWY+TT>BM&]\H#0,:"M0.^C"0RYUH7U#=(RV4"@W9 MEHQ4G-I*]93X1&D]7SGN,6_'TWJU'/T*G'\`F.IH?+`BC!F$!&`&G@+<,HWO M.L_ID\'R]B>C[N#KD]GL,$U27UF\]MP+8:>[>QTNLF M.'SAZLP&U]!A;[4-GDG7,!N\K0W>S@'=/&N9#=[)!F])`RNGAFUO?WD*H]QF MBL8K;=X*E3W5^QY#U8$/=E/2"0_*"[:P4DEQ^K$5C\)'GI,SP(?)7AHG MMG4?81X/QJ+`4&A&Q?R>N.)[4?T8_:5J8A2/,U=<';VI%2N\Y65ZGM4'+>P^ MC*88>%`9%\.=L>7ZDE4A(RMEL,SSW/',%EZ9)$MJT;S:Z'/+)F'(*(N6U[?9 MUCRP=L!P\,M1L[GA.ED%"&IW//,HO#7+&96KQVP%Z?,*4VUT<@WH:?_):4O3 M7(J#0*55-,)K2+N&D'0FI&^9DJ"2SF^H1QA:,K2T`5KZ2+JG(29#3&M-@[=" ME6CHAFBHR%#16M-';MN-2>&D`TA&T(VA&P(61-"-NJ%(69#S(:8#3'K1LQ[J&)LQ\)34U^IG?>J MW-N6F0O@T+&OI2$-0QJ&-`QI&-(PI&%(PY"&7NC9^9X8TMB+]NK[[P[GV6#. MFXU>X_?/,K)#]ED5#AUM#88T#&D8TC"D84C#D(8A#4,:>J%GYWMB2.-@75YZ MW>(^I4GJ^M80P%V20&$,(5LRA-3@C':>;;6ANKT_6%^^?O0JC24CEK/-2A,97JX61K`8./;>[C3.M MN-289@^?ZO321`S%'3[%';?T);D:EOO*G-B'2LEX8G?U)68C/P^2ZO2ZR1F* M.WR*VU,Y9R(#TL#K>Q/L!+T+^X&Q\&W5PM>]<+3B46-5/GR:TTL7,11G*,Y0 MG*$XU2H6E?0UVN&.&R%\"D=<;_V#HV]#WCJ,MZE7K M-D_@->!@LR$8AF]>`M^0\E-O*6MS.!@BWRV1M^UFM]Z08T/CAL9W2^-=N]L^ M%"5_A_:NFNR@3^#!FB#9/`]J`:@6QN5FPVXY>V!),D2N"\KVD,C;AKX-?1\P M?1_O&X$?HB5)"W(T?&.4'T/DN@"J!9&W[=;9'EA+#8WK@K(]I'&G8U^T#H7( M:S(EM?<[=.IKF+A^K3I>6S;;3"Z)@*TL%XWVW:[M5T7 M35MC%XWA'L,]VIKD#.,8QCD0QMFRK>_YG+-WMC[#D(8AC1YHN,=PSQ8P<&ZW M+[9K@3?,8YCG0)AG!V;/^KA',7N^3EQ`>`76U(G_3./$&TYS[/8BZW4V@H(/ M&LSJ,]\7B_GEJ'%$?\<3MR__7FU?RMM2-G(**H*%^^XDAD'DIQQ%C<;?6#M@&&BMV=RPTZ$`P8;MU/3\(T/^1O#\`9_F'>NS M<8]%5LNQK6;#6;-4ZE9P/L]SL-')-2"G_:>F+4US.4`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`:D/#*:#^&<9Z@_73KC?0PIX,A\MT2>=MN.XZA<4/C!TSC M%_9YYU!H?(<&KYI,H4_@P9H@V3P/:@&H%O;EYIG=4[2&1[X$I MR="W+BC;0_K>"U-2W4C8N2E)"WHTC+.F]M,\K[>3F3D=#)'ON!*)W3YK&QHW M-'[`-.YS_3SW&ZV*^B: M"-#"?-VZL!O.=@_6ML8^&L,]AGNTMN MHPB>VQ?G]2;IF//,<,^!PSV'RSW;-GS6QSV*X?-UX@+"L[_$ MVO[^.HU/[EUW\N:#ZT6_NW[*+N.8)?$GYL9IQ`8WP1=,K(P`WK=N[,5?`X`9]S_6MZR!.HG3,@B0^.>%/S\QU M,\R>5QZ_#7VO/[7ZL'LPVQ_5FU_MMOES2X; M3\O$4HN%EIY_9$C7N/W^0,Z+X[^QO`0VO%_<^S_3./&&4P[/"K@M4ZKRL1=9 MK\L;7J<->A;T!P+=BZUDQ*Q)Y/49?'(3ZS%,_8$5L3CU$VL8A6/+#2P2%O[4 M2B(WB-U^XH6!U6/)(V,!&K:_LP0X!SG*F[BP<`O&P6''G%(1&=;`3=BI=6D- M\\E''HOZ]!S'( M"/:6Q8DF)`=V1Y:)I'.6&YQ'J` M",OWW)[G4SJS=2SZ3:LK?04(&Q``?O@X.W_8@^UY0(:7JQ2#M`J#J`ODOS?5 MWP$W"0#Q;V8Q#Z:*K($7L7X"6X10!_E?,[-Y0;;"D-Z$70^6(>-45U*^22-K MF/&>E_.>Y0*]Q(F+JP)J=,<@H9.8DSC[*W5]&S'E3B91^,,;PV/V'.KZ8P0T M_LC41Y4G;?Q);H7@!*!TEP:/XW0\05X1\\*C/>9[+,-KD6DXYP'-(_YQ)T"P M$QU5+="&SWT_Q<.J,)';"],$CNOX.Y&AV'2@/!P(07:)>1/6'P7>7Z6E,IJ] MXBG8"0`(@/90"!"#]L,QHRG$4@@_;G_$ESIV`56($WP8!P49.4N+]+H7S#Q9 MQ27(CI$\[U0IHG*%3G1*FD)V=.%(FSV[B@<5323Z)GX`921^0^O$)_$7?E(- MI&`6[![@OJ%@$Z@\_GSY^RO<@'@$[!-;(^8/=$)I@?6WAM6L;85MY34MD72_ MG=[!B<9K7-P5:UQ(O+]1V.O##,UF^]'WPQC)FI_#$8/Y<'^0!>'7@BS&+Q]' M'C$:(U'_X`W20I5-DGUP5`^8V;V?[^!G>//:^L.-(E=J9=G^5.Y*;PJ2B"2K MU?."<(RB-Y>*XW#`_%-2.U3).U]9(>$'!Q5(9CB1`I+9,V!9??C@(4G$%BA; MWH-+FZYJ&S`W#G,58L0`S@:?*$B%3KFWK@^G!+/N1@RH!,7E'9LD;-R#,[[5 ML"U4SN6I@=-8CWQFB_U@4=^+I18(P/[4.NU<6!-XD02!#0^#N!_#_/2W\F#W MM`%##[RXC^>K1.T>?ZW.>A#J-^Q MO@#:(:!;>,;"I)L!V+DX;3OX>Q7,G7DP.Z>=CH"9_9AX$2>$@7@3&?%1;B-H MU)]0$T70.]JR'ZYD&/J@H9*2@0=M#+@*'[G`D3IR/XQ!TX#K;0P;%$3,13UG M8-V[H(A4?`]2+&;\6)^E?D4^`7_%`),W!-4:=L`+0&5/Z);0!Y3>A]$4N0#> MFZ5@&GR&1*KP+)&X4`3-VP3"B#"2_'+4.++ZS/>%<2#[.YZX??GW:CNV[.8K MK#)]V!EW$L,@\E-NFY,5Q\V@$7+36W;F@?6#A@.?CEJ-C<< MQE>`H':[@CB&RI2\GAUK*TB?%XRWTM#1?`H6/_04,:AC0, M:1C2,*1A2,.0AB$-O="S\STQI+$=]+QX=[C(!7^ST6O\_EE&=L@^J\*AHZW! MD(8A#4,:AC0,:1C2,*1A2$,O].Q\3PQI'*S+2Z];G*BA,\0:.EN\R1E#R'9[ MZ#A-K=S1QOAV^#2G5P"$H3A#<8;B#,69<]70G*&Y/<#[SC?;T-Q>GZPOWC^; MU7%52A$:7ZT61K(:./3<[C;.M.)28YH]?*K32Q,Q%'?X%'=<;SLIW9*D-ML, M<>&)W]25F(S\/DNKTNLD9BCM\BMM3.6-5;EPZM&WYE=?7]#1OX M=GIGN;S):TWW_D4(VZZM;+U&"#LTZJT'J!9F/Z=A7S3.:Y4*2_L:['#'#)&_ M!"*O-_[!T+>A[QU'6]2KUFV>P&O`P69#,`S?O`2^(>6GWE+6YG`P1+Y;(F_; MS6Z](<>&Q@V-[Y;&NW:W?2A*_@[M737909_`@S5!LGD>U`)0+8S+S8;=4[2&1MPU]&_H^8/H^WC<"/T1+DA;D:/C&*#^&R'4!5`LB;]NMLSVP MEAH:UP5E>TCC3L>^:!T*D==D2FKO=^C4US!Q_5IUO+9N1F8`R!J$:<]G^CEN M-]M@=$T$:&&];K;M=FN[+IJVQBX:PSV&>[0UR1G&,8QS((RS95O?\SEG[VQ] MAB$-0QH]T'"/X9XM8.#<;E]LUP)OF,^+Q;SRU'CB/Z.)VY?_KW:OI2WI6SD%%0$ M"_?=20R#R$\YBAJ-O^4P%PR\S[5`]UF0L&BY:-C6/+!VP##06K.Y8:=#`8(- MVZGI^4>&_(W@^0,^S3O69^,>BZR68UO-AK-FJ=2MX'R>YV"CDVM`3OM/35N: MYG*`4I(-5%J]"N-$0]HUA*0S(7T+(@:+_'>1E'YSO6!)^0)#2X:65J*ECV$< M+ZN%88C)$%-IF@^N%ZE$\[OKI\Q0D:$B':>Y&9I_6S.CMV]J-?FK(ESQE#SX5.S7M5<#2$;0C:$;`CY)1.RT2\,-1MJ-M1L MJ%D_:MY#)6,'G>9,&X;=MV%8`(>.W1(,:1C2,*1A2,.0AB$-0QJ&-/1"S\[W MQ)#&=M#SXCWB']D#\RWGS4:O\?MG&=DA^ZP*AXZV!D,:AC0,:1C2,*1A2,.0 MAB$-O="S\STQI'&P+B^];G&?TB1U?6L(X&ZVN?+.+1![:PBIP1E]MF8&_GZB M?>=[;4A.U_@'0W&&X@S%&8HSQZHA.4-RVJ-]YWMM2&ZOS]47[YR]"J-)&+D) M@_'Z:>0EWK)Z,<9"MK^QYD[#/CNOMSNT)JC?^7X;LM/U8#`49RC.4)RA.'.T M&K+;>[)KVJUFQU"=H;JM4MVYW>[4VYW%./'K<>('7M^;N/YN;OO&'K=5>US3 M=HP5V%"=L0(;BC,49RC.4)PY60W5[3'5=;MZW?0-S1T^S3EVIU%O*TF=_?J5 M-='WU]G_[?3.F_.:5^P0^/>>H!J8?YSVG;S?+O=F6>Z M$6C48-80^2$2>;VW2D/?AKYW2]_'-?L--T_A-2#AE=%^#.,\0?OIUAOI84X' M0^2[)?*VW78<0^.&Q@^8QB_L\\ZAT/@.#5XUF4*?P(,U0;)Y'M0"4"WLR\TS MN^7LP47$$+DN*-M#(M\#4Y*A;UU0MH?TO1>FI+J1L'-3DA;T:!AG3>VG>5YO M)S-S.A@BWW$E$KM]UC8T;FC\@&GK&V-?32&>PSW:&N3,XQC&.=` M&&?;QK[GL\[>&?L,1QJ.7$<1/+&>`^4>YZ+V9%[#/89[#I=[ MMFWXK(][%,/GZ\0%A"M8DQ][D?4Z>TCYOE9+)3=`CAB,Y/OA(V##(OAB>".! M+Z-D9/6F\"QVVGWTDI$76`D^[GH1HCMEULACD1OU1U/;"M/(\CVWY_F4``I@ MNPD;6&ZB/N_&5CBT[M@D8>,>BZQ6P[::#:=MN<'`>L?ZXEN'OFV=5J"C`M7* M`P2_U6>^+_;WEZ/&$?T=3]R^_'LUC)816L:G8"R@!=^=Q#"(_)133:/QMYQ) M-AU!N16?TJQH6#HMH`&0#?,Z[;6Y\BE.FEK,^O3\(\,)$#J_-'.?!0F+^-2S MU*R!QV9G<;W:4V7S11#E?Z@:W93(")K`Z)ZA!T#7P20U[&O85U_V_1:$AFD,T^C,-"O$B6E`#N9>>>AT>/R1 MK('.$E>U!K1H2&*[)-$T)&%(HD@2+4,2^I&$=ENPA2(3G>;>)0;B-WSWSYM.<\8EJU^ZTC;+.QF> M,CQE>,KPE.$I+7BJW3J4TFR&E_8!4$/T=852UI5#/N^J6&.N_Y[DD*\M*K9; MR.$Y$=UU%W+0/Z*[;@SL2IE]4ECWEHJV&*XR7&6XRG"5X2J]N&K;^K+A)DVX M:6>0&K+?Z'XMS;@S^6/[$%'U0O+'9M(>-3#6F#`_3:(U3/J821\SZ6,F?!#I3&8;]SZ'6A\[JLE\,E&P)J+<9&F8R'+#4X:G#$\9GGKA/-6T.UT="M,: M;C+<9+A))VXR254FJ2G[KALE_+>*> M,U023N`<''D).\&C%[:?8WGGQ/L!59_?4?71A&H_,3=.(S9F%?%GNTHSB8&N M-8'%).&LG(1C'4;TL(;23"[="#0CT(Q`>^$";4-1#,)(T#K?N[#YMZ[O!GUF MK5E.YFGXV6Z`U&&'/[W`X"9-H@+U9?:+TXM99N=?+F3VIF%VP^SK5?VSG;,E M5*,CLV_GN-W$ M3ZV)+U\[5_!QTW::7:UXN.XE+[EZ'(P46*8'&"E@I("4`H[=;IT;*;!9!6%1 M;KV&]X;EN?5)XE<;`3>?7W6(R50ONI'4\9D&KML=7P8*04!4K=##]X`?"IY_K709Q$*=TC;D%9[4]_ M_=__R[+^_G].3NXJ38RQ^:CL(1Z+#XYX2/,3,J;0XC@J,%-\(7UTR@" M)+UU8R]68W`H^`5^#@%"WW,3+PR^`NK>^F'_NP7?(AZ_L.$O1WW49!I.PTE" M^G31:AS]6D4P*R>UE,EK.S+6)#^9Y">3_&1R/$SRDTE^,HQADI_6`D7#=`&3 M_&1R!4RN@,D5.`QIEL7@&(%F!)H1:"];H)GD)Y/\9/(A3/+383"[27XRS&Z2 MGW9^W&L<0632'DS:@TE^,LE/1@KL'@P]I(!)?C+)3R;YR60GU"AB3/*327XR MR4]&O-3#6B;YZ3!R$4SRTVJ\:'(1=,Y%,,E/>R-P3/*3$3C[+W!>>O+39O*0 MLC2I/`++MI0T*$M.@&;3;`J+YK#^^96R5G`PBT;[?W.SII0AYX'\,G.C8DR. M$KE1O2D\B[%"CUXRFLV)&GDLZ%J9-N+ MC?2_`;58%^Z]T3/GP+"O85]=V5?;1!W#-(9IA)DF3&;U,>W(P=PK#YT.1>:@ M4V_FH!%-^T<234,2AB2*)%%S?K$AB:>0A'9;L(4X[TY3NT#,Y7'>$7K1?.L/ M-XKGZQSXJ$-(\59"'TS@YS8#/PU/&9XR/&5XRO#4(?'4MD."#2_I MP4LO.BOG<(A^"]DX\ZZ*&F?CK.`;V'28\4JBPH3&F]#X72NSVN?D&*XR7&6X MRG"5X2IMN,KDC;Y0;MH9I(;L-[I?>^V) M\F4$\)CT,9,^9M+'3"3:(1#J3V<:]SZ'6QXYJ,I],%*R)*#=9&B:RW/"4 MX2G#4X:G7CA/U=\2VG"3X2;#3?O'32:IRB15F4#U?8S8->D?AJL,5QFN,EQE MN$IWKMJ^QFSXR?"3X:=]X*>G])I;IWM;UE'N-]<+L&L<[+;WX&(4?]:R;&IY M0=]/!VP`'ZR`)98?QO&)$FUHJ7%^%H^PL[+0`.N?GRB+9WZ_.0$F]M;^PTM& M,^WPXF(_O.):Y'*GN(2/`-FU@/8Z>.]&`3P6S_2H:V4]ZEK8H^Y?&21OI]G' M_Y(-W&@=ES^\.'^,0T4_M/CBCJPT\/@$WQJ-YA$@LN^-73_^Y>BD=?3KB=-N MG0/G5&Q7W8M_H5M<:D.XA2T&M;BKPQ9?`2;@6Q;TI[9UZR;8L=[Z@+(']FV( MX\(VIY,PL*W/*2ZLO&DXBC*(&()&R`;X!N_SMV6/WT3OO'@2QJY_ M,\37Z"W^TFWH>_UI)B_7F1.DMP7#YNE8^]R'I= M/K7JM&C^F<:)-YR*G(W`!'(O7R#* M/I@/1*6/Z_1IG2ZMTWHZU-P4"A05$7@Q0P\`XGXNY9MZ$>HT.TP0>),D.S.3%?80`ON^[ M\<@:^N%C;"4AO14QGWAQY,-$<=-*C'`;VH\_8 M(*:O)E'X)^OCHI25*QA1D(`8Q#&'43C.AYOIMCJK?3U%J.0"+(#=8W"<`N&] MXG-S,9@B+#<3V'0\%V)`U#`$H-__E2(%?&+)*$2A_L#B!*<&AA!#?75_('N\ M_Y%$+E"W%[C1U+I.V!B^_`Q'#8P>A;Z/PU]C&"`,,",F:20$Z0,`E,.3@_.6 MH.'/T82?O"",`#(YY"7*;744#CB'6P&[0C\[4_6S92=OQVFU"R?O%F$WFSAO M$\M'Y#(-^:S9[)A=U&\7S];9Q7:[>VXV4;=-+-UWE[+B1?="FUV$P0#O$Q;$ ML*-O6<"&7O*J&KGPJ'A2//=,F=2LP,','#7#NP[W[1C8]:BLU>GN'+WKZ1E/ M`Q:TP3[<*%#9_">J?A;I?C.6DFS$_'F=;I]S\C?\50M#]7W0I'\Y>G=W^^&C M%R=?\:5-E8M:7A-J4_?,LD$X"2>5]VH!4;N#D\QF^GP.X5[8LDYF#=/;!G2N MT=I-DU`F3.X(W3 M,0TY<:=T+JJSODO1&*9`C*:(?"X+3F4O',R?TD8K"&$#KK\A/\-A/&'X.):W M_F;CY\\W'S,C0-/Y^96X@-^#O(L(V@$;LHBN^0"KN'SCZN%%?D4_@;\>W6A0 M6,`?="M_\!`\-">0#@&<`I=P;CYQ[UTOB+GA!(&LFH;;K"4BG@;([U639Z#A M^V$:+8(@8F[,#17N!-[[`>=%POPI;*@-`HDVYJ>N#9I$B<:*.[9HJT!YFC`J MK.1/9RP1NG`7\`$<<$C)SV>PUND&V*K%V0JT#%O0+/[MPE;><]\'&PXY5M6) MD*;1DM1$%L(,2956+O%]V(W4)VL3LH8UR#E1,)TP<#T3^(@-?6ZS"@.@)A=H MTH/WI\R-A,T138Z@,Q.](3A(IS`=G<9\]M/GRHE6)B=HK8;U5V1]QS[+6=]Y M*NNW]H3UK[D1.X[E=@!>?._?'+5`F!78LRV8PKTGCUAF*B;C.M9[LD!31R,P M7LU][SNB-`&2)_,X6=-C9*U)&/$9(MR_PD325N_!]YE-'6%B`RY:@(,YWY1` MG4=,`,V`31@%0Y/KC)X4G"#>%0;E(@M6R`?D6VG%#D$LP*;#4M">,/!`)$6, MZ+#'^.MLD,+^HR?`>DO4)N9V'US/IXG"WI]"CC&D7'C;5M@#27@$"G<(XZ.0 M*)_U2(LX7@KO10DP7D+/R:6A*;QJ784-[#'?8P_H\UBR;XLX&GZN4HV4+1RF M/HPH=HPP250G(2JALR$QRIC MTW%44AF:=D,*#J?+/U>B!9^8*8ZZ)^+BLFI%XJ`!(AXR$`6N3TN,$^3161VU M)-3)DU;$9.NR]`CSGR8+/1/*-98/[NGN#N?::S_,,- M4I09M/>-"\*?.P@GY+KKDY,+UWF?>@,B33R!`YW[D]1C7I6@, MXB(\&N,17$KIL7$>,0$LD,`+:9)K4)6CJX.5AT`"X9>I,!;3N=\9G1VHG?63 MS$W)O\<5<7V0@?`+3E%I0:]F$#["5W^EGO!K9DC`-^9")AV>_0I`0%8/N7#, M0)LG0N'='L.MB8$DN&3#I8*<3VST;>>'0\+ZHP"O_X"$R$MB>;3)*;2E[QNN MPY*:RU4X(.X.;:=@=MJ&.*4S#W>`_8!I`RZ(A;/XV^G=*1>T*9RP:(*F`1Z` MT,,T%D)%_1VHGV0Z',9\8IP#)$X`IS?#22IOR71RPBB@!@X\HC\\L!%(QJ62RK,!^ MLSM2X=I?8)E5#;YT';".X5RF3Z]0)MQ&;.)Z`VX]JS#YTI/RC>M`/$Y//]N) MT[[HMLH6]@7S;7,IZ[EA-K:$2WZ\Q=:M.R5E%JGE4A"6$C:[?'5R)#'093`0 MPRBC/'L#6UUGR?ZM`H;F2%F/%+KG&T7).ZF71QC2E:ZR2/G*%_[&,S?YPIEQ M@BV>KT[0U]L*YZPQXR->$?9K55I3B6?A9Y]=0^8[IL>$+^*97MURE$G5'#7" MNE8\16NGP*Y'S$YCQ\"NX\QMGZT#ZT<2G._Q(LEUS7>@5Y3AI(?R9_`19[GK M%CYU3IS&2EQJ$#M;\L<&BQY9YA[<0]UWMS2>W])FUPDR5^A//_ MGGAJP=)T=VOGR_E#&LW0T(AW(!^=1ACK/HGPPDIV&YXXP2/;W<>_&($^" M_&>XD($P<0'ZK[#Z"'YX\&(R=DS2*$Y='O4MO'(,#:CL/@^4CU4H./!XRY37 M-^'JFO#D$#+-Q(Q]MP;NV+T7]W(O^!/N>V0HB]`X/22+CN_SP'&XB_IHU-KY M=7QELOW=BP*6_%\\'T\M!B>F?VI;#Z?6)Z\?A7$XQ!V)T(M`9]/Q%1Y6W3=. MZ^3J]Y-&H]5Q3CZ^?S=3H[=^^KR!Z\4D\GRKV50IV[HM$<&G0T>%E.%1F>>-*2]3D$TNS:G4;3=EH=VSJSG?-S^/\& M?FP[Y_!+FSY>-&RGX^#'BZ9C-QWXB!0,?YZ?V M%E+^J75IC9A+]F_D(D#LF&YA@`=T+4EKJ10`XU"$QDXQW764L2*Z*T;,)X-/ M;J9I2Y?(C?JMDQEO.+_A1GAQC!=*%XVN`WCF'@O8"E,\SD%0#%B`*1TG7G!" MWR&CQ\SUX44.%^X)D@?SN`>CP+NQ/HSA:\2,J81,WDQGPW^ MC?LC-DA]X0G_1^I/+61?U%;W4VR"N+S"]!_K;AKSP.U1)XS+KH<[CD;\Q@,G",$5=P+ M@"8R]-G$5R3Y9K9A$68E8FU<.7I]`7_%,^(T/PSRD7`$;H2C,4FV\E.THX`\ MA-W`*[,*>K[A22@SNOEX!5'CW;H#JRFWV_=BVCT^+^B-&'$0\XU!1XC;!YF( M$PSESD@1)':#>T*R%7*?]Z,_/1$BGS]F5RQ=G'C9TD4+AY@\X]1S2CI).=Z:6;!#\42RL%$@<*,5I;XX)872(MX[%3N1,8I[ M'S'N58B!4P&#?0KPHJ^YR^_1@Z,SY:AY9,H+`]#+,TV44"M247+T"J]G'@4U M!@`2D.1C]XCF*N01` M?Q`\HIXY!8H4OL7\7.###6#XF<-$OLG90-V23YAO+WBOI;Q7?".17_>!O*EX M!L>HBX'-`R%N@C`X*:+,CP'!#.32F+RCG(21IG)B1=6"!&5&O.36!6H(L`C( M`+@-'I9*$.(*0P8?Y;K0V((0%OE)!0(`DT)+'C]R*L0#*`&DO$E*5/&<8PO= M3&RPZW.V^C":L]6<2-2MONDGH1*?PMD/OO\/T\^=EQT M%V.E`^`MH!KKIU;WW(*U^^+JD--2<0GJ#8-'361"CZ[9Y:/H1CE3FEUYS9D1 M,WCK_L3&,#*PYMBZF<#I+73O&](](W;O4C`3.B<3P>:2$'G4:2$SF2NDA#BY M$*EASHK\7*V,,**,<1DKCTZ!*>$_IR%QY1-`=H&X.;^*'1'GCR#HV2E5!57E MH5`>.S*1G11_`8H(ZLLB%K(MDNJO..E4!D6A^*=0:S-'L,VQ6/$]*?/X6X8U M,3=*YTR8\472K4!*$G%`NAA>U$8*&KC`2;GK.9UP%1QUAVQ>BN5JM1KY\W(Z MA;:XY*A\'Y^2\H0#,&`/HNEO7K%%094*OMB;\G7!Q5!$X'B.%ZXR"5*,V8-8 M,).!?P489=`E+#HDD@X?@_R4`>4!L^ZI'DL:(%&C2$*Q4X_N'X2P#)^+I9+- M`]0*5-9)/.([^(B>\A3D!]VN6E)T\&WF*B<6B)A,F)OI11EA#$CQSR7/F0@< M)R%+`H4_\8\T8/*\74E`N#Z_#W/-LCBIJ!%1):&Y!@F0QIFP_B!"^:ZP,`8< MNQ&:\20`-!`_J^7-7_XFW^,O MX(&4:>]9R&1FC1)'4O:#;!(_1&`9PZ&'2L]])L`+FSOT`A$K+Q2B=ND4 M(RV(]!\;=<>5!BLKK/#W[[>?.3;'B%*^]1 M.`6&F%)B"*_R$@8!XP*35%)^6>$Z9Q[RSF7\J74="%H6&Y5O--=6']P^#U"J MPG3A?,Y41KG>BC567(L(1A';BDO'2W85XND&6D0\WLS4*UY$VRJ`G85M!@D% MZBC#\<'M,Y2.^83.SR@WI%JA'B64(!`GV3`*1JM$"8\9$_(3CKK$*^X6Q[\M MCT1N*XF89%2^5/D7"^#Z$?0E!9=$6@'["M>V)2`9U2DT)JX%A7?]S"]5TD;) M1@541,PJEI('2[OQ=Z9>:4F_0]`)1]GD9>2K-A,N.I915FF["R`"4V!H/J8L MN&G,EN(I`\OCT4"4^R"$M["[8HPF!OPB@'?I!*-XQ3$#G_ML0+JHB,DE/@)$ M2'E0/G4()PBN*T3U#)_Q12DZ7F[2Q^>59V>XY*S`)4*UY76FLHR'(EKAOQ&L M(?&GDE'E#A+S(@]EPS<;/\=8"XY\5N,40WJ)1'PO^*XD96:H>'2]+'8[D5I@ M42GG)@YI[!U3),"N]:)U[;EV9M`5UC;ZL^SU$AK@#LRU5?>'W+R)Z;T@V"AK M#^^EZ!$)[D.*+!:&)!E,'N(YA3^T.\"!4ZY9S>IN146=(I!C;M2@@F'YS6Z6 M'NCJ:>=*([\O9YZ$@.=5P%43P14Z8B9(Q?UV6%C>$"XY=,:BR8L^R&61K.:J M3_.\4ME=40LECTUI5?S:PQ%+0"KJ%K?F72@*L@KPP!L(7(TYO$%NR./1S=G^ MJ,I`V390-)\22PJ]$VT&DSSQ(!2LQY>:@>=DN:\8"BWV0EUAX50K>HNR'1%4 MEXV9F2.4LZZ:$$`U\WCI.KJIHBF1'X8%"IA!`"J3"A(RZW$\\D!MIP5PQ&3F M9$6V(=8ITX%2'*@NKMOS\SRX1)%Q\@R[IX0?<5I(T_107&%=M"=P>[FPTV=Z M_JP>7HNW`W&?VR\`Y>*^/E?1$?K>#8_`!LQG0_L"? MY]IVS+B%I7##$+8P+A@X/"=%@H:Q&Z<7YW\C>A\`HWE<+Q!1!J8$<+,;LY0+0Z8E`AZ+EXLALZZXLR*N+?TYJ*64Q!P.\CY(>&;F![I? M2O=LSCATMN6ZZT:I5;45H;M9GE2*[EW4%-!_Y[,5=`LVQWF*.I^(/=HWK6.Q MTM'DRSSO=';G(YXUK"LG!AI@*QS"&8W9-0E$?`.S>'GV[F)C>ME'6`ZA4>)F M,M,1[52*0;I8PT&:MCPT=OD4 MB8RV/5YI(E9\MH\L)6 MM]()':@R_6[#X0-AA7^%Y"R/25'BRB2IX[T*N^/Q%?*_J'M(BJX(65("2Y^I3 M3$3N#A9<4[2C*!EMLX`C;W0OSHHXU)$*L4!%PR7L@9J$GH=$G,L3 M5O5WB7'%+6.I]1FI(Q:!2IFV3Y:D`1I7@:X"%L=V7D%!GJU*+`G5AI!!!%Z, M7)39&_%RG86V9J8M:90$^DT%#PEGL-#QU04WJ+%U\)B'2(%_9TN!ML1=CX$'2)GMJ%1#,<,U+YV1A4V1+ MI=+@`05QCD)N.$RH3$L,V]87GD\*!LDC<4`'I[1E/BDH/3ZH\.D]Q6Z)>A_R M],G6(*,ET1(51A@[BI%?%*6"]BO,,B%;JSR$^B`:8!$\!QAE$AV'@,(3E+KI MF-X41V1$^QU0E%$:T3U5$"6O$8(G'%H>@.P([C)4G&\'`V%`[4DM)(<&\0J' M*XE6Y6V5QX34P2<%LS&B?.G)YDZA,3SN4;49BX?E>S22/*5EY06JDIY&$3]# MZ=+]P/QPPAWM5_(7'I\FSG67A,64FRFF8GME++]/>4&*\LZ1E[W[2&GM0WHS M?\K"P@LH"M%4(9HYX-&4*&5,4@H'QO?NT:`4((@8^I'EUV.M)`X+@K="3O5* M>4AYQE.>NFE+S,QD-N7/B""K4 M6(VFT'#EG5"W+GE0C4UEQF93!>$]Y37QDGB'WJALJ]*9UU:EN*8NK(G*,)9>"^O5+WQW@2%T6N&]0DE^,]V!NR:Y1&P,LPN,?N\LOCS8;W" M;B2WLI(8G+O'WV*Z/+R2E>M1P<=+G#QYJDK;5ZP&!Y;COIWBH-=!-F(^8%5Q M]V>7LCCO7)27_PQP]@]?ZS(BJ"'='2#L`R]?M4&$92/6BK"S&:GU#%CV#UGK M<6-S)5;<,+)X@X=-(BL;L5;*:IV?SQPRSX!F_]"U9E,'QUF)%=='UZ,L5(2K MA^&"$"MZ4;;-+`8>\V>+C_(.7*:YWTP!N(4(ULB.5JX\+(WMF1/]0U:!45G. M70)72HH<>!MBK-?QT8?+N[='KZ2QNO+1;Q.R^A\?7=Y]@T?1Q([3G#@=6W6! MWT8L1GN(#'O,`;C+2T`J48[6;^1ZO^(!@39F*";AQ.O#X)V3=J,P=CWA\T6: M($PJ34I@"=^RNI]T&^^%*5H$T5<-=]^"-?HRMWP)_F78M/2*37`G$W\J0GW$XARG&KY7Y&+&,>B+&D9Z(*Y3@6:!T6( M4$T4R'E8@HP,93\F+K\)4QEH:6B=1/`HYL\KB9,%XQXY:ZA6)[X;2R([M>ZX M;[(/"YMR"E:P<.R\DD6%N<'>$P5.A7F>1PMNBTC0Z9>XW"Z*W;\3VRKLYG'S M5;8=B/F\1#)FE6"./J6/8)P0E<)67%^41..-\QKZQZU\Y0IRA]Q$2?7"93#3 M6'@<,%J7ZN,B=G)R*&S]Q'<#'+V=0RJW<)"Q@.CR.;-++52C"2M3>#DUN!C[N%23A_9!E&KMP1 M],<'O`RJY0XQXH,'>ZM]3*MK^Y*!GH3I,0ZH.B9Z\J=7YQ M:.0J@)4U;`C./(6#9^UV;5DVMOB6=(06Z(U[&&B@4^N]&_E4TM^7\;84M!(! MG268E%EH95!D=$GR@C)%T5]:5U:)F=P5Y(01L6(Y/K,@02[8D+)BI6I[5;E2 MC8YBRC12#F(X83.2@"-4/4&;MG5TA64Q`I[^;)U89&2U"E\>?Z5S\N[$>S8"2^E?RLZZ]#@+,@D:BQ; M\U)0#$ M"B3>N+".9)W-K`%EY/9E;8`K&!AV.XJ/))EW&]VB?)3?@I`'Q`'!BB+MHN!G MH>"Y$.V9*)4O=^RM:0>67.Z7'"Z[H!\HY_TXI("#`6`AFIZ(^*Q^Y=(RBDM& M$7J@41E%-%R+M_E:LXSA*T40%'I4J^[?DIK5)P^H")++]/%6NX'Z^/80R&M@ M7HK6$]3B0=1XO0)TY;VXFS_/(Z;3>=KU=2##2V2L2J3H511]E9&;S%W)E.>\ M&'B<[1"%#$R\/M\+`":(AXSB^4!>CCT4K_&2CV1U7X(JN@:(@#R: M4/0\B@6$JA*5E8[!GP14O')_+#0,^M+G43;LAVB1Q/4&##V>`>;4^L`5'QYE MS<>RV.1^(1KDSQMKL"?G`,QWNW;-VL0KUS`0;!6[=AM+.^3:A M6],QU'(ZS:WB;AT?>K?37A4XDKFD=>=D/Q>\#89/7+3.NM4@5OCZ-P7DNF$3 M3K/M;!W(-<,ENE2C?^N(7#>PI[4RC#<5AY9L7R8:E/'3F!([3F1:V3\_D-IZ.Z\S77^XX/"C( MFFA\I8'3O#J_0NOV$;/=$YY]UZULOU`1#K"D MZP0U?W!FFC]4-7S8&L@S&UQH*T%@O\5ZW>@N>T=])2<9[[RE(BS`-"IQ/['1 M@_ZFZ3^83!^QL+(XI7I0Y@QV@@S]\'X*W_MI7C21ZLJ@O,5^NB>8=%.L,2.* M9G)#*QX'K-`*_29+VH5[\6^7;[]1,?HN(>[E5E^ M\]LP"_K1E._>)`J3L!_ZPK@9JE/QSI98RX);!(`.QKP7>8C=%ZT`K]0Q%?@F MD\J[SW&[1'8M7AQ>_*W,* M=#U*FP%^\)$LC]N_O?[X]?TK-%T\AM'W^'36(-=CB6LE(MX+E[LR0MU89!3R M-.H[#M<[#M=GQ,4UKQ'N/3#"Q_'=N\_7KRBI5O;#Q%P?]&BI3=5OKY#FQCCT M!-.<9;=+P)>H;4(9:&BVY,47`'CXT8N%@?8'#$097;.8PAH>'NU]9;YY[NO^ MSJ860/"=C.$1K_(PHLPRO[(RKOY,RIML1H!MWPMEU\J*I+]85/^!)6='/VYO M3\JZ<3A@?LG&FY,3EN0LMD-N=47\">"PVT7.85BW.JM+3-G?A3?..EE:F2C) MI9B;8[X)((M9M4Q05HD^QPA&C;#T*;57X*48GR!_;"3W1T`8_BL-CIEO@8QX M+D==1HU9^`1U`V%YU3?B1,`5.Q8H@:"1< M%SO@\9[TY/3-C99<.'%"%S)!("/A57>O_##-UV5;G\*>Y[.3)#SAGZSC3\U/ MK\K80F^*G/..&/>*_!E"A*`/"4,Z>+,P\0#J*@>'%N61)!;##1NZ#_3&(I10FS M1D;*1E#*9`Z7")JA?-6Q;$=+;$>>4Y>D#94@PE+XPBTRSE*\?4$0PD]K/L8(*T40.8'`[JO,L)# M.E8J#,FJW#-Q1K+L!T\.EC,/&.(SYK%\Y,B<3@C[-$<^A2@\*L#``D;W<'%D M<;D;]=@%"9J.U6/,]\9>LL]1#[+'&"R3.Q?)08-]X]UB\;$6J'%YG1/J/`-_ M8"4P#"=&%)$*TOKM]M:VL/0JSL%SL._A?)_,U*0-!I5D+O.^91HZI35'E)7- M0VA`_L"7.<1,,MB?KPPU]#U(BS#YL9AD'79Q?=0.L$!B753L8\1CS\2E4?X M,8/R#''<5V*C"),?OEQ^?D?-10CT,=DID*ACCXN<,'?SB.`FV1>^C`&^&YZL M@D&KSM/\.;[=*.\@SQ$AEXB[EN,\.\WD1I8!Y*4FA^T#/FJAGY76$];4->'0IH MHY+4)9#&7-F1U>XI($$&L*9T!:Q&23"04D!B8K&RMZ]TE]^]LACV$D>6=7%; M)3D*WA#DJ$:B\(YK\R]M0B\EJ2,>P"(E+J\XG5)4$04)1+%=T@*S`$CY@*K/ MH_)(FK&D9)"&7`SE"Z4N>+)`=+92?FCD2RNO9N7+M.P%!QI3S/)`)5N>'++; M;M8@"JF1RG5@@'P)J*L,Q8?7$.,2-0^\'&YP(1@(J M`0#N2:_CU=FYO"\QN+QQYSCDC)F?@Q0P%8]D7XE"?71JTY'"YOIDYA'!"8^L MAQ&P6$3&S^(N0/A[>X4-/DA9Q*;R./P/GB8LT=XH_K3[;U$-+5^($:?_.!,N,? M/?1[>'UKRY,@OQ&#K&$NU?]'L$/>GBV+040M:XS&;-"#OB?8;:N>HZQD^5`P M*Z\-<6Y(E**'>,)54[S^S:+PI`]H4RMZX^+5(N``G,]FGZ)"XS8U(2-ECLP_ M,>I\0K.FY`TV\<.IC-$3$,VQNBA$`;O-?*Z7YEJ$*+0%\O@DLYJ2S*3B0(H- M%\X$#)+G0;C[RCE8!RF<,E8L_$BALTJM)AC#'8/.`=)XL-ZY6[REHMD/1\*> MLJB#D1B\9R3U28$D(PH+*#E'9+%P,)S2]*VKI/HC0.BH]Q\^N`0_P5"#A MI5QQ)M(P$W$'5X'BW_`PPP\W7[Y^^_S>ZC0:XHFS]L]6C)8"O#GTX0C#BEJ, M94T4U%6K@H&7(YMR8%.4_;Q9`9M(C>([*+4^PYYV>.J'_@,I#7!2\M2,!XR: MQJL-8)A'AO,X-J8.8!TW@_(.5#WKLJ#,O\P,-]RTS,=/GV MW2#(;:SP])!V-R.^+#(2`)!"3]R!_A2%P?@$XF"5P>->WC-QR`J-5CQ65OJR M4YQWL9J#6C8$%N%73:D@XBD1W"<4DYMAN))!M8U6KD8$]T%A&>\TX17\.*O[ MF&7IWM/="10;;JF`]Y&C`#\>&?6FPAR."8DP9)P(+1Q-,(_SB*&'RB2I7.Z8 M:A]+2D#!B/S_P(/[>;Y1/@#/C^(1N%D92MI']/+&(N*5E0P_Y>#UDJ;#MG(XTZ(03#7#KO%\-J+A1))-@6Q8U:(^V,FD`1?+KR;Q[O! M6S=##&)_9I!BNUA$8I4I=[JXM0('6\X^+6Z]R,UR[+7N:ULK>/L9:[MCY"YP MK#_<"`L$QR(?FBN%/]61LQB*!?@90-+7HE0J[CPR4"+ M;ZZS;_(MG+_/CE[[['!@_L5+\^`9\G4Z83PTDI9W+1>W=P2Q2A'09J?;WB!% M;(N]>4CK_K#W2NRP@)UT0)FNG+(M4;,I!&X++W>Y?66BMA:6L'V<90LB&VV?#"UZ<1S:54:[-22@.%2<^34[MC8#?B[MGZ MYVKB;FMJFI[:N<8T5*\XW!1Y;8I;=W%=T!S#VLK#+:!-!ZJZXC5OT-K/>V%@ MNTT.%/<7R8AEGBK0GW*7N2\""@-N6TM6MZU]X.-=B>&^XFAN7QBHO^9C_^9Z M`5K%+B,/W0+O*"[MEF*A-V1V7,$LMT%@#Q/CZUFQ#<8W0>/KF)\-QC=!X^NU MK6BN9/&O`^TK.$.P#A6U&<.`))_K3]*OZ&!Z+I0OQM.-#NX%UEEYZ'F^X%G:0* M=M:86X\%K\>4CG/1/*]EP;8Z9BZ/L8XCO!*$:L5_YJ9JER M`*J:?NM&-Q%%?O$VCB`PJ,SY*G[PUDROQ<8I+$^I8;7:7#M?6P65UKBV.[XV M:;&C/.W%"ZENZKE*9$)C'KS%GIV;!V[-6^EJP`FJD!5W@22(#.(E=$`;$?.U MK`*HHP+:6`"G.O"6P*W8]`V#*SHS_WM]D"_S-Y^`9:=1KH*V>(XMKV`%Q&]N M!1B=G8C\W367<*.\NGGB44;?.O3/Y]0YT$]<;R!+T$X\]IQ]WJW-6 M)I+9D6N";Z6&F*5^JVO"]SD,^JN`F#^W@9.MO/?.*9?+I"&S7/ZA_[U-7099WJMB2IS!7S,C?J M0AK#^S)7PG>+VH^Y#LE'U*< M3F6@Y?,PGO*T>/B9#`.:"]&V%?IEAYY1U_XTE\>^(TSJCM0P'F M95/5#/@J`O+DHM$IM3!8`^Z*;F^S<-,CRA.F\7:Q5GD%$C7.1<>>NP\R$5]I M;5@H>`=D(ZHC>&-9"2(OOUAJ\/=O6;V1N2!]1$T`5BS+Z%(]3<;U)$S$#C'G M.B_:0A439`/!K'TG#4@E^[(:L*)$1,I[7//2*+Z'.?-4!IJRN'L^M1+&@C_6 M7:H.$8L"@Y1#[K,?HHTLKPL"/))0(SW&J^WQQEDQ*[\NGN?5F["185X=TL[> M59MIB7(0LC,5586($XEQ3%X'%/#?_#Q*T`;,G0!>Q<*QS&#$AECU`4-X"Z47 M9&==D88O4O#MF3W-ZS-084XL1L*H(1@V[HJQ2`<5"));*++B>;T4I:5KL9A& M^"@+1,XMABPJ!;AQ'/9YVV51"Y$W0,1GE3HC:DD(NB'>R^WXF"U$V1*JBL3[ M6HG*-KQ88[)R'WFE2`\VDE.*\[Q:V,S2SKN#7BIP\L5]DM3T3J%/ZOVFMN@3 M=9GBV4Z)V(G6!_DJB8AX@>4DA&T7,\Z@*BQ8Q(2L:L#ZV/^9^VMXH8FL&"_U M*,,X9?XKKXM\BJTE>6FROA?!:1%32184*%E!YK#("'#7"?T'81U4($?\$W6+ MLNRZZ!*-"IO%*<5T:=(J_#CE?6>-?B)-Q:0]A;3O,? MA;R^S/:[T.7UC?4-CTDJ`D;%=$OU9S,R40_-K.P>5>^BPD)8)8\&*APW>*#< MBP/JD15*Q67'-;4=C6,A?=)"^4E6J`.%C@1Y5*LUH7A=4"YGA1RH7@,OV]9' M!A5]2D7QX4PL#L.H4O)2NX@949L=W*HJ(.KM/U>N9!3L#DDC,`$5'`F*("II)^2D5VDSY MY+LE"M?!<7RY4*PM2_71^&_CRXV!9<[-`=3V3U5GG414_;,5@0^ M/ZGXC5SI/$ZH5(L`XP[!/05NZ;S0/"TGVSM^4*&*JIP3%5"!]DPG+7\"C8I< MCXZQX%RNUJJ**AU87'>O:"#OYJWKJ?_QHSB>PQZW>%'CZ/M`I5-;+8OO5JNV MN#*\S?%ZA/Q[JN+H)F5E=X&2J_)Y+>W)BF+^";58S2%W@(<<&],I)((CO@@F MEO&L!#9_I*;SYR:X#W/3TC1ORT+FI7FGD'+UYXJA>G)A_54NME*)>JE MJ^$@TH@4,2P'2IUUZ#"3%B,FN]V'C[*"N'Q]!FQJ1,*AX]#(VU(J;AM_I5C[ M%6MDTJ5Z[)VX04"S2P%*4(@9XW2,?;/XA0%N%O/7)4QM7I2AHL).PI%%IU"N MT,MC2-1&+X&!?8+87RF9B4*U@Y$7B.JR!3U=V29N2/.I"+6`6XCI4^L2RPES M-0%$;(*"T1M/<"/HQ.!%005P_):C%HZM@H(,,)43DF2F&L#C$`Y7<8K("O%K M35!$#A?GA+R!4IZ_ZOY6MN)8@S0K68Q&*=%@15B$RWO`&UNK:+9Y,RPO]N3) M@G?WN3LA%(J8VYJU/7+,I>K@SYNM7*H^A\')E]S9\6UR\H$<(1]DH>E/7H`] MNO`+O`'1";"5Z]:',,KM;L3S\GQ`D5=RTF0.'+S"D.8Y%G"3Q51>0KR(;A^\ M/#.755*S#4)I.U/J_*UB0U=IQ;+=>\>(G#[##E MC8N2:IVZTDXY,QA0':.*Z=*DE'7.>DWWG:SC@:OV1Z"BWZJ)"HB`&^"5=O.E M:PF&:H5TK8+[G=.$/X)D%(O7Y%7$EL-Q-2!'WP1/NC$;T'JYKX# M`QF1S;_/_04QUMD.\,+3@_,BX+6O7=XWB:L'LKFAIJ+>W"Y>@K3G5P<2QT*E M>>^S+=TLY$Q%::/<$W(M*]/[>&A`[K=4;"U#TKJ8B&^*F#?NI5$LC`1T]7?' M[CT^XZ$1"(0!;WB)M@C.L?>8_\RC/_-AN;PF17(HO`34G51V'L66TP`:-L52 MNCWE;3P%0-1F1G1=R2P?O%8\Y7/(BO!49G\B#"+Q\V7#;,'ZI0$_BZ*';.N= ME'CRUW_RURU\WZ(!9DHVS4XI1Y&#:!)CM%Z(4$%$9G@1U+J7#76N`^LRO8=O ML/-MB_?OO'<#<8GBD4)T%\ZNTQ3[(^_HT@R;A-C[A4<@D#K2$?UP@+A_%_:EXT2:S\=`8?"E%3:F!0K+30%9R? MC"(F6HN"Z#@A326SSG-UJ6JMH**@00#6ZC^Q(>*S58#5:7`N1][-4F!^J7R7 M-\/D2%)Q,P\UKM3*]\_(37C^0NC+M,,MF],M)CYP/.O MLB`>%45J!;G:X2P. M9O+I!%.Q;CDL_XO4>F6E"N#<=-)C?1?=SUPQ4$'B2@5L2)QPA5Y*C$5,5`MY MK\2`MEI[P`'>!OK!/^9?$R(C0%O+;U MA9AWN)B?H86">6)%-/&?<[RO@*@%EI@U)YW%T1I@;':_:,R?-HI2=77[35[9Q'58J-I"XQ,*3_:2D&1)1`=G)ND><+ M6-D=SV\!C)68LT8BH3&;>.75BCU7POPFV%,H'"?\V3=6<_)CGX_NCRR.WUB7 M/!D/%&)8L7`HS3$L/HN0%R%ONZ>YT.HD(/_!*SPA0!;9R6LZ(.H&5(NC^_CL MHEFK<*@D(]WTLU<+4%"'(&JO((@T5AYF[Q"S5NE:95%[N2RJZ7B?P^(`D#4( M4TJ6>]9QJ/WE8TT$:*("M81:G6VHF40M,ZY6[:5YL`:0UBPA= M.,Y38))_YSFRM_RK1LY*MGW5Z$B/F@N)-BL;MYJZ2:H.2"O%+*3"C0OYWFCPB; MQ>6C&PVR1EJ7<9R.9<4Z#L=7F-]91LC_HF$RY+P?3_QPRIA2`4^@Z-?;[O_D M**@/X#U#9TFBZXO.N_Z(#5*??&P$SBCT08.)_Y,JT0-CHO_.SIO+A9'UA9=1 M^">%*"Z*7I)CWPS5D?FX.*P<]";B0QY4Y:0%H4(4G\SS]GJ8%/&8(5>I+:SX M6%=P/K?GNJJV4S1B`XZ^9]:LV*8C;;FW#)16F!8TY/;:RO)2,\FV"GU)Q9L# M4$1_G\(#."@W<(OQ`M>W/J=(DG52P#.@#(>:`I:)5E[V7@-STZ:M`E6S+ITC MXZ#FX7.0+":L*87>8A8X!A-J"A\H1^/*TH(Z`$<*FF'J%\O4I):XB:;4J4:W M:`KB\I@;PS^'R#]O6=\=ZWHD*LQM://ET6;6_<%L_LO;_*\\JQEMD*\U%4]7 MF"WM^QI#^!X3T@W_O$3^67!V:@*AFY"%=<5HC;VDTCVD&EG!0E.B>0,7I MI&+6>.R"ZA55E!C!@2CB$4M?G(R$F'%$K*G#XRQAT,4N-<._NV.1S48+[J>8 M:)UV+O9,0M1,M7L03F_B_I]#\D[GPKZH.8W/4+VA>KVH/JNSVERB@QC*UXZ@ M#.4_[R94=U:HH7E#\WK1O)'VAO)?)N4[G3.[;;3[Y]B4MV5_4PWNGZBI=[/A M+$I>+)C=)8B9Y>TL\\V5W'#KAVU7YCAN.7%YJ>5RO43FKU@6=*M<,2;PX!5];\%8DKP,U`1I:-K1\2%<]0\^&G@_# M7&=NFH"5U&Y[12FW'928.J>UFJZN6)]EB M(S1U_HH.;3)6<3>=V0JF\KPMVQ=9=S$)L>HK=HS`'@$PV756O^;T*;0]6QCN MR95M\KH[0'5`<;;U&^^E2`T>+@?8!C-.,,[]@5GO>?>(F;(Z_%7QXF4P*+XF MWGIFD3DL558L,[?:M#M=X#KEX;I.]WR_UK=>2;YNN[EG^[=>+;UFDY>8>_(" MO]Q]BZU[9%,0&<=>8,58J2%^=?*%P2L>U1CC=<46UA-[N[P\U]MR>2XN**X# MF">EDGHWV//EZ\@-1`FSWTAZ7`>WO('7>L7:YP,_Z@ MF`%L*`#Z*7;\HXVQL`VM-72]2';M'%JP;?]9W+YQ$X[TUNG9#N3>TI4;&IA+`\\^_,HTX'1.6SN0N88& MGD,#SY3U%330UIH&:+H3WAM6A=]Q$O)6)_^LITJR'VF3Z,3KO3+KHP*F>I"]CU/(*=BTYS+6!KYY"L M"N=.^"*;O;XK4+.S'-^;68,FN[;3`VXC&[K9(VY7!!!;#RS6T.OP.T&U/5?< MV?E9ZV(;EJCBPE;8C/H8I-Y-V+(!:!N(WX+0VN*>Z&>4>>H>RG9P51[4-1K& M/07D2OOR;U$8S]K+%GNLYW>*JQWM\]>P9QA>[)]X(H:;C>YFSN8#0O/36AXN M1G/7,6C>2*/.Q6B&&WAS$_%?*Z"9=VOBF+4FU%IJCF]TS8.5MZFJME->!WB4 M(Y@9JE8XS68G;:>$)9IU5XOCG+:9Q75/9QBMN+:L\VI,S,!7]Q#Z0!L^ MWO)PH:,T&$1LD(SJYYFJ'JN<]>`,6#*RIQ_R!#KLB"4="MJ7-V)"ZNNJ*]GT#-B^T M=K4!XH[M/KB>3YE9PS`2T52JZG7KNP%6>6K58`LD7\#-D$-R*0'Y$$:DP,PY M;A&@S^Z8(QS_0.!6MIX$#?@+EV3_*E:UL%LQ^:/8K$=G9UL1^GZ;5N/Y4C;/+PVGGNKVL$] M?=,1LRONW,SEU#EM;^)L>69L[(O:Q@TP8,4V-C=Q@33;N)D\EJ=NX\5IL[W[ M;10Z&\M=(,^M@\7O5\%VN]EJ%BS$ M3\^,)T24M4-6`>?,#;]M-0]L7BUK=99J[7J:K,YBW%: MHBC$?\H@F,LDB;Q>RHN0)"'7J"O4DJF\\2[/CSSNE\@8S`V\)7#+` M+P&WU6XTVRN#6V+(>`:H(GGGU3>6$L6O5:5L5J[N4JY\4E789WYMF_TJ4%-/ ME9>*]IL"HG:GNA(-5ENQSJURW;3M%::I`+EJCV?+U>+,C$R6\NG#7'?AC'KRP,DAVA M2F;!=UDB)\@@[X%7//$]MT>V_++,^19$#!#S;S;`\3[":#?!N^R]I4$)RZKQ MG#MG!?&X9+H=+VZ]2C4G[?,]6MMZ0=,@D+I[M+CUPM>==NMI._`FCK+ZA\5\:81N=``4.AZR?T)GACL,4IP"0PB@1 MA\G`B_O`6?`7S(Q/54(ECQVWCZD6;C`%_C.85BR%KHZ$7*]=E MS]L`9-]/41N$H0!JF-4G7(JS5K7#`+KSM7AJU'WIJ5C))''Q-LGG"<>@Z[L_ M<%9"U*R(\>@WN*C=6R&&8<)Z_F"XB!+8*+1&H)V&$6I,<)I/,"(EZ#,:.$0Y M!CV%*2>-OAM%M*6>\*6D918"DWW:0DN3E7`'&$ MC[!+,Y73?I>/7,HGWHFBAE_='Y<(W14-=QU<$F$_4ZUH.HUB";5UY]_A2M<[ MJKI[O=)UM"E2%/=TI>OI5MWFIE8Z4]-%6J7RM$&2*7UQ?/AI.3ZTA(F2@;;@ M&59R$=_BF)?!X)T8<:V==\KXZ#C-1JN`D*>!H3U:5C?E<;24LRP/%"T+)6(% M6IRS\Y>`EH5'8@5:.F?-3:+E.NBCXL*L=TQ\N`ZL6U21O8$LH(HID_TT4@VL M#Z/^&_FJ?/,Z$.^)U_*WGBE)6V1\A36O-^N.U[B>!E#SZJ[67]K51M;5ZEZL MO'57.U[9>E39;C2?O#(1M78SM&Y!(T?%_^8Q8`-U$9*1Q0/T^RJ^EK8*Y_7G M#[@%',BJ$3.(1&8>7DKX;:4?PA5G`/<;/YQ0P%W"W+$U76DUNG\3]\`>N/KI`2W'H# MTK[@NC?A&"C2C/*`W)0GH;O;E30Q.Z*";G[B<$B***1?^`M/@^"L(_&E#)5; MMP(7KNMX%!&$WMCZD-W)K\G,P?7H?Z(MVB)C]/]3`%Z]G;RLOZ^32VKUQ M;#6$ZVPS*QB9TFP]L+D#%&^#%:QH(]"[K!YC@3#``*Q,F)S2H6`%BGQ>/CQB>K&1%<[&0FBT$(9IZ`M9G<>Q&4YK?Y>:J;'$X MU+'WBIMMJE&B(`(>#B=,UJ?#\?"]9(21G@A'X`7,&@/4(XQ5`H$7S_53T?-X M$/\,\Z\#`.YFQ$;P'!G/,)%O@X`LAJ3G^K3?\8B1-2N9-QXLZ]3ZK_`1#IO(GC6Z/HT?!B%::X7UE!%Y>HKTI0U` M:ZXD_P$&PN.\:9#0R0&DVO`-5E+&G#"94ZE*%5_9TA882=<^TY0@1&)CV(R/J/3% M@IS@"HG*GC`K`_8*BD;V$G_G5KSRA=X0ZN)SW7J=3#%=:;9\0<$)M_I'X=3U MDRFWO1?UTIO@-WSD"W_BDC^PBIY2$Q$]= ML0Q8?\*2Y:O/77-[W27+B97<9!`I02(\GNN#"^_BZ MO.\HS)R_N=YZ.S,Z=I,O=KU)L[5^9:#!P*H03Y';+VP<_G8SE+^L<#_JB.M1 M\<5LKLL@0&>@I&W`K7S$MKZ`:$8IK,[/GQ>/WP3R8?GH!D131BI+IE))@R.# M&\9+NTX_;<1DS[TP$KKBT+DA,4N(GW-!D@_H=`DZB*YS6@7U=?4-ZIO3@$[2 MY9X%\A4NHZJ!@OO*'R4[JH;\`45!E[3]!6K^,$277/Q&W[:1-4Z_LA#8%KOW M0YPV0"UQ0YUHFY,?%EU?MF8A6M3@%#4&%G%0;D"N>&B3Y(I#G13P#"C#H::` M98*L2^?(.*AY^!PD,W@TI5!>&6FB+6OSDE":`D=> M;,/4+Y:I22UQ$TVI4S5L:@HB&E4-_[P\_GG+^NY8UR-186Y#FR^/-K.4:[/Y M+V_ST4@-]UWT\;W65#Q=H6_3]S6&D/J[&?YYB?RSX.S4!$(1T)$95P^02O>0 M:F1#2$V)!LL#+2`4Q4=1L!1O@EJ$/?K\;["O;O_[?12FP>!$`M[O,S8F6V<-7F+]>.3O?AZ09;-P5)X&[6&WC-DGH):KF-VV[ZUS8C597`WFWSK[5 MBYIYLAAFC=-)Q:SQV`75*ZIP?.)`Y/WTO8"=C(287H,$/YAO)?!N4W[4ZC86C>T/P+HGDC[0WEOTS*=SIG=MMH]\^Q*6_+_J8: MW#^Y47^$_IG.JF9W"6)F>3O+?',E-]SZ8=ME)+81B168&]+_=F2YM,9N=.\% M)_C'&^OLM(FST%,>9LG"=R?\2^[H#A/7WRI7M*NY8AD:ZV.%E7:QYNFUPT>% M0'\&1(:$MG$>`Q36($Q[/MLM=M8$;T7R.E`3H*%E0\N'=-4S]&SH^3#,=8:2 M#24;R6SH64_P]*'G79C6]I.6MVT*6E*WX0G5-30I,W$0=6+$@ZVN6@QGB^59 MU/DKRL?(6,7M`;1"<9@OHA4!-C/!LGUI9-UA2Y38NK9DD873I]!VL=#>3&VD MK*Q2'J)N89%!JM8HGU9J+F7-3GR0:G_;!AE3Z_7`U:\)OJ67B&1 MWPS%ES?1%]Q;WKF4H+J6LXC.I;_FQG:.A;E@<X\^O\<$C\7P"X/]R!*NDNC=' M-'AY>/&H[_:8_\O1!_'MR77"QB?.T1H3RP&+DT5$(5S4<^!A5$EH"6,('G`]W]_ MC6#`A_\?4$L#!!0````(`":(:D4$J1"CFPH``-V%```4`!P`=FAC+3(P,30P M.3,P7V-A;"YX;6Q55`D``ZWMW?.*>] M0>^D-W"NR'Q%T=N4.\.SLY^M"/V`]9^3[ M3DC.'`H9I`OH];I=V;N/\+=S^6,,&'2$U)B=+QFZZ$PYGY_W^^_O[[WWTQZA M;_V3P6#8__WA_L6=PAGH(LPXP"[L.(+^G(5?WA,7\%#EK>;+,?4C!J?]35]: M"OFI&Y%UY5?=X4GW=-A;,J^C1)2/#3J)R)<9>J63L-Y9/WRZ(16,4`'KC=K" M>HZSMA\E/GR&$T?^_OI\MVF]0!1#ONRY9-:7S_HOP6P&Z.IQ\H+>,)H@%V`N MG$0"S`4RGHB/7`39->0`^4Q(%'+GJSF\Z#`TF_LP^FY*X>2BLYBZ7>GXP=GI M0%KGAXK\^W5TN"+8@YA!3_S!!$=/`O>%BY\SB#E[G%P!-KWUR3O[BD'@(?&T MAB:U>MF3/F0VIW`J:-`"WA.V9[T*>MN/?H]S&7QDF-FK8KG=-*?1)?#EL'R9 M0LB;5T3'?5M^%_ANX(HU#&L3P,9A;!,YZ0V`>5^:H@]]SJ)O0N-T!T,5@']07_]QC\`8^8B+>#+" MPM'$_38EOB?2SLV?`>*KJ$\?C*%_T3$EYXA+RY23]RU0_"J@5(!;KVJ*(*O< MAJ`U=51Z8$]@!<8^%-86W]``>J5ZUFBI#%"I9=(R6X-L1)-&`M2-^A%_)D98 M-HTKBCZ3&5-RZXK1-(O:3RB9%3J2[*+^E@[G3I;:X<2IQ)Q0,3`N.B>RRGR' MLLQ3)6>;H)+"WHF2=P9?P;(`0L5T,6!T=!;#PT@U,S#H6"G7_VB/ZZ\A10NA MCBA>R@*(":FR4C&IK1BHH*`!#(JY*20,;4+"!`KAO&>X@#B`.@P4$6V\GT]D MK]\-E#+R>#X?Y>O3$E^W9)#B^HX8%$@ZT^1REH;Z&%FQM$@N+8NM*H1%6@IF MTDW0>^132!,SUW6RDO/7+Y`_3D36RJ;^.JWC@J!:Z_9&1O%8V,T,B8&2/S0J M=V!?(GF6ZU48>C>`8H3?V)9*(D(B%Z63BGD#94>3!K8BJ+*R!J`QX6E??!UY M'I):`?\)(%$N7X$YXL!/!YYBJBC`Z*ALA8&96B8!0\?(L.HXH,.?J"J00DW^ M#_P`IIQ=0*$LDDMAJY/+U3%P<"X3Y=R?['&N2%0S@K6>U3U6=L@^MM6G)8H8 M.#3+P7!9P-8)0FD=7'F"D,?1OD(G-=_[0K!K,FG.TN7/F[?I/@803!6MC(<" MQO:EN1%CD+-T&9/X,JI:U))^2^@+\.$+%+@( MH70-QSS^I-&P7NO(!E5;MS>&\UU)=K5`8A@G^@@+TZJ\[9NAB-)K+HKJF^5< MOM[-!U$A35RTYM%8"`@3;8K=KN%@7YB6.U)$PI&_9*)9"(ABSD;\"E"Z$K/H MW"JV2INHM#5K8R$8ZFA;#`Y#CH:EWN&-E(B=!?DQQPIA2$PVL:^B?:)D#BE? M/?ER)QKVI)/F^6DF_!71&J33RLHI7%Q,0?;4YQV"E-&EIOH[)C` MY'G92!FMAW6M2Z;QG_IIW>_%Y\/M2"O;W=<6!)4L^$V9-#UUTCY7?LIYWMX[ M0^@+GF_K'>*^W`?DS1!&C--P)X"2,/T>L5*CZ-VB8:/V!I[>;Z2FSHD1F6$? M+AP9LK4O$#]#!H5597ET#1?0)V'6R`>,$>WF75DAK:7PJ*)A.2I*N-E7AXEB M(7[7FW)^[C-EBM2SUN2/A;@5OA9)2'@D$$Z)T\XEG!`*M_;(/2!,*.*K.\PA MA4S63DDNZ]7`!\BG1#Q9")(PEZ6LTT+/RO8'[;DUSV[&EQ:?!13IA*W'ZB$# M41N0(29V2@2V`THI0V:N="I0#NP)E%\QABLBVF2B?*+O#J]&UFH3ICH!#:V[0'ELC&<*+74-.=23(DGF:V7)52)TC:'REHXEFED M`IT<'GGCLFOI$E_!R>06]XBE-S-'&YG%)S_PPE/O-`00YQ2-`RY?(+\2N(=:L]R/:W'AD&-_7XXFQ?HG8D;#,LBHD^K;OLE6 MC6,C-0Y)U#D@8H$1;D4I@=[P^N6NNWJE`#/@AO['7OAI#9UH/C*BB`D`7`=4 M(D5,38A7T89[Z+'$!8WVV.+*"ZU=3T_NH?YJY+RE M53/`[)U;=FVV7`\!864Q=AB\ANO?1GLNBYL6;KW4-6US0B9%?*)D@83W+U=? MF;P^9/,*9B22]6*]5SIG%2L[@VN`63SEVXE9#9-F+O@27_R1=M8=-MF:7;%5 MO-AEUJK5Q:\F?$SJFBB]>K:#,&JYS4R(*/8.=>MO_ZRFM`DFX\63W2&3OU8R MM&A:<@U%'>&B4&3QMP_5A<DU7)7^'W*;A4:;(Y,FC2Y!C`5<,X#6/.3`(% MQ9_M06(VO)I<5U>:2ZLPT:96,R;'@-]&#+CWQ&LFDWUO.[_3?4#-P7.'K3V[ MX]!TM\ZI177?RQ10>`G"Z?=,EJEY&;V8*-K)KR$Z!E@9&:!A-.GZ5"#ZI8FH M56N6JCU=5;VAX5S5CA-8AYNNFIWEVO^,->=4V)E%L2LK?NJ"C5)\:NBUL,S0 M'R<:B\VR=Q!FNK?OFBCMR`DWX)G&Q01Q62Q4Q,>)N`*#'"KFJ;ZC28%VMQ'HITLX3412Q^HQA?WF!&']_@4$9O77BM"@%2W2PF$=90#'5W M1%GW]IU;WA;Z-T`ID`=KU_*FQZH):0[@LJ3'AK428^P19MF>+;RLON$D7B\W M[".)&TMBWX*K1J/UH9B&DGA%9L5)W)B9%9%47I@G`/8`N-PZMGJ@76/BIA8TE*)L`'W'Y=[9\WVW=#MMJV)-^2 M9H[25FQ5>B-VJE7+]YW?`D3#FV;C_]V>UK^,+G$/>BY=BQ=>5G0>,=26F M63_QQ;>Y_.T[4);6:WWIPY9V\7]7^DS#<_71[A6Y>AD.+ZG0R%(EL>?BBDI*E]T8IZ M('^,1-D[=K)EN9R)C6VID;V.GG:HDAHQ#)%S`*D/-I?'X`B M)1ZX2`(BJ-&+#['9!_IKG(WF+[^^+H+!$B#LP_#RZ.SX]&@`0A=Z?OA\>13C MH8-=WS_Z]5]___N M'VX'%\>GQ^?'IX-K^+)"_O,\&IR]?_]N,!R/'\8^+8XB>3\Y/3\]._OOI8>+.P<(9^B&.G-`%1P-"_P$G/SY`UXD2 MDW.OOTY1D#&X.-G(XE+0_PTSLB']:7AV/KPX.W[%WE&J(GVL("0C?ZW0IS:1 MUGM_DCS=D!)&OH!USNR$/CK;$.<)WR7_\Z(CTLB#P;J9$0S`$Y@-Z-]?G^XW M[RU]%(+H]=B%BQ/Z[&023S'X(P9A=+LD?^`;$#E^@(G(A$^T>@&71]A?O`0@ M^VV.P.SR:#EWAQ0)I^\O3FES_<3E=-)$KP<_\I\3!S?7B,&CD2[?'(2<5FU3 MX=!(CTD$W>]7!&O>-5R\@!"W;!\)OT8Z$DX+/UJT@Q*+22-M[DE'N`!?G%?0 M0AL6DV;^BQ<+!ZW&LXG_'/HSWR60(/TFC,.(=-:/,/!=OXVB-?DWLN$JQGX( M,.&"7>2_4,",0H^`R,?CV2/M\<.H)2SKBV@5U5^<:0#:!'7&P"`F&NM8C[U! M"[*_C=FP%=#0BN+HI6$`;#WRM1KR6D9%BWC0.KII&];:CV?M!K+V(UB[H';MX/E=`'_@KZ$3>SYY MV@B9#:08LH=$*0)S0N,OP0/$ANT22#-CW_B%KKCIVMJH84PQ^BRZ<@*Z%IW, M`8BV$AX=1*3/043B-]!EE9(HTY:9-::A_C?0C:F[28=S2_K):'4?SB!:-.W* MQ.SR&CK(S91,_YG7<[,;X8?1B>`J&FX;0J"^3>UYK`A(_]&F\/9#_%@2#UPB0_F33$5%UF_8,1D0V[NZZ MT$`P>IA5I]80O3M55*=!.]1(,N'4IDG#";PV^4U6/MJ$$&AW-6?/J:T"% M!;XV8>Q=#6WL>1LV&M$FVI7:,:@-@[OY;J=VN!@5TFZ'?,?-G>F0:)#I$$"W M(#B@I[D0,:=9R11KYN!I,L^*\?#9<5Y.Z$+F!`01SGY)EC;#T[/T^/:G].?? M[QP?_>8$,_\D/SF.\%F)+IVDO;$I&W`/?EIL[<5.%,07![I M8D?F:+1MV[,[Z;QA[\.7.,*C*8Z0XT:\]F)3E9NA3%6T;@O=$2K:2>;S&SWXSM0/ M2`,`_`DX-"?%&X=/P(T1(D83@L\P1-E_DZYN%$0`A:2?6P(9]LQ(*6-7MY1] MPKY1#QB+'=U:I[%W;D?L&0TYHY%V"+!*@/4JKO2&TT4?PBFQXFL(IS0GDBX. MDG&9/(:DX0(_F:Y?.X$;!\D_GV`0W$'TPT%>LPAK+Z]>T+61]W;B4)M7.@K- M-OJGT?IW.Z(U-8XVR#<_FE=LPD6C<+$)LE9:);QX$6I"1CDJ]MEQ'%,^T@P1,\K[D,WB#W@W8>W#@H)&7>C9E=R6T9F`[EO.%K; M>LF6"&Y@1QK5_]BGJ)Z`B+BED&9I)HP9@LS$;4'0(5#5_6!Y9!843T/QGYV& MXCB:`Y2;MF\,WE[O*\54C3=2IRB]L0*BS> M_A$G??5&9]>-%W13`GBD'6BV$P).0(V@,ZTK,(.()L5(L-J2*P?+C;GN(=;U MM+#I6&BL97;V>MK38*%+$OW!PN3:.EA*7-]TL(A:V)Y@*6F9!4NWF0KK(V#Y MG%I*EP&:3[V@X\O-8-3MH3O-;AZ%'OV+!L22!$:H`JO:[Z4-7..] M/8!=TU;2#<,:>F2P[/;PFC_+5UZV*:_4]@)IRNVPN_78%DO='JU>!P[&XUF: M`3U&3[0*U.TK0*Z/P2/R7;!YB-.G^*S9>I-P#N*BWA.%T]Z+D#%#=GM/DLXKCQ=J&V]<7X)*5\&^0)DS1\R41 MOI1?9&2FRU[<)_35;2>3^>,R13)L=GN6L[5ZQ;([NV4.HO\`$!/N%[I91`F]7 ML*!@;!X;5=95)+!96C&],(",RL3>(FRPUCEMP2%E6#3YX?=/<10[P5T<>ICI%.[SU"+&\UZX M2&97?4\Q.-H1;Q"]0/J!N!LPC;8Y1NP05*'-HE),VPL4U+&W0>R*N5LQ<_\4 MA[[KOSC!%>1W`7R232_`(ND%!!2L:](7L)A:42[EZ^0+2M:=*TE?("=,FT=$ MV`L(*%M:'P@BUBUK>3"'\PE`1,)]EG['=*R0)DMZ8]/TPITJ]M7W)(>K%:4; M;L`,(`2\)[`$80Q&5,7G9%_I@5/SML8;:8LIO6%-"[!+&4JH.)9V75RPCJ^@ MJI'Y`%`00".`R]C$NN0+0`OZ38.0Y4?VP]2R\L-^>$UH4@-GE?FU7(HP?91Q M'RUH8F9E*<%ZN%D[%!_VPT="DQKXJ,ROY8*`Z:-1&))5Z:.SHM+'82;R";C` M7X)R)4I%ZNQBD(RZ'VZM9W0#/TL%6+$P>((K)XA6J2TE8+`?IDU2?M@/MPM- M:N#E,C\K2O65=!?/A\3SH+[X56Q4^WF/I7-^STNLDDWTRV2<.>^6K)=.YYFI M8=:[Y6Q%J;"2>IN_7/@48)1]UE MQB$3X^^&/Y'<];=+TP^&A\^T-.*U@]!JMOZ:#O?SI#7>R$I[J[S177%SKG;* MABO;VUDUR:5(+051%QM;VA`CV])J#93B9M9%?S:S-C.(41S- M(?+)_)1UR4U$M+F[PB;J=*-*%1)0T4@UT.2NN;%Y6C$\595C;AK(R+CN[WZ# M2>)2IM.E&TELIFQO6[5AU-+?C,MJ'7N"(B M^$^,?.SY+O.6)$UT'-$Y'F]32Q_#?)7FE@R[ M+4K=1/G/,8V,\2QYBM.8JF;]&./?MO'Y_#OJ_33B$IIO]WS/VE[S3=%NO1K; M,9)KLBOWR8:/]!Z8H4#CB=$<;U4QA[!3]X*]T5=5W(HE5F/SQNNZR(DM^#Y\ M!,B'ZT^-Z8H_N82VH2>2\+:C3KGM+0HXDZRXQ=?8:M$7+F[\I>^!T&-\R61G M\MK&MKJ\MQW-#?UB4?RJ6V#%%4VM=I:Z*>%'B'8OV$0,2P0?@KF-IRR/:HDI M5MS3U6KPDX^_WR$`DN,S@%F?KMN9/!/!S)9WB.$&?K$\=-D66'&E.C%B*K=S M6F?B0>OQE#^-:UY0/D8-"=J?X-R%)PQ%I2'5K;BRWKB9Z/?:H]5]B",4)R?W MXV@.T)>Y$S)7^+K&T89BVPZGM<7N3^#NWDL6#:ZU#49`P!QZ[9>@4*,3E?J'>2]G%8,67]B*B&K60 M?KBKJI%AL=NTI-O%2P!7(,M_9NO\&28%JDEHK6_-P,@)\L^O(8X^P^A_(.*6 M_3(N)_6G03E[$22[\H/^N#*H>1:*W28G&3-P/3S>093^1.G*.T'="#<=M!SA MATANZ[$>A3?'G"SF.TZ2HILFC,0,5C'(8[#]>55IN MQ]CEJ)3AN*?I+-+]AM^2L6?GV_5LL<;WYU0JHMYVQ-;WAD51JJ1\%ID=9ZNX<^#%`4@O?XFLQ3QS M606QM//-8DX?WYT6V=(<5H9:UT`,Z=,T"YB?^U/WZS%PPL_.@E6NGO4H]4+Q M4:>5O?0##0I-+P!0EVR*PZ),*RZ59RHQZT.Q'Y8`TGWM+Z8KH43]O)/S#/)^ MLJJF5PU/5>I;=>0K5M4N-6<)*W2)W:6A&A>SS#:50GZ\8-9-8C_,M7[^84>3 M:DXX0(GVK);?%CPJOVI%J*Q[7?876IC/LF2'XK/]&_1$QAL;]4I"^U'&@6O6 MUIK0$W;))D6HKOT;B>AN(&?#4V4%W[XM\_`OZ*&T"&\DWXJ^LJ>14)D@]#H6 M6!.EG0:#<+ZUDW"PIHCJ)HU@>T+%G/))Z\TQ#K0\&\MVXK)"].*['3YD0R,8/-PHWHY;;P5#Q%6Y3SZB=": M;:,!EW*)5DQX#&1*C.,(1T[H^>'S.CC-Y_EP19K+]V&(M#XT.FCY>I&T&P7[ M7:?UD"YK8[KL#H)07RJLP4!LFN;:T^*IARS7/0RT=AFLG8QRU>S4GEX&X9MX M!]$,^%%,OW,0>MLOSVK[%$`+T>8"3B#Z+0:@JB=O_'IK(>=JHWU,"+@:D7Q2J8%K/Q^.:%H@ZB+#/R6>S^R=/F& M&SS%W/8>I;;O0Z*?@J-K9.[QN?%3\0X)2(=4O$,JWB$2#JEXAU0\JU+Q#BDL M_4MAL?!$FC$YE-*)%@Z]F32J6JD^@11PM*+'8.K''`D5*$48Z'Z&)G7-1<"5LVCM("@,@S;``/6Y*0M#H3SC:9(,'4)=OQF\.N&L([2T5]($R>UQN3:3)JIH%>.9-XBL$?,9GF MW"Z!!:FO)7TJ^X$9L"5D&;:Y9(?"@+TH#"ASL_9R?QR!;8OX=;N94C2*61Y( M0,*.I4Z*]JC`06Z)LL.9K/)C>3^.!LIVL`\))%0<%-AQ<"!T.@,4"M?^&1Q9 MF+#L`*&J'7OO4T;']W;WJSV9,]G^EJ[T.&PY3K=JE=?:[=5]Z\X=SUK?M?&\ M<&W7Q/?6;`V7-&0O!$4T;)]WO64L#>&JM^7[OSRF#$];M9F[#Z?[LD%:N2(/ M9V@^%-;'$=WBE"^CO]8TK$DU_^#U!+ M`P04````"``FB&I%^NN6/S!5``#[V`0`%``<`'9H8RTR,#$T,#DS,%]L86(N M>&UL550)``.G-6%4IS5A5'5X"P`!!"4.```$.0$``.U]:W/<.);E]XW8_X"M MF8BV(R274YZ9C:J8SHFT)%=K1Y:TEMRU'8Z)"2H)I3C%)')(IFSUKU\`?)-X MD@"!E/VANV3R/I#$.1<7[W_]MV_;&#S!-(M0\N>?%F_>_@1@LD9AE&S^_-,^ M.PZR=13]]&_+__D__O5_'1__!A.8!CD,P?TS.(NR=8RR?0K!+8KW.;:0@9M/ MUQ\N+L_!NS=OWYR\>0M.T>XYC3:/.5C\\LL_@V-P\G;Q3^#N$6TSE(!/<)]C MWV"U7L-XG[T!JS@&5#P#*O7-U_?O4'IYN>3MV\7/_^_CY>WZT>X#8ZC),N#9`U_`EC^ MUXP^O$3K(*<_N:7^[3Z-*P/O?JY]<27(OXXKL6/RZ'AQ9;%OY4%I&\ M5G!2B7\;R)>_"7^]7WZF;VM1;"@2F*Y_-OYZ`!3?+T4Q_`0?`/GOYT\77.U? M?B82/R0?__%,6;7)Z']@O==F2K\;1ZD,T!EZ&SZ#[!?:D918_+H$O_5\0N_Y3`)85AY M)K8%L9.ZIL&66JYMHW7':DQ:$90R?PXUF,'UFPUZ^CF$T<^DX2-_'),_CM\N MRH;B'_"C_UQM<>GP__(/<;"IS-%?\N>?F._R*"<_H/?NYVYIB7ZGO+A)1?MT M#7L>!B7XS_@^UOI2G8HNBL8SNHVQ6Y)(]Q>[O+CSN]Y2-&65PM(\O'*;T'M_0HZ8B!' M@*/[\SR@.]VG*?&+T[@@_AL,4AR\SC"K>NB0B96_D2\V`94\HZ8`*K'/PZI0 M;5F^!<5K0-X#+`"(A%L02ZL2J7_V+K1Y&A7*Q19G`OP96N\)T^JFFH%VH4SY MFSDR$W#.M&@*Y"+C/(3S=9;5*U"\\P3:XGI#BI^Y"VJF>(5H@:V9X'R>X.(^ M_P[C^-\3]#6YA0'N4L/P(LOV,.V!3$FV_/42V0DP%UHV!7<5)SS8RW67A0@@ M,L=_$"%028%"S"T/U"H::=9'EQ="M8H?"K9GYQ&0"=.R9Q3W+M!CN M0XT*Y?0-J%[Y@&UV52&E;\M"X"V"&G5EQ>[._CZ/UAQ@%.1.UC/<=S';> M3T9LRYI9O`X-B]':EZ^P6CP'](4/2&55#U+XHBR4MD2[&!W8F!6AG^`FRO(T M2/*K8-N'CDBD@].^R&2H=@V:12O3MABP#)4*L\TK0-[Y`%M.A2&U#\P";U>Z MBU^6I7D39YRBI$%\D83PV[]#=GK`D>FFRGV9Z3ERUZ+AY)AI7)(5,W3J=+AX M!^A+@-_Z`&5>O2'%S\S,?+OBO92796M>.*/M%B6W.5K_-V.9ETT8LK6;BJ#TQ M2M_[,77$JT.D_,'9TT<]A?X$$M.>$Y`74UERF#/DF$#OR!F#>LNJ';`/':C! MO:\W`'PY8>H=Y%GUR00]Y].+8-]280-_8'-FZ-]ALQRTMU_U`%Z\,H!I8L@T MC%LV9_:9\>;(-@5<(-Q MGE5/^K@K'__GZFN0AJ0,`%.@[PZ=ZS7:)V0*YP;%T3J"V>J>C-FL^\/2 M'3S"]1_VM)DPZ:GA7X*>RM66E`':%!@B2$`2%#H@; M)2\XJ@6D(6EU:YC)8A4C#%JK^YX7S0O#S8J.7X-`7K20?--"87KAMO$C!+I(UVL*[X)N@J1++-0T33VXZ<=F6#2=_0B<22@ITE\5S MD`??ZG;#\4R:O$Z1YNMTN.*R*Y+8NRW^YCL/+S.'V%ZBK:[%#[")(N> M8%':2Y1E5S"_?L#%'M)EC'9#(CWMZ=32\:=+N'RXG7C`NA'^)5S4MKAL*0%$ MM,"ZK09BK.&D547Q\!K$U&*K#^]PA[?DXX(^Z=YH9A&)X+X)HAP"WT:[*(\B/M-G5BJ M:M)X4E-IS;9K-"<4NA"25*"Y;%Z"'7X+H@2LB_>.R2:I3Z3U\7O<82MT."*R MZ9`*_[7/XB\XQ-0Y# MNHSP?8"+2U(KG%?1@]_.OY$_^_%'3ZF*H(I*4V.BDAL;LRTZCH7A2]W0DJX` M/29'XX6TQUT)`5A(.8XR>CA!4VJQ%PF4]#ORBIK1'F`=GHK98T[; MK)`8C>"2'H()`OK$,;*[7QR)OEN3;P8CF8"+Z/!4L>\(T!10T5:IY2_%``)`^84 M!+D/J^4T/V\T5"33":<#&2/4Z%DU.J`H<"`G!$NO/H:T2-9<#\L)JVZ`?,&7 M9H&^)SX$/-.>8ZP+02Y$MV%8C\6S8EJ@C>;>R/3M[?G=K0_HE<-6%:]\H`H1 M.KUZ#;?B?=-Z=5NWU_YL:QA1S\+66*VBO6EW1>VMJ)TUV[Y:&NG06+0YD"_' M/=:=)M4'K(H69_*^J:`%Y;:H6!2*5^G8:A MIR"*R;KX#RB]#6)X_M_[*'^^A9AQQ:1BLTKJMQ1EV>D,P&/2V;EX"\=;Z+RS"$D57\ M]$*/&0>=H&6RS/[PSUQ#:+9,,[&.-+Z5M6/\_#C#]D!A$#06C]KK;`$U"GIT M/0+WU+`'ZY,/@KB\I,%KYOJ4J#0_0))[#`4YZ41;T'"$:DS;6"8D#(\6X/@9(/D5?]4;DMR!*S'<3F58G=Q-[5IVEJ9URF)\=,%HN.YGJT%.[ M?TC>>A8SID+72);)Q8VI)+/CP$R2R2BS/[SSH'O(+--,I#/3/21F7T+W<$[B M&N\>SL%#B38]+6G'L:=E+?'O^#$_;:?E=URO8&BI MM14.D(=^A0D9,I0Z"-QJ4^TL=`RH]1P8/N>#Y0R=4Z9/0YB4=5MQPU>I4,B" M]T$6>9:8V@&N=C?7!'+];%_.X'W>_(NSH&.JH3@XN.,^.C M/R.@P*M^`5V'Y[G5Q)EOV2(_*IG_`QI[;V#$*5VAZ?7=C@XZ5 M=BS0]SXSO(TEWV,>!=-^Z4D+%T1%F4@,=*VU,SXN%D4L=O_I-"\M. MTZ0<0E+$PX:TO1!4G4H[T5.7-Q!,?W.!4BOCV=&F[#8/TMP(,L=E/4Q#?&R2 M!2&;*$G(``!Z`,5O>.F`UC$82^$_8@@QQ4&L4A3"\=I>_F1ND[[Q)T^8%XVGK" M1-W&@7G*GF9+V,<=J:=GZ[`2=\4#U$95I0I[)>>K:?J=$["6AR]'GNBG:4S4 M['AXZ-]\&-;*Z4V"V.DX91QDV?7#[[AY#)+\.OT4;1[S]A7M5=,CDZN:&K[< M5*;R+!L=XY0X$?)0J+LLGV?@_IFB.WZ19,SM`VB1(4H74D152I)&V0I;%NG2\>--F%:VLO;]2,,]S$DG?6O M(OH42CX2J%?S,@H-JTB!1(62E$9MVWX1Z?P;3-=1!F_2:`WKEUGY-ENH4$S5 MAHA\X MU:.WN_R@B!@8OG#$N^[=U9XL4KA^:*U.#^*8W$C7+[]*PZMO3=0$ZUBS$7K4 M_1L_S<-,>;2#D::'Y74:;2)RO6ZA2'+SNFM[D65[&-+`1(-1YF,T&@%865P: MAQJ%`*5N6!JJ=,OHGEWFAEO-E,4RME&T]#WYQZ8[L%57A44=0Q*%2T`9_ MJ&GKW&E[T>9-H]SB#'WH(UVZE2JCRN#S*]"$ZD@ITK+LCAYHNXV*(QF:Z5#> M9F,UX8HF$N&I5!&:M[&P1<6AD#ER`\N6C&/BJ%4U&E,A/0()]3HD4O!@'57F MND-*KJ8!:M%!5&LU"8[.6`Y00=#T,@U!SVC]H2D>6MR"ZKQPF9%=Y M4UK.M7RC=(ZE4HE\5R,QQ2 MJ_KWD>+JA%:GKTVRSD3-:40,L^3:Z-8I8BCSQ@#4IN<]Q&WP3I M=7J;DW-VZ6+/&YC2^5H&>Q0U6BR2:AA@D\2':5:IN9.Q2\7*LIP^SXCD$=@% M*7BBBYV]G$G7P`<:78%#&DJ4^W14\N4#+9F[WCFOAX0SM)>]9]#\'#+;@2)Y MVEO1.4SYQ[=OWKY]NVA8`E;[_!&EY'377\'B[=NCM\7_R@E@LI/M%B.\."WA MW=LC0&J*-G%G<%T^7="G[XZJ^6/R%NWS+,=_X`#_*_CGQ=$__^]W1__TO_]% M:/:(:F+ADW?_.#,&W+S]\X)P,*E[7!#'-.*!1P;'9Y@&=<%\:)& M\6V!8OJF`MEAUK]@>$$'`*Z'$,KRT!8B*^J#'YE94L,`W94RA^^V74N9#\.% M(M8'FKVX'?FV'D=2JVST\ZJ`RX&V`H<*0YO^$*)I466D&$KRB-&6-$V.QK95 M@@S<:)&DI]TC2E"_]9@LC-H6$89=+1+2-$I"XO1M^T.>ZR9OE+&'(GDDODPS#%%=Q*J*5E9GEY?G9U?W9Z? M`?S7[?7EQ=GJ#O_C]@[_Y^/YU=TMN/Z`7WV\^73^%RQW\==S<'E]>PM>?4Z" M?1CE,'SMTZ2.,G[0Z`H>$%6FW..KFB\?:8O_%>]#>NQW2D\%S_,TNM_G9.G/ M';K"%8.2'%<2+M/F(LDA)I8&Q:=8EX>#<=;MA8XQY=$>VY,>YVVE?"/CTFB/ MRXY1$*/,_?26%9"KQ:RIR%*.;V,<*<;"\;_!/\::',6T4;:9Z;KH\[4P"UY= M8MZ^/@+DA'_T0.Z"/0*U#U`Z`6TO!$M=/Z!R](/_$W!ZR`'`[3`T1@0N%3U& MY%.4_7&:0IPAD[\&69!4LLYH!)*38QW7MMD.CK(.1XP!I5UB?OURE+AU)U>6 M*%4X&E$O?1X)U+I$DMIWQJ0S^`!3W!Y^@D\PV M<5N%O<.NF:?6ZJBPFSJ.BMD8P'1B,LW4\*?!=;Z9`;\].D!1HBFG'E5YVE)7(^K`GS=,#<.(C!+U-[W*Q#A\;,0,4[`R;+MKUW>D MP[:.ZO(F>"8UC_MG:Q@]N=Z)(:U/`6U8WU[,E$I#1(ZN58MPL=5;&C@9BQ5F M_Z>6>!FX4>NM:`/'I_X'>_VH1(H31TVM$^78M9F[J*\'%6DR>@R>+.B45:B` M$-*%FQP%$1O\6*#9*Y68`V+LF\:\+M85;R=F>]&`.QOF1^!]?EZ0NQ6K18R"^72K.U> M<=>-!K;;B@W"TRK"K8O78%'C1*UAU`**3UWA9N#SDG.HOH:&=.C_TMCQ^@H^YAGV[[L;-^C? MM2(<\O?H!'X=:"@-]C/K3G6H_Y)U(+^R+U\8238GJ.0R0SDV^]IR9CG76+:= MU`P\:9"LI\M(;1*4'/NP6L_[-&FX1QU)BJ.)N"#'&S!!PX4*;?+P7] M$K@A9]5J9$4\EQH<9)M87L(L^Q6LMFB/&1=L24Y$SM\*,B^7L/.AP">>L+J$ MM!MH"DC'\3(#\FRE4%QG4T''3*BJ!J`1?9G`4TNS)B//AZ2+G%2493#/R-&O M=-?C*H[15S)MQ@GX"AJ]F"_4,$0^@0]KO6&Y3Q46RJPLZ^<@J%Z`=9"F$6D" M-D&49#E(8-[L:\J#;[AM(";]H*<*8A@,5:Q2-D<%RBR:2GW-`U/CS82"/P,8 M;3<66!04LL5YV@5R:_&7C$A)LV$6DFX;CUT*UQ$M%/X[AK1T2;@J4E/Z?-!Z MJ*O4S8>*RF1BRIV8[;DK^Q,34]',LBU)#TP)6B*NV:B!"32^SOITE&MW^:CJ MS2$?T^@)%^0)7D;!?107-XAS9BWDHC7_1**3><T4JABI%\5?1KQM;KTD5GW@#:9^"`BN>"`,D-!8X3IF[9#%XX7-;(PE=M4 MN<"=EG3OP67""E7+I(JH$GA$Z>NP:<*V[(XD]?;UZP=RPA],LN)0,1B3\=%3 ME.49/:O\?9#!L-RZE7&99,9:1;>IUJ9R(JW`1NID1"DAOPL*0GW`,J M`=I&',<"0^!$5A#2BRK3#'="CXDRNF>2N;$3,V6Q3"(RYM(<[$+/]&OL@-(0 MH):.`+5U?$_Y5EGSZ)YU/XG'&\[QBGE.AX%4BW_?+CYOMZ<18[J)`$OO&9S/5_(EB@(H%>O;PF@Y`A\5C M>K-'ZYI@'Z_85D4&&E5]7>I*%-O<5/)A'X;&,FY%7Q,QB#/F2@I@L2(I/@(- M,$O9EP@Y3BYK%G,N<]%^\<0#NHK2G(AO>FA78M]D/JCF2H=HS)'>(<_\(I7" M4*]&I8@Y)1CT5?+ACE(/#W"=UW>YW`7?/N',[Q0E>93L<;&O<2L=L$Y`TU>L MB*:A.)5SRJZ,TD_7JY")>L:6M3Q=($;/L2UO7^](D9BW1TCE*KKRY::RDV?9*!DE3H3<$^J6 M(QK%"H=KHCMNJ<&3)^B-6P&7=M#'U8(93G977X,T MS.[(?9SM]V1,Y`KE?X,Y=]>,=3]]:IKW8XK:IDMF)318*J12:+'B>_DY29L- M"_1F=E#,"ZW;(Z_P&_G;==9NG2RLB&<3EYR(:=HE,^+:^5TO+V+?T+/K/J"T M?$3D%G.%<:%SV[&=X]S7@,\L[D&T`J*2.VD:^`5:_@ZCS2,9"PR><#=F`P$Q M3@Y7;*\C!\6!CR^TN1"3NLFR_ M+3I[YSAQ6N.?]E<4X]]"%H.3P8!>:-17+.M71W%BV%9W93+D:GL5A4M-8\OJ M'7BJ7WHX3#8"/&AJM7;#B[J-=FC0]>R>UA]A0-8_D(4-OT?YX^<$W66*5H9L?YLO7`DP!GCQ:L@&@5@)P`:MPG,^!:^F5>,]_8VA3[ MQ71'^L5/2^*`[M.'1Z#E`WS%3D#;"RC<@*X?^9#_O8DF:"I]#VU8Z9%PW2N&+H[VLGOC< MSQ)4,XOTXOK@D':HQ&0=S[9[UA1'E:R2L+7+NXP1X75#?RQPA<@,5"L:K.(< MI@G=^\K9&V+9"V-PQ:@7@R,Q!LME?"&YW7*J#O28]EQD2$_$.MEEEQ$E:A>0 M8T(>(9D]C3+R*J*CFC1[PGR#&Y0^>[.#Q3:#."-,EN#*'XXRZ)`W=F7\-_D; M'LQWHNR4T5%LZ'6?"@=5+RH$=!MNU3DB^PO:=JO>4LOTCV!A![PO*5IXT4-Z M_US_^9<(IAA1C\^7\`D# MG-FN"0Y6W%"N.DX4$.HS2:W@T3U%K?;"K':^/.MS>=[5FKV'9:UC%3>&_4N$ M[.<_<_61["4['O:(/.X(S=__L=7M:=E]27V?`Z*\K*=S`)SWHE^C.:>5<2:U MJ"U#2WV4?$Q[PF'K?4+;ZVIFP+ M75^XJ@4M27NL5./R9I9K1M9\2OR[CP'%4A+&("MMRGGG7(Y59Z^(55`WNY9- MZM#V&E;5`F@L0%,SN5R%_[4G6^3!&F7Y$=BDY+#D?9+"(*8GO-![7QG/R:'* M,*-3+@^\A:OWSR"+-DGT$*T#W*%@K%OU),+HHI:_L$P+2<(%8U)+@I5@BJ5P M0");*SV5G9MFD,[:3*H-OMS1SK0WEZ*X8H':NDGK-/!B1O#ZX4.4!+@''<2M M&^N*8WIY3:V*3K]]%>N8B@I,KLK]N>=G.>EQ^PAA_EN*]CL<2NI2W^8XFR&%/@V*X8[+*($7^!%_ MC?(T::ZNFP MX:VV'F>9O0Y[2BD]"%W/K!]`<*\?41! MDCW-WY4T.]7?MFUOTH'K2V/>?Z"]O&V-]5_GCS`%UX.U0Z^**''RVI/+2E1` MP%\4P*LMX<*`MI)@<<#0MEVDF1^9Y_N9`+/>>'LA=%0V/B`BA$F.PWEJ?&I7>"$.W=:2IJ*_#&V-`[&\766CP=K[J4?8+I/3)R MULGX=7G:=I?M(P\R,M,4@B!O#;MYPNU1D-,_J4![(9V.N1''#MA<4J?K>>Z# M0R8LKM,WK'D,B.?+[)RQ9=KQ'1;HXD7Z:N:`^=^"*+E$67:1K.-]",.+Y#Q( MR7YIRW?QR/W:N9I'Y->O^SKX);6]R<=FH6>\RT-2EB5Y3P)P"-/HJ3AD*:[W M_T:E$AEB2F!.MPUX$H=G(Z"]&SO4L&WU_@Y^$2Q>YR'[W>Y;%86F4#*A>AK$ MZWU787DJ6SO2 M.9R3J(-2_X"2]VD\&YGH3X;R^#[!*-=C^P\3?N5<8-#QPQ M1L\'5\ZUG/Z(1O/B_Z6'(Y=#'R1[/D5)CG\$3-;/-T%.#R9`^P0GT@_DM\'P M\PXE5WO&9-XXY;(Z=94GAFP]=Q:F%$850!111QA<%G^3+&M7B(,@CB$6C$GW MO%0">ZQ%-A^L=KN83LVOW[@-;'>XH2<#4=?I693M4!;$ MUP^7*-E<1D\P+):\%;N0>7/N4TR4'WV`OP:U.\].8].6J](KPYZ?.)H=#@CM.J8 M%_5.>,Z)JA*I#BL84D9(,;!KGA,\%W)*L#67I]=79^=7M^=G`/]U>WUY<;:Z MP_^XO?PV*`\\=>L_DV4C(F*6LVG.**`]BT<#3 M_&67Q[?Y2K,D0N">V@0Y,>=#^)N7;X.0.CN066%ZED(,0_^,O_VP@HZQL3\' MY?8HXBSJCLLK(OT:$-Z#QBUH_%9AJ;`&"G.@9>\(-'T@B/]U_@TG*R@-HX0< MP$&/ECHBMQSB>)/C:HF)^:K,/\*<`^I\CW'.ZV`2Q>>\(!3F6R2,#_\AP6=!68- M(<4M>[<+P54$K@A.XI'@D6M M!\91?:%P$78)QN)E^KV:`N/&;L:4^!B)E)-.*UN^!Z]*B=1F#:7;7^R*V'(^8I3#(X!DL_GN1 MW*1P%T0AC1##H*P@W(1EH?!T/@G,*X=FK817[E!"+)F!9?G$DYE)E6[+.I`W M'BMZ'@S/M"HYT^,_R\:R>@C2XJEWW.55O)"F@KJ1$;*G*N8>TX]'+"L7+B6; MTV`7Y4',7^*CJ)5CY)"8^V#GH+B[@C2WK:RTE]](ZL4 M-D+6JE2HC+X\&V(>BST[)'2]J)!>!54,CP[(*Q*JB!&S'C MN(K+ZATE%:(W;47E\N-R-OWU$3EMTS7'A+6+=.JBSQV6?)'CQ-NIV4\4-QV.G"IDB`ND[-;F#Y%:WCQZ99YOXJB=#N> MBJ1-\(-OWVR*H^)*RA>)A>4'&.(V-O;D1A75VN[S1JU*&/SA*PZ()//AD%#5 M]H4[[.HTR.$&I='?Z M'`"AC`DTMM;Z_)/I=BFHYLD3%C)W(?`$F"PSM/N@;](>BY1W'3"5!BSQ8[,! MM\JX))!M,NC+\D'NP>:"2](//_^VBXI]=F>8=HL>U$0BY6]GBTR$-LNH\1ZN MP(D(XURUY2E*=P@_A>`1!N%_[X.4E.$(Q'1:!]8J(,0R;L$OK%BD7A%=`K"D MVQ3@6[.$%V,=6Y&#,6#!G5KZ"C3OP-G!HX+3F1T+"Y<=V4NX">*/04X8C+O8 MS>F0$>3>9*BE4X=/)9W)_%#P8F'!N(Y?,8U4[2POHSS:4!RYYI(.&-"$NNJ3 M34&]RSYE?W.ATUO!H!(`TL&-94`K3(UCE-LBV`*ITS:CF24\ MW:'PJ+SBW"1Z!\=;@PX,7"$3CP),KA2'R;X\#[B.(0 M!^;BV!U^S!.*#R,@1]P<`Y@.;$9'D4-%@O!-E)&S?1$9R3VREO2?`*3RWG!( MC`@VHZ2UQJ474Y-#-H&7&0!H(R`+G4U%7S=84^"=OV"HR4.Y$:QY$N;+AH>S MD%$NR$UNC2U4Y)LV.24B]:*7Y/06'@XS7L=+#14J5ICSR)<2\G7$*9`G2P5E M%)831DE-,3.R02:A(TO44O$YI;GJTN[R8O7^XO+B[N+\%JRNR.GTUZ?__I?K MR[/S3[=_`N?_]_/%W=^\H:$:7#3:,BV*"BWH-&V^T!=E6>O6I[-@&VQPBLCN31@@L969(^D4MT./14]S8),:\(JD( M,'R22JI4R%&&KH"C7$^S8-16>R%P-QV>S/:BE`6%L!^WN=J$HEI[802++MN+ MC_LD6D>[('Z/DC!C+M$7B90?ARTRD6$LHR8[\0+[(@YQU9;U&Y"1R^N+L64_ M-K,(ZQ"I?_,N&5C2;?CSK3G#^Q7,+^K+-WK`8[XK?W'OW41H=ZP9[_&RK(L0 M/91?XD<@QO]RBUIVA2"%[]C%:4>L#5"&ONF:UK MU[S+@[IQ84Z#[/$F14]1",/WSY\S&%XD'Z(D2-8X'5RM\^BI&'YFS\",-]`T M7MH&IA-%TZ7)U&ZT=PGAQAA=$B7P$*.O67%=W4.E`():P_'_T>5Q+<841\ZTQ28=>6<6KS0-":.'?2Z(]1K4QD!C[8A](>T/PG&QY"_C7`[-JB!FF=&$ZJE-B)"]0M#NNLS)W7J!1!-MY M@691[-))GA?4Q@XT+W!*.+V\P`GC/,P+B@-[)HPG*A@0M_]"`W8BE,#E#..) M M`5X)Z!H`%P+;2!>+:=58KXEK71L!BW:XJUX<:NUS>A+ZU>\RWZ\+Q-T8)Y#H M!S6#F^08-JVTYUI[Y7A:Q8[I]EB[\ZZWJ-98P%;92<<09F);LJO.`;CI5NP@ M39\?4$K.Z\CNR)8H'M#%TGW0\Z1-$8!MWPH9A*Z4B"&PT(K\Q0$#;3'PA0HZ MWBBMB@`6@>35Q"$36Y%)+)$/#TG6O29%F6UL-2GM^FK6^-=U-`\1F3[',9)A MJD5-LC48K-OR1_W;H'QIV52!H\16?J6JTK9K08V_+*\>$ODR2N!%#K?3-H*]TTF/1&/*H<<8U5=)-D)37\)[BWC>*HY#^8Y6$ M-QBY,,GI/Z\?RH7>07R+GQ03,+RY#9,V*P*:L3F5JR9*8936!@LDC`#&_"S? M[S/<3.`P<0:S=1KM:'Y,+I-X'V111DYW;!L$7RIMUPVS45`CBYCJQ2<3YCNA MS%QY#S/JG479&K=S^Q3R5G/8,F\B%C+-NPR+C`)9.*C64A&MQ4R>2\WP><`Q M4\0#4^%3@CV#D93AR5A0Y?X*#VEM;G+54N'F9C29VFV9I>M1&\.4V9U\"!.\ M-@X:ZZ`Q[]'ELX<:`'A3U`<6`9Q.D.>/,#U%VUT*'V&214^PF=Z\@OGUPUWP MK9\V::A4J9"2RM0XJ.#$_.HA=:?"D*5JIEIC1.3!NJU`!W6.0`+I%2UY\,UQ M3-%!"1I?BSWJ*VAWZ*SL;29PFFMX-1R:0"9I("DH.[+=$UN/R#X$@LZ[EXY. M7LMD"9Z^MR`W,(U0B)^G,,C@&2S^RQN7-&90H_61&9R!_N(B:+=
  • #H1R.Q;=U8I5)2+Y@V:S.L5AS[---MPOT9 M]/>8>A,R@;FYYSR+:-U6^B&(4GKI7--G9J4):AKM/$"F82+\B'T8G5A4=B<- M'PI6EK<80S`#"_![D*:!\^V3.A#H$UN]CAC$%2L/F*GBR[O\_0-*8;1)BGN^ MU\]WN+XSJB_XKI2-=O0920.+-*HRQ*-F=[)3T`(QZ MM)2X&"RC\<@S2W'')#ZF2[$\?<1%@.3`>4@OS@9!^%_[+*=W6!8W7Q0>P;IT M"?+&B_^CV"#+8%7,;V# M#"7E26!T@L__0&^,/`K1W210U4+Z5(\J<=S,K_(X-E@?^S)52%=A06V4'F=8K=4"?T^0YK2"\V#:J[;J)B4'VN3/-QAZ^2H) MS_'3'1&1-55215Y+)5`TS76NJSG:*9ES+;J+C75:J5TI2E=DPTK.,W;+T2,B MMU*]2JC-M2%DML3SK`"VUU9)W9K#+J>EJG2.`-4ZHF`^__[`K-I064"STV8* M%^@JV,(SM,5]P7Y3Q'Q9-3>]EU,9V3%G(4C8(CB.$@S M@!MLD!&MUX[YI(<8-*4^>QQ4TN^P4\.C)[RE)1.2M"/!9&0I891^U*:%^7.^ M%W5^-5HB,OWCVS=OW[Y=-$0"JWW^B%(R`?$K6+P]PF_)_XJ7&0AR<(LY`+?W M6.'=VR-`ZJ_HD)S!=?EX01^_.P(76;;'7LE;M,^S'/\1)9M?@=@!+7U;H.F1<\#JTHX#AM(O: M*1)M0+*B>H11FR7(#-Y=0:,$:)NVES8QO*B38:`\C.A1$6E);E2$5J\2(F8] M<^G!JQ$12=HZ?*X,+7O%F*;I56#-4%C`G+:P!?8TYFTS:.!)ET4]`T,F!;6` MWVQBU+^$4>Q:DK.JT9,QJ^_!*W9=-QFH`KT8T@)^=:0M$*QEWS;#AJYT*=:W M,.18JS/@-\E8*)"PC%-5!FX48JI^L!Q&UG1&L(P^X`_5'GXQ/DWF*ZCX26U*J)UA!6)3J8)W[C93IW4 MCY@L$O5E)5%L=(?E2[+:\JL7QX`H53C2KY@^>_A:70;)K'M!(MJ[O*;GDF=5 M^8;#D(KR##IQY`URBNG!2@JCYE.59'P;`J:AG0>WKJKC@<,V:97Q*<=4Y?%. MX&<.`!I,@A2]3<;>H@\^*@E*45#+OE0`$@EERTX;U`=#K%N<8-LUGF1T)< ML?KRAKEUC1XIXYR1\II&^C4RX!E7JT?# M*,V7::(S2V8Z8S(@<2GG#TELVK8W<24BC6\^H,%0O`=_ MGCV'J,^#*('A>9`F4;+)5NOU?KN/R7Z@,_@0K:-^GJ^N4/-!KC"9'#(79IFB MZ$U,&R4CR]9SG+G0%Z[9HUS_:&P-]7DET^V23,V30\8]P60//\$UVB01&1&\ M07&T?N9=2ZPL7_--*C^9;A(/9MFFYDQ,-A4;RU(,M.1<?R;"!OG&<]#\:7LJIZU",;R\:R>@C2XJEO3.-5 MOI!I@OJ1,:VG*F8:T\\<:#/8/U?T-AEJ"V9@/P(U`*NW7XKX!;RYA]D>*+D= M>=.H=-JAC[(_LE42?L8?."5)(3TZEWW)I))L%?C%LE-I*+)N-+%2<"0DGU1_ M>4JPG>`'U1WHIQ@=.%TGJG3,C)Z"G-%_9_1!QY@W%\JIH0.-J,0>_T1J'>[) M[;NC'7H.XOQYM4EA<R1-+%51C2A/P2:"Y7^\T^R^G! M&`"SK`"()\-KDII%6M70(PA;H4,-D4U[L#&7&(E]C$0,28**MZ!Y_:(`PTMI M)B'&:?I2%(O3666^[$9-8]W0CCGS?4Z6>068=WJ357Y*US,]1AFNDV@=Q""E MLLX/].94UQ#9\HYC1XX!8Z-=PH%)K3"GWCSJ]/D8&E7U'UXEBZ.64BT/8]3T M:CXQW)KU3.O5[TG3=AUL/9],K^<3AVT1/7;@/LA@2*ZL@4E&>W0KLIME0]O, M]\^-2'FR\NIKD(;U_;:K+-MOJ_7/.T@F0>]@NEWT(&G?45D!-AU-I*.]HID< M/K!>2E&0L.Q\63TJ]]D`G,1LW0:=&8B!YH9@-Q;:\]F.J[9_F;L0O7Z$X3Z& MUP^T_.\%/S$K?^/[_F^\(XO/^Q'9M-TJ`)NS.S7>FBJ)T?!JN%#":&K4U[(R M1P9\J?`Q)1-HFP1MF^#^N2-8V@74,/A"33L>HS#/`F09@+W@:LI%)Y::+;['Z%"MU)ML9AD9=.^9"H9YGXZ-" M4TNB&.]&V%Y>)`\HW19A++A'^[P^]Z!]L)TW\6HD%-GQ:3PJN/%(SR0G_HPI METNN&)LNF%P*:T19]#*!EH4_@<(&($:.P.\U?5)0&"H;?7^68OC#)\Z(H7M" MN9PKN85Q3.Y*A@E,@WB5A*MP&R511I<>/$'VECL]I:IM5E2:&ER4W)AO=77< M"B.'NJ%E*7L$-H4T70@2=.3K8]T<1P$]Q*`I]=FCMY)^A\L:'F<#J[EF3\NE M&:0N6E#]K075KH(?>__F0"JO);((5:=MC*R/R^OB%NWG18)_SY[VA>FJM[O' M("D/A/F--JH7R0U,(]0_=&MNM^WYD5GH79*=:?:9D9OHQYEQE*,)B%F>U7O_@FXW=(NF,P7#WA!G0#Z?%J7[:D6\=PTN-(BNFB1%;_;X3795ZC\P8,/ M\@&E#S#*]^2"K(0*8_DTE7T2W<`H?331E$W%NJ+4:40HC#=+H7W]@8$J-7IIS''AO9K<;OD_`JT2T$F#5AE^1#DGM/D^P]Q! MSJ#P?VOK)LRK/6.;^9PN[>72#)?^-5:#0NKFSCO:03Q/PIGS9U[!9VZCV,58 MEK=%T.5000[PYR&C1.60^DO.E?D\L]MZ"'%LO=$8>+?<6'!^[8&$%ZT22+-WV"0_H@SLP/Z^P@TAC;+SE!28SOB MYRRP#^'E9([>=CP?<0IYVS(F?3RYN0Y=UO.XX-$YF[5M5FX0YA0U;G) MU[K[97.WZ$ONA0FO;)T+D-:3&>8]L?9_G>?QP/2A$/H^]#`KJ,C#,,M;BR=WO+RW*S#>BXB3*^#>"8F)M\U]A MEL-P]IV;;+?6-]'TW7J[1Z9;4'^ZG.,*[F:;"Z,HR_=P'6PA:$\7'G[6.99M MLVPZX2-YKCTEW1+,LV6$]:L/*-BX7YD[LM"^1)IJ16X&GNB['U'&&82_KS!S MD*MCF?OL?DM19FR#F=S#U-Q3Y,%5Y.>7R8M-U=+B68GF$J_+\OT+.N1#`?PF M@K0:V@R%8[XS(Y%7]EL.+\9>1@F\R.'66$@=&)P:05L&707,N@@6[M$S5B@K M4;'K9/H@+/A"+`)JTO7)I^80;B),,C%F*"K6MHT$P5Y)O2"E^Y[IH#CV^6AB M?^LRY'ZIWT\U<48VMQE#]_"G)C!]*- M=CPUW1[AV%4&H%U4+X8WQI;:2CXQKC#--7(966M>1K:G6I`&N<=]$J8PS!\/ M=H!D/`=-Y!^3T&TH3=$N@Y%T9N0O?QFM2T6ML^@I"F$2VFY41/YLM"5L?SXU M(:P2>MMR"`H[6X/!+<.R>@*>(QB'+[A9$++(5FL@`ZK%1H#EVEKLY__.PPOY MQ=;+\F+!;/441#%9;O0!I712P=C&+34WDS=MR=PX6X`M+I@7X5RMC':672NX MKE:J!-5;\(#2\GCGPY_\5"6(D872ZF`TM49:[-',^FB57W7P`7J?/Z(T^KO! M+;42^X9#AM1CL#7_A5\S;U[F;_+S1PPUMIN%A=WYCF\&>]E MWG^7\7XN_;\[7+Y5$M[@6'`5;.$9V@:1VEFE9ERH-C>C7-AN4T84:M:&8WSY M)K4.8]TNBY7[1`!\*9[[OG1_"O)UPO9$I&G&YA'>M`+PZ%_C+LKF..3C0EUB M%_'_V:=1%D9K\JL^0M8E1FK25>R324\-8V+[1B.2DBMA<%&PL*1"X$OQR'6( M4*QK-*I">L05*W8XJ.+#+9T(ZZ\?3H/L\4.,OF:K^RQ/@_5@J9"":)M(7%$3 M+.(8-TXAL1\I?T3JR]/KJ[/SJ]OS,X#_NKV^O#A;W>%_W-[A_WP\O[J[!=IR=75Z M#F[_E'&:W61_EX2/AX8"%35=VG MOZZM;C`85Q(G6-=:=B1?3SBZ#.8AOV@&_G^`7ND4>P>H=[H`1U3B*_B5OAJ< M\J2EI-+RM91L1H#:S6PM7-_C:(IW#2WQ/^FZ7DC6]!5D)G^MRY,CZ/[JP^#Y M$"^JW&;6I@:=:WUE"O<\NF7M(XI#W!85QWIR.YLRP38[.8(F&,DT;9R%(B]2 MYO&5E^WW?P*02OSJ`:?$-=OGD;0.&-QAZ@SX(K#L$4>DW)!RP@(7M+>SH#R( MI>DGRX4>`0K@WQ%O17/2@[]OZ%=#O0[:Q2@WUUT9F#6W"X)K7A\+BWX4+#_2 M*L_3Z'Z?TZV>^(O=X'8RR0\7':)^@28\G.;U^_L,$Q57Q?D3F1*^@]_R]]C? M'_T@*).K8B%?;BH'>):-9@<2)T(^"'67S6M0O'>,?6F%(LUOWR,"3Z7#![%= M;UC!RYHE8AQ.F,N8.89M,D(G6Q:I#OG@SS2*K%H%S%!(ESD:(E[XDBIWBW5' MVG(Q)3HB;#J4(F:I0(U:I$';O@8%&K4!_,$7^M(OZ'>KCP_[P><60OZNR@'E MUGR!^B7O''N)&!ORE^;.G.<8M@C]O@\-^%_VCGL?4.#2F\.B9?7*YP*S#H1\ MN&2>UBRTZ@LOV.LN13)L1IA:8\FR:I$+ZNLIN7H,%OBQH%)8B7SX2Q=/LL0% MP/=CH62O@<+^V%LT9'*<%*@E9S@/JBW;3(;Z3G0RHJ[ND`T^;4.0UJX@0V)6 MA#A-JE5$N5+/KD\467V+)/E27XI/CT+*/#F(7"GZFHBYQ4]+\@Z\BO';UP`E M8/W]8I`S8686A"ZGTCYG\/KA/,NC+0YX@QC/?%F%]-[+J43JF#.9W3`M"TDR M5%CB9P3W]5/'8&=7#%+YG#TD=^0ZP&58<`?3VSM,HVR?/M_"]3Z-\@AFS&$< MN6`%7X'@5"AS31N%M7G-[<@V,!D_0RR6L"301Z%*D:ZE=$C!5>G M0Q")96=D(4>+%-OFXQA])8?CGL$'F*8PO`N^K;(,YD56>9&LMF@_.&!_K'KY M#?75)])-UZ%)$H[T+:+F*)/+*YCW\K3B%-6@,N*6LZ,QAQX/>`')W!GO)@OBN_5._=1(IVK)GD'\NPB%Q#^67YR)?6C5TI2.%;=C'> M$6L#F*'O&IW9*@D_D:.RLBN4P[,H6^.^YSZ%G!5,FEI=1,NUS&!=YL<""Q1= M*O!#R5*+.9ZL@=(%QI!5.K7&Y)O,`(.):C[=<;1[B%WGL.WK?9[E01)&R>9] MD$5K_$O.HGB?#[:63S-2,7BDD:F$'N76*+^GE$!(]_&&E[_WC]BL-NHU>N"> M*`+\#Q`6JOYLVYN(2&02'[U(,LI>)[!,*-&(.//TN*;!X^TO[][2T($?_.=% MLB:]8YP=%_^]2&Y2N`NBD-Q$3O<&'7.>3H.2X]`TV"(4XGJ0@@^E3 MM";#DX]!#NZI4XBYC;8XNMS#!#Y$.`LAZJ7S+4HA$4[`XH0XRQ^S-V[#S0A4 MHREXZX84=1LDC(SQ.ANA)L^FC7-IADJ+GY:5`J@T<.6`4@>42J#1^CY0RYEF MLPW;X<2;/=R>&%I_,,ZS&?B>_+2LD`J+]UD[8'\?6#UQ@]63^5*STU%YV>FH MI.QTAHSLU$TZ=FHD%SMUE(B-3[YBF&6'E7SUH:L8%QBXTHL)IWH!X72FA.MT MYFSKU$RJ=:J?9YT>0L,U'9TCTZOQ\+2;6)VZR:I.S:14I^)\B@R6(1RP4U"E M"P&95'2\X,@^1D>F5>,Q:C"AJ@;8;C"\DCR[_IH,!L!%(N4O9HM,X!'+H.DD M2."#1Q"NRO(3W.&?0QZ"I+[3=5>(`43D'"<2PEI$:E^]BV^6=`5FOB4+H##2 MTHN,Z\(!M^'EQ;[7#Z!\">C;P\4`IR$>`X)I32S/JEI[*CLL5N9!%PHG-13Z M\>!PHZ!1U=`AZ+1AILM[YE3QX]8`PR M\)5ZQ[`NW#MNU"=`%ID`43<`Z-NJPL/84LS.'B.IQGC79GF#TY1"D0Z!">*6"*3!A*'!LW/`G%]\$<(.2KL`9"H+>[5<(BP3I%:'?2'^X;2S=@> MSY(%B!B:^.`;UP4'G=)@`.%P$<"=E="'P-3Y!K95A+C+#JG)-TXYML4JDJ-U#JDEN M%U.E*L>=Q\$.)?A;XX?OF/LOV2^K8-)[.05='5/&PPG+.A=E0V$<4!YPVTEJ M8X??`O*:A)3B)@ZRA01W&->MR^!!T-P&3U5CVVXNI7*"SB*M3IQ+&I@S^`X$].V>MWB=)56*ZW@PZQ; MWGB-8MT:S$SKZYMI%AQMZZN(+Y('E&YI>.1=AC)*MSZ^3TMW`I2U/)ENRL8X MYS%!W]:RV?I+VK]@O28K=FG^A>)H_4P'6/>5V6)8*-J"A\HP?E);=MPDCL,: MF@B!_AEM&F8J]H[P/2?8C;36H[P:@SENZVL=4"J!6@NTU,`7H@BHINLCIV;% M,_?0P3D`/2T3T79G+E$9Y=H8K$^48?T](9F3.,*4Q>[V`: MD/3PDBQTSXHYX&C]B>2W<;G M?K*8C62D9\$J+U9[X6;%S+GX&>13'=`=?3'# MQFD9N+(;<1PMI%BI71@SU+O(8YWY8-N)AI]T76 MM8%"VG4.&`X9"[QF>A08)C;#/+-:S>X33.^1H.$5.=$&Q0D?%/38QL=]$N+^ M2?[H^NC&:2#A-92C0&)RC`EEV2FB$S[DWH6S8(O#=E;Z(J>.P[,@BI]OBNYB M?_QIE'(U-J6I/&7<2LN5Z<9VE'?NJ)>^,;)P$P1)ZRR>L-"J>8;Q1MOM.(BP MY8>'ZO2>&&YP'KL-#1XT!L@<86&43`>2PWJ*=3(#P_L=>48F M#YLA"#+K6-HI"^8X-1@):S05;+U!/BT[]0#@".^S,LO,:/$HM^8X14:9L1)H M:1V!4@^4BD?TP@<(J"XHE;\O8/.&KV="]K1<2M^?N;&-<;[-X?ND/73,"NQ5 M[*X"=SNN_]<^W)"7=&0$:SN^HF]NT',RO;E`/W]N2&=&838R.>QKZV6'C;9] MIE>^'.6'/?<3R=ZQ9CY#C$KS@T#Q\-X-,20P,(GR4U;#N(\TYVR(WTAY\2&@3\M*30 M`.`-IH6GY,,F>4KSF4]1]D=U0EAK;5R&?^>>O.^O!1JG7'XU7>4)%-=S93HE M'.6=Q_`1QEH'W[47^C=2X!'%877X-]DF%R3/?\K`.L@>Z,4;B3JT%0L=-FN9ZMI29N^/W,YVSC?YM!]HA'1N]'\^P(X)TV;"^`&D[2/^WP?Q!_V M29@Q3P'@OB]_.>/]!.X-K)E.F'@.>!1BR[<7,@4)IL<3SIZ+\>X4;=)@"QZP M!N[;W#\7UTD2SM!3!,@E);BF0]S1CQ(01D_X:?008=&25L41^U%&+#W`+*,' MR<3/8!LD.'=WO1B*CP:D4(%=L@Q$*SYP;)B&E9%TA&M9"U`XJ2B>`_K"DXWH MXRJ;T_;KU;;!C2BW,(U@=E'=9LP,%AE*_3#GQ? MJ_NU<3"+-DE`+]O-0*$,+NHKIQV'+''=(L6JZ(*9*5X!6F#+!EB,A#&A=6V8 MX'`V0($G,6T:&CBQ;1PXAM'38">:+QJ=X=(O\4ZCR*K*IX>5HWREV`H5>GD)10]>R:[AVSKZE5[TJK:X`"K MEK_X0*EJ3?8.T^`YJ#PP9]8$$E4OD"4Q)5D:VC/>V^.ZX&9%'(T:B"0;:ET< M<`0V,($IG?DG0Y(!&8Z,R&6[U=VG#R"/MO`(8&%T;8+\(,WX/Q;L-W%=%'".MZ'V.[]/@=8!L31EAX: MFJ,C_/<:)EGEBWB@+=[NF3K!0MN`G'T9Q(4_2!7-8)PGR/?YQ MH*I&UW.$(I0B)5CUR8A[R9/B??MB;82=^2O*D#E2>S/^,KG]=M MU*Y]@\L=JBDEWCG[W/?E;V"\GX#,@373H9CG@(=-MOSRKHR=Y&+0SC'W]2(' M'(3+4!IEV1Z&;YI)3!+KRG=HGV=Y4%Q+%-!;1M/H"9?]"8(,KO=IE),)4+H* M;$,>DM!8K`UK@C4]81-_ST=RGF9+Z]4^V],&H;AZYC4@\*5JM$2XD<#I#,AV M^ZM7VM)X,TZ3)S@S7@5:MGS2U?H@5 MS>G1Z%6TP7[-.3G%F#8Y9SBC)3<7EPY[")'*E;]'(#5,5Z M2_*0ME]E(TM66.`*ID=(XQX(;JQ.3__VM^./'X_/SD!QB+[C-DM>WTBC:KI@ MYZI4H)?8M`4D(VV;U,,H".&VKGD/0@(GTEGV(Q*:P0JG"9P&EFE-HM"TN7DH MJ9M1D#GI0(8(O`24<-K/:2@QV)Z>E0W,*@G/Z0A5ZU(4SI4E.BKEKU93F8!\ M%0?&0J:.,QX5U&TL*U':FRV$N[==>7)#BA8NT,AZZ])(1;UBE(:K`HCMKWF) M_\(/JT?X_\CULOC)_P=02P,$%`````@`)HAJ150C9!5-*0``H;<"`!0`'`!V M:&,M,C`Q-#`Y,S!?<')E+GAM;%54"0`#IS5A5*`L``00E#@``!#D! M``#M75ESXSB2?M^(_0_>FN>Z9WJF.J9W0KYJO..R'+:K:^>I@Z8@B5L4H09) ME=6_?@$>$@_O_X,$H""#,Q.'K80[IR>W=]/+J^N+DXYMW;SZ\>7=R!M=;%"V6V5C"50J3DSN09[CNDTD8@CA/WYQ,XOBD($]/$$@!VH#9F]>O2>UQE'S_F?SQ M&*3@!+_?^[?]^N;X/EV`5 MO(Z2-`N2$+PZP?0_I\6/US`,LD+D1O&G1Q37##Z^W=7%I"#_>UV3O28_O7[_ MX?7']V^>TMFKJHGDLT0E-?E3C[Z2"6OOT]OBZXX4,XHXK'=B8^V=G)3Z0S`& M=V!^0O[^>G?%+/WI+:%XFX#L.G@$,:ZR*)YMU^"75VFT6L>@_FV)P)S.)T9H MQX9HYQ/1SON?B';^M.?\=DCS%@2+#S`+8C/M+/CUV]JK9GBC;TRIEM?D&Y-: MQG8*#J#E1C7#&WT+4`1G%\EL_(9WJS+5^/LL0`>`2K^RX0*,WVJ%IFXBA`>= MIS@R2[V.`_TG.0!5&)Z'SV;");/@,-FSJ&M6Z1[/JL6>I,:]C_AGWXK6W`'%A&I.,EN@A7H MB,@CJ42BD[1%:&)A@MKB!"BL.>)_MH#0]\U7%&_7A66_#I=1O,/0',&58J=` M*0F;K?_Y1*:"DPR>T!E#-`/HEU?OR'D1YCL'"%7>.([4AN`^0L1T3'EU&*Y]9_@P!= M)+-S/'MU,"(BJU3()O,&*9*2ZH&%S;S"RP?7\5**]PW$\;\2^".Y!T$*$S"[ M2M,<(.K`(J!M#3!,6F_@HR+SD`&'64,%I(]^`.E7&.-M?X"VEU$,4$H%$(.F M!9P>C6>`XDXX9.V%S(,4L]0(R7Q MH&4-HX(*0W_Q`T,%\L_P-+N`B+[XI5*T$-.A\`PH//F&X*/#MX+%3W[`XC9_ MC*/P,H9!UR/`_-Z"1.N[9X!@RS8$#BVN%1C^Z@<8R'D-3(H#I/LE5G8ZS3,2 M/T@"0>FSC42!]IS#+>`9?A2D'S3_<*NI$/8WUQ%6R[S?]EWB7[J+&`%5Q_/8 MH_(&0')RZJ&&R;N"RB>_H%(&)8K!0J&CPJ5%YRE@V+*:@$R+>^W#<][+6\OP M@-DR@-+\U,%&^XS;,"N7'07:)0OU5*ZGSSIM]Y M,NEU?(=CW?/.^V!K^78A]Q2'/9>F,P!T:+Q!A(R,PX:$#N<:(4.=JW]_VU/M M-?YAG%-WE=B$8?B=!^EC(7:>OEX$P;H$,8BSM/ZEB^;JY]]VT2S3^664X)9% M>"J&:<0YM50ZXD#)J60#T: M:W*1D#@\9I"_+G[/HTT0XW:ED^PL0&B+]Z*_!G'>.S)5*5.?G\J5L39"\_L. MZ@G='J*I511GIW*L]2,S-@`]PL[E.QLVM`FBF(3E7T)TCX6\!V&.\!A%[F\\ M9OO_52KJ6I=>Z=KN5$N[B\1ABI#$I'(E^F$ACJ#S%H%U$,TNGDAX/:!CD$M3 M*9A!XRZ>9(221`V#E7X(2-:[-&Q[[N?-^;RYWF4$\(20'2_:+/1C-;+>97QK M&A.JBK'&HZF,J:L]#]N1EZ:&SAN8A!*C9Y^,.H`VR1S$@Z1,(DBPV1S!O`K7 M`&7;VS@HW1-XB;LF>]4;T`>(F'0'$AZIDT"1EDT,%AXKV_&60^=9Z@1+G5F= M[&=J>^5F!.^G327/%12X?MHZDV&]UZ2)2=6)I>=U%#Q&<;'3PH9>A`LL88Q% M2HG19UN&)TJU6*5R^6(N*(3OC!,3]H5VQRU7W1I.;X,MV83CWL"_H!Q#M]?: M[GBI7K(>5%5*6AMC)/H5#M%">]AAUU8,-BJU^.^^*V5KW+]G(I!/M\<;B\Y] M=$E)J(@E%D_;-Z[T(7->-?8.;$"2,YQJ?*+Z1)=!Y#A2I&13@0F+H>*3.0T=:3C4`\=C:OF-E?7QQ*E!?^WH MQ+J@D6R,1$C`(I$62)KYN>J@%#%E'8K"H_0*6?(RZV.+6X>_OF9I5YJT\\Q) M=]EMW2E%ZVC!7!R*_7EG].X@D:-\F-\;HRB M[<^.0T(@CPH>^JP\GV8GLUEQDA+$MT$TNTK.@G64[9/?U8X]/E7MUF-1.8X/ M.>E48,+DZ.^T>4?24R=@=A&@!*\#TDD8YJL\)H'W>!$:A5%W^I0O4"E8IH#C M2%*66054,LS]]>(TI)EF2X!:F4U+WSC);WH#LNG\(7CJGSSHE-Z?1ZB5=AR& MP[2A--"IUC3`K>3"=-G7AG#3(-PL.`\GH4PJB*$QTT^]XZVO47ISJ;]_YU7A M[SPATH!B/(QB'(QG*%.4WHA?FU&1Y^<)J@%NFG%8>J%O\I49"BAP];)O.ZOZ MR\U?IU9*S\#-BO$W147'S`KWT"U`18XGKN=55(CJC&47XHD&@:6S-K*6>-T@4-@+(X6'[4UFI2GZ+O6,;RH`JJJ^YE4]L**X#:( MR5N$1?QZ-X2(^K$.%^I\M&:L(M5#@2!MFV1P*P*`.ER\CT.MS"Q95-EO6(E" MA725)CET%N/F4H`Q1-(\GN..BV&1KZ5J8"]D3H)V%RW'I;5F#>*^@FJ"MLV# MR;Z,D..R]=Y>[D&,>2X^@P0K(29)!V:K*"D><277.NF@4BM4G[5)%G(;9EJB M*^!-EK_G,>(]'8B&9]&P[#IN1`(I0(3":L"%?18KV6E[MS/);N/5^G8`X1:&2E^A(E$!7OR^PTTN92N@:_ M@&P)\1=L0^7E<:JGZJ`UM[Q?!ZK9;0NQU04*9G?`)HYQ_^3@MHQU4*V.3_%^ M=-Z[CRF@:MD(AA9W&D>2G$B<)6)`S!MM(N0$9<[-!_5:IKO/- M92SPQ)!&0(>)_D&B$^-#?6&XCN`Y#=(H)#[2*,ZS7@"#)'7]#K2(VF6LJ(DJ MC1XA6_U'GIU8.WX#T6*)!9EL\%R\`#?YZA&@Z;R0M7$`SX?9,"95E^@R<1F4 M1A0CC57=V@P]/NW6L7_K]CH9^NV?_E,NU->7Z1F'I0HE]I%%XA(O:Q9-DU?I M#Z7UBP1C]EK&UV<19+),E"_:D>+ MI,Q9&FX?4)"DN*7$>I)9\;^X0&7M2IV@*,73QGF.\)^EM(S,+0>L4=!!1FNT M=\!I#L_01N]TSE8'2U.<%!U""G_OD[+4LS\A^2>,R2IP?U"R?P9TN*6;JD9@ MWL.K.7*;-MP/AS3DX4T?Y[$]=Y>9QI<]6FM3$ZWP/;A*/=F=1DXWQ]/:C0#> M0\%SG'@N-SP,^']Q3H;36X@*%&09BA[SC#QY]0!)LGF89%B2N`C"*4_=Y+T1 M0[B+/1=ZW'VQ@''5JF4LQIMD\DE,Q_R,0;J\C.$/!_R+C2M@NU:)7=M%T@XP7N_3;E6I*M`G\'>*:G,X,7SJCFF M#N@M)4>L>CW'YY>=S/XOK^)I'N`=P`-Z&,6@)>,#'&9\8U:QRV`_1A46WV7" M2`JC`J;XWS&H7%N3%9F'_RA^[RA9I[!X3-E!+8^WA8XP&EF]# MR33,7[=E'5M!UEDK$JA%PS.?J%ZN,(B.%K-26CD,2EE-\?=>S_.\R#$V9(?< M`AD+N[)72%1<0Q(!H]XLH0^P8C.Q$A^GF?X.8%U?>T/0ZB$C=A(2Q8+[J'/I M@@ZII?/ZIE`;#'JF$GKT-N,657L6JFN@%[4H66<5M"^JR]^E;E^X6P36030K M+KX(<4P]XCBRFX5;NR*-T=_459'-,BQP].[3QW<%BO`/;`15=USH M+Z2[XJ;A1[E MJ7&5DSJW[L7UA9V$(%"1/& M8SG!MO(N3\+?\P@!W&P,C&Q[&P<)R5-",I,4N4H[:E(O6#^AHU#0M8%9!@1P M@&ZD!F%.(XJ'>!0JUS!SMW9'/6$GFR"*R2+Y$J+[(`;[.Q8B_(I+L@#,*WDL M");6SB@0YM5NT9UIZKTR&`(P*_)`$>&PB7X),B+?=CK_$J#OH(A&9B-9M_SN M33/E\KZB>J"FC&!;O0U'MV6DJ$A_RZC(3'F1YL>64=("C.K0A#D,;=#SWC+* M;TJ,;!FYU?D;5,*0MGIW2'_+*,&`/QIQ&;BQ7B'/+TW7A3%>/`$41BGE>5Y) M>MIZA$[OVN@KT]/=]8>$)J0&6$[=O?4&O4[O'Q]IRO@M0"@@+ZN4XO$6RRQ2 M"@[[I$<`08'\IM'7K^XY3!GZ"UM%9LI3B1\+6TE<&]6A">0/;9#G3[$,7-C* M+YV,+&RYU?F[_2:B3I(9^8LX?3=!3+QJ]*PEG3%)IVB=^4"IJ/,(':`)-6RJ M533&QM,O3*>HI`ONPGX]6K0CS):%TC&S4#9 MT:+OMP_/&7\]Z<=$H,:3&"4"+Y+VD<]!$["A/:I[.VEL#0*3CBZZMN#JI'6%QGEC+?:K%_Q MH,/T?;Y:!6@[G=]'BR2:1R$)G2FCL(M<87$4DJ-9:REM>DUA):81$M;I93B$ MUH9(RK2(PMPUH:171OVPS?[^KR(LOM*&XW2_CMTXH63#"E;5AM,+/ZM M-^J.;5%P!E>KJ'J8T6)*W+H-9*M<'!TL0$(&1*$1:Y7=I[-5*6LS97#=3K&I MRQ'W->"6N>MU*U04OST$*-59I>#EUN7QL%!$5?33A%G+K+A3;_EJ6-V@.Q"3 M:.L4K;AI\V<8=0]Q4E7*6#-!3J]!/8G;%MCG M3XQ-DJ_'!GB?/Z;@]QQSN]A8=1YT&\)Z34-`5J>F9I+9R[O=:1++>H5T#!%= ML%)A[T!Y^3KQ&0S.12YL-D]RYWLOYWQ:RX/=TT'%@TG1:G=>?)7,(5H5 M_<>R3*VRNPSD2F4=/XD;H@F5HS?%>CQ_#*85V5"H8\OV#HM)=[YA'JGC0%.0 M4P57?+;^7OWYFH+I_"+-(FP:_2<3J!_K\:GST7%<<&51&F$ZC/R]4%'EZR:) M^/&R03R$2--76I6@=QPTJA*KX$B"M_ZM"/>@Q4_A+TW/A)8[*?QUH:62LE\5 M6JP4_4;3JQX07Q\#" MZ[L0JZ&\L'H7I=_/<,NCC/RKOY`64>[7T6Q*QT$D+Z7B*IK-M0+/3_Z!I_$4 M%7\@$A/NGGID$SJ.'&D958##8UKAYJ_^X>9JM0XB5-PA0^=1NH9I$$_GUS!9 M7&-)9Y,T!9D`44-8U'&?6BP<1Z$!O:C@4Z^Z"KE_\P^YEUC:X@)CX_[,58+U MD1?A'J6D':@JE:GZ0+*,XV#4D5P%?9+\*[A]\@]N-^!'0P,()OB?(6@(QQ\D M=8OODM"H%G<[.;M<&WX!`9%O-DWN2*YDA+54W")D MP52W>'==)5W<<:`.U(?6:DNZ*OWC0;>@VGB@2QNO.CRZH%7CX0MR!VA&"[YJ M]>D?+.]?CN7VBZ'HX'`)9GD,\)Z37-E>;.019$L;TAZB7=G$C/U!CK MFWSU"!#N2EP%@>Z/I/?N`H^D]M-228XG$YN$"D;*ID:OV9H'AHJA(N`[*>0) MXJJAW<-2#LDN"0Z-Y'@P)*&"D3!$K]F::X2*H5L\)Y&-0-&Z#GBHW^K'-=K? MC@Q7^/`\Z&P=F MI]L'7'GAKN$?;_++T`\U6640IZJX#Y0L(-;`OX*CXYW`51(F2`MI% MI%10%[%WX01N@SC;3A8(E$/T%T"V+!VY!53UY1(6E;WD4BK]!67E[*2&DJBC MN%S"XFWQX3WJ@FV"@FU`$G"089H*!PY%/>[3*+R!@5@^/0A0^1J^`^N,6EO3 M03\D1F;L5-$RJ8X2#\.HQE"V"J>43EN("/5.F;1EM=ZH3ZSXLA[#:G=BL8!W M!N`*[V_D%TN]$L*E0J.$,QI@I`KE4S$D->X8?P!H1?(L)K0VTC]63>M^=,;0 M*5M[KB!\,VYLQ+M<7%N/U"V;K,A6LM.7](_[BX2MCR[W)5<0Z;[LUT+W_TEA^RY'3P M4,@]`I%(6%TP4?AJY*_X5((J`0N2.]\Q6/%1U'L=U^>Y2/#4K\9LI)&-@OZ> MKP/ZXWE\*,,VW54BZXW;54$;P7>L7_R>'/^;<<=GHR)_O?Q:%UZESL<'7'-E M\??7P4QR.9$P]J])"%`61$G&#K^0HJWWN7Q:@TZZ=H:J.O2UE5@CRG+:ZERO M,"M;F*"P-4.2ZS5:#C$5=;2-BELG-;.8H*XQ8I>=&\Q4[$LIOR2?K[_9D'>W M_4ZWIT&,<0/NEP!DGQ',UU@7M(`JE2+=VYS<(BXH8??/?T8`850NM]A"J"MT=@I0I;-Y5I%1U+LI2&;!^DQ_J%U>C0_61@"%3H`<6=HV+F9:.*T:S&Q8,=4# M^B7/\B"^S),9_0X-\WNE",IW3_I6))E.%U-X^NL>.X-H#1&6]!P\9O0/>BP27;C#HW$$^Q( MR*F?$46SM59)@^'T^* M<&^OYS6AL?5WQ;V7FB)S/S'-65#D1DRO&7`612'8?=SE"7W?W<`-X5%O[/1XV!_# M&/T-S:B%,;*U*RVV?'J5^>L1+I\5)8)UEV^]#_6:K?'!9=PP!9`&0Y/#$?CS5;F.N'A:@S`# MLU]AC/421]F6AR+I@I0W%T0%O<"8J@+4(2=1@V'?DY7]S<"U<]_NI4)RA]9/ M&1Q&NT]C[UF723+COVN#"6Y@@EJO=TSB*C7QAI4.9N1:Z,^\F*O%6N],-D$4 MDZWY)43W00SV3L3)"J*,7)P\@VDO+:=:J3IOAFPI^T/(2"B"NJICC#1FFUGD M\9!MWH"`59@%L>U`PJZ@_LLM-\C9U]._G$@Q/F62AXI^_]`UA=@Q/1U2;$ICMJHY!4S^%@SFZ0Y]F[ M2`@G5@3YB]CN!MMP(H-@Y7*-D%G),<%WU'0SQ"@W4#Z-QY&5=]J9.>E\O MO94_;EA+*\B!#?N0""`><'UWZ8[J(1S1)6RZW9[O%"6?21_H3A[5B^R[\WA* M'LMJ""%>52F4J!]"E2EA?X`R/M.H:XHQ]!B;::1:=`SAD0;G&L^F&+,SBZ^Y MOB754 MK#ZU^6=(??;[KG$O_EN4+7MRI&U!TK;8M6:V!2]6?XU1!R?!D($Z[(^NHV.< MD9#!=`=IS;;ZXK%R/A@02W_*=B@]NZYN&*HAAVK$@7^5A'$^`[.KY")`"29C M!NP?JMZ!XX-&O2]CQI@=Z=$XHB'J$81!FU'2/L8=02@5C3-DM"IZ M&2.,=I7_@T)+ML%GW[ZN+JSO*GKO)KSL*US;5PB>MG#:^.5V%AJA`\X\M6'! M*VC,SV/-43A$@C'"31R^9&_XPO?01(:ZC?`WW:=V$0H`=G3FQ"NRIKQIA"N2`0D2,]!%D1Q M^LI>]L>J*?OS*L;IKP3E+M\CA])BGLNJ5>227Y*"4Y"`><24DD[5E;!+93$Q MC+AWH*QXW;0P3-9EZA(&2\^SMU_,YR`D1W@[`/R9XN58N=[K M0$B]8*5VE8*N`TU;"4K84ZG%7Z\;F03+KHUC^(-,A/5[7%C@(@#J;$G>X[I* MJ(^TZQ:O.D2]N.O8'*@0)82JU^5OMH.N9&E?^`XT%4ITWNODEG`=@.IB*V%. MBKWG-QBJD3U9D$.6LP"A[;S<+*>TYZXDJ>OH.A&U_37L),^6$$79EII^GD?4 M7<%VB!P2C?H^E8B,*9[U5Z>NDB(H+*[>T+P':!.%X.KNGI%D7XIZ)ZZ`VOZ( MR.HOJ"HK8RCL\"]W)@*^_N8/*=Q.).H=5Q'_3XZB=!:%1"/T++)RU'5N,A&U MTV!2DU4>3$*^_KXQ+)@PH/2H*]+F/J4LBYV_D=*R2PRJ-H5Y9`73SNQVA+%T_KJ'22 MG??S$*H6$Z*L6\Q_S'$581B!W;K\77,H3)?J@[KRW"E5A;_*EG1+J7E)E%Q2 M0M:&7N4XZ#'N&5RMHB)IO_5CW$932/Z&X@!D`1)RI"X\V-4JNWL#2ZFLJ:=3 M]G`"00K2VR(P*@KO2,?&U3DD>XDD4:8WCW'+6#-LO:Z#>LIH&[Q2U>TA@%NE MYZ?&A7#M:;K[1`&/I%(UG<0_F$F(.A!5]!I,9G$XZ)1RG\'P^RD6"2.[3M,CS_TA:?AMLRPZD3S=FF-7'@0.9V7/@ADLP MRV/<[*)YO2Z?D.P.;[6='X;!\E-L*(] MV4S[5$G>_F2]\=13,?K'C@`#3L"HBS#"%__XD7KD0/_8:%'SH[6)C:$W*&A_ M>\YJ,R&34K?P&&L:"UKJG@IP44?747T"T"WJK]_?_(`+N<-16Z_&:F]VBN_G M!J54G>?YZF1^M&]U_K[V-[O/26EUY5Z"9,:=,,:LHOG$E?$J[(4#K]8QW`)0 MK-"G:^99NY"N#O9ET]D;R\9$!93736>,&Z%51?`PNS7^CGUW`&]M(O*&42$6 M%:)3P>'@5RG!1[? M6Z2N[N!!UCN=JXW-ENS>P33>@I=]4VO?Q%O=C[AQZE3K[U`MU`5+%=>,@"QS M#&5W%1(,_5/O34Y&Y@JK:17@]\?^4&&HMD7\ARJ?S=_=65T>F3+SRT#-*ZX# MA&V7FI'4V^SYX:TIC31>'_A,%E8CF2FK&L/6VJ_FQ6A5^L%EV^TW_1DN7DK? M3UHH(+U*RLB4XN$R4X8KKF&HS?)J>.[F*JU]IRR5UVI_[XB;5<K;^B@(%_?U;AP%Z7?+Q$`17(0D&9C M#P>\^L88!>CUO1B_5L\X;_-T&2I3_\E34W\4*^=197WT`-"J>PEK_(J:QCU2 M1<=DU8?HB]',>:3&5W;\5T_M6$>WY-GY;'N5I!G*B^"+XH'5AV604%T?IF9N MS6J'3N#*U1Z3Q1^^GYR:SI5%J4:#O[V,!BP='>PX8*QV'7@\>3E"L-W3/H]( M\L<.G_P;LDBFY)!<(:=KL\I7T;UA(+%%+1V.8B6Q#ZH`8C:`V M;!B/T'Y8V^ZB4YD`ER[O#4PV("7F7*9E@ED0-[^35`HW,/LW*)ZL6B24\-/1 MZ^E>G3-?SY$8V:%Z8@R['+'MM2E[&-PVFE;*N?P2HNHG0M=UEMFI?&QK9U3^ M,@0,[S.OQ@6&0/5@X6.0';DX>I6F.9B=Y^3MR5+$0F7I#?A1?.H%MRH5VN6* MERMT)$:EI:-1]GB2#:E![&/@%T_$QIW]].()H#!*^[>AM!G(@)O!X#D`749W M!P<]HU&U`3RG<"BA'^?78HH\^!D*O=K1?9[=:H_%1.WTDU\>RZXH]7#PG**@ M\)JXU$9/6\R9\P!5#;ZD*%/5;:Z>A/#@'S?5=95VR_G9$W8Y),KLC M)[KI#=70*2J:2S]%>W>33U`H!.XY:M4A[9EA!- MPF@;KVO3&7K^<(;8-*$*LB4T6L]!7*;'/I7(CH@JTPJ'I[\9TZA"]?Q_O!&8 MY2P4$;LE\BXI'@AS%&5X)#H+XAC,3K?U@%012NE$G1M/:2K/"0+N;A*[X5M6,$U>(Z33Z2 MZ:('4/U4<9IG:18DLRA9E(/"^.?BS"K'.Q^G5.F!85G0O:H='J:)^@>=ZS)< M+@M0YJWQOL2VN1G;=@!#-AFW-J(QZ\:D:81H'^L\_!*7YK&9#HTYLS+/]N/) M-`+&C]4<+R&:@RC+R8,!R>SB:1VA@JFQ]/@#JA[/7#E5/T_SE>T+!\R9TU3] M-)C':MXN['I_^_"R[[6W[^UIWP$39N]\-0*]RYWO13+3-U_J,?!^9"D2WT!4 MN]DZ)B2DJ^^ZL^D\@*JLE*KHXO#5SY#H[@&QW'DFZ^1M\*'FM8F8>ML'Q:K1 MR2PMB\/@)6MBJMOC`/;K*(L6I5UJA[!3A]4]8T;P.9N@ZB,:@;4UVS5,TS.8 M9'@J`TFXO07%K(;1$*U2ZHI+OD`MKD0!:[;(Z2RH(6O;_/K,B:7),-6W.$?2 M>G6$/`]6P0+O=\BR"LQHZ2[E"]!A12W@!ZS$LFK`BLK4\U/5ST&4-"T'+[B* M_72>S*Z2.4FZ`&9?US"ACEMZA:L.4"WL*/`&Z4`&A*H5C',Q2V3L':3>)=D&;1T(7S/:E M[&YSZ->S!50,T1RXLMUO$?W>M8B.+:'U&]"=-M'OA?%HZ+)9OQ'V5[B.I$9*OPUUN(A8O?V\6 MO^3^>,G]8;Q3=NFY]WE8J;.?D*Z;]KU/=[3Y061U@>*RZJ^D#](HE3\R_\# M4$L#!!0````(`":(:D5`L``00E#@``!#D!``#M7-USXC@2?[^J^Q]T/,T] M\)7,S$Y2PVR10&:H(H$"=N?>MH0M0#6VY)5D`O_]MF2,92`VAOD@=7Z*+'6W MNOO7:K6%E8^_KWP/+8F0E+-6I5EK5!!A#G7U+!B%K5'.[7]2R-FVMMC4=\PM0# M%WZ'S'#HJ5;E[Q![=$:)6T%@/I.W*[F5\OS\7'N^KG$Q!R&-9OU_C_VQF3>F M72Z6@4*JNI\&)EKNMZ>(HE MV>J]1[]1'9Q]4S>C6U(01#-$4R859@ZQZ5VU9;")W]6CP9B4LB61.Z22.+4Y M7]:C,6WI==I2%OJ'M7&5J&OWU(&"".IL&3@[@H>SZ@Z?2^AAU6#`1@""#"$= M9I@QKK`.9].UZ0P"RF9\TP-]VK>W,1XC,D/&V[=:BU9%4C_PM"M-WT*06:L" M<5.-8^2O0)`:J!=3".Z1#&ST<#W0"X)%BO63>6,16#A[4O:"`83P@`A%(?B2 M6*I_+ZL<[!6U"EB[`VA6_"J(*HVZID4FSGC6=.`/O4@*3?:,!& M%4NPFYBY*!*'+'D?Z[M"=N6'DK@#]LFT=]?QAGM#DL6YLU:.9TS'XV&^36^, MP.MVG<;>C6^-!O]=I3^#AKMUO/]UWT?A+MSL9HS?;&?Y;8GD:ED,L MP!$+HBA85AC8-+=M/Q2=T2`:@4:WQ0$UU6-6T#3/#QKT)F5`&42Y0;1UMQS, M!H%^I]!O#\=DACS.3+2OCD\1XPG\>>P^`=*#!S08=D?M20\(RF1Q*L[WW`<7 M+("&+DF?R\)P9PC(1/WZ5-3O!X_#4?<+T/7^[*+^8%RB?SKZ6"X>//Y<'/5] MQDRTWYZ,=GO\!3WT!U]+E%]"^2Z4E!$I.T0Z@@9Z4BBP[["D`-30LCW"]GCR M3$3?QQ5Y@R:9()7,4!V M1PX*U_LH1-S(L)=^3NUGOD^5V8+B?2KIR/'SVWT_6]REF^U4I+CS#3*VWO[] M`.H`:_=X82S'^>\.I!HM"!E)R!95(F$A\14+@;?1OGW*\?;[?6_'K*5W+>_V M89ZY%=O6;X^\.A4B46@2(9I=L+ M5Y.G5)4'J\O=`\'CZ\BAS-.^$J.CSOUVZLW#@]F5Y.$9;^ MK/\@8YUX2L8]U414;27=^`/D3'6R;@QDJK/+HQMG*W#@-L4Q.EALFW8U$7&: M)N8U2*P+JV+SQ0_G*Q,*6+[.NC`X*<;MT]DPD96S**S+ELFTSM:!8>J8&T;- M(DHD7%&SF@@X30U)G<)*Q#RZ<8H"NS<8;J)]@I$Y-I^=O:!#BLT3(L55U7*J MS:MJ\_WY>JC".JA3YD\[506B.!(QDVE]#RSLBV;'^,"PZ*=JS*<]<:T]<886 M;^M"WV`Y4@%#K:>%!?FAVFP4`V#OTMR1L\8,>N)WIUEZ^%K<,?/;G$\1X]DK M8/]B7S%-3EC\\6MI1N M(B3#9YOKL49'&@@28NB!,?Z3[Q%FT2:JHNEXNG+^*\$37 MT\Q5U%N?0UK#8MU3Q-<5)%@));.BRMPD_BQX&,2D%$@JB%'/TS_7M"I*A$". M@5J`H:W*#'OF3JPA#B!*N#LQ,[FAV'QT$8U-H]LGK0JHZE)UNB/NBWKA_M6Y M`);]E(C!;`C;G_X0^YG%GVQK>P^/VL91ILB#S3-A&#_"Y9?N?A&W`F?$[4@(K'P%%[;_MCQ/P?VCT\E!D^O\11/K9`*6Z+TYK6&?ZQ>:1Z)5BJ;W3'^D=W6Z_=;F/Z?<( MF>CYE(C97GTPP4']!\H@85#L63=>)V2E[CSN?$O,*LB6LEK%_;]VK20G;>V- MN,2\0V-VQ$$?Q.(O!6YS&X[-^WH#DE'^HLY('QYYFVW(6OM'DE_,?N62:=9V M-6"?.1@SXFOLJ77[&0O7WJ]>&-Z$(<0@Z."`M%^:,O2=MGMN?E[6YQ`=[.,Y MD1ME_\1>2#J8>NLA7ONI3%B4[[5@>J1=)N,06=PA">-K\0@8I:,T8AY1^2VN MPZQTNU756NQ%^7[R9IJ?W!Y#%6+O(62NW-U0#PQ=VIXZ!FHB>_&/;;L6O#!\ M:59,B/#U+5RVLS?N]E]>%=P&%^H"U^2_`8M5'1&'T*6]3>02OJ)$842W?7W& MGDH$J?[78D];X#6.E=]=/P<'+VWU;+]MW:^=#PQ=8GT,12&-:#KPSJ7?C%-W MAK0E&20_I%H^PYJL_Q"T7_\?1_T+WPC,#ZW1.2$\_0-02P$"'@,4````"``F MB&I%Y(=[_.^M```X/0H`$``8```````!````I($`````=FAC+3(P,30P.3,P M+GAM;%54!0`#IS5A5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`":(:D4$ MJ1"CFPH``-V%```4`!@```````$```"D@3FN``!V:&,M,C`Q-#`Y,S!?8V%L M+GAM;%54!0`#IS5A5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`":(:D5Y MOOXJ5Q,``#U``0`4`!@```````$```"D@2*Y``!V:&,M,C`Q-#`Y,S!?9&5F M+GAM;%54!0`#IS5A5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`":(:D7Z MZY8_,%4``/O8!``4`!@```````$```"D@`Q0````(`":(:D54 M(V0532D``*&W`@`4`!@```````$```"D@44B`0!V:&,M,C`Q-#`Y,S!?<')E M+GAM;%54!0`#IS5A5'5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`":(:D5< MG.K!^@@``-A/```0`!@```````$```"D@>!+`0!V:&,M,C`Q-#`Y,S`N>'-D M550%``.G-6%4=7@+``$$)0X```0Y`0``4$L%!@`````&``8`%`(``"15`0`` !```` ` end XML 30 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
    In Thousands, except Per Share data, unless otherwise specified
    3 Months Ended 9 Months Ended
    Sep. 30, 2014
    Sep. 30, 2013
    Sep. 30, 2014
    Sep. 30, 2013
    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]        
    Revenue $ 292 $ 1,612 $ 809 $ 1,911
    Operating expense:        
    Research and development 374 316 1,066 1,002
    Selling, general and administrative expenses 6,168 6,429 19,119 22,150
    Total operating expense 6,542 6,745 20,185 23,152
    Loss from operations (6,250) (5,133) (19,376) (21,241)
    Gain (loss) on change in value of derivative liability 1,817 (48) 2,126 1,438
    Interest and other income (expense), net (35) 47 25 105
    Loss before taxes (4,468) (5,134) (17,225) (19,698)
    Income tax expense 0 0 (2) (356)
    Net loss $ (4,468) $ (5,134) $ (17,227) $ (20,054)
    Basic and diluted loss per share (in dollars per share) $ (0.09) $ (0.10) $ (0.33) $ (0.39)
    Weighted average shares outstanding basic and diluted (in shares) 51,572 51,203 51,454 51,178
    XML 31 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Warrants
    9 Months Ended
    Sep. 30, 2014
    Warrants [Abstract]  
    Warrants
    Note 6 —Warrants

    Information about warrants outstanding during the nine months ended September 30, 2014 follows:
     
    Original Number
    of
    Warrants Issued
      
    Exercise
    Price per
    Common
    Share
      
    Exercisable at
    December 31,
    2013
      
    Became
    Exercisable
      
    Exercised
      
    Terminated /
    Cancelled /
    Expired
      
    Exercisable
    at Sept 30, 2014
     
    Expiration
    Date
      
    2,619,036
    (1) 
     
    $
    3.59
       
    159,967
       
       
    2,500
       
       
    157,467
     
    March 2015
    Total
           
    159,967
       
       
    2,500
       
       
    157,467
     
     
     
    (1)Referred to as our Series I Warrants.
    XML 32 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Stock Based Compensation
    9 Months Ended
    Sep. 30, 2014
    Stock Based Compensation [Abstract]  
    Stock Based Compensation
    Note 5 —Stock-Based Compensation

    We have a stock incentive plan for employees and others called the VirnetX Holding Corporation 2013 Equity Incentive Plan (the "Plan"), which has been approved by our stockholders.  The Plan provides for the granting of up to 14,124,469 shares of our common stock, including stock options and stock purchase rights (“RSUs”), and will expire in 2023.  As of September 30, 2014, 1,816,217 shares remained available for grant under the Plan.

    During the three months ended September 30, 2014 we granted options for a total of 206,500 shares and none for the same period in 2013. The weighted average fair values per option issued at the grant dates during the three months ended September 30, 2014 was $11.47.

    During the nine months ended September 30, 2014 and 2013, we granted options for a total of 261,500 and 274,625 shares, respectively. The weighted average fair values of options issued during the nine months ended September 30, 2014 and 2013 were $11.23 and $19.24 per option, respectively. The fair values of options at the grant date were estimated utilizing the Black-Scholes valuation model with the following weighted average assumptions for the nine months ended September 30, 2014 and 2013, respectively: (i) dividend yield on our common stock of 0 percent for both periods (ii) expected stock price volatility of 87 percent and 93 percent; (iii) a risk-free interest rate of 2.56 percent and 2.06 percent; and (iv) an expected option term of 6 years respectively.

    During the three months ended September 30, 2014 we granted 137,666 RSUs, and none for the same period in 2013. The weighted average fair values at the grant dates for RSUs issued during the three months ended September 30, 2014 were $15.40 per RSU. During the nine months ended September 30, 2014 and 2013, we granted 154,332 and 156,415 RSUs, respectively. The weighted average fair values at the grant dates for RSUs issued during the nine months ended September 30, 2014 and 2013 were $15.30 and $23.72 per RSU, respectively. RSUs, which are subject to forfeiture if employment terminates prior to the shares vesting, are expensed ratably over the vesting period.

    Stock-based compensation expense included in general and administrative expense was $2,221 and $5,952 for the three and nine months ended September 30, 2014, respectively and $2,110 and $5,454 for the three and nine months ended September 30, 2013, respectively.

    As of September 30, 2014, the unrecognized stock-based compensation expense related to non-vested stock options and RSUs was $10,358 and $5,515, respectively, which will be amortized over an estimated weighted average period of approximately 2.52 and 2.83 years, respectively.

    During the nine month period ended September 30, 2014 we issued 337,335 new shares of common stock as a result of share-based awards.  Options to purchase 256,096 shares were exercised and 78,739 RSUs vested and were paid out as well as 2,500 shares from warrant exercise.
    XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Warrants (Details) (Warrants [Member], USD $)
    9 Months Ended
    Sep. 30, 2014
    Warrants [Line Items]  
    Exercisable at Beginning of Year (in shares) 159,967
    Became Exercisable (in shares) 0
    Exercised (in shares) 2,500
    Terminated / Cancelled / Expired (in shares) 0
    Exercisable at End of Period (in shares) 157,467
    Series I Warrants [Member]
     
    Warrants [Line Items]  
    Original Number of Warrants Issued (in shares) 2,619,036 [1]
    Exercise Price per Common Share (in dollars per share) $ 3.59
    Exercisable at Beginning of Year (in shares) 159,967
    Became Exercisable (in shares) 0
    Exercised (in shares) 2,500
    Terminated / Cancelled / Expired (in shares) 0
    Exercisable at End of Period (in shares) 157,467
    Expiration Date March 2015
    [1] Referred to as our Series I Warrants.
    XML 34 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Summary of Significant Accounting Policies (Details) (USD $)
    In Thousands, except Per Share data, unless otherwise specified
    3 Months Ended 9 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 3 Months Ended
    Sep. 30, 2014
    Sep. 30, 2013
    Sep. 30, 2014
    Institution
    Sep. 30, 2013
    Dec. 31, 2013
    Sep. 30, 2014
    Cash [Member]
    Dec. 31, 2013
    Cash [Member]
    Sep. 30, 2014
    Series I Warrants [Member]
    Dec. 31, 2013
    Series I Warrants [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Mutual Funds [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Mutual Funds [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Corporate securities [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Corporate securities [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Municipal securities [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Municipal securities [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    U.S agency securities [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    U.S agency securities [Member]
    Sep. 30, 2014
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Series I Warrants [Member]
    Dec. 31, 2013
    Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
    Series I Warrants [Member]
    Sep. 30, 2014
    Significant Other Observable Inputs (Level 2) [Member]
    Dec. 31, 2013
    Significant Other Observable Inputs (Level 2) [Member]
    Sep. 30, 2014
    Significant Other Observable Inputs (Level 2) [Member]
    Series I Warrants [Member]
    Dec. 31, 2013
    Significant Other Observable Inputs (Level 2) [Member]
    Series I Warrants [Member]
    Sep. 30, 2014
    Significant Unobservable Inputs (Level 3) [Member]
    Sep. 30, 2013
    Significant Unobservable Inputs (Level 3) [Member]
    Dec. 31, 2013
    Significant Unobservable Inputs (Level 3) [Member]
    Sep. 30, 2014
    Significant Unobservable Inputs (Level 3) [Member]
    Series I Warrants [Member]
    Dec. 31, 2013
    Significant Unobservable Inputs (Level 3) [Member]
    Series I Warrants [Member]
    Sep. 30, 2013
    August 2013 Contract [Member]
    Sep. 30, 2013
    Araya Contract [Member]
    Deferred Revenue [Abstract]                                                                
    Term of contract     5 years                                                          
    Contract amount     $ 10,000                                                          
    Annual payment on contract, received     5,000                                                          
    Revenue from historical royalties 292 1,612 809 1,911                                                     1,500 112
    Deferred Revenue, Beginning Balance     667                                                          
    Payment received     2,500                                                          
    Less: Amount amortized as revenue 292   (792)                                                          
    Deferred Revenue, Ending Balance 2,375   2,375                                                          
    Concentration of Credit Risk and Others Risks and Uncertainties [Abstract]                                                                
    Number of financial institutions holding company's cash     2                                                          
    Fair Value Assumptions [Abstract]                                                                
    Warrant exercise price (in dollars per share)               $ 3.59 $ 3.59                                              
    Common share price (in dollars per share)               $ 6.00 $ 19.41                                              
    Discount rate (in hundredths)               1.78% 1.75%                                              
    Expected volatility rate (in hundredths)               90.28% 91.55%                                              
    Fair value of securities on the basis of investment category [Abstract]                                                                
    Adjustment Cost 24,437   24,437   39,014 4,119 11,699     20,318 27,315 112 73 8,607 10,782 691 2,173 10,908 14,287                          
    Unrealized Gains 4   4   0 0 0     4 0 0 0 2 0 0 0 2 0                          
    Unrealized Losses (4)   (4)   (25) 0 0     (4) (25) 0 0 (3) 0 0 0 (1) (25)                          
    Fair value 24,437   24,437   38,988 4,119 11,699     20,318 27,289 112 73 8,606 10,782 691 2,173 10,909 14,262                          
    Cash and cash equivalents 8,498   8,498   19,173 4,119 11,699     4,379 7,474 112 73 0 2,325 0 665 4,267 4,411                          
    Investments Available for Sale 15,939   15,939   19,815 0 0     15,939 19,815 0 0 8,606 8,457 691 1,508 6,642 9,851                          
    Fair value of liabilities [Abstract]                                                                
    Series 1 Warrants 431   431   2,564     431 2,564 0 0                 0 0 0 0 0 0 431   2,564 431 2,564    
    Changes in fair value of Level 3 liabilities [Roll Forward]                                                                
    Beginning Balance                                                   2,564 4,172          
    Gain on derivative liability included in net loss                                                   (2,126) (1,438)          
    Settlements                                                   (7) 0          
    Ending Balance                                                   $ 431 $ 2,734          
    XML 35 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Summary of Significant Accounting Policies (Policies)
    9 Months Ended
    Sep. 30, 2014
    Summary of Significant Accounting Policies [Abstract]  
    Unaudited Interim Financial Information
    Unaudited Interim Financial Information

    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the SEC’s requirements for Form 10-Q and, in the opinion of management, contain all adjustments, of a normal and recurring nature, which are necessary for a fair statement of (i) the condensed consolidated statements of operations for the three and nine month periods ended September 30, 2014 and 2013; (ii) the condensed consolidated statements of comprehensive loss for the three and nine month periods ended September 30, 2014 and 2013; (iii) the condensed consolidated balance sheets at September 30, 2014 and December 31, 2013; and (iv) the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2014 and 2013. However, the accompanying unaudited condensed consolidated financial statements do not include all information and notes required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated balance sheet, included in this report, as of December 31, 2013 was derived from our 2013 audited financial statements, but does not include all disclosures required by U.S. GAAP.
    Basis of Consolidation
    Basis of Consolidation

    The consolidated financial statements include the accounts of VirnetX Holding Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated.
    Use of Estimates
    Use of Estimates

    The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, fair values of stock-based awards, income taxes, and derivative liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
    Revenue Recognition
    Revenue Recognition

    We derive our revenue from patent licensing. The timing and amount of revenue recognized from each licensee depends upon a variety of factors, including the specific terms of each agreement and the nature of the deliverables and obligations. Such agreements may be complex and include multiple elements. These agreements may include, without limitation, elements related to the settlement of past patent infringement liabilities, up-front and non-refundable license fees for the use of patents, patent licensing royalties on covered products sold by licensees, and the compensation structure and ownership of intellectual property rights associated with contractual technology development arrangements. Licensing agreements are accounted for under the Financial Accounting Standards Board (“FASB”) revenue recognition guidance, "Revenue Arrangements with Multiple Deliverables." This guidance requires consideration to be allocated to each element of an agreement that has stand-alone value using the relative fair value method. In other circumstances, such as those agreements involving consideration for past and expected future patent royalty obligations, after consideration of the particular facts and circumstances, the appropriate recording of revenue between periods may require the use of judgment. In all cases, revenue is only recognized after all of the following criteria are met: (1) written agreements have been executed; (2) delivery of technology or intellectual property rights has occurred or services have been rendered; (3) fees are fixed or determinable; and (4) collectability of fees is reasonably assured.

    Patent License Agreements: Upon signing a patent license agreement, including licenses entered into upon settlement of litigation, we provide the licensee permission to use our patented technology in specific applications. We account for patent license agreements in accordance with the guidance for revenue recognition for arrangements with multiple deliverables, with amounts allocated to each element based on their fair values. We have elected to utilize the leased-based model for revenue recognition with revenue being recognized over the expected period of benefit to the licensee. Under our patent license agreements, we do or expect to typically receive one or a combination of the following forms of payment as consideration for permitting our licensees to use our patented inventions in specific applications and products:

     Consideration for Past Sales: Consideration related to a licensee’s product sales from prior periods may result from a negotiated agreement with a licensee that utilized our patented technology prior to signing a patent license agreement with us or from the resolution of a litigation, disagreement or arbitration with a licensee over the specific terms of an existing license agreement. We may also receive royalty for past sales in connection with the settlement of patent litigation where there was no prior patent license agreement. These amounts are negotiated, typically based upon application of a royalty rate to historical sales prior to the execution of the license agreement. In each of these cases, since delivery has occurred, we record the consideration as revenue when we have obtained a signed agreement, identified a fixed or determinable price, and determined that collectability is reasonably assured.
     
     Current Royalty Payments: Ongoing royalty payments cover a licensee’s obligations to us related to its sales of covered products in the current contractual reporting period. Licensees that owe these current royalty payments are obligated to provide us with quarterly or semi-annual royalty reports that summarize their sales of covered products and their related royalty obligations to us. We expect to receive these royalty reports subsequent to the period in which our licensees’ underlying sales occurred. As a result, it is impractical for us to recognize revenue in the period in which the underlying sales occur, and, in most cases, we will recognize revenue in the period in which the royalty report is received and other revenue recognition criteria are met due to the fact that without royalty reports from our licensees, our visibility into our licensees’ sales is limited.
     
     Non-Refundable Up-Front Fees and Minimum Fee Contracts: For licenses that provide for non-refundable up-front or fixed minimum fees over their term, for which we have no future obligations or performance requirements, revenue is generally recognized over the license term.  For licenses that provide for fees that are not fixed or determinable, including licenses that provide for extended payment terms and/or payment of a significant portion of the fee after expiration of the license or more than 12 months after delivery, the fees are generally presumed not to be fixed or determinable, and revenue is deferred and recognized as earned, but not in advance of collection.
     
     Non-Royalty Elements: Elements that are not related to royalty revenue in nature, such as settlement fees, expense reimbursement, and damages, if any, are recorded as gain from settlement which is reflected as a separate line item within the operating expenses section in the consolidated statements of operations.
    Deferred revenue
    Deferred revenue

    In August 2013 we began receiving annual payments on a contract with a total value over 5 years of $10,000.  From the inception of that license to September 30, 2014, we received a total of $5,000 ("August 2013 Contract Settlement"), all of which is non-refundable.  We recognized $292 and $792 of revenue related to these payments in the three and nine-month periods ended September 30, 2014, respectively.
     
    During the three month period ended September 30, 2013, we recognized $1,500 of revenue for historical royalties under the August 2013 Contract Settlement, and $112 of revenue for royalties earned subsequent to the settlement and execution of this license agreement and other licenses.  Revenues for historical royalties were estimated based on estimated past and future usage of our IP on our customer's products.  No amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
     
    For the nine months ended September 30, 2013, we recognized royalty revenue of $1,911.  In addition to revenue recognized under the August 2013 Contract Settlement described above, we recognized royalty revenue as part of license agreements entered into with customers during the patent infringement actions (see Note 7 - Litigation). These revenues relate to both payment for use of our patented technology prior to the signing of a license agreements and royalty payments after the execution of the license agreement; no amounts were allocable to settlement fees, expense reimbursement, damages or any other amounts other than historical and future sales because such amounts were not requested or received.
     
    During 2014, activity under the August 2013 Contract Settlement was as follows:
     
    Deferred Revenue, December 31, 2013
     
    $
    667
     
    Payment received
      
    2,500
     
    Less: Amount amortized as revenue
      
    (792
    )
    Deferred Revenue, September 30, 2014
     
    $
    2,375
     

    Earnings Per Share
    Earnings Per Share

    Basic earnings per share are computed by dividing earnings available to common stockholders by the weighted average number of outstanding common shares during the period.  Diluted earnings per share are computed by dividing net income by the weighted average number of shares outstanding during the period increased to include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued.
    Concentration of Credit Risk and Other Risks and Uncertainties
    Concentration of Credit Risk and Other Risks and Uncertainties

    Our cash and cash equivalents are primarily maintained at two major financial institutions in the United States. A portion of those balances are insured by the Federal Deposit Insurance Corporation.  During the nine months ended September 30, 2014 we had funds which were uninsured.   We do not believe that we are subject to any unusual financial risk beyond the normal risk associated with commercial banking relationships with major financial institutions. We have not experienced any losses on our deposits of cash and cash equivalents.
    Derivative Instruments
    Derivative Instruments

    Our Series I Warrants are required to be accounted for as derivative liabilities and carried at fair value on our Condensed Consolidated Balance Sheets as a result of an anti-dilution provision which precludes them from being considered indexed to our stock.  The warrant liabilities are marked-to-market each period and the change in the fair value is recorded as gain or loss on derivative liability in the accompanying Condensed Consolidated Statements of Operations.
    Impairment of Long-Lived Assets
    Impairment of Long-Lived Assets

    On an annual basis we identify and record impairment losses on long-lived assets when events and changes in circumstances indicate that the carrying amount of an asset might not be recoverable.  Recoverability is measured by comparison of the anticipated future net undiscounted cash flows to the related assets’ carrying value.  If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future net cash flows arising from the asset.
    Fair Value of Financial Instruments
    Fair Value of Financial Instruments

    Fair value is the price that would result from an orderly transaction between market participants at the measurement date. A fair value hierarchy prioritizes the inputs used to measure fair value.  The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurement) and the lowest priority to unobservable inputs (Level 3 measurement).  Level 2 measurements utilize either directly or indirectly observable inputs in markets other than quoted prices in active markets.

    Our financial instruments are stated at amounts that equal, or approximate, fair value.  When we approximate fair value, we utilize market data or assumptions that we believe market participants would use in pricing the financial instrument, including assumptions about risk and inputs to the valuation technique.  We use valuation techniques, primarily the income and market approach that maximize the use of observable inputs and minimize the use of unobservable inputs for recurring fair value measurements.

    Mutual Funds: Valued at the quoted net asset value (NAV) of shares held.

    Corporate, Municipal and U.S. Agency Securities:  Fair value measured at the closing price reported on the active market on which the individual securities are traded.

    Series I Warrants: Fair value measured by using a binomial valuation model. The assumptions used to measure fair value of our outstanding Series I Warrants carried as derivative liabilities on our Condensed Consolidated Balance Sheet for September 30, 2014, included a warrant exercise price of $3.59 per share, a common share price of $6.00, discount rate of 1.78%, and a volatility of 90.28%. The assumptions used for December 31, 2013, were a warrant exercise price of $3.59 per share, a common share price of $19.41, a discount rate of 1.75%, and a volatility of 91.55%. The expiration date of the warrants is March 2015.

    The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.

      
    September 30, 2014
     
     
    Adjusted
    Cost
      
    Unrealized
    Gains
      
    Unrealized
    Losses
      
    Fair
    Value
      
    Cash
    and Cash
    Equivalents
      
    Investments
    Available
    for Sale
     
    Cash
     
    $
    4,119
      
    $
    -
      
    $
    -
      
    $
    4,119
      
    $
    4,119
      
    $
    -
     
                             
    Level 1:
                            
    Mutual funds
      
    112
       
    -
       
    -
       
    112
       
    112
       
    -
     
    Corporate securities
      
    8,607
       
    2
       
    (3
    )
      
    8,606
       
    -
       
    8,606
     
    Municipal securities
      
    691
       
    -
       
    -
       
    691
       
    -
       
    691
     
    U.S agency securities
      
    10,908
       
    2
       
    (1
    )
      
    10,909
       
    4,267
       
    6,642
     
       
    20,318
       
    4
       
    (4
    )
      
    20,318
       
    4,379
       
    15,939
     
    Total
     
    $
    24,437
      
    $
    4
      
    $
    (4
    )
     
    $
    24,437
      
    $
    8,498
      
    $
    15,939
     

      
    December 31, 2013
     
     
    Adjusted
    Cost
      
    Unrealized
    Gains
      
    Unrealized
    Losses
      
    Fair
    Value
      
    Cash
    and Cash
    Equivalents
      
    Investments
    Available
    for Sale
     
    Cash
     
    $
    11,699
      
    $
    -
      
    $
    -
      
    $
    11,699
      
    $
    11,699
      
    $
    -
     
                             
    Level 1:
                            
    Mutual funds
      
    73
       
    -
       
    -
       
    73
       
    73
       
    -
     
    Corporate securities
      
    10,782
       
    -
       
    -
       
    10,782
       
    2,325
       
    8,457
     
    Municipal securities
      
    2,173
       
    -
       
    -
       
    2,173
       
    665
       
    1,508
     
    U.S agency securities
      
    14,287
       
    -
       
    (25
    )
      
    14,262
       
    4,411
       
    9,851
     
       
    27,315
       
    -
       
    (25
    )
      
    27,289
       
    7,474
       
    19,815
     
    Total
     
    $
    39,014
      
    $
    -
      
    $
    (25
    )
     
    $
    38,988
      
    $
    19,173
      
    $
    19,815
     

    The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.
     
      
    September 30, 2014
     
      
    Quoted
    Prices in
    Active
    Markets for
    Identical
    Assets
      
    Significant
    Other
    Observable
    Inputs
      
    Significant
    Unobservable
    Inputs
      
    Total
     
      
    (Level 1)
      
    (Level 2)
      
    (Level 3)
       
    Series l Warrants
     
    $
      
    $
      
    $
    431
       
    431
     
    Total
     
    $
      
    $
      
    $
    431
       
    431
     
     
      
    December 31, 2013
     
      
    Quoted
    Prices in
    Active
    Markets for
    Identical
    Assets
      
    Significant
    Other
    Observable
    Inputs
      
    Significant
    Unobservable
    Inputs
       
      
    (Level 1)
      
    (Level 2)
      
    (Level 3)
      
    Total
     
    Series l Warrants
     
    $
      
    $
      
    $
    2,564
      
    $
    2,564
     
    Total
     
    $
      
    $
      
    $
    2,564
      
    $
    2,564
     

    The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.
     
      
    Nine Months Ended
    September 30, 2014
       
    Nine Months Ended
    September 30, 2013
     
      
    Fair Value
    Measurements
    Using
    Significant
    Unobservable
    Inputs (Level 3)
       
    Fair Value
    Measurements
    Using
    Significant
    Unobservable
    Inputs (Level 3)
     
    Balance December 31, 2013
     
    $
    2,564
     
    Balance December 31, 2012
     
    $
    4,172
     
    Gain on derivative liability included in net loss
      
    (2,126
    )
    Gain on derivative liability included in net loss
      
    (1,438
    )
    Settlements
      
    (7
    )
    Settlements
      
     
    Balance September 30, 2014
     
    $
    431
     
    Balance September 30, 2013
     
    $
    2,734
     
    New Accounting Pronouncements
    New Accounting Pronouncements

    In August 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-15, “Presentation of Financial Statements – Going Concern, Subtopic 205-40, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.”  The amendments in this Update apply to all entities and require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of  consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued).  The amendments in this Update are effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

    In June 2014, the FASB issued (ASU) No. 2014-12, "Compensation - Stock Compensation (Topic 718)," which makes amendments to the codification topic 718, "Accounting for Share-Based Payments," when the terms of an award provide that a performance target could be achieved after the requisite service period. The new guidance becomes effective for annual reporting periods beginning after December 15, 2015, early adoption is permitted.  We are currently evaluating the impact this guidance will have on our financial position and results of operations.

    In May 2014, the FASB issued (ASU) No. 2014-09 "Revenue from Contracts with Customers" (Topic 606).  Topic 606 supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, including most industry-specific revenue recognition guidance throughout the Industry Topics of the Codification.  In addition, the amendments create a new Subtopic 340-40, Other Assets and Deferred Costs—Contracts with Customers.  In summary, the core principle of Topic 606 is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For a public entity, the amendments in this Update are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted.  We are currently evaluating the impact this guidance will have on our financial position and statement of operations.

    In July 2013, the FASB issued (ASU) No. 2013-11 "Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry forward, a Similar Tax Loss, or a Tax Credit Carry forward Exists." The guidance is a new accounting standard on the financial statement presentation of unrecognized tax benefits. The standard provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carry forward, a similar tax loss or a tax credit carry forward if such settlement is required or expected in the event the uncertain tax position is disallowed.  The standard became effective for us on January 1, 2014 and had no material effect on our financial position or results of operations when implemented.
    XML 36 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Litigation
    9 Months Ended
    Sep. 30, 2014
    Litigation [Abstract]  
    Litigation
    Note 7 —
    Litigation

    We have four intellectual property infringement lawsuits pending against multiple parties in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that these parties infringe on certain of our patents. We seek damages and injunctive relief in all the complaints.

    VirnetX Inc. et al., v. Microsoft Corporation (Case 6:13-CV-00351-LED)
    On April 22, 2013, we initiated a lawsuit by filing a complaint against Microsoft Corporation in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we allege that Microsoft has infringed U.S. Patent Nos. 6,502,135, 7,188,180, 7,418,504, 7,490,151, 7,921,211, and 7,987,274. We seek an unspecified amount of damages and injunctive relief. A hearing on claims construction and multiple motions by both parties was held on September 4, 2014. On September 10, 2014, the court issued an order granting in part and denying-in-part our sealed motion to compel interrogatory responses, denying Microsoft’s sealed motion to enter order focusing patent claims and prior art, denying Microsoft’s sealed motion to compel, denying Microsoft’s sealed motion to stay the case and granting our request for leave to file a Motion for Partial Summary Judgment. The jury trial in this case is scheduled for July 13, 2015.

    VirnetX Inc. v. Cisco Systems, Inc. et al (13-1489-LP VirnetX, Case 6:10-CV-00417-LED)
    On August 11, 2010, we initiated a lawsuit by filing a complaint against Aastra, Apple, Cisco, and NEC in the United States District Court for the Eastern District of Texas, Tyler Division, pursuant to which we alleged that these parties infringe on certain of our patents. We sought damages and injunctive relief. Subsequently, on February 4, 2011, we amended our original complaint, filed on August 11, 2010, against Aastra, Apple, Cisco and NEC, to assert U.S. Patent No. 7,418,504 against Apple and Aastra. On April 5, 2011, we further amended our complaint to include Apple’s iPad 2 in the list of Apple products that are accused of infringing our patents and to assert our newly-issued patent, U.S. Patent No. 7,921,211 against all of the defendants in that lawsuit. A claim construction hearing was held on January 5, 2012 and the court issued a Markman ruling on April 25, 2012. Aastra and NEC agreed to sign license agreements with us and we agreed to drop all the accusations of infringement against them. At the pre-trial hearing, the judge decided to conduct separate jury trial for each defendant, and just try the case against Apple on the scheduled trial date. The jury trial against Cisco was held on March 4, 2013. The jury against Cisco the jury came back with a verdict of non-infringement also determined that all our patents-in-suit patents are not invalid. Our motions for a new trial and Cisco’s infringement of certain VirnetX patents was denied and the case against Cisco was closed.

    The jury trial against Apple was held on October 31, 2012 and on November 6, 2012, a jury in the United States Court for the Eastern District of Texas, Tyler Division, awarded us over $368 million in a verdict against Apple Corporation for infringing four of our patents. On February 26, 2013, the court issued its Memorandum Opinion and Order regarding post-trial motions resulting from the prior jury verdict denying Apple’s motion to reduce the damages awarded by the jury for past infringement. The Court further denied Apple’s request for a new trial on the liability and damages portions of the verdict and granted our motions for pre-judgment interest, post-judgment interest, and post-verdict damages to date. The Court ordered that Apple pay $34 in daily interest up to final judgment and $330 in daily damages for infringement up to final judgment for certain Apple devices included in the verdict. The Court denied our request for a permanent injunction and severed the future infringement portion into its own separate proceedings under Case 6:13-CV-00211-LED.

    On July 3, 2013, Apple filed an appeal of the judgment dated February 27, 2013 and order dated June 4, 2013 denying Apple’s motion to alter or amend the judgment to the United States Court of Appeals for the Federal Circuit (USCAFC). On October 16, 2013 Apple filed its opening appeal brief to the USCAFC. Our response to the opening brief was filed on December 2, 2013, and on December 19, 2013, Apple filed its final response to complete the briefing of the court. A hearing was held on March 3, 2014 at the USCAFC. On September 16, 2014, USCAFC issued their opinion, affirming the jury’s finding that all 4 of our patents are valid, confirming the jury’s finding of infringement of VPN on Demand under many of the asserted claims of our ‘135 and ‘151 patents, and confirming the district’s court’s decision to allow evidence concerning our licenses and royalty rates in connection with the determination of damages. In its opinion, the USCAFC also vacated the jury’s damages award and the district court’s claim construction with respect to parts of our ‘504 and ‘211 patents and remanded the damages award and determination of infringement with respect to FaceTime –for further proceedings consistent with its opinion. On October 16, 2014, we filed a petition with the USCAFC, requesting a rehearing and rehearing en banc of the Federal Circuit’s September 14, 2014, decision concerning VirnetX’s litigation against Apple Inc. In our petition, we have asked the court to rehear its decision with respect to damages and affirm the district court’s damages award against Apple in full because the Federal Circuit’s decision is contrary to the patent statute and Supreme Court precedent. We are also asking the Federal Circuit to reinstate the jury’s award that Apple infringed the ’504 and ’211 patents on the basis that the district court correctly construed the claim term “secure communication link”. We are waiting for the Court’s ruling in this matter.

    VirnetX, Inc. v. Apple, Inc. (Case 6:13-CV-00211-LED)
    The Court ordered the parties to mediate over an ongoing license in the following 45 days for Apple’s future infringing use not covered by the Court’s Order, and ordered us to file an appropriate motion with the court if the parties fail to agree to a license. On March 28, 2013, Apple filed a motion to alter or amend the judgment entered by the Court. The mediation was held on April 9, 2013 and the parties did not come to an agreement on an ongoing royalty rate for infringing Apple products. We filed our opposition to this motion on April 10, 2013. As ordered by the Court, we filed a sealed motion with the Court on April 16, 2013, requesting the Court’s assistance in deciding an appropriate royalty rate for all infringing products shipped by Apple that are “not more than colorably different” with regards to the accused functionality. On August 1, 2013, a hearing was held in the United States District Court for the Eastern District of Texas, Tyler Division on our motion for an ongoing royalty. On March 6, 2014, the court issued a public version of the order previously issued under seal on March 3, 2014, awarding us an on-going royalty of 0.98% on adjudicated products and products “not colorably” different from those adjudicated at trial that incorporate any of the FaceTime or VPN on Demand features found to infringe at trial. On March 27, 2014, Apple filed its notice of appeal to the United States Court of Appeals for the Federal Circuit. On March 28, 2014 Apple also filed a motion for Entry of Final Judgment by Apple Inc. with the United States District Court for the Eastern District of Texas, Tyler Division. The Court stayed the proceedings in this matter while the Court’s ruling in the Case 6:10-CV-00417-LED is pending.

    VirnetX Inc. v. Apple, Inc. (Case 6:12-CV-00855-LED)
    On November 6, 2012, we filed a new complaint against Apple Inc., in the United States District Court for the Eastern District of Texas, Tyler Division for willfully infringing four of our patents, U.S. Patent Nos. 6,502,135, 7,418,504, 7,921,211 and 7,490,151, and seeking both an unspecified amount of damages and injunctive relief. The accused products include the iPhone 5, iPod Touch 5th Generation, iPad 4th Generation, iPad mini, and the latest Macintosh computers. Due to their release dates, these products were not included in the previous lawsuit that concluded with a Jury verdict on November 6, 2012 that was subsequently upheld by the United States District Court for the Eastern District of Texas, Tyler Division, on February 26, 2013. On July 1, 2013, we filed a consolidated and amended complaint to include U.S. Patent No. 8,051,181 and consolidate Civil Action No. 6:11-cv-00563-LED. On August 27, 2013, we filed an amended complaint including allegations of willful infringement related to U.S. Patent No. 8,504,697 seeking both damages and injunctive relief. The Markman hearing in this case was held on May 20, 2014 and on August 8, 2014, issued its Markman Order, denying Apple’s motion for summary judgment of indefiniteness, in which Apple alleged that some of the disputed claims terms in the patents asserted by us were invalid for indefiniteness. In a separate order, the court granted in part and denied in part our motion for partial summary judgment on Apple’s invalidity counterclaims, precluding Apple from asserting invalidity as a defense against infringement of the claims that were tried before a jury in our prior litigation against Apple (VirnetX vs. Cisco et. al., Case 6:10-CV-00417-LED). The jury trial in this case is scheduled for October 13, 2015.

    One or more potential intellectual property infringement claims may also be available to us against certain other companies who have the resources to defend against any such claims. Although we believe these potential claims are worth pursuing, commencing a lawsuit can be expensive and time-consuming, and there is no assurance that we will prevail on such potential claims. In addition, bringing a lawsuit may lead to potential counterclaims which may preclude our ability to commercialize our initial products, which are currently in development. Currently, we are not a party to any other pending legal proceedings, and are not aware of any proceeding threatened or contemplated against us by any governmental authority or other party.
    XML 37 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Subsequent Events
    9 Months Ended
    Sep. 30, 2014
    Subsequent Events [Abstract]  
    Subsequent Events
    Note 8 —Subsequent Events

    Subsequent to the quarter ended September 30, 2014, options to purchase 423,225 were exercised and the shares were issued.
    XML 38 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Summary of Significant Accounting Policies (Tables)
    9 Months Ended
    Sep. 30, 2014
    Summary of Significant Accounting Policies [Abstract]  
    Schedule of deferred revenue
    During 2014, activity under the August 2013 Contract Settlement was as follows:
     
    Deferred Revenue, December 31, 2013
     
    $
    667
     
    Payment received
      
    2,500
     
    Less: Amount amortized as revenue
      
    (792
    )
    Deferred Revenue, September 30, 2014
     
    $
    2,375
     
    Adjusted cost, gross unrealized gains, gross unrealized losses and fair value of securities by significant investment category
    The following tables show the adjusted cost, gross unrealized gains, gross unrealized losses and fair value of our securities by significant investment category as of September 30, 2014 and December 31, 2013.

      
    September 30, 2014
     
     
    Adjusted
    Cost
      
    Unrealized
    Gains
      
    Unrealized
    Losses
      
    Fair
    Value
      
    Cash
    and Cash
    Equivalents
      
    Investments
    Available
    for Sale
     
    Cash
     
    $
    4,119
      
    $
    -
      
    $
    -
      
    $
    4,119
      
    $
    4,119
      
    $
    -
     
                             
    Level 1:
                            
    Mutual funds
      
    112
       
    -
       
    -
       
    112
       
    112
       
    -
     
    Corporate securities
      
    8,607
       
    2
       
    (3
    )
      
    8,606
       
    -
       
    8,606
     
    Municipal securities
      
    691
       
    -
       
    -
       
    691
       
    -
       
    691
     
    U.S agency securities
      
    10,908
       
    2
       
    (1
    )
      
    10,909
       
    4,267
       
    6,642
     
       
    20,318
       
    4
       
    (4
    )
      
    20,318
       
    4,379
       
    15,939
     
    Total
     
    $
    24,437
      
    $
    4
      
    $
    (4
    )
     
    $
    24,437
      
    $
    8,498
      
    $
    15,939
     

      
    December 31, 2013
     
     
    Adjusted
    Cost
      
    Unrealized
    Gains
      
    Unrealized
    Losses
      
    Fair
    Value
      
    Cash
    and Cash
    Equivalents
      
    Investments
    Available
    for Sale
     
    Cash
     
    $
    11,699
      
    $
    -
      
    $
    -
      
    $
    11,699
      
    $
    11,699
      
    $
    -
     
                             
    Level 1:
                            
    Mutual funds
      
    73
       
    -
       
    -
       
    73
       
    73
       
    -
     
    Corporate securities
      
    10,782
       
    -
       
    -
       
    10,782
       
    2,325
       
    8,457
     
    Municipal securities
      
    2,173
       
    -
       
    -
       
    2,173
       
    665
       
    1,508
     
    U.S agency securities
      
    14,287
       
    -
       
    (25
    )
      
    14,262
       
    4,411
       
    9,851
     
       
    27,315
       
    -
       
    (25
    )
      
    27,289
       
    7,474
       
    19,815
     
    Total
     
    $
    39,014
      
    $
    -
      
    $
    (25
    )
     
    $
    38,988
      
    $
    19,173
      
    $
    19,815
     
    Liabilities stated at fair value
    The following tables set forth by level within the fair value hierarchy, our liabilities stated at fair value as of September 30, 2014 and December 31, 2013.
     
      
    September 30, 2014
     
      
    Quoted
    Prices in
    Active
    Markets for
    Identical
    Assets
      
    Significant
    Other
    Observable
    Inputs
      
    Significant
    Unobservable
    Inputs
      
    Total
     
      
    (Level 1)
      
    (Level 2)
      
    (Level 3)
       
    Series l Warrants
     
    $
      
    $
      
    $
    431
       
    431
     
    Total
     
    $
      
    $
      
    $
    431
       
    431
     
     
      
    December 31, 2013
     
      
    Quoted
    Prices in
    Active
    Markets for
    Identical
    Assets
      
    Significant
    Other
    Observable
    Inputs
      
    Significant
    Unobservable
    Inputs
       
      
    (Level 1)
      
    (Level 2)
      
    (Level 3)
      
    Total
     
    Series l Warrants
     
    $
      
    $
      
    $
    2,564
      
    $
    2,564
     
    Total
     
    $
      
    $
      
    $
    2,564
      
    $
    2,564
     
    Summary of changes in fair value of Level 3 Liabilities
    The following table sets forth a summary of changes in the fair value of our Level 3 liability stated at fair value for the nine months ended September 30, 2014 and 2013.
     
      
    Nine Months Ended
    September 30, 2014
       
    Nine Months Ended
    September 30, 2013
     
      
    Fair Value
    Measurements
    Using
    Significant
    Unobservable
    Inputs (Level 3)
       
    Fair Value
    Measurements
    Using
    Significant
    Unobservable
    Inputs (Level 3)
     
    Balance December 31, 2013
     
    $
    2,564
     
    Balance December 31, 2012
     
    $
    4,172
     
    Gain on derivative liability included in net loss
      
    (2,126
    )
    Gain on derivative liability included in net loss
      
    (1,438
    )
    Settlements
      
    (7
    )
    Settlements
      
     
    Balance September 30, 2014
     
    $
    431
     
    Balance September 30, 2013
     
    $
    2,734
     
    XML 39 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Commitments (Details) (USD $)
    In Thousands, unless otherwise specified
    9 Months Ended
    Sep. 30, 2014
    Commitments [Abstract]  
    Corporate headquarters, periodic monthly rental expenses $ 5
    Corporate headquarters, lease expiration date Oct. 31, 2015
    XML 40 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) (USD $)
    In Thousands, unless otherwise specified
    3 Months Ended 9 Months Ended
    Sep. 30, 2014
    Sep. 30, 2013
    Sep. 30, 2014
    Sep. 30, 2013
    CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) [Abstract]        
    Net loss $ (4,468) $ (5,134) $ (17,227) $ (20,054)
    Other comprehensive loss, net of tax:        
    Change in equity adjustment from foreign currency translation, net of tax 0 0 0 (12)
    Change in unrealized gain (loss) on investments, net of tax 45 (31) 25 (35)
    Total other comprehensive loss, net of tax 45 (31) 25 (47)
    Comprehensive loss $ (4,423) $ (5,165) $ (17,202) $ (20,101)
    XML 41 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Commitments
    9 Months Ended
    Sep. 30, 2014
    Commitments [Abstract]  
    Commitments
    Note 4 —Commitments

    We lease our corporate headquarters for $5 per month. Our lease expires in October 2015.
    XML 42 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 65 157 1 true 19 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://virnetx.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) false false R3.htm 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://virnetx.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) false false R4.htm 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfOperationsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) false false R5.htm 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfComprehensiveLossUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) false false R6.htm 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://virnetx.com/role/CondensedConsolidatedStatementsOfCashFlowsUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) false false R7.htm 060100 - Disclosure - Business Description and Basis of Presentation Sheet http://virnetx.com/role/BusinessDescriptionAndBasisOfPresentation Business Description and Basis of Presentation false false R8.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 060300 - Disclosure - Income Taxes Sheet http://virnetx.com/role/IncomeTaxes Income Taxes false false R10.htm 060400 - Disclosure - Commitments Sheet http://virnetx.com/role/Commitments Commitments false false R11.htm 060500 - Disclosure - Stock Based Compensation Sheet http://virnetx.com/role/StockBasedCompensation Stock Based Compensation false false R12.htm 060600 - Disclosure - Warrants Sheet http://virnetx.com/role/Warrants Warrants false false R13.htm 060700 - Disclosure - Litigation Sheet http://virnetx.com/role/Litigation Litigation false false R14.htm 060800 - Disclosure - Subsequent Events Sheet http://virnetx.com/role/SubsequentEvents Subsequent Events false false R15.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R16.htm 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R17.htm 080600 - Disclosure - Warrants (Tables) Sheet http://virnetx.com/role/WarrantsTables Warrants (Tables) false false R18.htm 090100 - Disclosure - Business Description and Basis of Presentation (Details) Sheet http://virnetx.com/role/BusinessDescriptionAndBasisOfPresentationDetails Business Description and Basis of Presentation (Details) false false R19.htm 090200 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://virnetx.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R20.htm 090300 - Disclosure - Income Taxes (Details) Sheet http://virnetx.com/role/IncomeTaxesDetails Income Taxes (Details) false false R21.htm 090400 - Disclosure - Commitments (Details) Sheet http://virnetx.com/role/CommitmentsDetails Commitments (Details) false false R22.htm 090500 - Disclosure - Stock Based Compensation (Details) Sheet http://virnetx.com/role/StockBasedCompensationDetails Stock Based Compensation (Details) false false R23.htm 090600 - Disclosure - Warrants (Details) Sheet http://virnetx.com/role/WarrantsDetails Warrants (Details) false false R24.htm 090700 - Disclosure - Litigation (Details) Sheet http://virnetx.com/role/LitigationDetails Litigation (Details) false false R25.htm 090800 - Disclosure - Subsequent Events (Details) Sheet http://virnetx.com/role/SubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports 'Monetary' elements on report '090700 - Disclosure - Litigation (Details)' had a mix of different decimal attribute values. Process Flow-Through: 010000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 010100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Process Flow-Through: 020000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Process Flow-Through: 030000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) Process Flow-Through: 040000 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) vhc-20140930.xml vhc-20140930.xsd vhc-20140930_cal.xml vhc-20140930_def.xml vhc-20140930_lab.xml vhc-20140930_pre.xml true true XML 43 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Income Taxes (Details) (USD $)
    In Thousands, unless otherwise specified
    3 Months Ended 9 Months Ended
    Sep. 30, 2014
    Sep. 30, 2013
    Sep. 30, 2014
    Sep. 30, 2013
    Dec. 31, 2013
    Income Taxes [Abstract]          
    Income tax expense $ 0 $ 0 $ 2 $ 356  
    Effective tax rate (in hundredths)       2.00%  
    Net change in valuation allowance 2,100 1,700 6,200 6,100  
    Valuation allowance carried against net deferred tax assets 22,000   22,000   16,000
    Federal [Member]
             
    Operating Loss Carryforwards [Line Items]          
    Operating loss carryforwards 38,000   38,000    
    Operating loss carryforwards, expiration dates     Dec. 31, 2027    
    State [Member]
             
    Operating Loss Carryforwards [Line Items]          
    Operating loss carryforwards $ 38,000   $ 38,000    
    Operating loss carryforwards, expiration dates     Dec. 31, 2016